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ABSTRACT 
We have investigated the dopaminergic toxicity and cell death signaling 
mechanisms of the potential environmental risk factors, dieldrin, 
methylcyclopentadienyl manganese tricarbonyl (MMT), and manganese, for Parkinson's 
disease (PD) in the dopaminergic rat pheochromocytoma (PC 12) and rat mesencephalic 
(IRB3AN27 or N27) cell lines. Dopaminergic cells were more susceptible to both 
dieldrin and MMT toxicity as compared to non-dopaminergic cells, such as M213-20 
(rat striatal GABAergic) cells, a-TC (rat clonal pancreatic) cells, and HCN-2 (human 
cortical neuronal) cells. Acute exposure to dieldrin or MMT altered dopamine 
catabolism, as observed by an increase in DOPAC formation and dopamine release, and 
subsequent decrease in dopamine content. Also, a rapid generation of reactive oxygen 
species (ROS) was observed within 5 min of dieldrin (30-300 pM) or MMT (30-200 
(j,M) exposure. This ROS generation was partially blocked by a-methyl-p-tyrosine or 
selegiline, inhibitors of tyrosine hydroxylase or monoamine oxidase-B, respectively, 
indicating that the presence of dopamine and disruption of dopamine catabolism and 
degradation may serve as an additional source of ROS. Dieldrin, MMT or manganese 
treatment in dopaminergic cells triggered apoptotic cell death process, as measured by 
mitochondrial depolarization, release of cytochrome c, and caspase-9 and caspase-3 
activation. These initial pro-apoptotic processes were almost completely blocked by 
the over-expression of the anti-apoptotic protein, Bcl-2. Thus, one of the primary 
cellular targets of dieldrin, MMT, and manganese could be the mitochondria; specifically, 
mitochondrial function was inhibited to initiate the apoptotic cascade. Interestingly, we 
observed proteolytic cleavage of the novel protein kinase CS (PKC8) following dieldrin, 
MMT, and manganese exposure. PKCô (72-74 kDa) was cleaved into the regulatory 
(42 kDa) and catalytic (38 kDa) subunits by caspase-3, resulting in increased kinase 
activity. Other PKC family proteins, including PKCa, PKC(3II, and PKCÇ, were not 
cleaved during dieldrin or MMT exposure, indicating that the proteolytic cleavage of 
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PKCô was isozyme specific. Both pharmacological and genetic modulation of PKCô 
resulted in attenuation of toxicant-induced DNA fragmentation and apoptosis, suggesting 
that PKCô plays an important role in the execution of apoptosis. Additional 
experimental results indicate that PKCô amplifies the caspase cascade by positive 
feedback activation during the neurotoxic insult. Another regulatory role of PKCô was 
observed during dieldrin or MMT treatment; translocation of PKCô into mitochondrial 
membranes was increased, and it was followed by release of pro-apoptotic molecules 
such as cytochrome c and Smac, and time-dependent activation of caspase-9 and 
caspase-3. Down-regulation of PKCô by TPA or pretreatment with rottlerin 
significantly blocked dieldrin-induced cytochrome c release, yet rottlerin did not inhibit 
translocation of PKCô into mitochondria. These results strongly support that PKCô 
modulates mitochondrial function and triggers the initiation process of apoptosis. 
Delivery of recombinant active PKCô into dopaminergic cells mimicked the effect of 
dieldrin-induced PKCô translocation into mitochondria, indicating that PKCô plays a 
critical role not only in the execution process, but also in the initiation of apoptosis. 
Taken together, these experimental results suggest that environmental neurotoxic agents 
(dieldrin, MMT, and manganese) promote dopaminergic degeneration by sequentially 
activating the following cellular events: i) generation of oxidative stress to initiate the 
apoptotic cascade, ii) induction of apoptotic cell death by caspase-3 dependent 
proteolytic activation of PKCô, and iii) amplification of the caspase cascade by positive 
feedback regulation of upstream molecules associated with mitochondrial mediated 
apoptotic cell death. 
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CHAPTER I: GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation is written in an alternative thesis format. It contains a general 
introduction, six research papers, a general discussion, and an acknowledgement. A list 
of references cited is included in the end of each chapter. The general introduction 
(Chapter I) includes a research objective, background information, and literature review 
of the relationship between environmental factors and Parkinson's disease. Chapter II, 
"Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptotic 
cell death in dopaminergic cells", and Chapter III, "Oxidative stress and 
mitochondrial-mediated apoptosis in dopaminergic cells exposed to 
methylcyclopentadienyl manganese tricarbonyl (MMT)", have been published in Free 
Radical Biology and Medicine (31:1473-1485, 2001) and the Journal of Pharmacology 
and Experimental Therapeutics (302:26-35,2002), respectively. Chapter IV, "Dieldrin 
induces apoptosis by promoting caspase-3 -dependent proteolytic cleavage of protein 
kinase Cô in dopaminergic cells: relevance to pathogenesis of Parkinson's disease", has 
been submitted to Neuroscience. Chapter V, "Dieldrin induces apoptosis in a 
mesencephalic dopaminergic neuronal N27 cell line via caspase-3-dependent proteolytic 
activation of protein kinase Cô", Chapter VI, "Role of protein kinase Cô and Bcl-2 in 
caspase-3-dependent apoptosis during manganese exposure in dopaminergic cells", and 
Chapter VII, "Mitochondrial translocation of protein kinase Cô inactivates Bcl-2 by 
proteolytic degradation during environmental neurotoxic insult in dopaminergic cells", 
will be submitted for publication in Neurotoxicology, the Proceedings of National 
Academy of Sciences, and the Journal ofNeurochemistry, respectively. 
This dissertation contains the experimental results obtained by the author during 
his graduate study under the supervision of his major professor, Dr. Anumantha G. 
Kanthasamy. 
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Research Objective 
Parkinson's disease (PD) is one of the major neurodegenerative disorders 
affecting approximately 1-2% of the population over the age of 50 in the United States 
(Aschner, 2000; Shastry, 2001). The prevalence of the disease increases up to 4-5% by 
the age of 85 (Giasson and Lee, 2001). The etiopathogenesis of dopaminergic 
neurodegeneration in PD remains unknown. Aging and genetic defects have long been 
considered the primary risk factors of PD. However, recent epidemiological findings 
as well as genetic analyses reveal that genetic factors may not be major causal factors of 
sporadic PD (Golbe and Pae, 1988; Ho et al., 1989; Tanner, 1989; Roller et al., 1990; 
Tanner and Langston, 1990; Semchuk et al., 1992; Seidler et al., 1996; Liou et al., 1997; 
Chan et al., 1998a; Gorell et al., 1998; Tanner et al., 1999; Zorzon et al., 2002). Rather, 
these studies strongly suggest that environmental factors initiate a neurodegenerative 
process in dopaminergic neurons in the substantia nigra to cause typical pathological 
features of PD. Exposure of mine workers to manganese produces Parkinsonian-like 
symptoms known as Manganism, a neurological condition affecting extrapyramidal 
motor function of the central nervous system (CNS) (Inoue and Makita, 1996). Hence, 
the recent legalization of a manganese-containing gasoline adduct, 
methylcyclopentadienyl manganese tricarbonyl (MMT), is of concern due to the possible 
health hazards resulting from exposure to high levels of manganese. The exact 
mechanisms of CNS toxicity induced by manganese and MMT have not been well 
characterized, yet these compounds could be risk factors for dopaminergic degeneration. 
In addition to transition metals, pesticides have accumulated in brains of PD patients 
(Fleming et al., 1994; Corrigan et al., 1996; Corrigan et al., 1998). Dieldrin, a 
chlorinated cyclopentadiene pesticide, has been detected in brains from PD patients and 
is believed to promote progressive dopaminergic neurodegeneration. Studies in 
animals have also shown that chronic exposure to dieldrin significantly reduces brain 
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levels of dopamine and induces transient tremors, pathological and symptomatic features 
of PD (Sharma et al., 1976; Wagner and Greene, 1978). However, the cellular and 
molecular mechanisms of dieldrin-induced dopaminergic neurodegeneration have not 
yet been characterized. 
The major objectives of this dissertation are: (i) to determine the involvement of 
oxidative stress as an initiation factor of environmental chemical-induced dopaminergic 
toxicity; (ii) to characterize environmental chemical-induced mitochondrial dysfunction 
and the subsequent activation of cell signaling molecules involved in pro- and 
anti-apoptotic functions; and (iii) to define the pro-apoptotic function and regulatory role 
of protein kinase Cô (PKCô) during environmental chemical-induced dopaminergic 
degeneration. Together, these studies will enhance our understanding of cell death 
mechanisms underlying dopaminergic degeneration and will also give further insight 
about the role of environmental factors in the pathogenesis of Parkinson's disease. 
Background and Literature Review 
This section provides background information related to the studies presented in 
the dissertation: (1) Parkinson's disease; (2) Environmental risk factors; (3) Toxic effects 
of dieldrin, manganese, and MMT; and (4) Signal transduction mechanisms of apoptosis 
in neurodegeneration. 
Parkinson's disease 
Parkinson's disease (PD) was first described by a British physician, James 
Parkinson in 1817 under the heading of "paralysis agitans" in his Essay on the Shaking 
Palsy. However, evidence suggests a possible case of PD in India in 3000 B.C., 
indicating that the disease may have been known for thousands of years (Roman et al., 
1995). Research progressed slowly until the 1960s, when scientific discoveries linked 
the disease to the loss of dopaminergic brain neurons in the substantia nigra (SNc), the 
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brain region that controls motor activity. Currently, PD is characterized by a slow but 
progressive and selective degeneration of dopaminergic neurons in the nigral-striatal 
pathway, resulting in irreversible motor dysfunction. In most cases, PD is prevalent 
among older individuals. In fact, almost 2,000,000 individuals in the United States 
have been diagnosed with PD, which accounts for approximately 1-2% of the population 
over the age of 50 (Aschner, 2000; Shastry, 2001). The prevalence increases up to 
4-5% by the age of 85 (Giasson and Lee, 2001), indicating that age is an undisputable 
risk factor of the disease. On the other hand, the age of PD onset has been decreasing 
in several countries, and PD is currently divided into three major groups: idiopathic PD, 
young-onset PD (YOPD), and juvenile Parkinsonism (JP). Although the clinical 
symptoms are similar among the groups, the age of disease onset and some pathological 
features are distinct. In general, patients who develop PD at 40 years of age and older 
are considered to have idiopathic PD while patients who develop PD between 21-40 
years of age are diagnosed with YOPD. JP develops in patients younger than 21 years 
of age. The prevalence of YOPD (including JP) is rare, approximately 10-47 cases per 
1,000,000 people, in the U.S. and Europe, and accounts for 4-12% of all PD cases. 
Alternatively, up to 40% of all PD cases are YOPD in certain regions of Japan, 
indicating that as yet unidentified factors may be involved in the development of YOPD. 
Despite the extensive research efforts to understand this debilitating disease, the exact 
pathophysiological mechanism underlying nigral dopaminergic degeneration in PD 
remains unknown. 
The major symptoms of PD are resting tremor, rigidity, bradykinesia, and 
postural instability. The resting tremor is considered the most common symptom, yet 
tremors may be absent both in the early and advanced stages of PD, with the first 
obvious disease manifestation only an intermittent trembling confined to one finger of 
one hand (Selby, 1990). The trembling may be limited to one finger for two to three 
years before it progresses to other regions. Usually observed in one side of an arm or 
leg, the resting tremor is considered a unilateral tremor. Body rigidity is associated 
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with bradykinesia, but the two symptoms are not parallel to each other (Duvoisin, 1991). 
Rigidity can be described as muscle stiffness due to resistance to passive movements in 
opposing muscles. In early and advanced stages of PD, rigidity is detected more 
frequently than resting tremor (Selby, 1990). The other common manifestation of 
bradykinesia is associated with the loss of automatic movements, such as the swing of 
arms while walking, eye blinking, swallowing of saliva, or minor movement for postural 
adjustment (Duvoisin, 1991). Together with rigidity, bradykinesia contributes to the 
reduction of emotional facial movements (Selby, 1990). As a result, patients have a 
mask-like appearance, with little facial expression. All of the above-mentioned 
symptoms are related to abnormal movements that can be explained by the pathological 
changes in the PD brain. In addition to the motor disabilities, a significant cognitive 
decline prevails in the late stages of PD. In the following section, the anatomy and 
pathology of PD in the substantia nigra and related regions will be described. 
In 1664, distinct subcortical structures were clearly identified for the first time, 
and the basal ganglia was referred to as the corpus striatum (Parent, 1986). The corpus 
striatum was recognized as the major component of the "extrapyramidal motor system" 
by S. A. K. Wilson in 1912 (Nauta and Domesick, 1984). This term loosely grouped 
the corpus striatum with an array of brain stem nuclei and reflected the assumption that 
this grouping constituted a complete and independent motor unit (Carpenter et al., 1981). 
The term "basal ganglia" has been generally used to refer to these major anatomical 
telencephalic subcortical nuclei at the base of the forebrain. More formally, this 
definition groups the corpus striatum (striatum and globus pallidus) with the substantia 
nigra and subthalamic nucleus (Figure 1). Information from the cerebral cortex 
projects to the basal ganglia, and the outputs then funnel back to the frontal areas of the 
cortex via the thalamus or directly to the motor systems in the midbrain and hindbrain 
(Houk, 1995). Fine motor activities and modification of movements are controlled by 
the basal ganglia and cerebellum. The output of the cerebellum is generally excitatory, 
while the basal ganglia output is inhibitory. The balance between these two systems 
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allows for smooth, coordinated movement, while a disturbance in either system 
manifests as movement disorders. 
The region most affected pathologically in the development of PD is the 
substantia nigra in the basal ganglia. PD is described as a selective degeneration of 
dopaminergic neurons in the substantia nigra pars compacta (SNc) (Marsden, 1990; 
Duvoisin, 1991). The SNc contains approximately 400,000 dopaminergic neurons at 
birth, which account for 80-90% of the dopaminergic neurons in the body. Every year, 
about 2,400 dopaminergic neurons in the normal SNc die. Major clinical symptoms of 
PD are observed when at least 60-85% of the tyrosine hydroxylase 
(TH)-immunoreactive dopaminergic neurons are lost in the SNc, or when the 
dopaminergic tone to the striatum has diminished to 50-80% of normal (Fearnley and 
Lees, 1991; Hornykiewicz, 1998; Betarbet et al., 2002). In particular, the caudorostral 
and ventrolateral areas of the SNc are the most severely affected, followed by the 
medioventral, dorsal, and lateral areas (Jellinger, 2001) and the neuromelanins, 
by-products of dopamine metabolism, are depleted by 45-66% in the SNc (Jellinger, 
2001). In the normal brain, 60% of dopaminergic neurons would not be depleted 
before at least 100 years. In the brain affected by PD, some unknown factors, possibly 
originating in the environment, genetic background, or both facilitate the abnormal rate 
of dopaminergic neuronal loss in the substantia nigra. On the other hand, JP patients 
have preserved, non-degenerated dopaminergic neurons in the SNc but lack 
neuromelanin, suggesting that JP is caused by a genetic defect in dopamine synthesis. 
In support of this hypothesis, about 40% of YOPD and almost all JP patients in Japan 
have a family history of Parkinsonism. In particular, several gene mutations have been 
identified in patients with a certain type of JP, which will be discussed later in this 
chapter. 
7 
Cortex 
Striatum 
caudato 
puiamon 
Globus pallidas 
oxtorna (G Pe) 
Thalamus 
thalamic nuclei 
ventrolateral nucleus 
Subthalamic nuclous in:ema iGPi) 
Superior coiliculus 
Substantia nigra 
pairs reticulata (SNpO 
pafscômpacta (SNpcg 
Excilaiory (Giulainulc) 
Inhibitory (GABA) 
Excitatory and Inhioitory (Dopamine) 
Excitatory (Acotylchohne) 
Figure 1: Anatomy of Basal Ganglia (Modified from Kibiuk, 1997) 
The dopaminergic neurons in the SNc project to the inhibitory GABAergic 
neurons with dopamine receptors in the corpus striatum. Dopamine receptors are G 
protein coupled receptors divided into five Dt through D5 subtypes. Di and D$ 
receptors are Gas coupled and stimulate adenylate cyclase (AC), whereas D^, D3, and D4 
receptors are Gai/o coupled and inhibit AC activity. Di and D2 receptors are found in 
the striatum, and the D% receptor mediates the striatonigral (direct) pathway, whereas the 
D2 receptor mediates the striatopalladial (indirect) pathway. A simple schematic 
diagram of the basal ganglia based on the description by Webster (1990) and Young and 
Penney (1988) is shown in Figure 2 (Young and Penney, 1988; Webster, 1990). In the 
normal brain, dopamine released from the SNc excites GABAergic neurons in the corpus 
striatum and stimulates (Di receptor; direct pathway) or inhibits (D2 receptor; indirect 
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pathway) the release of the inhibitory G ABA neurotransmitter. In the direct pathway, 
striatal GABAergic neurons project to the globus pallidus interna (GPi) and release 
G ABA upon stimulation by dopamine to inhibit G ABA release from the GPi to the 
thalamus followed by stimulation of glutamate release to the cortex. In the indirect 
pathway, dopamine inhibits the release of G ABA from the striatum to the globus pallidus 
externa (GPe) to subsequently stimulate the release of GABA from the GPe to the 
subthalamic nucleus to inhibit glutamate release from the subthalamic nucleus to the 
substantia nigra reticulata (SNr). As a result, the release of GABA from the SNr to the 
thalamus is suppressed, and the signal is transmitted to the cortex. 
Once dopaminergic neurons in the SNc are reduced significantly (>70%), the 
basal ganglia regulatory loops that control motor function will be disturbed, and 
downstream neural transmission will be altered significantly. Some of the major 
symptoms of PD can be explained pathophysiological^. Rigidity may result from 
severe degeneration of dopaminergic neurons in the ventrolateral part of the SNc that 
project to the Di receptor-containing GABAergic neurons in the dorsal putamen 
(Jellinger, 2001), which eventually increases the inhibitory tone to the 
ventrolateral/medial thalamus. Furthermore, it is more common to observe the 
up-regulation of D^ receptor in striatum in PD patients. 
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Figure 2: Schematic Diagram of Neuronal Connection in normal and PD 
The selective destruction of dopaminergic neurons in the SNc has not been 
definitively identified, but accumulating data strongly indicate that genetic and/or 
environmental factors may be responsible for the etiology of PD. Genetic factors and 
gene mutations have long been investigated for an association with the etiology of PD. 
Specifically, mutations in tyrosine hydroxylase (TH) and other enzymes responsible for 
dopamine biosynthesis have been studied because of specific expression patterns in 
dopaminergic neurons. Thus, tyrosine hydroxylase and its related enzymes were best 
candidate genes to determine dopaminergic neuron susceptibility. The mutation of 
GTP cyclohydrolase, a rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin, 
has been found in dopa-responsive dystonia (DRD), a disease clinically similar to 
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juvenile Parkinsonian syndrome (Bandmann et al., 1996b; Ichinose and Nagatsu, 1997). 
Because of malfunction of tetrahydrobiopterin synthesis, a co-factor of TH activity, 
dopaminergic neurons in DRD patients are incapable of producing dopamine, and 
patients exhibit abnormal motor activity like PD patients. However, a clinical study of 
99 sporadic PD patients and 161 control patients revealed no significant evidence of TH 
mutations associated with the incidence of PD (Kunugi et al., 1998). In addition, GTP 
cyclohydrolase was not mutated in PD patients with no family history of DRD 
(Bandmann et al., 1996a). Furthermore, other possible enzymes, such as glutathione 
peroxidase, catalase, superoxide dismutase, and amyloid precursor protein were not 
positively correlated with the etiology of PD (Gasser et al., 1994; Parboosingh et al., 
1995). However, the genetic factor hypothesis regained momentum when mutations in 
the a-synuclein gene were identified (Polymeropoulos et al., 1997; Kruger et al., 1998) 
and linked to a region on chromosome 2 in familial PD (Gasser et al., 1998). The 
physiological function of a-synuclein has not been fully identified, yet it appears to be 
involved in vesicular fusion and/or chaperone-like functions (Davidson et al., 1998; 
Souza et al., 2000a). Over-expression of wild-type a-synuclein has shown both 
protective and facilitative effects on dopaminergic cell death (Zhou et al., 2000; Junn 
and Mouradian, 2002; Kaul et al., 2002). The a-synuclein point mutations alanine to 
proline at position 30 and alanine to threonine at position 53 cause accumulation and 
aggregation of a-synuclein and the formation of Lewy bodies, characterized as 
distinctive protein aggregations in dopaminergic neurons of PD patients. Also, 
mutations in the parkin protein appear to be associated with the etiology of JP, and has 
been investigated extensively, especially in Japan (Kitada et al., 1998). Yet, these 
mutation-related PD cases are rare. In general, genetic-related PD cases account for 
approximately 5% of the whole population of PD patients (Chan et al., 1998b), and PD 
caused by mutations of a-synuclein is less than 1%. The hallmarks of genetic factors 
in PD will be discussed in more detail later in this chapter. 
A recent landmark epidemiology study by Tanner and colleagues (1999) of 
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nearly 20,000 monozygote (MZ) and dizygote (DZ) twins from a WWII veterans health 
care database determined that the concordance of PD incidence is similar between MZ 
(0.155) and DZ (0.111) twins, with a relative risk of 1.39, which is not significantly 
different from the entire population with PD (Table 1) (Tanner et al., 1999). 
Interestingly, if one of twin is diagnosed with PD at age 50 or under, the concordance 
and relative risk are significantly higher. Thus, genetic factors may be more important 
in young-onset PD, and other factors may play a more significant role in the incidence of 
late-onset or geriatric PD. In addition, more data have accumulated that indicate the 
significance of exogenous or environmental factors in the etiology of PD. 
Concordant pairs Discordant pairs Pairwise concordance 
MZ DZ MZ DZ MZ DZ Relative risk 
Overall 11 10 60 80 0.155 0.111 1.39 
First twin diagnosed <50 yr 4 2 0 10 1.00 0.167 6.00 
First twin diagnosed >50 yr 7 8 58 68 0.108 0.105 1.02 
Table 1: Genetic Risk Factors and Parkinson's disease: A Case Study in Twins 
(Modified from Tanner et al., 1999) 
Environmental risk factors and PD 
Age has long been considered a potential risk factor of Parkinson's disease 
because most patients develop Parkinson's disease after age 50 (Burton and Calne, 1990). 
The environmental factor hypothesis emerged in the PD field following the discovery of 
the Parkinsonian toxin MPTP ( 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine). In 1977, 
an unusually high number of young-onset Parkinson's-like syndrome was observed in 
Virginia as well as in San Francisco, U.S.A.; those afflicted were later found to have 
used the synthetic designer drug meperidine, which is an analogue of 
l-methyl-4-phenyl-propionoxy-piperidine (MPPP). They first suffered from symptoms 
of visual hallucinations, jerking limbs, and stiffness. In the later stage, they 
experienced immobility, a flexed posture, and tremor, similar to symptoms often 
observed in PD patients. These symptoms were remarkably attenuated by 
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administration of the antiparkinsonian drug L-DOPA. Furthermore, positron emission 
tomography (PET) using 6-fluorodopa showed a significant reduction in activity of 
dopaminergic neurons in the basal ganglia, as normally seen in PD patients. Scientists 
isolated MPTP as a contaminant and a possible toxicant for dopaminergic neurons from 
the synthetic drug (Davis et al., 1979) (Figure 3A-B). The intensive investigation of 
MPTP toxicity and its association with PD has elucidated the mechanism of 
dopaminergic neuronal cell death by MPTP. MPTP is not a toxic compound, but its 
metabolite, 1 -methyl-4-phenylpyridine (MPP+), is a potent neurotoxin selectively toxic 
to dopaminergic neurons (Schapira, 1993; Hartley et al., 1994). When MPTP is 
administered to humans and other mammals, it passes through the blood-brain barrier 
and accumulates in the brain. Astrocytes convert MPTP into the intermediate 
compound, MPDP+, and then MPP+ is formed spontaneously in the nerve terminal. 
Intercellular MPP+ is selectively taken up by the nerve terminals of dopaminergic 
neurons via dopamine transporters. As a result, MPP+ selectively destroys 
dopaminergic neurons by inhibiting mitochondrial respiratory function (Complex I 
function) (Figure 3B). The discovery of a potent Complex I inhibitory property of 
MPP+ brought additional attention to the potential exogenous causes of PD because 
patients with idiopathic PD have less functional mitochondrial Complex I activity in 
dopaminergic cells, which may cause dopaminergic cell death in PD (Parker et al., 1989; 
Schapira, 1993; Anglade et al., 1997b). Complex I of the mammalian electron transfer 
chain is composed of at least 43 protein subunits, seven of which are encoded by 
mtDNA. Complex I catalyzes the transfer of electrons from NADH to ubiquinone and 
translocates protons from the mitochondrial matrix to the intermembrane space and may 
also play direct roles in the mitochondrial permeability transition and in cell death 
pathways (Greenamyre et al., 2001). Currently, several other environmental chemicals 
that inhibit Complex I are under extensive investigation, which will be briefly described 
later in this section. Although MPTP and MPP+ are currently used as a 
well-established model in PD research, some pathological differences have been 
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Figure 3: Chemical Structure and Mechanism of MPTP Neurotoxicity 
reported between MPTP- or MPP+-induced dopaminergic neurodegeneration and 
idiopathic PD. For example, pigmented aggregates known as Lewy bodies are 
observed in idiopathic PD, but not in MPTP-induced PD; thus, the actual dopaminergic 
cell death mechanism of idiopathic PD may differ from MPTP-induced dopaminergic 
cell death. 
The discovery that MPTP/MPP+ causes acute neurotoxicity brought attention to 
other chemicals and environmental factors possibly involved in the etiology of PD, 
undermining aging as the primary causal factor of PD. Several pesticides structurally 
similar to MPP+, such as the widely used paraquat and diquat, have been examined to 
establish the role of environmental factors in the pathogenesis of PD. (Figure 4 and 
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Table 2). Paraquat induced dopaminergic cell death via a mechanism similar to that of 
MPP+ in PC12 cells (Li and Sun, 1999; Chun et al., 2001b). Also, repeated, 
intraperitoneal (i.p.) paraquat injections in mice caused dose- and age-dependent 
dopaminergic neuronal cell death in the SNc whereas other neurons, including 
GABAergic neurons, were not significantly affected (McCormack et al., 2002). This 
dopaminergic neurodegeneration may be due to the up-regulation and increased 
aggregation of a-synuclein, which may lead to the formation of Lewy bodies (Uversky 
et al., 2001; Manning-Bog et al., 2002). However, a recent study reported that the 
dopamine transporter is not involved in paraquat uptake, indicating that paraquat 
selectivity in dopaminergic cells may not be as high as that of MPP+ (Miller and Quan, 
2002). Diquat, structurally similar to paraquat, has been reported to accumulate 
significantly in pigmented nerve cells following i.p. injection in frogs (Lindquist et al., 
1988), indicating that dopaminergic cells may be one of the target regions due to the 
high levels of neuromelanin. Additionally, a farmer acutely exposed to diquat (10% 
solution) for 10 min developed severe PD-like symptoms including bradykinesia 10 days 
after the exposure, indicating that diquat may mimic the toxic mechanism of MPP+ 
(Sechi et al., 1992). Cyperquat, which contains MPP+, was tested for herbicidal 
activity during the 1960s because of its structural similarity to paraquat. Unlike 
paraquat, cyperquat was not widely distributed in agricultural areas. Maneb 
(manganese ethylene-bis-dithiocarbamate), another chemical used as a fungicide, 
contains manganese in its chemical structure. Because of the possible association 
between manganese exposure and the etiology of PD-like syndrome (described in the 
later section), maneb is suspected to be one of the chemical risks for PD. Several 
human cases of PD-like syndrome following maneb exposure have been reported in Italy 
(Meco et al., 1994), and case-control study focusing on maneb exposure and its 
association with PD-like symptoms was documented in Brazil (Ferraz et al., 1988). 
These studies strongly suggest that maneb may be a potent dopaminergic neurotoxicant, 
yet the cellular neurodegenerative mechanism needs to be investigated. Furthermore, 
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Figure 4: Chemical Structures of Selected Pesticide 
combined exposure to paraquat and maneb for up to 4 weeks in mice causes an 
immediate decrease in motor activity and an additive reduction in dopaminergic neurons 
in the SNc (Thiruchelvam et al., 2000), suggesting that multiple chemical exposures may 
facilitate dopaminergic degeneration and further enhance the risk of developing PD in 
humans. 
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Use General Toxicity Symptoms Study relative to PD 
Paraquat Herbicide and drying agent GI, kidney and lung Decreased locomotor activity 
reduced ambulatory activity 
mice - degeneration of dopaminergic neurons 
Ci2Hi4N2 used on rice and soya bean No carcinogenic, teratogenic, mice - up-rcgulation and aggregation of a-synuclein 
186.26 but maybe mutagenic activation of caspase-dependent cell death pathway 
Activation of AP-1 transcription fector (PC 12) 
Diquat used to desiccate potato vines Preliminary kidney and heart 
No carcinogenic, teratogenic, 
but maybe mutagenic 
Loss official expression, 
flexed posture, akinesia 
frog- accumulation of diquat m pigmented neurons 
Clinical case: acute diquat causes PD-like symptoms C12H12N2 and seed crops, to control 
184.26 flowering of sugarcane, and for 
industrial and aquatic weed control 
Also use on fruits, grains and 
vegetables, aquatic areas and cotton. 
Maneb fungicide used in the control of No carcinogenic, mitagenic, Decreased locomotor activity 
when combined with paraquat 
mice - degeneration of DA neurons with 
combination with paraquat 
maneb exposure causes PD-like symptoms 
C4H6N2S4M11 
265.29 
early and late blights on potatoes, but teratogenic 
tomatoes and many other diseases 
of fruits, vegetables, field crops, 
and ornamentals. 
DDT insecticide N/A N/A No significant relations!^) between 
DDT toxicity and PD or 
dopaminergic neurodegeneration 
C14H9CI5 used to kill mosquito and control 
354.5 malaria 
Rotenone used for control of leaf-eating N/A Akinesia, rigidity, tremor, mice - causes dopaminergic neurodegeneration 
C23H22O6 caterpillars, beetles, squash bugs, flexed posure and formation of Lewy bodies 
394.43 thrips, and scales on woody causes aggregation ofa-synucfeii (formation of 
ornamentals and herbaceous perennials a-synucfeii inckisions) 
Table 2: Summary of Toxicity in Selected Pesticides 
Recently, the house pesticide rotenone has been evaluated in PD research. 
Rotenone, a natural chemical compound made from tropical legumes, Lonchocarpus, 
and Derris often referred to as Cube Root, is especially effective against the most 
troublesome of pests, such as leaf-eating caterpillars, beetles, squash bugs, thrips, and 
scales on woody ornamentals and herbaceous perennials. Rotenone is a well-known 
inhibitor of mitochondrial complex I; its chemical structure is shown in the Figure 4. 
Betarbet et al. (2000) demonstrated that chronic infusion of rotenone to rats reproduces 
PD pathology including Lewy body formation in the substantia nigra and also causes 
PD-like symptoms, such as hypokinesia and rigidity (Betarbet et al., 2000). Rotenone 
treatment induces the aggregation of a-synuclein and depletion of ATP in in vitro studies 
(Uversky et al., 2001; Lee et al., 2002). In SH-SY5Y dopaminergic cells, chronic low 
dose (5-20 nM) treatment with rotenone causes calcium overload and may result in cell 
death (Sherer et al., 2001). 
Pesticides are currently being evaluated by many research groups as one of the 
potential risk factors of PD. However, other chemical risk factors also are likely to 
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contribute to the etiology of PD. In this regard, we must recognize that we are exposed 
to multiple chemicals from various sources in our daily lives, and these chemicals may 
interact and potentiate adverse effects. The case-control studies further reveal some 
other possible risk factors in the environment. 
Some epidemiological studies have reported that early onset Parkinson's disease 
tends to be observed in rural areas where farming is a major occupation (Tanner and 
Langston, 1990; Jerrner, 1998). To identify any possible risk factors for Parkinson's 
disease, large-scale case control and epidemiological studies have been conducted 
mainly in rural areas around the world (Golbe and Pae, 1988; Ho et al., 1989; Tanner, 
1989; Koller et al., 1990; Tanner and Langston, 1990; Semchuk et al., 1992; Seidler et 
al., 1996; Liou et al., 1997; Chan et al., 1998a; Gorell et al., 1998; Zorzon et al., 2002). 
The summary of each study is compared in Table 3. Several differences have been 
observed among these studies. However, farming and pesticide/herbicide uses were the 
factors with consistently high and significant odd ratios (OR), ranging up to 5.2 for 
farming and 3.6 for pesticide/herbicide uses, indicating that these factors have a positive 
association with the incidence of PD and could increase the risk of PD in humans 
(Semchuk et al., 1992; Seidler et al., 1996; Liou et al., 1997; Gorell et al., 1998). 
Seidler et al. (1996) specified that organochlorines and organophosphates were 
particularly high risk factors of Parkinson's disease. In contrast, Koller et al. (1990) 
concluded that drinking well water and rural living significantly increased the risk of 
Parkinson's disease, whereas pesticides and herbicides did not increase the risk. 
However, since the well water did not undergo chemical analysis, the well water may 
have been contaminated with pesticides or other agricultural chemicals. 
Heavy metals are other important environmental factors. Manganese, copper, 
iron, lead, and aluminum have been suspected to be risk factors of PD. A more detailed 
explanation/discussion of manganese appears later in this chapter. Here, other metals 
associated with PD will be discussed. A case control study conducted by Gorell et al. 
(1997) revealed that chronic metal exposure significantly increases the risk of PD 
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(Gorell et al., 1997). Comparing 144 PD patients with 464 controls, they found that PD 
is positively associated with more than 20 years of exposure to copper (OR = 2.49), 
manganese (OR = 10.61), lead-copper (OR = 5.24), lead-iron (OR = 2.83), and 
iron-copper (OR = 3.69). Iron, mercury, and zinc were not statistically associated with 
PD in this study. Thus, dopaminergic neurodegeneration is not caused by non-specific 
toxicity of heavy metals, but probably by the specific neurotoxicity of these selected 
metals. The incidence of PD following manganese exposure is remarkably high. 
Manganese induces more in vitro DNA fragmentation in PC 12 cells than nickel, copper, 
or zinc (Hirata, 2002). Several PD cases have been reported following more than 30 
years of lead exposure (Kuhn et al., 1998). However, these cases of PD may not have 
resulted solely from lead poisoning. Copper, on the other hand, is positively associated 
with PD as shown above. In addition, copper increases the in vitro aggregation of 
a-synuclein, providing possible insight into the etiopathology of PD (Paik et al., 1999). 
Aluminum, another abundant metal, has been considered a risk factor for PD because 
significantly greater accumulation of aluminum was found in the substantia nigra, 
caudate nucleus, and globus pallidus of PD brains as compared to controls (Good et al., 
1992; Yasui et al., 1992). In addition, aluminum in the CNS has been reported in 
Parkinsonism-dementia in Guam (Perl et al., 1982). Thus, excessive intake or 
absorption of aluminum may result in deposition of aluminum in the CNS, leading to 
neuronal cell death. Despite these reports, the cellular/molecular mechanisms of heavy 
metal-induced dopaminergic neurodegeneration have not yet been identified. 
Interestingly, several exogenous factors have been shown to prevent the risk of 
PD in case control studies (Hellenbrand et al., 1997; Liou et al., 1997; Chan et al., 
1998a; Checkoway et al., 2002; Zorzon et al., 2002). These possible factors are 
cigarette smoke, coffee/tea, and alcohol. The compounds studied most intensively for 
their protective effects against PD are nicotine and caffeine (Golbe et al., 1986; 
Benedetti et al., 2000; Ross et al., 2000; Tanner et al., 2002). All the case control 
studies mentioned above showed significantly lower ORs for smoking, averaging about 
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one-half of the risk as compared with non-smokers, strongly indicating that smoking has 
a negative association with PD. Furthermore, the risk of PD decreases up to an OR of 
0.2 as the daily amount and/or duration of smoking increases (Hellenbrand et al., 1997; 
Checkoway et al., 2002). Similar results were reported by Benedetti et al. (2000). 
The risk of PD was reduced to 0.65 or 0.62 when the number of cigarettes smoked were 
1-20 or more than 20 per day, respectively, and 0.63 or 0.59 if the years of smoking were 
1-30 years or more than 30 years, respectively. The 'Twin study' revealed that one twin 
without PD smoked on average 9.7 more packs a year than his twin brother with PD 
(Tanner et al., 2002). The exact mechanism by which smoking prevents PD is not 
known. Several lines of evidence have led to possible mechanisms of the protective 
effects of cigarette smoking. For example, cigarettes reduce brain monoamine oxidase 
(MAO) A and B, which converts MPTP into the active metabolite MPP+ in astrocytes in 
animals as well as humans (Fowler et al., 1996; Mendez-Alvarez et al., 1997). MAO-B 
activity especially, is believed to play an important role in PD; thus, MAO-B inhibitors, 
such as selegiline (Deprenyl®), are potential therapeutic drugs for PD (Ebadi et al., 
2002). Nicotine has been reported to have an antioxidant effect, which inhibits MPP+ 
uptake in dopaminergic neurons, and attenuates MPTP-induced neuronal degeneration 
(Carr et al., 1992; Maggio et al., 1998). The protective effect of nicotine may be due to 
activation of one of the nicotine receptor subtypes that might have neuroprotective 
influences on the nigrostriatal dopaminergic system. Nevertheless, more experimental 
evidence is needed to delineate the protective effect of nicotine. Emerging 
experimental results indicate that a certain adenosine receptor subtype in a select brain 
region might contribute to the protective effect observed from coffee and tea drinking. 
The association between PD and alcohol consumption is inconclusive because fewer 
study results are available in this area. 
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Case-control studies Case/Control Rural Farming Well water pesticide/ 
living drinking herbicide 
China (Tanner et aL, 1989) 100/200 0.6 0.2 0.74 2.4 
Hong Kong (Ho et aL, 1989) 35/105 2.1 5.2 N/A 3.6 
Kansas, U.S.A. (Koller et aL, 1990) 150/150 1.9 1 1.7 1 
New Jersey, U.S.A. (Golbe et aL, 1988) 106/106 2 1 1 7 
Chicago, U.S.A. (Tanner et aL, 1990) 78/78 1 3 1 1 
Detroit, U.S.A. (Gorell et aL, 1998) 144/464 1.2 3 1.1 3.21 
Taiwan (Lion et aL, 1997) 120/240 2.04 1.81 1.1 2.89 
Germany (Seidler et aL, 1996) 380/376 N/A N/A N/A 2.2 
Calgary, Canada (Semchuk et aL, 1991) 130/260 0.9 1.2 0.9 N/A 
Italy (Zorzon et aL, 2002) 136/272 1.9 5.2 2.3 2 
China (Chan et aL, 1998) 215/313 1 0.98 1 1.8 
Case-control studies Case/Control Smoking Coffee Alcohol Tea 
Italy (Zorzon et aL, 2002) 136/272 0.8 N/A N/A N/A 
Washington, U.S.A. (Checkoway et aL, 2002) 210/347 0.5 0.8 0.8 0.4 
Germany (Hellenbrand et aL, 1997) 380/755 0.5 N/A N/A N/A 
China (Chan et aL, 1998) 215/313 0.4 N/A N/A 1 
Taiwan (Liou et aL, 1997) 120/240 0.4 N/A 0.6 N/A 
Table 3: Summary of Case Control Studies associating Environmental Factors and 
Parkinson's disease 
It is extremely difficult to identify exact risk factors from the case control 
studies because data are strictly based on the memory of patients and family members. 
However, results suggest that environmental factors, especially pesticides and herbicides, 
may play an important role in the etiology of Parkinson's disease. 
Since pesticides and herbicides were most strongly associated with Parkinson's 
disease, we selected the pesticide dieldrin, which was used as an insecticide until the mid 
1970s, as a possible risk factor of Parkinson's disease. In addition, we have 
investigated manganese and the manganese-containing organic compound 
methylcyclopentadienyl manganese tricarbonyl (MMT) as other possible environmental 
risk factors of PD based on the similarities between PD and Manganism. Intensive 
investigation of dieldrin toxicity in dopaminergic neurons is necessary to determine its 
association with Parkinson's disease. In the following section, the chemical and 
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toxicological properties of dieldrin are reviewed. 
Dieldrin 
The formal chemical name of dieldrin is 
l,2,3,4,10,10-hexachloro-6,7-epoxy-l,4,4a,5,6,7,8,8a-octahydro-endo,exo-l,4:5,8-di-me 
thanonaphthalene (HEOD) (Figure 5). Dieldrin was first synthesized in 1946 in the 
laboratories of Julius Hyman & Company in Denver, U.S.A. (de Jong, 1991) by the 
Diels-Alder reaction; thus, dieldrin was named after this reaction (Hassell, 1990). 
Dieldrin production began two years after the first synthesis and was distributed 
commercially as an insecticide in 1950. Dieldrin was widely used as an insecticide 
around the world until the middle 1970s, mainly for the control of soil pests, such as 
termites, grasshoppers, locusts, beetles, and textile pests, and for the treatment of seeds. 
Dieldrin was a very effective soil insecticide, especially for perennial crops, such as 
sugar cane, palm, and banana. Dieldrin has also been used to control tsetse flies and 
other vectors of tropical diseases, including malaria, yellow fever, Chagas disease, Oraya 
fever, African sleeping sickness, river blindness, and filariasis (de Jong, 1991). 
Dieldrin had various industrial uses as well. For example, it was used to protect 
electricity and telephone cables and preserve timber (de Jong, 1991). 
In 1974, The United States Environmental Protection Agency (US EPA) 
restricted the use of dieldrin due to its possible carcinogenic actions and its 
bioaccumulation. Henceforth, dieldrin was used only for termite control and other 
specific applications that did not give rise to residues in food or the environment. At 
the same time, production of dieldrin in the U.S. was ceased. Other developed 
countries followed the same action and strictly banned the use of dieldrin in agriculture. 
Finally, in 1987, the US EPA banned the use of dieldrin for almost all applications. 
Currently, some developing countries continue to use it as an insecticide (Suwalsky et al., 
1997). Dieldrin is classified as one of the 12 most persistent bioaccumulative and toxic 
(PBT) chemicals by the US EPA (www.epa.gov/opptmtr/pbt/cheminfo.htm"). and as one 
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Figure 5: Structure of Dieldrin (Modified from Hassell, 1990) 
of the top 20 human hazardous substances by the Agency for Toxic Substances and Drug 
Registry (ATSDR) (www.atsdr.cdc.gov/cxcx3.html). As described later in this chapter, 
dieldrin is highly persistent in the environment, and many of people, especially those 
who live in agricultural regions, risk exposure through food supplies. 
Chemical Properties of Dieldrin 
Dieldrin is classified as a chlorinated cyclodiene compound with the chemical 
formula CnHioClieO and a molecular weight of 380.92. As mentioned above, dieldrin 
can be synthesized through the Diels-Alder reaction between a diene and a dienophile to 
produce a cyclic diene. Aldrin is a chlorinated cyclodiene compound and resembles 
dieldrin structurally and chemically. Aldrin does not possess an epoxide ring, which 
differentiates it from dieldrin. Dieldrin's epoxide ring is unusually stable in the 
environment compared to the epoxide rings of other chemicals (Hassell, 1990). A 
typical chlorinated compound, dieldrin is highly lipophilic. Along with its lipophilicity, 
the vapor pressure of dieldrin (3.1 x 10"6 mmHg at 20°C) enhances its stability in the 
environment. Its low vapor pressure does not allow ready migration. As a result, 
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dieldrin persists in the same location for years as an environmental pollutant. 
Fate of Dieldrin 
Dieldrin is largely stored in adipose tissue due to its high lipophilicity (de Jong, 
1991). Some dieldrin may cross the blood-brain barrier and remain in brain tissues. 
Dieldrin is metabolized through enzymatic oxidation or hydrolysis reactions. Three 
different metabolic processes are common among species (Figure 6) (Hassell, 1990). 
Mono-oxygenases transfer oxygen to the carbon in the unchlorinated bridge to form 
9-hydroxydieldrin. Epoxide hydrolase hydrolyzes the epoxide ring to form aldrin 
6,7-trans-dihydrodiol. The last and major metabolite, 2-keto-dieldrin, is formed by 
oxidation, dechlorination, and molecular rearrangement and is found in the urine of 
many species (Hassell, 1990). Aldrin is readily metabolized to dieldrin by the 
NADPH-dependent enzymes in hepatic microsomes by the same metabolic pathways as 
dieldrin (Hassell, 1990). 
In the environment, some microorganisms degrade dieldrin by removing a 
chlorine atom from the methylene exo-bridge. However, this reaction is extremely 
slow, and consequently not an effective method of remediation of dieldrin in the 
environment. Typically, the half-life of dieldrin in the environment is up to 25 years 
(Meijer et al., 2001). 
24 
OH 
9-hydroxydieldrin 
Oxidation 
Hydrolysis 
HO. 
HO 
Aldrin 6,7-trans-diydrodiol 
Oxidation and Rearrangement 
2-keto-Dieldrin 
Figure 6: Metabolic Pathways of Dieldrin (Modified from Hassell, 1990) 
Toxicity of Dieldrin 
The general toxicity of dieldrin has been well documented (Ashwood-Smith, 
1981; de Jong, 1991). The most commonly used index of toxicity is the LD50, or lethal 
dose that kills 50% of the animals in a group. The oral LD50 of dieldrin in rats is 37-87 
mg/kg body weight and 45-50 mg/kg body weight in rabbits (Treon and Cleveland, 
1955; de Jong, 1991). Because of its high lipophilicity, dieldrin is rapidly absorbed 
through the skin. The dermal LD50 in rats is 56-90 mg/kg body weight (Bojanowska 
and Brzezicka-Bak, 1967; de Jong, 1991) and about 150 mg/kg body weight in rabbits 
(de Jong, 1991). The main target organ for acute dieldrin intoxication in animals is the 
liver. Diverse toxicological results have been reported from chronic animal studies, yet, 
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the main target organ is unquestionably the liver. However, the central nervous system is 
also affected by dieldrin (de Jong, 1991). 
One of the reasons for EPA's ban of dieldrin's use as an insecticide was because 
of its possible carcinogenicity. The first report of carcinogenicity of dieldrin was in 
1962 when Davis and Fitzhugh administered 10 ppm of dieldrin orally to mice for 2 
years and observed cancer development in the liver (Davis and Fitzhugh, 1962). The 
dieldrin-treated mice developed more hepatomas (24%) than the control mice (7%) 
during the 2-year period. Additionally, other studies have shown that dieldrin causes a 
dose-dependent increase in the incidence of benign and malignant liver tumors only in 
mice (Epstein, 1975a, b). The National Cancer Institute (NCI) also tested 
tumorigenicity of dieldrin on rats by feeding 250 ppm for 104-105 weeks and found no 
sign of tumors; thus, it concluded that dieldrin-induced liver cancer was species specific, 
particularly seen only in mice but not in other species (NCI, 1978). Dieldrin has not 
demonstrated carcinogenicity in humans or other animals besides mice. Different 
metabolic pathways for dieldrin among species may account for the species-specific 
carcinogenicity of dieldrin. The liver is the main organ to detoxify foreign compounds 
following oral administration. Mice may metabolize dieldrin differently and produce 
carcinogenic intermediates or reactive intermediates that cause DNA adduct formation 
and mutations, which develop into hepatomas. However, this is a speculation, and 
scientific evidence demonstrating species-specific metabolic pathways and toxic 
metabolite production does not exist. This issue remains to be clarified. 
Because of its possible carcinogenicity and to reveal the mechanism of 
tumorigenesis in mice, mutagenicity of dieldrin has also been investigated. Structurally, 
one epoxide ring in dieldrin enables its mutagenicity (Ashwood-Smith, 1981). In 
general, epoxide groups are highly reactive due to steric hindrance and electron 
deficiency. Epoxide groups readily bind to nucleophiles to form covalent bonds. 
Since DNA is negatively charged and considered nucleophilic, epoxide rings can bind to 
DNA and form DNA adducts, eventually leading to DNA mutations and development of 
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cancers. To determine if dieldrin is mutagenic, the commonly used Ames test has been 
conducted in different laboratories. Dieldrin was not mutagenic in bacterial or yeast 
test systems with or without S9 microsomal preparations (Hanna and Dyer, 1975). In 
other Salmonella test systems, such as TA1535, TA1536, TA1537, and TA1538, dieldrin 
(1 mg/plate) was not mutagenic with or without metabolic activation (Marshall et al., 
1976). On the other hand, another report using TA98, TA100, and TA1535 showed 
positive Ames results following dieldrin (1 j^g/ml) exposure (Majumdar et al., 1977). 
Thus, the mutagenicity of dieldrin is inconclusive from the Ames test. 
Dieldrin genotoxicity has been further evaluated both in vivo and in vitro. 
Human embryonic lung (WI-38) cells were exposed to 1 jxg/ml (2.6 pM) dieldrin for 24 
hr, and chromosomal abnormalities, such as DNA breaks and fragmentation, were 
observed (Majumdar et al., 1976). Also, 24 hr after intraperitoneal dieldrin 
administration (1 mg/kg) to STS mice, two- to three-fold increases in chromosomal 
abnormalities were observed in bone marrow cells (Majumdar et al., 1976). In addition, 
a significant increase in DNA replication in hepatocytes was observed in 8-week-old 
B6C3F1 mice exposed to 20 mg/kg dieldrin by gavage for 48 hr (Miyagawa et al., 1995). 
These results strongly indicate that dieldrin may be a potent genotoxic compound. A 
recent finding suggests that dieldrin-induced DNA damage and adduct formation, such 
as 8-hydroxy-2'-deoxyguanosine (8-oxodGuo), may be mediated by oxidative stress 
because dieldrin increases the generation of reactive oxygen species (ROS) in PC 12 cells 
(Stedeford et al., 2001). 
Some human exposure data are available. The acute lethal dose in adults is 
approximately 1.5-5 g based on a clinical case (Steentofl, 1979) although 120 mg/kg 
dieldrin did not cause death in another clinical report (Black, 1974). Hunter and 
Robinson (1967) and Hunter et al. (1969) examined changes in blood concentrations of 
dieldrin over time (Hunter and Robinson, 1967; Hunter et al., 1969). In these 
experiments, human male volunteers ingested 0, 10, 50, or 211 p,g of dieldrin daily for 
18 months. The blood dieldrin concentrations were 5 and 15 ng/ml of blood following 
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the 50 and 211 |ig doses, respectively. Hunter and his colleagues also calculated the 
half-life of dieldrin in human blood to be 396 days. Another group determined 
dieldrin's half-life as 266 days in human blood in occupationally exposed workers (Jager 
et al., 1970). Concentrations of dieldrin and other chlorinated hydrocarbons (CHCs) in 
the fat tissues of 262 German children (183 healthy, 46 with malignant tumors, and 33 
with benign tumors) were analyzed, yet tumorigenesis and dieldrin body burdens were 
not correlated (Teufel et al., 1990). Mortality and liver tumors in workers 
occupationally exposed to dieldrin were not clearly associated either (Brown, 1992; de 
Jong et al., 1997), indicating that dieldrin acts via complex toxicological mechanisms in 
humans exposed to low doses. 
The main target organ following both acute and chronic dieldrin exposure in 
humans is the central nervous system. Dieldrin did not induce any significant liver 
damage following occupational exposures (de Jong et al., 1997). The major symptoms 
of dieldrin poisoning are headache, nausea, vomiting, convulsion, and coma. 
Mechanisms of Action 
The exact mechanisms of action of dieldrin toxicity in the liver (animals) and 
the central nervous system (animals and human) are not known yet. The insecticide 
dieldrin as well as several other organochlorine pesticides inhibits the GABA(A) 
receptor in a manner similar to that of picrotoxin (Ikeda et al., 1998). The GABA(A) 
receptor channel consists of five subunits, and each subunit has four transmembrane 
domains (Olsen and Tobin, 1990). Upon inhibition of the GABA(A) receptor, dieldrin 
causes hyperexcitation and leads to a massive influx of Ca2+ via the glutamate 
receptor-channel. Consequently, cellular enzymatic activities are altered due to 
elevated intracellular Ca2+ and physiological functions are disrupted (Narahashi et al., 
1998). 
Other physiological function of dieldrin is not clear yet. Since dieldrin does 
not appear to damage nuclear DNA, it apparently acts on other organelles to destroy 
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cellular functions. One study showed that dieldrin inhibited mitochondrial oxidative 
phosphorylation in vitro in rat liver mitochondria (Bergen, 1971). Briefly, rat liver 
mitochondria were isolated from male rats, and mitochondrial activity was determined 
by measuring the consumption of oxygen in samples. Oxygen consumption was 
significantly reduced as soon as dieldrin was added to the isolated mitochondria, 
indicating that mitochondrial oxidative phosphorylation was directly inhibited by 
dieldrin. Further investigation showed that cytochrome c function was not inhibited by 
dieldrin, whereas electron flow in other respiratory proteins, such as NADH 
dehydrogenase, succinate dehydrogenase, and cytochrome b was blocked remarkably. 
Thus, dieldrin may induce inhibition in or near cytochrome b, which might be close to 
antimycin's site of inhibition. Preliminary results from the same laboratory indicate 
decreased mitochondrial respiratory function in liver mitochondria from rats chronically 
exposed intraperitoneal^ to dieldrin (Bergen, 1971). 
The in vivo and in vitro results described above indicate that dieldrin impairs 
mitochondrial function irreversibly when it reaches mitochondria. Once mitochondrial 
oxidative phosphorylation is impaired, cells cannot produce enough energy (ATP) to 
maintain cellular integrity. The energy depletion may be especially critical in neurons 
in the central nervous system (CNS) due to the high dependency of the CNS on aerobic 
respiration. Along with depletion of energy production, other destructive cascades, 
such as calcium influx or caspase activation, may cause necrosis or apoptosis. 
Dieldrin and Parkinson's disease 
As mentioned earlier, some environmental factors may be responsible for the 
etiology of Parkinson's disease (PD) (Tanner and Langston, 1990; Semchuk et al., 1992; 
Seidler et al., 1996; Liou et al., 1997; Gorell et al., 1998). Pesticide and herbicide 
exposure appears to be associated with especially high risk of development of PD. 
Unfortunately, individual pesticides or herbicides cannot be identified as risk chemicals 
from these case-control studies. More specific investigation of each potential chemical 
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hazard is necessary to identify chemicals that increase or facilitate the risk of PD. 
Dieldrin has been identified as one of the possible environmental risk factors of 
PD. Brain concentrations of various organochlorine pesticides were measured from 
human postmortem brain samples (Fleming et al., 1994). Concentrations of 
organochlorine compounds detected in brains from PD patients, Alzheimer's disease 
patients, and an age-matched control group were compared. Only dieldrin and DDT 
and its metabolites, pp-DDE and pp-DDT, were detected above the minimally detectable 
limits from brain samples. Dieldrin was detected in six of 20 brains from PD patients 
and in none of the 14 age-matched control brains. DDT and pp-DDE were found in 
most brains, and pp-DDT was found more in brains from Alzheimer's disease patients. 
The only significant correlation was between dieldrin and PD. A similar study 
conducted by Corrigan and his colleagues (Corrigan et al., 1998) demonstrated 
detectable levels of dieldrin in both control brains and brains from PD patients, but 
dieldrin levels in the caudate nucleus from PD patients were significantly higher than 
those in control brains. They also detected several PCB congeners as well as pp-DDE 
in most samples. All of the organochlorine compounds tended to be found in higher 
amounts in brains from PD patients. 
The significant levels of dieldrin detected in human brains, even after the ban of 
dieldrin decades earlier, are attributed to its stability in organisms and the environment. 
A study conducted in Taiwan revealed that dieldrin was the most abundant of the 
cyclodiene compounds in selected river sediments (Doong et al., 2002). Also, high 
levels of its metabolites indicate that dieldrin persists in the environment for a long 
period of time. In Japan, pesticide residues were measured in selected domestic and 
imported agricultural products from 1995 to 1999 (Akiyama et al., 2002). Low levels 
of multiple pesticide residues were found in 32% of domestic products and 51% of 
imported products. However, dieldrin levels above the legal maximum limit were 
detected in cucumbers. In India, more than 1 p,g dieldrin per 1 g of vegetables was 
detected (Kannan et al., 1997), indicating higher contamination in developing countries. 
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World Health Organization sets acceptable daily intake (ADI) of dieldrin as 100 ng/kg 
body weight and oral reference dose (RfD) as 50 ng/kg-day. Recent studies indicate 
that dairy products, meat, and seafood are also believed to be primary sources of human 
exposure to dieldrin, and the daily intake level of dieldrin through these contaminated 
food sources was estimated at 0.059 (j,g per average person in Taiwan (Doong et al., 
1999) and 1.0-1.3 pig in Poland (Falandysz, 1999), indicating the risk of human exposure 
to dieldrin is still high. Dietary exposure to dieldrin in the U.S. among over 100,000 
adults has been estimated to be 0.5 pig/day (Macintosh et al., 1996). Because of 
dieldrin's half-life in humans (approximately 300 days) and its highly lipophilic nature, 
dieldrin accumulates in the body and persists for a long time. Interestingly, a recent 
Centers for Disease Control (CDC) investigation revealed that farmers and spouses in 
Iowa have significantly higher serum dieldrin levels, and dietary dieldrin consumption 
may reach as high as 0.4-0.5 |ig/kg-day, which is 8- to 11-times higher than RfD as well 
as ADI (Brock et al., 1998). In Table 4, soil, water and food contaminations of dieldrin 
is summarized (Romero et al., 2000; Amaraneni and Pillala, 2001; Campoy et al., 2001; 
Jabber et al., 2001; Meijer et al., 2001; Rao and Pillala, 2001; Akiyama et al., 2002; 
Aktumsek et al., 2002; Doong et al., 2002; Hung and Thiemann, 2002; Schmitt, 2002). 
Thus, accumulation of organochlorine compounds, including dieldrin, may 
cause or facilitate PD. Since dieldrin was the only organochlorine compound 
significantly correlated with PD, it may act on dopaminergic neurons in the SNc and 
destroy them selectively. However, a cause-effect relationship between dieldrin and the 
death of brain dopaminergic neurons has not been clearly substantiated. Experiments 
with animals or tissue culture are necessary to uncover a cause-effect relationship or 
possible mechanism. 
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Doong 2002 river sediment 0.12-5.8 ng/g (highest sigmaHCH 0.57-14.1 ng/g) inDa-han and Erh-jen 
rivers (Taiwan) 
Doong1999 daily intake 0.059 |ig per adult (Taiwan) 
Akiyama 2002 0.03 ng/g in cucumber (maximum residue limit MRL 0.02 jig'g) (Japan) 
Hung 2002 river water mean 2.19-4.3 ng^L (minor level) (highest DDT 43.7-56.1 ng/L) from Red river 
and Duong river (Vietnam) 
Amaraneni 2u01 maximum concentration 1.98 gg/g fish (highest DDT 157.4 f-ig/g) in India 
Campoy 2001 human breast miïk dieldrin mean 0.6-5.6 ng/ml (max DDE 30.3-36.8 ng/ml) in Spain 
Rao 2001 sediment from Kolferu Lake dieldrin up to 128 |ag/kg dry weight (DDT 191 |ig/kg) (India) 
Meijer 2001 Soil in Broadbalk 9.7 ng/g dw (1986), soil in Luddington 2.9 ng/g dw (1990) highest among 
other detected pesticides 
Romero 2000 human breast milk dieldrin is the 3rd most abundant, mean 0.018 gg/g milk tat 
(range 0-0.355 mg/g) DDE 2.805 mg/g, DDT 0.129 mg/g 
Macintosh 1996 daily intake 0.5 |ig per adult (U.S.A.) 
Fahndysz 1999 daily intake 1.0-1.3 fig per adult (Poland) 
Brock 1998 daily intake 50 ng/kg among Iowa farmers (U.S.A.) 
Kannan 1997 more than 1 jxg/g dieldrin was detected from several Indian vegetables (India) 
Table 4: Level of Dieldrin in Soil, Water, and Food 
Several in vivo and in vitro studies have been conducted to understand the 
relationship between dieldrin toxicity and PD (Bergen, 1971; Sharma et al., 1976; 
Wagner and Greene, 1978; Heinz et al., 1980; Sanchez-Ramos et al., 1998). Chronic 
exposure of cultured mesencephalic cells to dieldrin showed that dieldrin is selectively 
toxic to dopaminergic neurons compared to other neurons, such as GABAergic neurons 
(Sanchez-Ramos et al., 1998). Dopaminergic neurons are somehow more sensitive to 
dieldrin-induced toxicity, but unfortunately, a mechanism of the selective toxicity was 
not proposed. This observation supports the hypothesis that dieldrin is a potential risk 
factor that causes or facilitates PD. In addition, a correlation between dieldrin and 
selective toxicity to dopaminergic neurons has also been reported in in vivo models. 
Ring doves administered low doses of dieldrin in the daily diet for 8 weeks had 
significantly depleted brain levels of both dopamine and norepinephrine by 58.6% and 
38.0%, respectively (Heinz et al., 1980). Dopamine depletion was more severe than 
norepinephrine depletion. The same effect was observed in rats and ducks exposed to 
dieldrin chronically (Sharma et al., 1976; Wagner and Greene, 1978). Thus, dieldrin 
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has a high potential to deplete brain dopamine levels, and may be selectively toxic to 
brain dopaminergic neurons. This assumption is further supported by the findings of 
Miller et al. (1999). They measured the expression and activity of the dopamine 
transporter (DAT) and the vesicular monoamine transporter (VMAT2) in pre-synaptic 
terminals of dopaminergic neurons in the striatum. Exposure of C57BL mice to an 
organochlorine pesticide (up to 12 mg/kg) for 2 weeks significantly increased the 
expression of both the DAT and VMAT2 in the striatum (Miller et al., 1999a). In 
addition, the organochlorine pesticide inhibited VMAT2 function in an in vitro model. 
These results suggest that levels of free dopamine are not protected by vesicles and can 
be enhanced in pre-synaptic terminals to possibly enhance the risk of oxidative stress. 
Another study has shown that DAT binding (27-64%) was increased in the striatum of 
Sprague-Dawley rats exposed to dieldrin (3 mg/kg-day) (Purkerson-Parker et al., 2001), 
indicating that dopamine reuptake was facilitated by dieldrin. Together, the above 
studies indicate that dieldrin alters neurochemical function in the striatum, an area 
involved in PD. However, data regarding the neurochemical mechanisms underlying 
the dopaminergic toxicity of dieldrin have not been reported. 
As mentioned earlier, dieldrin is a chlorinated cyclodiene compound and 
belongs to the class of polychlorinated biphenyls (PCBs). To date, 209 congeners have 
been named in the PCB family. PCBs were manufactured between the 1930s and the 
1970s and have been used extensively in industries related to the following: dielectric 
and heat transfer fluids; hydraulic and lubrication oils; condensers, transformers and 
capacitors in electrical systems; plasticisers in paints and sealants; putties, waterproof 
wall coverings and printing inks based on their inflammability and stability. The 
toxicity of PCBs has been broadly studied and may be involved in human 
carcinogenicity, endocrine disruption, reproductive toxicity, neurotoxicity, and immune 
suppression (Safe, 1994; Faroon et al., 2001; Tharappel et al., 2002). Even low levels 
of PCB exposure can induce neurotoxic responses, including subtle changes in behavior 
and cognition; the cellular and molecular basis of PCB-induced neurotoxicity remains 
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unclear at this point. The involvement of Ca2+ signaling in PCB-induced neurotoxicity 
during the development and maturation of neurons has been reported (Tilson and 
Kodavanti, 1998; Tilson et al., 1998; Inglefield et al., 2001; Jessen-Eller et al., 2002; 
Kodavanti and Derr-Yellin, 2002). PCB (Arochlor 1254) caused in neocortical cells 
increased intracellular ip3 signaling due to phospholipid hydrolysis, resulting in 
increased intracellular Ca2+ through the ER and plasma membrane associated Ca2+ 
channels (store-operated channels or SOC) (Inglefield et al., 2001). However, 
PCB-induced increased intracellular Ca2+ levels do not appear to activate 
caspase-dependent apoptosis, but these cells undergo necrosis (Inglefield et al., 2001). 
In non-neuronal cell lines, PCB induces apoptotic cell death via a Ca2+ and/or 
caspase-dependent process (Lee et al., 2001; Jeon et al., 2002; Shin et al., 2002b). 
Mechanistically, Arochlor 1254 has been reported to produce significant levels of ROS 
in cerebellar granule cells (Mariussen et al., 2002) and rat synaptosomes (Voie and 
Fonnum, 2000). Interestingly, Arochlor 1254 inhibits mitochondrial transition pore 
opening and cytochrome c release (Salvi and Toninello, 2001), which partially explains 
the PCB-induced caspase-dependent apoptosis (Jeon et al., 2002). Furthermore, 
activation of protein kinase C (PKC) attenuates PCB-induced apoptotic cell death in 
HL-60 cells (Shin et al., 2002a). However, the effect of this PCB mixture on the 
dopaminergic system is not known. To our knowledge, dieldrin is most closely 
correlated with other PCBs with regard to dopaminergic toxicity. 
Manganese 
Manganese (Mn) was first discovered in 1771, and its name is derived from the 
Greek word for magic. It is essential in the function of certain enzymes and membrane 
transport systems in all mammalian tissues. Mn is present in over 100 common salts 
and mineral complexes distributed in rocks, soils, lakes, and oceans, which comprise 
about 0.1% of the Earth's crust. Mn has 11 oxidation states, ranging from 3- to 7+ 
(Aschner et al., 1999), and the manganous (Mn2+) and manganic (Mn4+) oxidation states 
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are the most common in the natural environment. However, Mn exists as one of three 
oxidation states (2+, 3+, and 7+) in mammalian tissues. Mn forms tight complexes 
with other ligands, thus, the level of free plasma Mn is low. Mn is an abundant metal, 
essential in blood clotting, energy metabolism, and immune system function in mammals. 
Mn is a constituent of metalloproteins, including superoxide dismutase, pyruvate 
carboxylase, and glutamine synthetase. Deficiencies in dietary Mn cause a failure to 
thrive, congenital abnormalities, impaired reproductive function, ataxia, and defects in 
lipid and carbohydrate metabolism (Hurley, 1981). In addition, seven human 
volunteers who ate a Mn-deficient diet (0.11 mg/day) for 39 days experienced the 
development of dermatitis, hypocholesterolaemia, and elevation of serum calcium and 
phosphorus (Friedman et al., 1987). On the other hand, excess Mn intake also leads to 
psychiatric disturbance and movement disorders, described later in this chapter. 
In adult humans, average total body Mn levels are approximately 10-20 mg 
(200-400 |o,mol) (Andersen et al., 1999), and the required daily dietary intakes for Mn 
are 0.3-1.0 mg/day in infants, 1.0-3.0 mg/day in children, and 2.0-5.0 mg/day in adults 
(Keen and Zidenberg-Cherr, 1990). Mn is absorbed in the small intestine by 
high-affinity, low-capacity active transport (Garcia-Aranda et al., 1983). Infants absorb 
nearly 99% Mn, but the absorption rate decreases with age, and only 3-5% of total Mn is 
absorbed in adults (Zlotkin and Buchanan, 1986; Davidsson et al., 1988). Mn is 
transported to various tissues by carrier proteins, such as transferrin, a2-msvtohlobulins, 
and albumins (Aschner and Aschner, 1991) and is distributed to various tissues and 
organs. High concentrations have been found in bone (3.3 ppm), liver (1.68 ppm), 
kidney (0.93 ppm), pancreas (1.21 ppm), hair (0.80 ppm), brain (0.34 ppm), and gonads 
(0.09 ppm) (Underwood, 1977). Especially high concentrations up to 25% of the total 
Mn body content have been found in bone. Mn is excreted through the liver in bile and 
feces. 
Historically, Mn was used for manufacturing glass during the Egyptian and 
Roman Empires. Today, Mn is one of the most widely used metals in the world, and 
35 
industrial uses of Mn include the manufacture of dry cell batteries and various alloys and 
steels, which contain Mn metal up to 14%. It is also produced as a high-purity salt with 
many chemical uses, some of which include textile dyeing, oxidation catalysis, paint and 
varnish drying, paint pigmentation, fertilizer production, food packaging, nutritional 
additives, pharmaceutical preparation, explosives, and fungicides. The production of 
organic Mn, including Maneb (manganese ethylenebisdithiocarbamate) as a fungicide 
and MMT (Methylcyclopentadienyl Manganese Tricarbonyl) as an anti-knock agent in 
gasoline (Sax and Lewis, 1987; Pal et al., 1999), is also important. 
Manganese Exposure and Toxicity 
Essential dietary Mn levels are derived from food. As shown in Table 5, the 
highest Mn concentrations are found in nuts and grains, which contain up to 46 j-tg of 
Mn per gram (Pennington et al., 1986). Environmental and accidental exposures to Mn 
are mainly by ingestion or inhalation, and the most commonly reported Mn exposure is 
through industrial or mining occupational exposure. Atmospheric Mn concentrations 
have been measured in various locations. Zayed et al. (1999) collected samples from 
gas stations, downtown areas, and near an express way in Montreal, Canada, to 
determine whether the use of an organic Mn anti-knocking agent (MMT, discussed 
below) increased atmospheric Mn concentrations (Zayed et al., 1999). Their results 
indicate that the concentrations of atmospheric Mn particles in these locations were 
0.103-0.141 |4,g/m3, whereas the US EPA atmospheric reference concentration (RfC) for 
Mn is 0.05 |ag/m3 (Davis et al., 1998), indicating that the Mn concentrations were two-
to three-fold higher than the regulatory limit. In the United States, the mean 
atmospheric Mn concentration in urban areas was reported to be approximately 0.033 
|j,g/m3 in 1982 (Lynam et al., 1994), which was lower than that in Canada. Industrial 
exposures to inorganic Mn occur from Mn mining and during the industrial uses of Mn, 
as mentioned above. The ambient levels of Mn in a factory in Taiwan were 
approximately 20,000 ng/m3 due to a malfunctioning ventilation control system, and 
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these levels caused toxicity (Huang et al., 1989). The ambient levels of Mn dust in the 
vicinity of drilling in a mine might contain as much as 450,000 jo-g/m3 (Rodier, 1955). 
The smoke from welding might contain more than 25,000 p,g Mn/m3 (Wang et al., 1989). 
Upon inhalation, Mn is absorbed into blood from lungs and binds to cationic carrier 
proteins, such as transferrin (Tf), albumin and divalent metal transporter-1 (DMT-1), and 
then is transported to various tissues including brain (Egyed and Wood, 1996; Davis et 
al., 1998; Aposhian et al., 1999). Free Mn2+, Tf bound Mn3+, and DMT-1 bound Mn2+ 
readily cross the blood-brain barrier (BBB) and accumulate in certain regions of the 
brain. High Mn concentrations have been observed in the caudate-putamen, globus 
pallidus, substantia nigra, and subthalamic nuclei (Scheuhammer and Cherian, 1981; 
Newland et al., 1989; Olanow et al., 1996). A highly selective accumulation of Mn in 
the basal ganglia suggests that Mn might be one of the possible causes of selective 
degeneration of dopaminergic neurons in the substantia nigra, which may result in the 
development of PD. Furthermore, individuals with chronic liver failure are at risk of 
Mn accumulation in the brain due to the incomplete excretion of Mn from the body 
through the biliaric tract. Post-mortem study reveals that high levels of Mn accumulate 
in the basal ganglia in patients with liver cirrhosis (Krieger et al., 1995). 
Exposure to Mn appears to be associated with depletion of striatal dopamine 
levels due to degeneration of dopamine nerve endings and massive cell loss in the 
internal segment of the globus pallidus where inhibitory GABAergic neurons are present 
(Bemheimer et al., 1973; Brouillet et al., 1993). On the other hand, Pal et al. (1999) 
showed that Mn primarily affects GABAergic neurons in the globus pallidus, and does 
not cause significant damage to dopaminergic neurons in the substantia nigra (Pal et al., 
1999). Furthermore, Shinotoh et al. (1995) described the morphological changes in 
monkeys exposed to Mn in the globus pallidus (Shinotoh et al., 1995) as Mn-induced 
Parkinson-like syndrome, pathologically distinct from idiopathic PD. However, a 
recent clinical case questions the effect of Mn in the globus pallidus. Two patients with 
a long history of occupational Mn exposure presented with Mn-induced Parkinsonism. 
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Manganese level in food ppm (ug/g or mg/L) 
Nuts and nut products 18-47 
Grains and grain products 0.4-41 
Legumes 2.2-6.7 
Fruits 0.2-10.4 
Fruit juices and drinks 0.05-11.5 
Vegetables and vegetable products 0.4-6.6 
Desserts 0.04-8 
Infant foods 0.2-4.8 
Meats, poultry, fish and eggs 0.1-4 
Mixed dishes 0.7-3 
Condiments, fats, and sweetners 0.04-1.5 
Beverages 0-2.1 
Soups 0.2-0.7 
Milk and milk products 0.02-0.5 
Table 5: Manganese Contamination in Selected Food 
[C 23)I] -( 1 r)-2 p-carboxymethoxy-3 (3-(4-iodophenyl) tropane (J3-CIT) single-photon 
emission computed tomography revealed that significantly low dopamine transporter 
levels in the striatum, one of the pathological hallmarks of idiopathic PD, were measured 
in these patients (Kim et al., 2002). This finding suggests a direct effect of Mn in 
dopaminergic neurons in the SNc, and that Mn toxicity in the globus pallidus may not be 
the primary causal factor of Mn-induced PD-like syndrome. 
Many different researchers have studied the molecular mechanisms of Mn 
toxicity. The biological half-life of Mn in tissues is 36 to 41 days (Gavin et al., 1990, 
1992; Goyer, 1996; Inoue and Makita, 1996). Mn accumulates in mitochondria and 
inhibits mitochondrial complex I activity (Galvani et al., 1995). In addition, Mn 
inhibits aconitase and succinate dehydrogenase (Complex II), two important enzymes in 
oxidative phosphorylation in both in vivo and in vitro models (Zheng et al., 1998; 
Malecki, 2001). As a result, the mitochondrial electron transport system (ETS) is 
impaired, ATP production is decreased, and lactate formation is increased (Brouillet et 
al., 1993; Hirata et al., 2001). Also, due to the impairment of mitochondrial function, 
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the unconsumed cellular oxygen level increases, and some is converted to reactive 
oxygen species (ROS). Oxidative stress appears to play an important role in Mn 
toxicity (Donaldson et al., 1982; Graham, 1984; Archibald and Tyree, 1987; Liccione 
and Maines, 1988; Desole et al., 1996; Desole et al., 1997). Increased intracellular 
ROS levels not only cause imbalance of cellular antioxidant defense mechanisms, such 
as glutathione (GSH), superoxide dismutase (SOD), and catalase, but also activate the 
oxidative stress-mediated cell death processes (Medina et al., 1996). Mn exposure in 
dopaminergic PC12 cells or SN4741 cells induced the early activation of mitogen 
activated protein (MAP) kinase activity, several caspase activities, and resulting DNA 
fragmentation (Hirata et al., 1998; Chun et al., 2001b; Hirata, 2002). Also, Mn 
mobilizes caspase-12 in the endoplasmic reticulum and further facilitates 
caspase-dependent cell death in the dopaminergic cell line SN4741 or in NIH3T3 cells 
(Chun et al., 2001a; Oubrahim et al., 2001). On the other hand, Mn-induced apoptotic 
cell death in dopaminergic PC 12 cells was not inhibited by caspase inhibitors, indicating 
that other cell death pathways may also be important in cell death following Mn 
exposure (Roth et al., 2000). 
Another proposed mechanism of toxicity is secondary excitotoxicity that 
follows bioenergetic defects in which ROS and Ca2+ mediate neuronal damage (Beal et 
al., 1993). Studies demonstrate that decortication or treatment with MK-801, an 
NMDA antagonist, prior to Mn administration protects against pathological changes 
(Brouillet et al., 1993). In many respects, the mechanisms of Mn toxicity are similar to 
those of other known mitochondrial toxins, including aminooxyacetic acid, malonate, 
3-nitro-propionic acid, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and 
paraquat (Dawson et al., 1995; Cassarino et al., 1999). In addition, mitochondrial 
defects have recently been found in patients with PD, implicating mitochondrial toxins 
as possible environmental stressors important in the development of PD. 
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Manganese exposure and PD 
Excessive exposure to Mn generally results from inhalation of high levels of 
Mn in mine workers and may cause pulmonary or neurological dysfunction. Exposure 
to high levels of Mn is known to cause Manganism, with neurological symptoms similar 
to those caused by Parkinson's disease (PD) (Inoue and Makita, 1996). The first 
reported neurological disturbances associated with exposure to Mn were described by 
Couper in 1837 in France (Couper, 1837). Five workers in a Mn ore crushing plant 
developed neurological symptoms, such as muscle weakness, tremor, postural instability, 
and mumbling. Since this first report, Mn-associated neurological disorders have been 
observed all over the world including Chile, Cuba, India, Japan, and the U.S. (Schuler et 
al., 1957; Cotzias, 1958; Balani et al., 1967; Mena et al., 1967; Greenhouse, 1971; Cook 
et al., 1974; Huang et al., 1989; Montgomery, 1995; Gorell et al., 1999; Mergler et al., 
1999). Due to its neurotoxicity, Mn appears to be transported into the brain easily via 
simple diffusion of Mn2+ and transferrin-bound Mn3+ (Aschner and Aschner, 1990; 
Aschner and Gannon, 1994). High levels of Mn are found in the pallidum, thalamic 
nuclei, and substantia nigra, where high transferring receptors are also found. Animal 
studies using monkeys have confirmed that low dose exposure to Mn over 1-2 years 
develops signs of motor dysfunctions and selective damages and significant 
accumulation (60-80% over control) in globus pallidus and substantia nigra (Bird et al., 
1984; Newland and Weiss, 1992). Clinical reports have also shown significantly high 
levels of Mn in the substantia nigra and cerebellum in PD patients as compared to 
age-matched control groups (Yase, 1972). Mn levels in cerebellum range from 0.12 to 
0.53 p.g/g tissue wet weight (Sumino et al., 1975). Mn also selectively targets 
pathways intrinsic to the basal ganglia, and high Fe3+ and/or catecholamine levels 
potentiate the neurotoxicity of Mn2+ (Sloot and Gramsbergen, 1994). Mn is also 
closely associated with neuromelanin in vivo, a phenomenon that could decrease the 
pigment's scavenging of free radicals (Lyden et al., 1984). However, the exact 
mechanisms by which Mn is selectively accumulated and neurotoxic in these regions 
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remain to be uncovered. 
The clinical syndrome of Mn related neurotoxicity may be broadly divided into 
three stages: (i) neurobehavioral changes or the initial phase, (ii) parkinsonian features 
or the intermediate phase, and (iii) dystonia with severe gait disturbances or the 
established phase (Pal et al., 1999). The clinical symptoms of the first stage of 
neurological damage from Mn exposure include fatigue, anorexia, headache, poor 
memory, reduced concentration, apathy, insomnia, loss of appetite, diminished libido, 
hallucinations, and psychosis (Huang et al., 1993; Pal et al., 1999). These symptoms 
are categorized as non-specific symptoms, and the appearance and severity of these 
symptoms vary among individuals. A generalized slowing of movements during the 
initial stage is also observed in some cases (Mena et al., 1967). A direct link between 
psychiatric symptoms and motor dysfunction, called "locura Manganica (manganese 
madness)", observed in Manganism has not been established, and not every patient 
shows both types of symptoms during the initial phase. The intermediate phase usually 
follows the initial phase by 1 to 2 months. Extrapyramidal signs emerge, including 
monotone speech, expressionless face, and impairment of writing, dexterity, movement, 
posture, and gait. Speech disturbances include slurring and stuttering, writing 
disturbances include micrographia, and facial expression becomes blank or mask-like, 
interrupted by periods of spasmodic laughing or dystonic grimace. Movements are 
generally slow, clumsy, and uncertain and walking backwards becomes difficult (severe 
retropulsion), as does turning "en bloc" (Huang et al., 1989). In the established phase 
of neurological Manganism, patients experience a dystonic posturing of the foot known 
as "cock-walk", where the patient walks with small steps, elevating the heels and 
rotating them outward. During this phase, tremors are less frequently observed (Mena 
et al., 1967; Huang et al., 1989). The disorder becomes progressive when it reaches the 
established phase, and patients do not recover even if the high exposure levels of Mn are 
removed. 
Chronic Mn exposure has not been verified as a risk factor for idiopathic PD. 
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In case-control studies, Mn exposure and development of PD were not significantly 
associated (Semchuk et al., 1992; Seidler et al, 1996). On the other hand, Gorell et al. 
(1997, 1999) reported that more than 20 years of exposure to Mn were positively 
associated with an increased incidence of PD (Gorell et al., 1997, 1999). According to 
these reports, exposure to Mn for more than 20 years significantly increases the risk of 
PD (odds ratio, OR = 10.61). Furthermore, combinations of other metals, such as 
lead-copper (OR = 5.24), lead-iron (OR = 2.83) or iron-copper (OR = 3.69), may also be 
associated with PD. Pathologically, Mn primarily causes toxicity in the globus pallidus 
rather than the substantia nigra, where dopaminergic neurodegeneration occurs in 
idiopathic PD (Yamada et al., 1986; Pal et al., 1999). However, recent clinical results 
reveal a direct toxic effect of Mn on dopaminergic neurons and indicate that Mn-induced 
PD and idiopathic PD are not different pathologically (Kim et al., 2002). Still, 
pathological differences have been characterized between PD and Manganism, and the 
role of Mn in the pathogenesis of these diseases has yet to be elucidated. 
At the cellular level, Mn inhibits tyrosine hydroxylase (TH) activity in 
dopaminergic cells (Hirata et al., 2001) and accumulates preferentially in 
neuromelanin-rich cells including pigmented neurons in the substantia nigra (Lyden et 
al., 1984). Chemically, Mn possesses strong oxidation-reduction properties. 
Intracellularly, Mn is in dynamic equilibrium between divalent (Mn2+) and trivalent 
(Mn3+) states, and Mn3+ is a strong oxidizing agent. Dopamine, one of the most 
unstable neurotransmitters in nature, readily gives up an electron under strong oxidizing 
conditions and forms toxic free radical quinone compounds (Donaldson et al., 1982). 
These findings imply that Mn exposure can cause dopaminergic degeneration and 
decrease dopamine production, resulting in decreased dopamine levels in the striatum, 
and therefore may induce extrapyramidal signs and symptoms resembling idiopathic PD. 
Mn also depletes dopamine in the striatum when administered to monkeys and rodents 
(Neff et al., 1969; Brouillet et al., 1993; S loot and Gramsbergen, 1994). In addition, 
chronic Mn exposure in rats revealed significant accumulation of Mn in the globus 
42 
pallidus but not in the caudate putamen. However, neuronal cells in both the globus 
pallidus and caudate putamen were significantly destroyed (Salehi et al., 2001). These 
results further support the correlation between Mn neurotoxicity and the risk of PD. 
MMT 
Methylcyclopentadienyl manganese tricarbonyl (MMT), first synthesized by 
Ethyl Corporation in the 1950s, has been used as an anti-knocking gasoline adduct in 
Canada (Lynam et al., 1999). This tetrahedral compound has an aromatic ring structure 
and three carbonyls attached to a Mn atom (Figure 7). The methylcyclopentadiene ring 
has a net charge of -1 due to its delocalized electrons, and it bonds to Mn through the 
interaction of its n orbital cloud with the d orbitals of Mn. The remaining d orbitals of 
Mn interact with the three carbonyl groups, all of which are considered neutral ligands. 
The yellow, volatile, water-soluble liquid has a molecular weight of 218.1. MMT is 
produced from reaction of MnCh, cyclopentadiene, and carbon monoxide in the 
presence of manganese carbonyl (Sax and Lewis, 1987). MMT is thermally stable but 
photochemically unstable (Hysell et al., 1974), degrading within 15 sec in sunlight to 
produce a mixture of manganese oxides (Ter Haar et al., 1975). However, significant 
amounts of MMT have been found in rain water and storm runoff collected along 
highways (Yang and Chau, 1999), even though it is photochemically unstable. The 
purity of commercial MMT, called AK-33X or HITEC 3000, ranges from 24.4% to 
25.2%. Gasoline contains up to 72 mg of MMT per liter; a recent measurement of 25.8 
mg/L MMT was reported in MMT-added gasoline (Zayed et al., 1999). The chemicals 
emitted from MMT-containing gasoline are manganese tetraoxide, manganese sulfate, 
and manganese phosphate (Ressler et al., 2000). 
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A. Chemical structure 
CH 
B. Combustion of MMT 
MMT • MnS04 + Mn203 + MnP04 
combustion 
Figure 7: Chemical Structure of MMT 
MMT is now approved for use in Argentina, Australia, Bulgaria, the U.S., 
France, Russia, and conditionally in New Zealand. Nevertheless, these countries are 
using MMT non-intensively while waiting for further evidence indicating no adverse 
human health effects (Zayed, 2001). MMT was used in gasoline in the U.S. from the 
early 1970s until passage of the amendments to the Clean Air Act in 1977 (Lynam et al., 
1999). Though MMT is a legal gasoline additive in the U.S. now, public health 
concerns still exist (Frumkin and Solomon, 1997; Davis, 1998). Toxicity data 
generated by Canadian research groups regarding ambient Mn levels and adverse health 
effects from MMT exposure have not been useful in U.S. Environmental Protection 
Agency (EPA) risk assessment of MMT, due to the lack of proper controls in the 
Canadian studies (Davis, 1998). The USEPA tried to ban the use of MMT as a 
gasoline additive, but failed in 1996 after a lawsuit by Ethyl Corporation claimed unfair 
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denial of their request for a waiver of the ban (Davis, 1998). The judgment was 
awarded based on a legal technicality associated with the North American Free Trade 
Agreement (NAFTA). 
The environmental fate and contamination of MMT and effects of chronic human 
exposure have not been investigated. In some urban areas, combustion of gasoline 
containing MMT contributes nearly 8% of the total Mn levels in the air (Loranger and 
Zayed, 1995). In areas of the U.S., the level of Mn from vehicle emissions varies. 
For example, automobiles contribute an average of 13 ng Mn/m3 of atmospheric Mn 
levels in southern California, whereas automobiles contribute only 3 ng Mn/m3 in central 
and northern California (Davis et al., 1988). The absorption, distribution, metabolism, 
and excretion of MMT in animal models have been evaluated. The biodistribution of 
MMT differs greatly from that of its inorganic counterparts (Gianutsos et al., 1985; 
Komura and Sakamoto, 1992, 1994). Cerebellum Mn concentrations were significantly 
higher in mice treated with MMT (0.5 g/kg for 12 months) than in mice treated with 
MnClz (2.0 g/kg for 12 months) (Komura and Sakamoto, 1994). The differences in 
bioavailability and biodistribution between MMT and inorganic Mn may be partially 
explained by the results of Zheng et al. (Zheng et al., 2000). They assessed the 
toxicokinetics of MMT and inorganic Mn in rats and revealed that the clearance rate of 
Mn derived from MMT in plasma was much slower (37-fold) than the clearance rate of 
inorganic Mn, indicating that MMT may have prolonged effects on organisms. MMT 
is mainly biotransformed in liver and is excreted in the urine as two major metabolites, 
(CO^MnCsHUCC^H and (CO^MnC^FLtCHzOH, which account for 67% and 14%, 
respectively, of the MMT administered (Hanzlik et al., 1980). The urinary excretion of 
Mn derived from MMT was only 5% of the daily amount of MMT administered 
(Komura and Sakamoto, 1992). Organic forms of Mn were apparently absorbed much 
easier and faster than inorganic forms of Mn. Mn is metabolized mainly by 
cytochrome P-450 enzymes. Only a small fraction of MMT was found in feces, 
indicating that MMT was efficiently absorbed systemically. The bioavailability of 
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MMT in the CNS has not been evaluated. However, due to its high lipophilicity, MMT 
may accumulate in the brain. MMT induces neurological effects, including agitation 
and convulsion, as well as pulmonary damage (Penney et al., 1985). Fishman et al. 
(1987) observed seizure activity following MMT administration to mice, an effect not 
seen following MnCla administration (Fishman et al., 1987). Furthermore, MMT 
inhibited the binding of t-[3H]t-butylbicycloorthobenzoate (a ligand for the 
GABA-A-receptor) in mouse brain membranes with an IC50 value of 22.8 f-iM, 
indicating that MMT-induced seizure activity may result from GABA-A receptor 
inhibition. 
MMT clearly affects the CNS and causes neurological syndromes, but the 
particular brain regions affected are not known. MMT has been investigated to 
determine if it is correlated with the development of PD. Chronic MMT treatment (5 
months) in rats did not cause significant degeneration of dopaminergic neurons in the 
substantia nigra although Mn levels were elevated significantly (Yong et al., 1986). 
Tyrosine hydroxylase activity was not altered either during the treatment period. On 
the other hand, administration of MMT to mice for 3 weeks decreased dopamine 
concentrations in the striatum and olfactory tubercles (Gianutsos and Murray, 1982). 
The G ABA content in the striatum was also elevated after either treatment while the 
cerebellar G ABA content did not change. G ABA levels in the substantia nigra of 
MMT-treated mice were also increased, indicating that MMT affects both dopaminergic 
neurons and GABAergic neurons in the basal ganglia. This is additional evidence that 
MMT may target nigrostriatal neurons. The acute toxicity of organic Mn is 
apparently due to its effect on neurotransmitter function, which results in the subsequent 
manifestation of neurological signs. However, systematic chronic exposure studies in 
animal models evaluating long-term health effects of MMT have not yet been 
conducted. 
MMT toxicity using in vitro systems has not been well established either. MMT 
inhibits mitochondrial phosphorylation at site I in isolated hepatocytes (Autissier et al., 
46 
1977). MMT affects Na/K-ATPase activity in sciatic nerves and decreases levels of the 
Na/K-ATPase catalytic alpha 1 subunit (Liu et al., 2000), which may partially explain the 
neurodegenerative process of MMT. However, more extensive research is necessary to 
understand the biochemical mechanisms of MMT neurotoxicity and the relevance to the 
etiopathogenesis of PD. 
Mechanisms of apoptosis and neurodegeneration 
Although the causes of neuronal death in neurodegenerative disorders are still 
enigmatic, several mechanisms are currently under discussion. These mechanisms 
include programmed cell death (apoptosis), passive cell death (necrosis), and autophagy 
(Anglade et al., 1997b). Apoptosis has been evaluated extensively in the quest to 
understand cellular and molecular mechanisms underlying the pathophysiological 
mechanisms of many neurodegenerative disorders including PD, Alzheimer's disease, 
Huntington's disease, amylotrophic lateral sclerosis, and ischemia as well as other 
diseases such as cancer and autoimmunity (Burke, 1998; Hartmann and Hirsch, 2001; 
Roth, 2001; Sathasivam et al., 2001). One of the reasons why apoptosis may be more 
favorable than the other cell death mechanisms is because these neurodegenerative 
disorders result from specific patterns of cell loss, which is not as easily explained by 
necrosis or autophagy. 
Apoptosis is morphologically and biochemically well characterized as a cell 
death mechanism. Unlike necrosis, the cellular structural integrity is preserved, the 
plasma membrane remains intact, and the mitochondrial and nuclear membranes are well 
preserved until the late stage of apoptosis. Membrane blebbing is often observed, and 
genomic DNA is most commonly fragmented into approximately 180-200 base-pairs. 
Also, no inflammatory response is observed throughout the process. Neurons 
undergoing apoptotic death are stimulated or initiated in several different ways via 
caspase-dependent and caspase-independent pathways. The caspase-dependent 
pathway has been investigated intensively, and activation of this pathway is classified 
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into the death receptor-mediated and the mitochondria-mediated initiation processes. 
These processes are described in detail in the following paragraphs. 
The family of cysteine-directed proteases closely associated with apoptotic cell 
death is called caspase (cysteinyl aspartate-specific protease). To date, 14 isoforms 
have been identified (Cohen, 1997; Nicholson and Thomberry, 1997) (Figure 8). The 
physiological functions of caspases differ somewhat but are broadly categorized into 
inflammatory responses and apoptotic signaling, as depicted in Figure 8A. All 
caspases exist in cells as zymogens (pro-caspases), and are activated when pro-caspases 
are proteolytically cleaved into one large subunit (-20 kDa) and one small subunit (-10 
kDa) and form heterotetramers with two identical large and two identical small subunits 
(Figure 8B). Each active caspase contains two catalytically active sites that are 
permanently active until degradation (Cohen, 1997). Each caspase recognizes a 
specific sequence of tetrapeptides (Table 6). Caspases proteolytically cleave aspartate 
residues at the carboxylic end of tetrapeptide sequences. 
Class Name Regulatory Adapter Optimal 
unit molecule tetrapeptide 
Activators 
caspase-2 CARD RAIDD DXXD 
caspase-8 DED FADD (I/V/UEXD 
caspase-9 CARD Apaf-1 (I/V/UEHD 
caspase-10 DED FADD (I/V/UEXD 
Executioners 
caspase-3 DEXD 
caspase-6 (I/V/UEXD 
caspase-7 DEXD 
Cytokine 
processors 
caspse-1 CARD CARDIAK (W/Y/F)EHD 
caspase-4 CARD (W/Y/F)EHD 
caspase-5 (W/Y/F)EHD 
caspase-11 
caspase-12 
caspase-13 
caspase-14 
CARD: Caspase recruitment domain 
DED: Death effector domain 
Table 6: Classification of Caspases (Modified from: 
www.neuro.wustI.edu/neuromuscuIar/mother/apoptosis.htm) 
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B 
Sequence homology Function 
apoptosis other 
12 
11 
13 
4 
5 
1 
inflammation 
inflammation 
2 initiator/effector? 
9 initiator 
8 initiator 
6 effector 
3 effector 
7 effector 
10 initiator? 
precursor 
prodomain 
large subunit 
small subunit 
0 
active 
catalytic sites 
Figure 8: Classification and Activation Caspases (Modified from Thornberry and 
Lazebnik, 1998) 
Apoptosis-related caspases are subtyped based on their activation processes and 
roles as initiator caspases and effector caspases (Wolf and Green, 1999). Initiator 
caspases, including caspase-2, caspase-8, caspase-9, and caspase-10, possess specific 
regulatory sequences or adapter domains, namely the caspase recruitment domain 
(CARD) or the death effector domain (DED). Effector caspases, including caspase-3, 
caspase-6, and caspase-7, are activated by initiator caspases (Thornberry and Lazebnik, 
1998). Unlike the initiator caspases, effector caspases do not possess known regulatory 
sequences, and their pro-domains are relatively short. The role of the caspase cascades 
in cells has been investigated intensively. Two distinct caspase-dependent apoptotic 
pathways have been identified as the death receptor-mediated apoptotic pathway and the 
chemical-induced mitochondrial-mediated apoptotic pathway (Figure 9). In death 
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Receptor-mediated 
Fas or Tl 
receptor 
FADD 
Pro-caspase-8 or 
Pro-caspase-10 
PKCS 
Caspase-2 
Chemical-induced 
Chemicals 
I Cleaved Bid 
Cytochrome c 
Caspase-8, -10 
Apaf-1 
I dATP Smac 
Caspase-3, -6, -7 Caspase-9 AIF 
Endnuclease G 
Endonucleases PARP 
i Z 
APOPTOSIS 
(Caspase-independent) 
Figure 9: Apoptotic Pathways 
receptor-mediated apoptosis, tumor necrosis factor-a (TNFa) or the Fas (APO-1/CD95) 
receptors are associated with caspase-8 or caspase-10 by DED adaptor domains and 
undergo conformational changes when ligands bind to the receptors, resulting in 
activation of initiator caspase-8 or -10. Effector caspases (caspase-3, -6, and -7) are 
then activated, which further initiates apoptosis by cleaving vital cellular target proteins. 
In the chemical-induced apoptotic pathway, mitochondria play central roles in 
regulating apoptosis (Desagher and Martinou, 2000). When apoptotic stimuli are 
introduced to cells, mitochondrial functions, particularly respiratory chains, are inhibited. 
As a result, the mitochondrial permeability transition (MPT) pores located on the inner 
membrane of mitochondria are opened to reduce the proton gradient, generate reduced 
forms of electron transport proteins which process NAD+ and FAD+ by uncoupling, and 
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increase oxygen consumption (Crompton, 1999). MPT pore opening, however, results 
in depolarization of the mitochondrial transmembrane potential (A^Fm), swelling of the 
matrix, and generation of highly toxic oxygen radicals or reactive oxygen species (ROS). 
Consequently, several mitochondrial factors are released into cytosol. Mitochondria 
contain several pro-apoptotic molecules including cytochrome c, Smac/DIABLO, Htr2A 
(Omi), apoptosis-inducing factor (AIF), and endonuclease G (Desagher and Martinou, 
2000; Shi, 2001; Wang, 2001). Some caspases are also localized in mitochondria 
(Zhivotovsky et al., 1999). AIF and endonuclease G execute apoptosis independently 
from caspases (Wang, 2001), while cytochrome c and Smac/DIABLO serve as initiation 
signals of the apoptotic cascade. When Apaf-1 (apoptotic protease activating factor-1) 
and cytochrome c form a complex called the apoptosome in the presence of dATP or 
ATP in the cytosol, caspase-9 is recruited and activated through the CARD adaptor 
domain (Pan et al., 1998). Caspase-9, like caspase-8, further activates effector caspases 
and induces apoptosis. The other mitochondrial molecule Smac/DIABLO inhibits the 
inhibitor of apoptosis protein (IAP) and thereby promotes apoptosis (Srinivasula et al., 
2001). Recently, the important role of caspase-2 in mitochondrial-mediated apoptosis 
was demonstrated (Lassus et al., 2002). The apoptotic function of caspase-2 has been 
understood for some time, as it was the first mammalian apoptotic caspase to be 
identified (Kumar et al., 1994; Wang et al., 1994). Caspase-2 acts upstream of the 
mitochondria in chemical- or UV-induced apoptosis in several different cell lines, such 
as IMR90 (human fibroblasts), A549 (lung adenocarcinoma), and U20S (osteosarcoma), 
and regulates the release of cytochrome c and Smac as well as the translocation of 
pro-apoptotic Bax into mitochondria by altering mitochondrial membrane 
permeabilization by unknown mechanisms (Lassus et al., 2002). This finding may 
change the view of mitochondria as a central regulator in apoptosis. Additionally, 
caspase-2 may be localized in golgi complexes and cleave golgin-160 (Mancini et al., 
2000). Thus, the golgi complex may be another key organelle for the initiation of 
apoptotic cell death. 
51 
Recently, cross-talk between the receptor-mediated and mitochondrial-mediated 
pathways in apoptosis has been reported. Caspase-8 cleaves one of the pro-apoptotic 
Bcl-2 family proteins, Bid, upon activation (Li et al., 1998; Gross et al., 1999). 
Cleaved Bid translocates into the mitochondrial membrane to inhibit Bcl-2 and/or 
BC1-XL anti-apoptotic function, resulting in depolarization of AYm and release of 
pro-apoptotic molecules including cytochrome c from mitochondria. This cross-talk 
may work as an amplification mechanism of apoptotic cell death (Gross et al., 1999; 
Tang et al., 2000). 
ROS, on the other hand, reacts with cellular macromolecules, lipids, and 
nucleotides to disturb normal cellular functions. ROS has also been reported to activate 
certain stress-activated protein kinases (SAPK) and/or mitogen activated protein kinases 
(MAPK) to induce the apoptotic process (Kang et al., 1998; Luo et al., 1998; Crenesse et 
al., 2000). Some of the MAPK are activated in response to oxidative stress (Frasch et 
al., 1998; Luo et al., 1998; Bhat and Zhang, 1999; Assefa et al., 2000) and activate many 
redox-sensitive transcription factors including NF-kB and AP-1, which may play critical 
roles in the execution of apoptosis (Grilli and Memo, 1999; Li and Sun, 1999). Thus, 
disruption of the oxidation balance in biological systems results in activation of 
apoptotic cell death. 
Several pro- and anti-apoptotic proteins regulate the activation of the caspase 
cascade. Mitochondria are one of the most important organelles involved in caspase 
activation and apoptosis. Mitochondrial products rate-limit the activation of caspases 
and endonucleases, the major executors of apoptosis, in cell-free systems (Zamzami et 
al., 1995; Ellerby et al., 1997; Kluck et al., 1997; Yang et al., 1997). In addition, 
downstream caspase activation and other execution processes are significantly blocked 
when mitochondrial membranes are stabilized (Zamzami et al., 1995; Marchetti et al., 
1996). These results suggest that mitochondria or mitochondrial proteins are important 
in the regulation of apoptosis. Among them, Bcl-2 family proteins play major roles in 
the initiation phase of apoptosis (Tsujimoto, 1998). Bcl-2 family proteins are abundant 
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particularly in the outer mitochondrial membrane and are divided into two subgroups 
based on their pro-apoptotic and anti-apoptotic roles. Pro-apoptotic Bcl-2 proteins 
include Bad, Bax, Bak, Bid, and Hrk, and anti-apoptotic Bcl-2 proteins include Bcl-2 
and BC1-XL (Figure 10). Anti-apoptotic Bcl-2 proteins share three or four regions in 
their structure, depicted as BH1-4 in Figure 10. Also, most of the anti-apoptotic Bcl-2 
proteins possess a membrane-spanning domain at the C-terminus, enabling their 
localization to nuclear membranes, the endoplasmic reticulum (ER), or mitochondrial 
membranes. The exact mechanisms of these proteins are still under investigation. An 
important function of Bcl-2 and BC1-XL is inhibition of the mitochondrial permeability 
transition (MPT) pores. In some cases, MPT pore formation plays a significant role in 
the initiation of apoptosis as the megachannel, multiprotein complex formed at the 
contact site between the mitochondrial inner and outer membranes that regulate the 
mitochondrial Ca2+ level, pH, transmembrane potential, and mitochondrial volume 
(Kroemer, 1999). Cellular depolarization of AYm and release of mitochondria 
associated apoptotic signaling molecules, including Apaf-1, Smac/DIABLO, or 
cytochrome c result (Shi, 2001). Also MPT pore opening disturbs Ca2+ homeostasis by 
increasing cytosolic Ca2+ levels (Macho et al., 1997). Bcl-2 and BC1-XL interact with 
MPT pores to inhibit pore activity (Kroemer, 1999). MPT pores have also been 
implicated in CNS injuries including excitotoxic neuronal death (Albin and Greenamyre, 
1992; Beal et al., 1993; Ellerby et al., 1997; Nicotera et al., 1997). Pharmacologically, 
MPT pores can be blocked by cellular treatment with cyclosporine A (CsA, 1 |iM) or 
bongkrekic acid (50-100 JJM) and rescued from apoptosis (Cao et al., 2001). 
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Figure 10: Sequence Homology of Bcl-2 Family Proteins (Modified from Strasser et 
al., 2000) 
However, in some cases, these pharmacological inhibitors do not inhibit 
depolarization of Af m and apoptosis. CsA-insensitive pores have been found in 
mitochondria, and pro-apoptotic Bcl-2 proteins may be responsible for the formation of 
these pores during certain apoptotic processes (Shi, 2001). When pro-apoptotic Bcl-2 
proteins, such as Bad and Bax, are abundant in mitochondrial membranes, they form 
homodiamers or heterodiamers and create small pores (Tsujimoto, 1998; Desagher and 
Martinou, 2000; Shi, 2001). This pore formation initiates apoptotic signals, similar to 
the effects caused by MPT pores. Bcl-2 and BC1-XL are believed to bind with Bax and 
Bad to form heterodiamers and prevent mitochondrial depolarization and release of 
pro-apoptotic signaling molecules (Chiang et al., 2001). 
The Bcl-3 homologous (BH3) proteins, such as Bad, Bid, Bim, Bax, Hrk, and 
54 
Bik, are the major pro-apoptotic Bel 2 proteins and initiate cytotoxic stimuli-induced 
apoptosis. These proteins initiate apoptosis by inhibiting anti-apoptotic Bcl-2 proteins 
(eg. Bcl2 Bcl-xl )anti-apoptotic functions in mitochondria, (Bouillet and Strasser, 2002). 
The BH3 domain in these proteins binds to the BH3 domain in anti-apoptotic Bcl-2 
proteins to neutralize the anti-apoptotic functions. In neuronal cells, activation of the 
BH3 protein Bim regulates cytochrome c release and caspase-dependent apoptosis 
(Putcha et al., 2001), indicating that Bim activation is upstream of mitochondrial effects. 
Recently, protein kinases and phosphatases have been suggested to regulate the 
apoptotic cascade (Berra et al., 1997; Murray and Fields, 1997; Cardone et al., 1998; 
Whelan and Parker, 1998; Reyland et al., 1999; Reyland et al., 2000; Chiang et al., 
2001). Caspase-3 is involved in proteolytic cleavage and activation of certain isoforms 
of protein kinase C (PKC) and phosphatases (Santoro et al., 1998; Reyland et al., 1999). 
As mentioned above, Bcl-2 proteins may be primary targets (Komblau et al., 2000; 
Chiang et al., 2001). Upon phosphorylation, pro-apoptotic Bcl-2 proteins dissociate 
from the mitochondrial membrane and bind to chaperone proteins, such as the 14-3-3 
protein in cytosol. As a result, upstream apoptotic signaling is suppressed. 
Protein kinase Cô and apoptosis 
Protein kinase Cô (PKCô), discovered in 1986 by Gschwendt et al., is a novel 
type of PKC that translocates to the membrane following phorbol ester treatment 
(Gschwendt et al., 1986). In the following year, PKCô cDNA was cloned from a rat 
brain cDNA library, which localized on chromosome 19 (Ono et al., 1987; Kurkinen et 
al., 2000), enabling the localization of the PKCô gene on human chromosome 3 and 
mouse chromosome 14 (Huppi et al., 1994). PKCÔ is an isoform in the AGC kinase 
family. Currently, there are 11 PKC isoforms further classified into three distinct 
sub-family groups based on their activation patterns (Figure 11). These sub-family 
categories are conventional PKC (cPKC), novel PKC (nPKC), and atypical PKC (aPKC). 
Conventional PKCs include PKCa, (31, (311, and y, and they are dependent on 
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intracellular calcium concentrations and activated by diacylglycerol (DAG) or phorbol 
ester. Novel PKCs include PKCô, e, r\, 0, and j-i, and they are also activated by DAG 
or phorbol ester but are calcium independent. The last group of atypical PKCs include 
PKCÇ and X(i), which are calcium-independent and are not activated by DAG or phorbol 
ester. The means of activation of enzymes in the different subfamilies are primarily 
due to differences in the molecular structures of the kinases. All PKC proteins consist 
of the regulatory domain (N-terminus) and the catalytic domain (C-terminus) (Figure 11). 
Both cPKC and nPKC contain cysteine-rich sequences that interact with phospholipids 
and phorbol ester activators (Ono et al., 1989), whereas aPKC enzymes lack these 
sequences. Furthermore, only cPKC enzymes possess the calcium-binding region (C2) 
in the regulatory domain and are thus calcium-dependent (Ono et al., 1988). The 
amino acid sequence homology has been determined to be 82% ((31), 85% ((311), 75% (y), 
58% (ô), 60% (s), and 51% (Q compared to the PKCa isoform (Ono et al., 1988). 
PKCô, one of the nPKC family protein, contains a carboxy-terminal catalytic 
domain with two conserved regions, an ATP binding region (C3) and a catalytically 
active/substrate binding region (C4), and an amino-terminal regulatory domain with an 
inhibitory pseudo-substrate sequence and two cysteine-rich zinc-finger-like sequences 
(Cysl and Cys2) in the CI region (Gschwendt, 1999). Functional studies have 
revealed that the Cys2 region may play a critical role in the translocation of cytosolic 
PKCô into cellular membranes following activation by phorbol esters (Szallasi et al., 
1996; Hunn and Quest, 1997). Five of six cysteine residues and two histidine residues 
interact with Zn2+ to form a specific coordination and attract phorbol ester binding 
(Kazanietz et al., 1995; Zhang et al., 1995). 
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Figure 11: Structural Homology in PKC Family Proteins (Modified from Ono et al., 
1988) 
Activation of PKCô requires several signals and changes in its structure. 
Figure 12 schematically depicts the brief mechanism of PKCô phosphorylation and 
activation. Conventionally, PKCô is activated by phorbol ester (TPA) stimulation 
and/or generation of phospholipid (PL) or diacylglycerol (DAG) in cellular membranes. 
Upon binding of the cysteine-rich domain (CI) to TPA, PL or DAG, the catalytic domain 
is uncovered, allowing substrates to bind to the site. Phosphorylation of S643 appears 
to be required prior to kinase activation. Mutation of S643A causes more than a 70% 
decrease in kinase activity (Li et al., 1997). Further investigation revealed that S643 is 
autophosphorylated, thus enhancing catalytic activity, when PKCô is in a low activity 
form (Li et al., 1997; Le Good et al., 1998). However, Stempka et al. (1999) reported 
that S643A did not reduce kinase activity (Stempka et al., 1999), indicating more studies 
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are required to draw an accurate conclusion regarding the role of S643A. In addition, 
several other serine or threonine phosphorylation sites that may be required for 
activation have been identified in PKCô. Phosphorylation of T505 in the activation 
loop and S662 in the hydrophobic C-terminus appears to be important for PKCÔ 
activation because unphosphorylated T505 and S662 sites in PKCô resulted in less than 
1/10 of the normal kinase activity (Le Good et al., 1998). A threonine residue (T505) 
in the activation loop of PKCô may be phosphorylated by 3-phosphoinositide-dependent 
protein kinase 1 (PDK1) (Hodgkinson and Sale, 2002). These studies suggest that 
other sites may play a more important role in the activation of PKCô. Tyrosine 
phosphorylation and subsequent activation of PKCô will be discussed later in this 
section. Another amino acid in the catalytic domain, E500, contributes to the negative 
charge in the activation loop, which is critical for kinase activity (Stempka et al., 1999). 
Kinase activity in E500V PKCô was reduced by about 75% in a mutation study 
(Stempka et al., 1999). However, the detailed mechanisms are still unclear at this 
point. 
N-terminal Position iC-terminal 
PKC isozymes 
PKCa 
PKC|3I 
PKC (111 
PKCy 
PKCô 
PKCE 
PKCTI 
PKCC 
-7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 
S 
S 
S 
S 
s 
R R 
K 
R R R K G F R R K A 
F L K R K G F K K F A 
Y K L K R K G F K K K A 
R R 
A R 
R R R K G F K R K A 
R K R K G F F Y G 
F 
G 
Y Y X K R K M s 
S 
s 
F F E F 
A R R R R R '  R F R R X R 
F F R R F K R Q G F F Y 
Table 7: Optimal Amino Acid Motifs for Selected PKC Isozymes (Modified from 
Nishikawa et al., 1997) 
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Figure 12: Activation Mechanism of PKCô (Modified from Gschwendt, 1999) 
Upon activation, PKCô phosphorylates serine/threonine residues in specific 
substrates. The specific amino acid substrate sequences phosphorylated by PKCô are 
not well characterized. Based on a study with synthetic peptides, a general consensus 
phosphorylation site motif for PKC has been defined as RXX(S/T)XRX, where X could 
be any amino acid (Pearson and Kemp, 1991). Recently, Nishikawa and his colleagues 
examined the specific amino acid sequence motifs for major PKC isozymes and 
identified the common and different substrate amino acid sequences among PKC 
isozymes (Nishikawa et al., 1997). In particular, PKCô requires a hydrophobic amino 
acid at position +1 in the carboxyl-terminal of the phosphorylation site (Ser), basic 
amino acids at positions -6, -5, -4, and -2, and glycine at position -1. All the PKC 
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isozymes evaluated require that substrates have arginine at position -3, which reconciles 
with the consensus sequence motif. Their data also indicate that the optimal amino 
acid sequence for PKCô phosphorylation is A(A/R)R(K/A)RKGSFF(Y/F)GG, where 
the underlined serine (S) is the phosphorylation site, and the bold letters are particularly 
important for sequence recognition by PKCô. Amino acid sequence motifs for other 
PKC isozymes are shown in Table 7, and some PKC isozymes share common motifs, 
indicating that PKC phosphorylation sites may be conserved among the isozymes 
(Nishikawa et al., 1997). 
PKCô is ubiquitously expressed in most tissues and cell types (Leibersperger et 
al., 1991; Wetsel et al., 1992). The expression of PKCô in different murine tissues has 
been examined and extremely high levels of PKCô were found in epidermis, placenta, 
uterus, brain, lung, and kidney (Leibersperger et al., 1991). PKCô as well as PKCa, (3, 
s, and Ç are present in the CNS at birth, and the expression of PKCô increases in the 
brain but decreases in the lung, kidney, and heart as age progresses (Goldberg and 
Steinberg, 1996). This age-dependent change in specific tissues may affect the 
responsiveness of these tissues to certain stimuli. Within the CNS, PKCô is 
particularly abundant in the cerebellum (Merchenthaler et al., 1993). PKCô is rapidly 
induced in certain brain regions following birth or global brain ischemia (Chen and 
Hillman, 1994; Koponen et al., 2000) (Table 8). The exact mechanism by which PKCô 
is rapidly induced following ischemic insult is not known, yet the expression of PKCÔ is 
regulated by several transcription factors. The PKCô gene encodes the binding sites of 
AP-1, NF-kB, and nerve growth factor induced-C (NGFI-C), and these transcription 
factors activate PKCô (Kurkinen et al., 2000; Kikkawa et al., 2002). AP-1 and NF-kB 
may be involved in apoptosis (Li and Sun, 1999; Aggarwal, 2000; Garg and Aggarwal, 
2002), and NGFI-C is responsible for neurite growth and differentiation (Wemersson et 
al., 1998). As discussed later in this section, regulation of the PKCô gene by these 
transcription factors further indicates that PKCô can mediate apoptosis, delay cell death 
as well as control cell differentiation (O'Driscoll et al., 1995; Miettinen et al., 1996; 
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Sawai et al., 1997; Chen et al., 1999; Li et al., 1999; Koponen et al., 2000; Cerda et al., 
2001) (also refer to Table 8). 
The physiological roles of PKCô appear to be diverse, with critical functions in 
cell differentiation and proliferation as well as in regulation of apoptotic cell death 
(Table 8). Selective activation of PKCô facilitates nerve growth factor-induced neurite 
outgrowth and differentiation in PC12 cells (O'Driscoll et al., 1995) as well as 
differentiation and growth arrest in human tumor CaCo-2 cells (Cerda et al., 2001). In 
addition, PKCÔ expression is important during pre- and post-natal developmental phases 
(Chen and Hillman, 1994; Goldberg and Steinberg, 1996), supporting a regulatory role 
of PKCô in cell proliferation and differentiation. Endocrine secretion is also regulated 
by PKCô. Neurotensin is secreted from pancreatic cells upon translocation of PKCÔ 
into the membrane (Li et al., 2002), indicating that the kinase activity may be an initial 
signal for the secretion mechanisms of certain endocrines. PKCô activity is important 
during apoptosis induced following treatment with hydrogen peroxide, UV-B radiation, 
etoposide, TNFa, and anti-Fas antibody (Emoto et al., 1995; Ghayur et al., 1996; 
Konishi et al., 1997; Reyland et al., 1999; Fukunaga et al., 2001; Konishi et al., 2001). 
Three distinct PKCô activation mechanisms have been proposed: translocation 
of native PKCô into the cellular membrane; proteolytic cleavage of native PKCô into the 
catalytic and regulatory subunits by caspase-3; and tyrosine phosphorylation of PKCô 
(Figure 13A). As mentioned above, the most conventional activation mechanism is 
translocation of PKCô into membranes upon PL, DAG, or TPA stimulation. Recently, 
PKCô was found to translocate into the mitochondrial membrane following TPA 
treatment and trigger cytochrome c release, an initial apoptotic signaling process (Li et 
al., 1999; Majumder et al., 2000), suggesting that PKCô may act as an early 
pro-apoptotic signal. PKCô proteolytic cleavage and subsequent activation were first 
reported by Emoto et al. (1995). Follow-up studies revealed that activation of 
caspase-3 by exogenous chemicals such as etoposide or TNFa or by radiation insult 
generates the active PKCô fragment (Table 8). Genomic results suggest the possible 
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cleavage site as DIPD at position 324-327 (Figure 13B), yet it has not been confirmed. 
Tyrosine 52, 155, 187, 311, 332, 512, 523 and 565 are known to be phosphorylated and 
may play a role in modulating kinase activity (Szallasi et al., 1995; Li et al., 1996; 
Konishi et al., 1997; Kikkawa et al., 2002). Tyrosine phosphorylation at positions 311, 
332 and 512 following hydrogen peroxide or UV-B treatment induces activation of 
PKCÔ in HaCaT or COS-7 cells (Konishi et al., 1997; Fukunaga et al., 2001; Konishi et 
al., 2001). Tyrosine phosphorylation at these positions may induce conformational 
changes and open the catalytic domain (Kikkawa et al., 2002), as two major tyrosine 
phosphorylation sites (Y311 and Y332) are in the hinge region of PKCô. Upon 
phosphorylation of these residues, PKCô may undergo conformational change and 
expose the catalytic domain, yet further studies are necessary to confirm this hypothesis. 
Tyrosine phosphorylation is also an important modulator of PKCô activity in general. 
Several different tyrosine kinases are involved in phosphorylation of PKCô (Li et al., 
1994; Szallasi et al., 1995; Denning et al., 1996; Joseloff et al., 2002), and some of the 
phosphorylation sites may be isoform specific. Regulation of kinase activity by 
tyrosine phosphorylation is particularly important for PKCô as PKCô is 
tyrosine-phosphorylated most efficiently among the PKC family. Tyrosine 
phosphorylation negatively modulates PKCô activity in epidermal growth factor 
(EGF)-treated epidermal cells or following phosphorylation by the Src family enzymes 
(Denning et al., 1996; Joseloff et al., 2002). On the other hand, tyrosine 
phosphorylation positively modulates PKCô activity when cells are treated with phorbol 
ester, NGF, or substance P (Li et al., 1994; Soltoff and Toker, 1995; Szallasi et al., 1995). 
The pro-apoptotic function of PKCô has been investigated extensively, but the 
exact mechanism remains unknown. Although the events downstream of PKCô and 
those that lead to apoptosis remain unclear, studies from many research groups over the 
last few years have shown that the catalytically active PKCô fragment regulates the 
activity of a host of cell signaling molecules such as scrambalase, an enzyme which 
induces bi-directional movement of phospholipids across the membrane during 
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apoptosis (Frasch et al., 2000), DNA protein kinase (DNA-PK), an enzyme essential for 
the repair of double-stranded DNA breaks (Bharti et al., 1998), small heat-shock 
proteins-25/27 (Maizels et al., 1998), histone H2B (Ajiro, 2000), and lamin kinase 
(Cross et al., 2000). In addition, PKCô phosphorylates other cell signaling molecules 
such as MAP kinases (Chen and Chen, 1999), the tyrosine kinase Jak2 (Kovanen et al., 
2000), and Stat3 signal transducers and activators of transcription (Jain et al., 1999). 
Most recently, PKCÔ has been shown to activate the redox sensitive transcription factor, 
NF-KB, and thereby promote apoptosis in neutrophils (Vancurova et al., 2001). 
Furthermore, PKCÔ has been shown to translocate to the nucleus, mitochondria, 
cytoplasm, plasma membrane and other cellular organelles to initiate programmed cell 
death (Sawai et al., 1997; Chen et al., 1999; Dal Pra et al., 1999; Li et al., 1999; 
Dempsey et al., 2000; Majumder et al., 2000). Hence, the constitutively active PKCÔ 
fragment results in the loss of regulatory function of many of its substrates, resulting in 
rapid apoptotic cell death. 
Cell line Treatment Mode of Activation Functional Change Reference 
BON cells TPA Translocation (membrane) Neurotensin secretion Li et al., 2002 
CaCo-2 Over-expression Translocation (membrane) Differentiation/Apoptosis Cerda et al., 2001 
CI 41 UV-B Translocation (membrane) Apoptotic features Chen et al., 1999 
HL-60 Ceramide Translocation (membrane) Apoptotic features Sawai et al., 1997 
PC 12 NGF Translocation (membrane) Differentiation O'Driscoll et aL, 1995 
U-937 H2O2 Translocation (mitochondria) Apoptotic features Majumder et al., 2001 
MCF-7 TPA Translocation (mitochondria) Apoptotic features Majumder et aL, 2000 
Keratinocytes TPA Translocation (mitochondria) Apoptotic features Liet al., 1999 
HeLa cells Aplidin Proteolytic cleavage Apoptotic features Garcia-Fernandez et aL, 2002 
HeLa cells Etoposide Proteolytic cleavage Apoptotic features Cross etaL, 2000 
Salivary cells Etoposide Proteolytic cleavage Apoptotic features Rayland et al., 1999 
HeLa cells TNFa Proteolytic cleavage Apoptotic features Ghayur et aL, 1996 
U-937 Ionized radiation Proteolytic cleavage Apoptotic features Emoto et aL, 1995 
HaCaT cells UV-B Tyrosine phosphorylation Apoptotic features Fukunaga et aL, 2001 
COS-7 H202 Tyrosine phosphorylation N/A Konishi et al., 1997 
Animal Studies Models Mode of Activation Functional Change Reference 
Rat Brain ischemia Induction N/A Koponen et aL, 2000 
Rat Brain ischemia Induction N/A MiettinenetaL, 1996 
Table 8: Mode of Activation and Cellular Function of PKCÔ 
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A. Activation mechanism of PKCô 
Growth and differentiation signal Apoptotic signal 
TPA H2O2 
Translocation 
Z 
^ (Tyr-kinase) (Caspase 3) \ ; t 
PKC8 
C IB CIA KC2-like)— H2N 
COOH 
C.2 UoX IC1A C"B 
Tyrosine phosphorylation Fragmentation 
B. Amino acid sequence of rat PKCô 
1 MAPFLRISFN SYELGSLQAE DDASQPFCAV KMKEALTTDR GKTLVQKKPT MYPEWKSTFD 
61 AHIYEGRVIQIVLMRAAEDP MSEVTVGVSV LAERCKKNNG KAEFWLDLQP QAKVLMCVQY 
121 FLEDGDCKQS MRSEEEAMFP TMNRRGAIKQ AKIHYIKNHE FIATFFGQPT FCSVCKEFVW 
181 GLNKQGYKCR QCNAAIHKKC IDKIIGRCTG TATNSRDTIF QKERFNIDMP HRFKVYNYMS 
241 PTFCDHCGTL LWGLVKQGLK CEDCGMNVHH KCREKVANLC GINQKLLAEA LNQVTQKASR 
301 KPETPETVGIVQGFEKKTAV SGNDIPDNNG TYGKIWEGSN RCRLENFTFQ KVLGKGSFGK 
361 VLLAELKGKE RYFAIKYLKK DVVLIDDDVE CTMVEKRVLA LAWENPFLTH LICTFQTKDH 
421 LFFVMEFLNG GDLMFHIQDK GRFELYRATF YAAEIICGLQ FLHGKGIIYR DLKLDNVMLD 
481 KDGHIKIADF GMCKENIFGE NRASTFCGTP DYIAPEILQG LKYSFSVDWW SFGVLLYEML 
541 IGQSPFHGDD EDELFESIRV DTPHYPRWIT KESKDIMEKL FERDPAKRLG VTGNIRLHPF 
601 FKTINWNLLE KRKVEPPFKP KVKSPSDYSN FDPEFLNEKP QLSFSDKNLIDSMDQTAFKG 
661 FSFVNPKYEQ FLE 
Figure 13: Amino Acid Sequence and Activation Mechanism of PKCÔ (Modified from 
Kikkawa et al., 2002) 
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Progression of Parkinson's disease and biochemical hallmarks 
The pathological features of PD are well established, and possible cell death 
processes have been identified to some extent in recent years. Although the 
dopaminergic neuronal degeneration has not yet been characterized in idiopathic PD, 
several lines of evidence strongly suggest that dopaminergic neuronal loss in the SNc 
has certain positive correlations with mitochondrial dysfunction, activation of caspase-3, 
and other pro-apoptotic signaling processes (Hartmann et al., 2000). PD is associated 
with a systemic defect in mitochondrial complex I activity (Schapira, 1993; Haas et al., 
1995; Swerdlow et al., 1996). Mammalian complex I in the inner mitochondrial 
membrane consists of at least 43 proteins, at least seven of which are encoded in 
mitochondrial DNA (Greenamyre et al., 2001). Mitochondrial complex I mediates an 
initial electron transfer from NADH to ubiquinone to generate a proton gradient by 
promoting proton uptake into the inter-membrane mitochondrial space and produce 
cellular energy. Decreased mitochondrial complex I activity has been observed in PD 
patients' brains (Mizuno et al., 1989; Parker et al., 1989; Hattori et al., 1991), and 
treatment with a mitochondrial complex I inhibitor induced PD-like symptoms in animal 
models (Tipton and Singer, 1993; Betarbet et al., 2000; Betarbet et al., 2002). The 
defect may result in increased production of ROS and other oxidative stressors, which 
subsequently activate pro-apoptotic signaling processes. Several environmental toxins, 
such as rotenone and paraquat as well as MPTP, are known to inhibit mitochondrial 
complex I activity and are suspected risk factors of PD (Betarbet et al., 2002). 
Exposure to certain environmental chemicals may cause dysfunction of mitochondrial 
complex I and result in neurodegeneration. Thus, either genetic or acquired complex I 
abnormalities may be important in the pathophysiology of PD. 
Mitochondria use more than 90% of the total cellular oxygen to produce ATP 
(Kidd et al., 1988). When mitochondria become dysfunctional, free cellular oxygen 
may be unused and converted to ROS. In general, the brain is especially susceptible to 
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oxidative stress. First, antioxidant activities of catalases and peroxidases are normally 
lower in the brain than in other organs while SOD activity is higher, resulting in the 
excessive formation of hydrogen peroxide in the brain. Second, the brain consumes 
much higher levels of oxygen than other organs, contributing to the greater generation of 
endogenous ROS. The enhanced vulnerability of the substantia nigra to oxidative 
insults is related to the high levels of dopamine and low levels of GSH. Dopamine, one 
of the most unstable neurotransmitters in the brain, readily undergoes auto-oxidation to 
form highly reactive and toxic dopamine quinones (Graham, 1984). One of the most 
intensively studied dopamine quinones important in PD pathology is 
6-hydroxydopamine (6-OHDA). The formation of 6-OHDA is accelerated by metal 
ions, such as copper, manganese, or zinc (Youdim et al., 1989). In the normal 
dopamine degradation process, hydrogen peroxide is produced as a by-product during 
conversion to DOPAC by MAO-B (Stokes et al., 1999). In addition, GSH levels are 
lower in the SNc than in other brain regions and may also contribute to the enhanced 
susceptibility of the SNc to oxidative stress (Perry et al., 1982; Jenner, 1998). GSH 
functions as an antioxidant and as a cofactor of cytochrome P450 enzymes (Youdim et 
al., 1989; Jenner, 1998). Depletion of cellular GSH could be one of the major causal 
factors of neurodegeneration. These additional sources of oxidative stress and low 
antioxidant defense mechanisms make the SNc a primary target of oxidative insults and 
trigger of apoptotic cell death of dopaminergic neurons in the SNc. 
Caspase-3 is in a latent state during the progression of PD. The highest level 
of activated caspase-3 (68.4% activated caspase-3 positive neurons) was observed in the 
lateroventral part of the SNc, where the most severe neuronal loss (91%) occurs in PD 
(Fearnley and Lees, 1991). Activated caspase-3 was also measured in the dorsal 
(47.2%) and ventromedial (30.4%) parts of the SNc, where 56% and 71% neuronal loss 
was observed in PD patients, respectively (Hartmann et al., 2000). Although active 
caspase-3 positive dopaminergic neurons were also detected in control brains, the 
relative percentage of active caspase-3 positive dopaminergic neurons in PD brains was 
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five times higher than the control group. Active caspase-3 correlated with apoptosis in 
postmortem PD brains has also been reported elsewhere (Tatton, 2000). Therefore, the 
caspase-3 cascade and resulting apoptosis may be one of the possible mechanisms of 
dopaminergic degeneration in PD. Furthermore, apoptotic dopaminergic neurons in the 
SNc have been observed in Lewy body-associated disorders (Tompkins et al., 1997), 
normal aging (Anglade et al., 1997a), and PD (Anglade et al., 1997b; Kingsbury et al., 
1998). Interestingly, one of the pro-apoptotic Bcl-2 family proteins, Bax, was also 
up-regulated in SNc dopaminergic neurons of PD patients (Tatton, 2000). In addition, 
the SNc from aged PD patients contains lower amounts of the dopamine transporter 
(DAT) as well as decreased levels of DAT mRNA and vesicular monoamine transporter 
(VMAT2) in the striatum (Counihan and Penney, 1998; Ma et al., 1999; Miller et al., 
1999b). 
Several proteins have recently been identified as important in the progression of 
dopaminergic neurodegeneration and PD. In this section, three proteins, namely 
a-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase (UCH)-Ll, will be 
discussed. Two mutations in a-synuclein, A3 OP and A53T, have been identified in 
familial PD in a German family and a Greek-Italian family, respectively 
(Polymeropoulos et al., 1997; Kruger et al., 1998). a-synuclein is abundant in the CNS, 
accounting for approximately 5% of the total synaptic proteins. The human synuclein 
family consists of a-, (3- and y-synuclein and synoretin (Jakes et al., 1994; Iwai et al., 
1995; Buchman et al., 1998). a- and (3-synucleins are mainly found in the CNS, 
whereas y-synuclein and synoretin are found in the PNS and retina, respectively 
(Surguchov et al., 1999). a-synuclein consists of 140 amino acids and is characterized 
by repetitive, imperfect repeats (KTKEGV) distributed throughout most of the 
amino-terminal half of the peptide and an acidic C-terminus with 3% a-helixes and 23% 
(3-sheets (Souza et al., 2000b). The exact physiological function of a-synuclein is not 
known, but it may act as a chaperone protein because its N-terminal portion (residue 
1-61) shows 40% homology with the 14-3-3 proteins, which are well-known chaperone 
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proteins (Ostrerova et al., 1999). a-synuclein has been reported to associate with 
14-3-3, PKC, BAD, ERK, and tau proteins (Jensen et al., 1999; Ostrerova et al., 1999). 
Pathologically, a-synuclein plays an important role in the formation of Lewy bodies, and 
is a major component of these cytoplasmic protein inclusions found in PD. The 
formation of a-synuclein aggregates is accelerated by the mutations A3 OP and A53T 
(Conway et al., 1998; Giasson et al., 1999; Narhi et al., 1999). In addition, nitration of 
a-synuclein tyrosine residues (Y39, Y125, Y133, and Y136) and resulting formation of 
dityrosine cross-linkages facilitated fibril and aggregate formation and stabilization in 
brain (Souza et al., 2000b; Paxinou et al., 2001). 
Parkin is responsible for ubiquitin proteosome system (UPS) and may play an 
important role in the pathogenesis of the common, familial, young-onset PD, known 
particularly as autosomal recessive juvenile parkinsonism (AR-JP) (Kitada et al., 1998). 
In most cases, the onset of AR-JP occurs before the age of 40. Parkin is coded in 
chromosome 6q25.2-q27 and has more than 500 base-pairs and 12 exons, encoding a 
465 amino acid protein (Kitada et al., 1998). With a molecular weight of 52 kDa, 
parkin functions physiologically as an E3 ubiquitin-ligase. Parkin contains a 
ubiquitin-like sequence at its N-terminus and two RING sequences with an in-between 
RING finger at its C-terminus, where the E2 ubiquitin-conjugating protein binds. In 
UPS, three steps are required for protein degradation (Figure 14A). First step is the 
activation of ubiquitin by ATP and El ubiquitin-activating proteins. Activated 
ubiquitin is passed to E2 ubiquitin-conjugating proteins. Fonally, ubiquitin is 
conjugated to target proteins by E3 ubiquitin-ligase. These poly-ubiquitinated proteins 
are unfolded, and ubiquitins are hydrolyzed by (UCH)-Ll for recycling. Unfolded 
proteins are degraded by proteosomes. Mutations at R42P, K161N, K211N, C212Y, 
T240R, R256C, R275W, D280N, C289Q G328E, R334C, T415N, G430D, and C431F 
are considered important in the development of PD, yet not all mutations result in 
pathological features of idiopathic PD. Among these mutations, R275W results in 
Lewy body formation in typical regions affected in PD (Farrer et al., 2001). Parkin is 
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Figure 14: Ubiquitin Proteosome System (Modified from Taylor et al., 2002) 
also detected in Lewy bodies along with a-synuclein, cytochrome c, ubiquitins, and heat 
shock proteins, indicating that parkin may be involved in the pathogenesis of PD 
(Schlossmacher et al., 2002). 
Parkin and the ubiquitin protein degradation system may be involved in 
a-synuclein degradation. The o-glycosylated form of a-synuclein (aSp22) was 
recently identified as a different isoform of a-synuclein, and wild-type parkin facilitates 
the degradation of aSp22 (Shimura et al., 2001). Also, brains from patients with 
AR-JP (with a mutated parkin gene) were incapable of degrading aSp22, and significant 
accumulation of aSp22 was detected in Lewy bodies (Shimura et al., 2001). Parkin is 
proteolytically cleaved by caspase at Asp-126 (Kahns et al., 2002) and is responsible for 
the degradation of the unfolded parkin-associated endothelin receptor-like receptor 
(Pael-R) and for accumulation of Pael-R in the endoplasmic reticulum (ER) of 
dopaminergic neurons. Parkin dysfunction has been observed in AR-JP brains, causes 
69 
ER stress, and may be a triggering factor for stress-induced neuronal cell death (Imai et 
al., 2001; Imai et al., 2002). 
Mutation of (UCH)-Ll may be positively associated with the etiology of PD. 
As mentioned above, (UCH)-Ll is also an important enzyme in the ubiquitin protein 
degradation process (Figure 14B). Removal of ubiquitin from target proteins is 
necessary prior to degradation by proteosomes. (UCH)-Ll consists of 230 amino acids 
and is one of the most abundant proteins in the brain, accounting for approximately 2% 
of all the brain proteins (Wilkinson et al., 1989; Wilkinson et al., 1992). It is also found 
in Lewy bodies in PD (Lowe et al, 1990), suggesting its importance in the pathogenesis 
of PD. Mutation of I93M (isoleucine to methionine at position 93) was identified in a 
German family with a history of familial PD (Leroy et al., 1998). The mutation site is 
highly conserved among subtypes as well as species and results in a significant reduction 
(about 50%) in its catalytic activity, suggesting that the mutation leads to malfunction of 
the protein degradation and subsequent protein accumulation and aggregation in neurons 
(Leroy et al, 1998). However, epidemiological evidence indicates that the mutation of 
I93M in (UCH)-Ll is extremely rare and may not contribute to the etiology of PD 
(Harhangi et al., 1999; Lincoln et al., 1999). Furthermore, the mutation of S18Y 
(serine to tyrosine at position 18) in (UCH)-Ll significantly lowers the risk of PD (OR = 
0.53), especially young-onset PD (Maraganore et al, 1999). Similar results were 
reported by other groups (Wintermeyer et al, 2000; Zhang et al., 2000), yet the exact 
mechanism of the protective effects of this mutation in PD remains unclear at this point. 
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CHAPTER II: DIELDRIN-INDUCED OXIDATIVE STRESS AND 
NEUROCHEMICAL CHNAGES CONTRIBUTE TO APOPTOTIC CELL 
DEATH IN DOPAMINERGIC CELLS 
A paper published in Free Radical Biology and Medicine 
Masashi Kitazawa, Vellareddy Anantharam, and Anumantha G. Kanthasamy 
ABSTRACT 
We examined the acute toxicity of dieldrin, a possible environmental risk factor 
of Parkinson's disease, in a dopaminergic cell model, PCI2 cells, to determine early 
cellular events underlying the pesticide-induced degenerative processes. EC50 for 1 hour 
dieldrin exposure was 143 pM for PC 12 cells, whereas EC50 for non-dopaminergic cells 
was 292-351 j-iM, indicating that dieldrin is more toxic to dopaminergic cells. Dieldrin 
also induced rapid, dose-dependent releases of dopamine and its metabolite, DOPAC, 
resulting in depletion of intracellular dopamine. Additionally, dieldrin exposure caused 
depolarization of mitochondrial membrane potential in a dose-dependent manner. Flow 
cytometric analysis showed generation of reactive oxygen species (ROS) within 5 min of 
dieldrin treatment, and significant increases in lipid peroxidation were also detected 
following 1-hour exposure. ROS generation was remarkably inhibited in the presence of 
SOD. Dieldrin-induced apoptosis was significantly attenuated by both SOD and 
MnTBAP (SOD mimetic), suggesting that dieldrin-induced superoxide radicals serve as 
important signals in initiation of apoptosis. Furthermore, pretreatment with deprenyl 
(MAO-inhibitor) or a-methyl-L-p-tyrosine (TH-inhibitor) also suppressed dieldrin-
induced ROS generation and DNA fragmentation. Taken together, these results suggest 
that rapid release of dopamine and generation of ROS are early cellular events which 
may account for dieldrin-induced apoptotic cell death in dopaminergic cells. 
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Key words: Dieldrin, PC 12 Cells, Oxidative Stress, Dopamine, Superoxide, Apoptosis, 
Parkinson's disease 
INTRODUCTION 
Parkinson's disease is an age-related neurodegenerative disorder with a lifetime 
incidence of 1-2%, and every year, 5-24 people per 100,000 of population are diagnosed 
with this disease.1' 2 Although the exact etiology of Parkinson's disease remains 
unknown, the discovery of the neurotoxin 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP), which induces a Parkinson-like syndrome, brought attention to the possibility 
that some exogenous chemicals might contribute to the etiopathogenesis of Parkinson's 
disease.3 Recently, a study that examined the extent of genetic contribution to the 
pathogenesis of Parkinson's disease by comparing thousands of twins concluded that 
genetic factors play a role in the pathogenesis of young-onset of Parkinson's disease, but 
not the more common geriatric-onset Parkinson's disease, which further supports the 
view that environmental factors are dominant risk factors in the etiology of the 
idiopathic Parkinson's disease.4 Decreased mean age of onset of Parkinson's disease has 
been reported in some rural areas, and several epidemiological and case-control studies 
conducted in rural areas have revealed that certain pesticides and other environmental 
factors have positive association with the increased incidence of Parkinson's disease.5"9 
On the contrary, a few case-control studies found no association with environmental 
chemicals, indicating that the role of environmental factors in pathogenesis of 
Parkinson's disease is still debatable.10"13 Nevertheless, taking into consideration the 
variability of study methods, selection of subjects, and geographical regions among 
these case-control studies, it is remarkable that majority of studies found a significant 
association between environmental factors and Parkinson's disease.14 
Dieldrin is a chlorinated cyclodiene compound that was widely used as a 
pesticide around the world until mid-1970, but is still used in several developing 
countries. A recent study indicates that dairy products and meats are still believed to be 
the primary sources of human exposure to dieldrin, and the daily intake level of dieldrin 
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through these contaminated food was estimated at 0.059 |ig per average person.15 Since 
the half-life of dieldrin in human blood is estimated to be around 300 days,16 prolonged 
exposure to dieldrin through food may greatly increase the accumulation of dieldrin in 
the brain and other lipophilic tissues. 
Evidence from several lines of research, ranging from studies of post-mortem 
pathology studies to cultured neurons, have implicated a possible relationship between 
dieldrin and the etiology of Parkinson's disease in humans. Fleming et al.11 measured 
amounts of various organochlorine pesticides in human postmortem brain samples from 
Parkinson's disease patients, Alzheimer's disease patients, and age-matched controls. 
Dieldrin was detected in 6 of 20 brains from Parkinson's disease patients, but in none of 
the 14 age-matched control brains. Another study reported significant levels of dieldrin 
in the caudate nucleus from Parkinson's disease patients.18 Chronic exposure to dieldrin 
in a mesencephalic cell culture shows that dopaminergic neurons are more susceptible 
than other neurons to dieldrin toxicity.19 In addition, in vivo studies reported massive 
dopamine depletions in brains following chronic exposure to dieldrin.20,21 These results 
suggest that chronic exposure to dieldrin, a highly lipophilic compound,22 could 
selectively destroy dopaminergic neurons in substania nigra pars compacta (SNc) and 
could be a risk factor for Parkinson's disease. However, these studies did not examine 
the mechanisms and processes underlying dieldrin-induced selective dopaminergic 
degeneration, and no data have been reported regarding the effect of dieldrin on early 
cellular events. Understanding the early neurochemical and biochemical alterations 
following acute exposure of a neurotoxic agent might provide mechanistic insights into 
toxin-induced neurodegenerative processes. 
In the present study, we specifically examined the acute effect of dieldrin in 
dopminergic cells to identify the early cellular events that might contribute to the 
degenerative process following dieldrin exposure. These early cellular responses play 
critical roles in determining the fate of cell survival. We have mainly utilized rat 
pheochromocytoma (PC 12) cells in this study because these cells give rise to a 
homogeneous population with dopaminergic secretory properties. PC 12 cells also 
possess many important neurochemical and signal transduction processes in a manner 
73 
similar to dopaminergic neurons.23,24 Numerous toxicological studies have utilized 
PC 12 cells as in vitro models to examine dopaminergic toxicity of various 
compounds.25"28 Herein, we report that dieldrin induces neurochemical changes and 
oxidative events following acute exposure in PC 12 cells, and these initial changes of 
oxidative stress contribute to apoptotic cell death. 
MATERIALS AND METHODS 
Chemicals 
Dieldrin, ^-Nicotinamide adenine dinucleotide, reduced form (NADH), sodium 
pyruvate, 3-(4,5-dimethylthiazol-3-yl)-2,5-diphenyl tetrazolium bromide (MTT), 
superoxide dismutase (SOD), a-methyl-L-p-tyrosine (a-MPT), (R)-(-)-deprenyl, and 
neurotransmitter standards (dopamine, DOPAC, L-DOPA, 5-HIAA, and H VA) were 
purchased from Sigma (St. Louis, MO). Mn(III)tetrakis(4-benzoic acid)porphyrin 
chloride (MnTBAP) was obtained from OXIS international Inc. (Portland, OR). 
Fluorescent dyes, hydroethidine, 5-dodecanylamino fluorescein and DiOC6 (3,3'-
dihexyloxacarbocyanine iodide), were purchased from Molecular Probes (Eugene, OR). 
All tissue culture supplies were obtained from Gibco-BRL (Gaithersburg, MD). Other 
routine laboratory reagents were obtained from Fisher Scientific (Pittsburgh, PA). 
Cell culture and treatment 
Dopaminergic PC 12 cells were obtained from the American Type Culture 
Collection (ATCC, Rockville, MD). Additionally, two non-dopaminergic cells were 
used in the cytotoxicity experiments to determine the differential toxic response of 
dieldrin in dopaminergic cells vs. non-dopaminergic cells. These non-dopaminergic 
cells were human cortical neuronal (HCN-2) cells which are primarily GABAergic in 
nature (ATCC, Rockville, MD) and mouse pancreatic a-endocrine (a-TC) cells 
(generous gift from Dr. W. H. Hsu, Iowa State University). PC 12 cells were grown in 
Dulbecco's modified Eagle's medium (DMEM) containing 10% heat inactivated horse 
serum, 5% fetal bovine serum, 2 mM L-glutamine, 50 units penicillin and 50 jj,g/mL 
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streptomycin. a-TC cells were grown in RPMI1640 medium containing 10% fetal 
bovine serum, 2 mM L-glutamine, 50 units penicillin and 50 (J,g/mL streptomycin. 
HCN-2 cells were grown in DMEM medium containing 10% fetal bovine serum, 2 mM 
L-glutamine, 50 units penicillin and 50 p,g/mL streptomycin. These cells were placed in 
75 cm2 cell culture flasks (Nalge Nunc International, Rochester, NY) at 37°C under an 
atmospheric condition of 5% CO2 and 95% air, and 4-6 day old cells were used for the 
experiments. 
Cells were suspended in Krebs-Ringer solution (125 mM NaCl, 5 mM KC1, 25 
mM HEPES, 6 mM glucose, 5 mM NaHCOg, 1.2 mM MgSC>4,1.2 mM KH2PO4, and 2.4 
mM CaCla, pH 7.4) or serum-free RPMI1640 or DMEM at a concentration of 2xl06 
cells/ml. Cells were then treated with dieldrin (30-1000 pM). Dieldrin was first 
dissolved in dimethylsulfoxide (DMSO) to prepare stock solution, and then it was 
further diluted in incubation medium to achieve the final concentrations with 1% or less 
DMSO. After 1-hour incubation with dieldrin at 37°C, dead and live cells were 
determined by trypan blue exclusion method with an Improved Nebauer Hemacytometer 
(Fisher Scientific, Pittsburgh, PA). The cell viability was normalized as percent of 
control. 
Lactate dehydrogenase (LDH) assay 
LDH activity in the cell-free extracellular supernatant was quantified as an 
index of cell death. The method originally described by Vassault29 was modified to a 96 
well format. Briefly, 50 pi of the extracellular supernatant was added to 3 ml of 0.08 M 
Tris buffer (pH 7.2) containing 0.2 M NaCl, 0.2 mM NADH, and 1.6 mM sodium 
pyruvate. LDH activity was measured continuously by monitoring the decrease in the 
rate of absorbance at 339 nm by the Beckman DU-64 spectrophotometer (Beckman 
Instruments, Fullerton, CA). Temperature of cuvettes was maintained at 37°C during 
reading. Changes in absorbance per minute (AA/ÀT) were used to calculate LDH 
activity (U/I), using the following equation: U/I = (AA/ÀT) x 9682 x 0.66, where 9682 
was a coefficient factor, and 0.66 was a correction factor at 37°C. 
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HPLC analysis of neurotransmitters 
Extracellular and intracellular neurotransmitters were analyzed by high-
performance liquid chromatography with electrochemical detection (HPLC-EC). A 
detailed description of this procedure has been described previously.27,30 Briefly, the 
HPLC system consisted of Rainin pressure module and Rainin HPXL solvent delivery 
system (Rainin Instrument Co. Inc., Woburn, MA) with a Bio-Rad automatic sampler, 
model AS-48 (Bio-Rad Laboratories, Hercules, CA). Neurotransmitters were separated 
isocratically by a Microsorb-MV (86-200-E3 C-18 3p.m 100A J2 10086-4) reversed 
phase column (Rainin Instrument Co. Inc., Woburn, MA) with a flow rate of 1 ml/min. 
Electrochemical detection (EC) system consisted of an ES A coulochem model 5100 A 
with a microanalysis cell model 5014A and a guard cell model 5020 (ESA Inc., Bedford, 
MA). All systems were controlled by Rainin Dynamax HPLC method manager software 
program ver. 1.4 (Rainin Instrument Co. Inc., Woburn, MA). The mobile phase 
contained 0.15 M monochloroacetic acid, 0.13 mM sodium octyl sulfonate, 0.67 mM 
disodium EDTA, 0.12 M sodium hydroxide, and 1.5% acetonitrile (all chemicals were 
HPLC grade), and pH of the mobile phase was adjusted to 3.1 with phosphoric acid. 
The HPLC-EC was calibrated with 3,4-dihydroxyphenyl-L-alanine (L-DOPA), DOPAC, 
dopamine, 5-hydroxyindoleacetic acid (5-HIAA), and H VA. Loading amount of each 
sample was 20 pi. The injector was automatically washed after the end of each injection 
with 50% acetonitrile in deionized water. 
3-(4,5-dimethylthiazol-3-yI)-2,5-diphenyl tetrazolium bromide (MTT) assay 
MTT assay is widely used to assess cell viability following treatment with 
various toxic substances.25, 31' 32 MTT assay measures activity of mitochondrial 
dehydrogenase enzymes that cleave tetrazolium ring to produce formazan. Thus, the 
assay can be used as an index of mitochondrial function. After dieldrin treatment, cells 
were washed once and further incubated in serum-free medium containing 0.25 mg/ml 
MTT for 3 hours at 37°C. Supernatant was removed, and MTT crystals were solubilized 
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with acidic isopropanol. Mitochondrial enzyme activity was measured by 
spectrophotometer at 570 nm with reference wavelength at 630 nm. 
Depolarization of mitochondrial membrane potential following dieldrin exposure 
Depolarization of mitochondrial membrane potential (AYm) were assessed by 
flow cytometric analysis using DiOC6.33'34 40 nM DiOC6 was added to incubation 
medium 15 min before the end of treatment period, and the incubation continued at 37°C. 
Then, the cells were washed once, resuspended with PBS, and analyzed by flow 
cytometry with excitation at 484 nm and emission at 501 nm. 
Detection of reactive oxygen species (ROS) and lipid peroxidation by flow 
cytometry 
Flow cytometry is a powerful tool to quantitate the generation of intracellular 
ROS and lipid peroxidation.35"38 The major advantage of flow cytometry over 
conventional fluorometry is that a flow cytometer measures fluorescence intensity only 
inside the cells and it does not account for fluorescence in the extracellular medium.39 
All flow cytometric data were collected on a Becton Dickinson FACScan™ flow 
cytometer (Becton Dickson, San Francisco, CA). Hydroethidine, a sodium borohydride-
reduced derivative of ethidium bromide, was used to detect ROS, specifically o2".35"37 
When hydroethidine is loaded in the cells, it binds to cellular macromolecules. Once O2" 
is generated, it converts hydroethidine to ethidium bromide and increases red 
fluorescence (620 nm). For lipid peroxidation detection, 5-dodecanoylamino fluorescein 
was used.38 The original form of this dye is fluorescent. When it binds to a product of 
lipid peroxidation, the dye loses its fluorescence; thus, decreased fluorescence intensity 
is observed in cells with increased lipid peroxidation. A 15-mW air-cooled argon-ion 
laser was used as an excitation source for both hydroethidine and 5-dodecanoylamino 
fluorescein at 488 nm. The optical filter was 585/42 nm band pass for hydroethidine and 
530/30 nm for 5-dodecanoylamino fluorescein. Cells were detected and distinguished 
from the background by forward-angle light scattering (FSC) and orthogonal light 
scattering (SSC) characteristics. All the flow cytometric data were analyzed by 
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Cellquest™ data analysis software to determine the significant increase or decrease of 
fluorescence intensity. 
PC 12 cells were resuspended with Hanks balanced salt solution (HBSS) with 2 
MM calcium at a density of 0.5 x 106 cells/ml. Cells were then incubated with 10 |IM 
hydroethidine or 1 JJ,M 5-dodecanoylamino fluorescein for 15 min at 37°C in the dark to 
allow dye loading into the cells. After incubation with dye, excess dye was removed, 
and the cells were resuspended with HBSS. Following addition of dieldrin (30-100 (J,M 
final concentration), and ROS generation was measured at 0, 5, 15, and 30 min after the 
exposure, and lipid peroxidation was measured after 1 hour of exposure. 
Apoptosis assay 
When cells undergo apoptosis, several distinct morphological changes can be 
observed. One of these unique changes is DNA fragmentation, which results in DNA 
cleavage into -200 base pairs. Recently, a highly sensitive detection kit called the Cell 
Death Detection Elisa Plus Assay Kit (Roche Biochemicals) was developed, and it 
provides quantitative measurement of histone-associated low molecular weight DNA 
fragments.40 Apoptotic PC 12 cells were measured using this kit exactly as described by 
the manufacturer. Briefly, following dieldrin exposure, cells were centrifuged and 
washed once with PBS. Cells were then incubated with lysis buffer (supplied with the 
kit) for 30 min, centrifuged at 5,000 rpm for 10 min, and then 20 pi of cell lysate was 
placed in streptavidin-coated 96-well multititer plates. The antibody cocktail was a 
mixture of anti-histone-biotin directed against histones (HI, H2A, H2B, H3 and H4) and 
anti-DNA-peroxidase (POD) directed against both single and double stranded DNA in 
the nucleosomes. After incubation, unbound components were removed by washing 
with the incubation buffer, and quantitative determination of the amount of nucleosomes 
retained by anti-DNA-POD in the immunocomplex was determined photometrically 
with ABTS® as a HRP substrate. Measurements were made at 405 nm against an 
ABTS® solution as a blank (reference wavelength 490 nm). 
Morphological changes of apoptosis can also be assessed by Hoechst 33342 
staining as described in previous studies41'42. Since Hoechst 33342 binds to DNA and 
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condensed chromatin, apoptotic cells are expressed in an optically distinct nucleus. 
Cells were plated on collagen (6 pg/cm2) coated cover slides, and treated with dieldrin. 
After exposure, cells were fixed with 10% buffered formaldehyde for 30 min at room 
temperature and stained with Hoechst 33342 (10 pg/ml) for 3 min in the dark. Images 
were taken with a fluorescent microscope (Nikon Inc., Melville, NY) under UV 
illumination. 
Data analysis and statistics 
Data were analyzed using one-way ANOVA or student t-test. Dunnett's post-
test or Bonferroni's multiple comparison test were performed as post-tests, and p<0.05 
was considered as significant. 
RESULTS 
Effect of dieldrin on cell viability 
PC12 cells were exposed to 0, 30, 100, 300, 500, 1000 or 3000 pM dieldrin for 
one hour, and cell viability was measured by trypan blue dye exclusion. Figure 1 shows 
the relationship between dieldrin concentration (log JJ.M) and percent cell survival 
relative to the control. Exposure of PC 12 cells to various doses of dieldrin for one hour 
resulted in a dose-dependent decrease in cell viability as evidenced by trypan blue 
accumulation in damaged cells. The effective concentration of dieldrin (EC50) was 
calculated to be 143 pM by three-parameter non-linear regression. 95% confidence 
interval was 104-198 (IM. Vehicle treated PC 12 cells showed close to 90% viability, 
and were considered as the baseline cell viability. 
To further determine whether dopaminergic cells are more susceptible to dieldrin 
toxicity, we compared the cytotoxic effect of dieldrin on two non-dopaminergic cell 
lines, HCN-2 (Human cortical GABAergic cell line) and a-TC (endocrine cells) (Fig. 1). 
Cytotoxicity was determined by trypan blue following 1 hr exposure to various 
concentrations of dieldrin, and EC50 was calculated as 351 pM and 292 pM for a-TC 
and HCN-2 cells, respectively. 95% confidence interval of EC50 in a-TC cells is 230-
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535 pM, and that in HCN-2 cells is 199-427 pM. Both non-dopaminergic cells show 
significantly higher EC50 than dopaminerigic PC 12 cells. 
Effect of dieldrin on LDH release 
To further substantiate the cytotoxic nature of dieldrin, LDH release was 
measured. Extracellular LDH activity showed a dose-dependent increase with dieldrin 
treatment ranging from 200 to 700% over control group (Fig. 2). Statistical analysis of 
cytotoxic exposure revealed a significant (p<0.05) toxicity in dieldrin-treated groups at 
concentrations greater than 100 pM as compared with control or DMSO-treated 
(vehicle) groups. The final concentration of DMSO (1% or less) used in these 
experiments did not appear to be cytotoxic to PC 12 cells, and no significant increase in 
LDH release was detected when vehicle-controls were compared with untreated PC 12 
cells. As observed in cell viability data, LDH release confirmed the dose-dependence of 
cell death from acute treatment with dieldrin. 
Effect of dieldrin on dopamine release and depletion 
In order to determine whether or not dieldrin treatment altered cellular dopamine 
levels, we measured the extracellular release of dopamine as well as intracellular content 
of dopamine by HPLC-EC analysis. As depicted in Fig. 3 A, dieldrin induced a dose-
dependent release of dopamine during one-hour exposure. Release of dopamine 
appeared to be one of the most sensitive events measured with respect to dieldrin 
neurotoxicity. Levels of release at 30 pM, 100 pM, 300 pM and 500 pM dieldrin were 
81%, 167%, 207% and 235% of control level, respectively. 1000 pM dieldrin treatment 
resulted in a nearly complete release of cellular dopamine (data not shown). Dieldrin-
induced dopamine release was accompanied by concomitant depletion of intracellular 
dopamine content (Fig. 3B), indicating that the synthesis of dopamine was not affected. 
Effect of dieldrin on DOPAC content 
Major metabolites of dopamine, including DOPAC and H VA, were measured 
simultaneously by HPLC-EC detection. DOPAC was detected in large quantity and 
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showed a dose-dependent increase of release (Fig. 4A). This observation is reasonable 
since DOPAC is the major metabolite of dopamine in PC 12 cells, and more cytosolic or 
free dopamine was available for conversion to DOPAC as doses of dieldrin increased. 
Another interesting observation was that, unlike dopamine, DOPAC releases were 
relatively minimal at lower dieldrin exposures. For example, DOPAC release was not 
statistically significant at 100 pM dieldrin. However, significant increases (p<0.05) in 
DOPAC levels were observed at higher doses of dieldrin. On the other hand, 
intracellular DOPAC content increased significantly between the doses of 100 pM and 
500 pM (Fig. 4B). At 500 pM dieldrin, a maximum intracellular DOPAC level was 
1006% over control level. 
Effect of dieldrin on mitochondrial function 
One of the cellular targets for dieldrin is reported to be mitochondria, as it 
inhibits the respiratory chain by blocking at or near cytochrome b.43 Mitochondrial 
activity was determined by MTT assay. When mitochondria are functioning normally, 
dehydrogenase enzymes present in mitochondria converts MTT into formazan, and the 
production of formazan was used as an index of mitochondrial activity. The 
mitochondrial activity was remarkably inhibited by 1-hour exposure to dieldrin (Fig. 5A). 
Dieldrin concentrations ranging from 30-500 pM produced a significant (p<0.05) 
decrease in mitochondrial activity. 
To further confirm that dieldrin acts on mitochondria and causes mitochondrial 
dysfunction, we have assessed mitochondrial membrane potential (A^Pm) using DiOC6 
(mitochondrial membrane potential sensitive fluorochrome) in flow cytometry. As 
shown in Figure 5B, PC 12 cells underwent depolarization of A%i in a dose-dependent 
manner. The changes were 85%, 35%, and 11% of control following lh treatment with 
30, 100, and 300 pM dieldrin, respectively. 
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ROS generation and lipid peroxidation following dieldrin treatment 
An immediate increase in ROS generation was detected in dieldrin-treated PC 12 
cells (Fig. 6). All dieldrin-treated cells showed significant (p<0.01) increases in ROS 
from basal level (0 min) within 5 min of the dieldrin exposure. The lower doses of 
dieldrin exposure (30 and 100 pM) showed higher levels of ROS generation over a 30 
min period, whereas the response of 300 pM dieldrin declined over time. 
To test whether or not an antioxidant enzyme suppresses dieldrin-induced ROS 
generation, we treated the cells with 100 units/ml SOD for 5 min prior to dieldrin 
exposure, and ROS generation was measured at 0, 5, 15 and 30 min. SOD significantly 
(p<0.01) blocked ROS generation over a 30 min time period in 30 pM (Fig. 7A) and 100 
pM (Fig. 7B) dieldrin-treated cells. SOD consistently attenuated 60-70% of dieldrin-
induced ROS, suggesting that dieldrin primarily causes cellular O2 generation. 
Since membrane lipid peroxidation occurs as a result of ROS generation, we 
measured the level of lipid peroxidation following 1 hour of dieldrin exposure. Decrease 
in fluorescence intensity of 5-dodecanoylamino fluorescein when compared with 
vehicle-treated cells, indicated an increase in lipid peroxidation following dieldrin 
treatment. As depicted in Figure 8, lipid peroxidation was detected in dose-dependent 
manner, and the significant (p<0.05) lipid peroxidation was observed in both 300 pM 
and 500 pM dieldrin-treated PC 12 cells following one hour of exposure. The levels of 
decrease in fluorescence intensity were 9%, 15%, 35% and 49% in 30 pM, 100 pM, 300 
pM, and 500 pM dieldrin treatments, respectively. 
Effect of SOD and SOD mimetic on dieldrin-induced necrosis and apoptosis 
In order to determine the role of oxidative stress in dieldrin-induced cell death, 
both necrosis and apoptosis were examined. We have reported that dieldrin exposure 
showed a dose-dependent increase in LDH release (Fig. 2). Following pretreatment with 
SOD, LDH release, which is used as a marker of necrotic cell death, did not attenuate 
dieldrin toxicity over a 2-hour period (Fig. 9). On the other hand, SOD showed a 
protective effect on dieldrin-induced apoptosis (Fig. 10A). DNA fragmentation assay, 
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which is the hallmark of apoptotic cell death, revealed that dieldrin-induced DNA 
fragmentation increased dose-dependently, and it was significant (p<0.05) at 100 pM 
dieldrin exposure (Fig. 10A). Interestingly, SOD significantly (p<0.01) reduced 
dieldrin-induced DNA fragmentation, indicating that SOD is capable of attenuating 
dieldrin-induced apoptosis, but not necrosis. 
To further confirm the anti-apoptotic effect of SOD in dieldrin treatment, a cell 
permeable SOD mimetic, MnTBAP, was used. Pre-treatment with 2 pM MnTBAP 
significantly (p<0.05) attenuated dieldrin-induced apoptosis (Fig. 10B). Over 30% of 
dieldrin-induced DNA fragmentation was attenuated by MnTBAP treatment, confirming 
that superoxide generation contributes to apoptotic cell death following dieldrin 
exposure in PC 12 cells. 
To further visualize apoptotic features in dieldrin treated cells, Hoechst 33342 
staining for nuclear condensation was performed. As depicted in Figure 11, dieldrin 
treated cells showed a prominent condensed chromatin, reflecting morphological 
changes commonly observed in apoptotic cells. In the case of SOD pretreatment (100 
unit/ml) dieldrin-induced apoptotic characteristics were attenuated, supporting the 
antiapoptotic effect of SOD presented above. 
Effect of tyrosine hydroxylase (TH) and monoamine oxidase-B (MAO-B) inhibitors 
on dieldrin-induced ROS generation and apoptosis 
To determine whether or not dopamine or dopamine metabolites participate as 
intrinsic factors in dieldrin-induced dopaminergic toxicity, a series of experiments were 
conducted using inhibitors of dopamine synthesis and catabolism. Cellular dopamine 
levels were reduced by inhibiting the rate-limiting enzyme of dopamine synthesis 
tyrosine hydroxylase using a-methyl-L-p-tyrosine (a-MPT). PC 12 cells were treated 
with 100 or 500 pM a-MPT for 24h, and availability of dopamine was determined by 
HPLC. As shown in Table 1, intracellular dopamine was dose-dependently depleted, 
and 500 |xM a-MPT caused 84% reduction in dopamine level as compared with the 
untreated group. Measurement of ROS in dopamine-depleted cells showed a significant 
(p<0.05) reduction as compared with normal PC 12 cells (Fig. 12A). Additionally, 
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dieldrin-induced DNA fragmentation was also significantly (p<0.05) attenuated in 
dopamine depleted cells as compared with cells producing normal dopamine level (Fig. 
12B). 500 JJM a-MPT did not alter basal DNA fragmentation, but attenuated dieldrin-
induced DNA fragmentation from 530% to 360% of control at 1 hour exposure period, 
indicating that dopamine, at least in part, contributes to the dieldrin-induced apoptotic 
process. 
In the next study, we examined the effect of an MAO-B inhibitor on dieldrin-
induced ROS generation and apoptosis to determine whether the increased DOPAC 
formation during dieldrin exposure contributes to dopaminergic cell death through 
oxidative stress. Treatment with 100 pM deprenyl (MAO-B inhibitor) for 30 min 
reduced nearly 80% of DOPAC formation in PC 12 cells (Table 1), confirming a 
significant (p<0.01) blockade of MAO-B activity. Subsequent flow cytometric analysis 
revealed that dieldrin-induced ROS generation was significantly (p<0.01) suppressed in 
deprenyl-treated PC 12 cells (Fig. 12A). Consequently, deprenyl also attenuated 
dieldrin-induced DNA fragmentation from 530% to 300% of control following lhr 
treatment (Fig. 12B), indicating that alteration of the dopamine catabolic process 
involving the formation of DOPAC has a significant role in dieldrin-induced 
degeneration of dopaminergic cells. 
DISCUSSION 
In the present study, we have shown that dieldrin depletes dopamine, increases 
dopamine release, and generates ROS in a dose-dependent manner. We have also 
demonstrated that dieldrin-induced ROS generation contributes to apoptotic cell death in 
PC 12 cells. Our results reveal that dopaminergic cells are more susceptible to the 
neurotoxic effect of dieldrin than non-dopaminergic cells during acute exposure. This 
result is consistent with a previous report in which dieldrin was found to be more toxic 
in dopaminergic neurons than non-dopaminergic neurons during chronic treatment.19 By 
extension, our observation that depletion of dopamine in PC 12 cells by the tyrosine 
hydroxylase inhibitor a-MPT, significantly protected against the generation of ROS and 
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DNA fragmentation, indicating that dopamine may serve as a susceptibility factor in 
dieldrin-induced cytotoxicity in dopaminergic cells. 
Several organochlorine pesticides have been reported to increase ROS formation 
in PC 12 cells.44 ROS generation was one of the earliest cellular responses to dieldrin 
toxicity, and was observed within 5 min of exposure. Consequently, the increase in 
membrane lipid peroxidation following dieldrin exposure was also observed to be dose-
dependent and is thought to result from the excess production of ROS. Products from 
lipid peroxidation have been shown in many studies to contribute to DNA damage.45 
Recent studies have demonstrated that ROS serves as a signal for stimulation of 
apoptosis by activating an array of cell signaling molecules including cytochrome c, 
caspases, kinases and endonucleases.46"48 Known neurotoxic agents, such as MPTP, 
paraquat, cyanide, manganese and methylcyclopentadienyl manganese tricarbonyl 
(MMT) that promote dopaminergic cell death, have been shown to induce apoptosis 
through the activation of similar cellular signaling mechanisms.27' 49-52 It has been 
demonstrated that elevation of intracellular ROS activates transition pore opening on the 
mitochondrial inner membrane.53 We demonstrate here that dieldrin treatment elevates 
intracellular ROS levels and depolarizes AvFm, which could subsequently activate a 
series of pro-apoptotic signaling cascades including cytochrome c release and activation 
of initiator caspase-9, followed by activation of caspase-3, leading to apoptotic cell death. 
In this regard, our recent observations have demonstrated that dieldrin exposure, indeed, 
activates an array of apoptotic molecules including cytochrome c, caspase-9 and 
caspase-3.54 Furthermore, we have noted from a time-course study that ROS generation 
precedes the activation of proapoptotic molecules following dieldrin exposure in PC 12 
cells. 
In the present study, we also observed significant increases in DNA 
fragmentation following 1 hour of dieldrin exposure in PC 12 cells. Pretreatment with 
SOD, an enzyme that effectively scavenges superoxide anions, significantly attenuated 
dieldrin-induced ROS generation and apoptosis as measured by flow cytometry, which 
exclusively measures intracellular events. However, SOD did not alter dieldrin-induced 
necrosis as measured by LDH release. Also, scavenging of superoxide anions by a cell 
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permeable SOD mimetic, MnTBAP,55'56 effectively blocked dieldrin-induced apoptosis. 
These data strongly suggest that dieldrin exposure increased superoxide production, and 
that superoxide may act as an initiator of a downstream cellular apoptotic cascade in 
dopaminergic cells. In agreement with our results, it has recently been demonstrated by 
other researchers that the addition of exogenous SOD attenuated both generation of ROS 
and apoptosis in neuronal cells.55'57'58 
Another significant response following dieldrin exposure was massive dopamine 
release. The inverse relationship between intracellular and extracellular dopamine levels 
implies that dopamine synthesis is not altered by dieldrin, but rather dieldrin evokes the 
release of dopamine. Neurotoxicant-induced dopamine release has been reported in both 
in vitro and in vivo models with neurotoxic agents that are known to disrupt the 
dopaminergic system.27' 30' 50' 59' 60 Excess release and accumulation of released 
dopamine in the extracellular space often temporally accelerates neurotoxicity,61 
suggesting that dieldrin toxicity may be increased by the massive dopamine release 
shown in this study. Dieldrin and other organochlorine compounds have been shown to 
bind and/or affect the function of important neurotransmitter vesicular proteins such as 
the vesicular monoamine transporter (VMAT2), which may be indicative of an 
additional target for neurotransmitters.62 Furthermore, our finding that TH inhibition 
attenuates dieldrin-induced ROS generation and apoptosis supports the view that 
excessive dopamine secretion might contribute to the oxidative stress-dependent cell 
death. In support of our view, recent studies demonstrate that addition of exogenous 
dopamine not only causes apoptotic cell death but also potentiates other chemical-
induced apoptosis.63"65 
Dieldrin-induced cell death was also significantly suppressed by inhibition of 
MAO-B. It is known that the catabolic process of dopamine to DOPAC by MAO-B 
produces ROS as a byproduct, and the acceleration of dopamine catabolism may cause 
further destruction of cells due to the increase of oxidative stress as described above.63'66 
Our results showed that DOPAC levels were significantly elevated in all dieldrin-treated 
groups, and inhibition of DOPAC formation during dieldrin exposure blocked both ROS 
generation and apoptosis. Although mechanisms underlying toxic effect of dopamine 
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remain unclear, existing reports suggest that presence of excess dopamine in an ROS-
rich environment may augment the oxidative stress and cell death process by formation 
of highly cytotoxic radicals.47' 67 Taken together, our data indicate that massive 
dopamine release and increased ROS through DOPAC formation might further 
contribute to the onset of dopaminergic neurotoxicity following dieldrin exposure. 
In conclusion, dopaminergic cells are relatively more susceptible to dieldrin 
toxicity. Dieldrin stimulates massive extracellular dopamine release in a manner similar 
to other dopaminergic neurotoxins such as MPTP, cyanide, MMT and manganese,27'30'50' 
68 and generates ROS as an early event in cellular toxicity. Dieldrin promotes an 
environment of excessive extracellular free dopamine along with ROS which may 
augment oxidative stress-mediated cell death. Although several reports exist in the 
literature that do not support the causal role of oxidative stress in Parkinson's disease,71' 
72 recent studies implicate oxidative stress as one of the major factors in the pathogenesis 
of Parkinson's disease.69'70 Additional studies that examine early cellular responses 
following neurotoxic insults are further needed to resolve the exact role of oxidative 
stress in the neurodegenerative process. The results of short-term dieldrin exposure 
studies presented here denote cell death mechanisms that may play a role in earlier 
stages of the pesticide exposure. Collectively, our results suggest that dieldrin exposure, 
one of the possible environmental factors in Parkinson's disease, is capable of promoting 
apoptotic cell death in dopaminergic cells via oxidative stress. Additional mechanistic 
studies delineating the oxidative stress-dependent cell death pathway are being 
undertaken, and may shed more light onto the role of environmental factors in the 
dopaminergic degeneration. 
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Treatment Dopamine (% control) DOPAC (% control) 
Control 100.0 ± 4.2 100.0+18.0 
100 juiM a-MPT 47.9 ± 3.6** N.D. 
500 |JM a-MPT 16.4 ±2.1** N.D. 
100 |iM deprenyl 103.7 + 7.1 20.3 ± 18.1** 
Table 1: Levels of dopamine and DOPAC following TH or MAO-B inhibitors 
PC 12 cells were treated with 100-500 |o,M a-methyl-L-p-tyrosine (a-MPT) for 
24 hours or 100 |iM deprenyl for 30 min, and levels of dopamine and DOPAC were 
measured by HPLC-EC. Each value is expressed as mean ± SEM. Data represent two 
separate experiments in triplicate. **p<0.01 compared with control group. N.D.= not 
detected. 
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Figure 1: Effect of dieldrin on cell viability in PC12 cells 
PC12 cells, a-TC cells, and HCN-2 cells were exposed to 0 - 3000 pM dieldrin 
for 1 hour at 37°C, and the viability was determined by a trypan blue dye exclusion. 
Each point represents the mean ± SEM for at least two separate experiments in duplicate. 
The EC50 was calculated by three-parameter nonlinear regression analysis. 
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Figure 2: Effect of dieldrin on extracellular LDH release in PC12 cells 
PC12 cells were exposed to 0 - 500 |o,M of dieldrin for 1 hour in Krebs-Ringer at 
37°C. After the exposure, cell-free extracellular supematants were collected, and LDH 
activity was measured by spectrophotometer. Values represent mean ± SEM for three to 
five separate experiments in triplicate. Significance was determined by ANOVA 
followed by Dunnett's post-test between the vehicle-treated group and each treatment 
group (*p<0.05; **p<0.01). 
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Figure 3: Effect of dieldrin on extracellular and intracellular dopamine levels in 
PC12 cells 
Panels represent extracellular dopamine (A) and intracellular dopamine (B) levels 
at 1 hour in dieldrin-treated PC 12 cells. Dopamine content was analyzed by HPLC-EC. 
Data represent mean ± SEM for two to three separate experiments performed in triplicate. 
Significance was determined by ANOVA followed by Dunnett's post-test between the 
vehicle-treated group and each treatment group (*p<0.01). 
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Figure 4: Effect of dieldrin on extracellular and intracellular DOPAC levels in 
PC12 cells 
Panels represent extracellular (A) and intracellular (B) DOPAC levels at 1 hour 
in dieldrin-treated PC12 cells. DOPAC content was analyzed by HPLC-EC. Data 
represent mean ± SEM for two to three separate experiments performed in triplicate. 
Significance was determined by ANOVA followed by Dunnett's post-test between the 
vehicle-treated group and each treatment group (*p<0.05, **p<0.01). 
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Figure 5: Effect on mitochondrial activity following dieldrin treatment 
PC 12 cells were treated with dieldrin for 1 hour. (A) MTT assay following dieldrin 
treatment in PC 12 cells. Relative mitochondrial activity was calculated by absorbance at 
570 nm and 630 nm. (B) depolarization of mitochondrial membrane potential (A^Fm) was 
measured by flow cytometer using 40 nM DiOC6. Relative fluorescence intensity was 
calculated, and depolarization of ATm was expressed as percent of control. Data 
represent the mean ± SEM for two separate experiments performed in triplicate. 
Significance was determined by ANOVA followed by Dunnett's post-test between 
vehicle-treated cells and dieldrin-treated cells (**p<0.01). 
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Figure 6: Generation of ROS following exposure to dieldrin in PC12 cells 
PC 12 cells were treated with varying concentrations of dieldrin (30, 100, 300 
I^M) for 0-30 min. Hydroethidine fluorescence intensity was measured at various time 
points (0, 5,15, 30 min) by a flow cytometry. Data represent the mean ± SEM for three 
separate experiments performed in triplicate. Significance was determined by ANOVA 
followed by Dunnett's post-test between the vehicle-treated group and each treatment 
group (**p<0.01). 
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Figure 7: Effect of superoxide dismutase (SOD) on dieldrin-induced ROS 
generation 
Panels represent the effect of SOD pretreatment (100 units, 5 min) on 30 fxM (A) 
and 100 pM (B) dieldrin-treated PC 12 cells at time points up to 30 min. Hydroethidine 
fluorescence intensity was measured by flow cytometry. Data represent the mean + SEM 
for three separate experiments performed in triplicate. Significance was determined by 
ANOVA followed by Dunnett's post-test between the dieldrin treated cells with and 
without SOD pretreatment (**p<0.01). 
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Figure 8: Formation of lipid peroxides following exposure to dieldrin in PC12 cells 
PC 12 cells were treated with varying concentrations of dieldrin (30,100, 300 
and 500 pM) for 1 hr. Dodecanyl aminofluorescein fluorescence intensity was measured 
by flow cytometry. Data represent the mean ± SEM for three separate experiments 
performed in triplicate. Significance was determined by ANOVA followed by Dunnett's 
post-test between the vehicle-treated group vs each treatment group (**p<0.01). 
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Figure 9: Effect of superoxide dismutase (SOD) on dieldrin-induced cytotoxicity 
PC 12 cells were exposed to 30 or 100 |aM dieldrin for 1 hour, with or without 
SOD (100 units) pretreatment. LDH activity was measured in the incubation buffer by 
spectrophotometer in 96-well format. Data represent the mean ± SEM for three separate 
experiments performed in duplicate. Data were analyzed by ANOVA followed by 
Dunnett's post-test. SOD pretreatment did not show any significant decrease in LDH 
activity as compared with groups treated with dieldrin alone. 
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Figure 10: Effect of superoxide dismutase (SOD) on dieldrin-induced DNA 
fragmentation in PC 12 cells 
Panels represent results of DNA fragmentation assays in PC 12 cells pretreated 
with SOD (A, 100 units/ml, 5 min) or MnTBAP (B, 2 |aM, 30 min). DNA fragmentation 
was quantified by anti-histone-biotin directed against histones (HI, H2A, H2B, H3 and 
H4) and anti-DNA-POD directed against both single and double stranded DNA. Data 
represent the mean ± SEM for two separate experiments performed in triplicate. ap<0.01 
compared dieldrin-treated groups with vehicle-treated group using ANOVA followed by 
Dunnett's post-test, and bp<0.05 or cp<0.01 compared SOD- or MnTBAP-treated groups 
with dieldrin-treated groups using t-test. 
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Figure 11: Hoechst 33342 staining of dieldrin-induced apoptosis in PC12 cells 
Cultured PC 12 cells were treated with dieldrin (100 or 300 jJVt) alone or in the 
presence of SOD (100 units) for 1 hour. Hoechst 33342 was used to visualize apoptosis 
by a fluorescent microscope under UV illumination. Arrows indicate apoptotic features 
of chromatin condensation. Each image represents in two separate experiments. 
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Figure 12: Effect of MAO-B or TH inhibitor on dieldrin-induced ROS generation 
and apoptosis 
(A) PC 12 cells were pre-treated with 500 jaM a-methyl-L-p-tyrosine (a-MPT) for 24 
hours or 100 pM deprenyl for 30 min prior to dieldrin exposure. Intracellular ROS was 
measured using hydroethidine in a flow cytometer during 0-15 min dieldrin exposure. 
The data represent mean ± SEM from two separate experiments in triplicate. *p<0.05 or 
**p<0.01 compared with dieldrin-treated group. (B) PC 12 cells were pre-treated with 
500 |oM a-MPT for 24 hours or 100 faM deprenyl for 30 min prior to 100 JJM dieldrin 
exposure for 1 hour. DNA fragmentation was quantified as described in "Material and 
Methods". Data represent the mean ± SEM for two separate experiments performed in 
triplicate. **p<0.01 compared with dieldrin-treated group. 
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CHAPTER III: OXIDATIVE STRESS AND MITOCHONDRIAL-MEDIATED 
APOPTOSIS IN DOPAMINERGIC CELLS EXPOSED TO 
METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL (MMT) 
A paper published in the Journal of Pharmacology and Experimental Therapeutics 
Masashi Kitazawa, Jarrad R. Wagner, Michael L. Kirby, Vellareddy Anantharam, 
Anumantha G. Kanthasamy 
ABSTRACT 
Methylcyclopentadienyl manganese tricarbonyl (MMT), an organic manganese-
containing gasoline additive, was investigated to determine whether MMT potentially 
causes dopaminergic neurotoxic effects. MMT is acutely cytotoxic and dopamine 
producing cells (PC 12) appeared to be more susceptible to cytotoxic effects than non-
dopaminergic cells (striatal GABAergic and cerebellar granule cells). MMT also 
potently depleted dopamine apparently by cytoplasmic vesicular release to the cytosol, a 
neurochemical change resembling other dopaminergic neurotoxicants. Generation of 
reactive oxygen species (ROS), an early effect in toxicant-induced apoptosis, occurred 
within 15 min of MMT exposure. MMT caused a loss of mitochondrial transmembrane 
potential (AWn), a likely source of ROS generation. The ROS signal further activated 
caspase-3, an important effector caspase, which could be inhibited by antioxidants 
(Trolox or N-acetyl cysteine). Pre-depletion of dopamine by using a-methyl-p-tyrosine 
(tyrosine hydroxylase inhibitor) treatment partially prevented caspase-3 activation, 
denoting a significant dopamine and/or dopamine byproduct contribution to initiation of 
apoptosis. Genomic DNA fragmentation, a terminal hallmark of apoptosis, was 
concentration-dependently induced by MMT but completely prevented by pretreatment 
with Trolox, deprenyl (MAO-B inhibitor) and a-methyl-p-tyrosine. A final set of critical 
experiments were performed to verify the pharmacological studies using a stable Bcl-2 
overexpressing PC 12 cell line. Bcl-2 overexpressing cells were significantly refractory 
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to MMT-induced ROS generation, caspase-3 activation, loss of AYm and were 
completely resistant to MMT-induced DNA fragmentation. Taken together, the results 
presented here demonstrate that oxidative stress plays an important role in mitochondrial 
mediated apoptotic cell death in cultured dopamine producing cells following exposure 
to MMT. 
INTRODUCTION 
Methylcyclopentadienyl manganese tricarbonyl (MMT), an organic manganese-
containing compound, has been recently legalized for use as a lead replacement in fuels 
in the United States and is marketed as HITEC 3000 or AK-33X and contains around 
25% manganese (Zayed et al., 1994; Frumkin and Solomon, 1997). In the past, the 
major health effects of MMT have centered on possible exhaust products and ambient 
particulates caused by MMT combustion. Excessive manganese exposure has been 
reported to cause Parkinsonian-like symptoms, known as Manganism (Calne et al., 
1994). Although Manganism differs from Parkinson's disease (PD) in neuropathology, 
clinical presentations of each disease are similar (Aschner, 2000). Furthermore, 
numerous epidemiological studies have demonstrated a positive association between 
environmental risk factors and increased incidence of idiopathic, geriatric-onset PD 
(Veldman et al., 1998; Tanner et al., 1999). The results of these studies demonstrated 
that no significant genetic correlate exists in geriatric-onset PD, which by implication 
suggests an environmental factor, and may contribute to the promotion of the disease. 
Considering the epidemiological and toxicological evidence collectively, MMT and its 
manganese combustion products may be considered as potential environmental risk 
factors for PD and its related disorders. 
The manganese atom of MMT is linked to a methylcyclopentadiene ring and three 
carbonyl groups and these organic substitutions make MMT highly lipophilic, which 
might increase the bioaccumulation of this organometallic compound. Recently, a 
comparative toxicokinetic study in rats has demonstrated that the MMT-derived 
manganese accumulates in plasma 37 times more than inorganic manganese along with a 
110 
slower clearance rate (Zheng et al., 2000). Gianutsos and Murray (1982) have also 
demonstrated MMT-induced dopamine depletion in rat brain, which is suggestive of 
deleterious cytotoxic effects. Concern has recently been expressed over toxicity of MMT 
itself due to the possibility of exposure through dermal absorption from accidental spills, 
deliberate use of gasoline as a solvent cleaner, and solvent abuse such as intentional 
gasoline fume inhalation (Zayed et al., 1994). Further, Garrison et al. (1995) argue that 
critical exposure sources for MMT do not include engine exhausts, but instead 
accidental releases during manufacture, handling, transportation, and storage as most 
likely sources for environmental and human exposure. 
Apoptosis, the presumed mechanism of nigrostriatal cell death in PD (Hirsch et al., 
1999; Offen et al., 2000), can be initiated by either receptor-stimulated (e.g., Fas-ligand 
mediated) or toxicant-induced pathways. Both signal pathways share a mitochondrial 
link to downstream apoptotic events, the specifics of which can vary by initiator 
stimulus and cell type. A common link between varying detail of apoptotic pathways is 
the role of Bcl-2 as an inhibitory lock on apoptosis (Voehringer and Meyn, 2000). 
Overexpression of Bcl-2 in in vitro cell line studies has been shown to inhibit cell death 
and reduce reactive oxygen species (ROS) generation, which directly implicate 
mitochondria as prime targets in apoptotic cell death. 
The present study entails a detailed assessment of MMT-mediated toxic effects in 
dopamine producing PC 12 cells and extends work reported by us previously 
(Anantharam et al., 2002). PC 12 cells have proven to be an in vitro experimental model 
of choice to study effects of various neurotoxic agents including 6-hydroxydopamine, 
MPP+, paraquat, and manganese on dopaminergic cells (Shafer and Atchison, 1991; 
Desole et al., 1997b; Li and Sun, 1999; Viswanath et al., 2001; Anantharam et al., 2002; 
Park et al., 2002). PC12 cells are electrically excitable and neurosecretory (DA, NE 
and/or ACh), and contain many membrane-bound and cytosolic macromolecules 
associated with neurons (Shafer and Atchison, 1991). In the present study, we have 
examined cytotoxicity, neurotransmitter depletion, ROS generation, caspase-3 activation, 
depolarization of mitochondrial membrane potential, and DNA fragmentation as 
toxicological endpoints during acute exposure of MMT to delineate the early cellular 
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events that might contribute to the degenerative process in dopamine producing cells. 
Further, we demonstrated protective effects of Bcl-2 protein overexpression, 
antioxidants, and dopamine synthesis and catabolism inhibitors toward reduction of 
MMT-induced ROS generation, caspase-3 activation and DNA fragmentation, 
suggesting causal roles of mitochondrial dysfunction, oxidative stress and dopamine 
catabolism in MMT-induced cytotoxicity. 
MATERIALS AND METHODS 
Chemicals. Methylcyclopentadienyl manganese tricarbonyl (MMT; Aldrich, 
Milwaukee, WI) is a viscous yellow liquid with an herbaceous odor. MMT was prepared 
fresh and dissolved in DMSO. Trolox was purchased from Aldrich (Milwaukee, WI). 
Manganese (II) chloride, deprenyl, a-methyl-L-p-tyrosine (a-MPT), cytosine arabinoside 
and N-acetyl-L-cysteine (NAC) were obtained from Sigma (St. Louis, MO). Caspase-3 
substrate, Ac-DEVD-AMC, was purchased from Bachem Biosciences Inc. (King of 
Prussia, PA). Cell culture media and reagents were purchased from Life Technologies 
Inc., (Gaithersburg, MD). Dihydroethidine, dichlorofluorescein-diacetate, acridine 
orange, DiOCe were purchased from Molecular Probes Inc., (Eugene, OR). Other routine 
laboratory reagents were obtained from Fisher Scientific (Pittsburgh, PA). 
Cell culture. Dopamine producing PC 12 cells were obtained from the American 
Type Culture Collection (ATCC, Rockville, MD). Non-dopaminergic cells were used in 
the cytotoxicity experiments to determine the differential toxic response of MMT in 
dopamine producing cells vs. non-dopaminergic cells. Striatal GABAergic cells (M213-
20 cells) were a generous gift from Dr. William J. Freed, National Institute on Drug 
Abuse, Cellular Neurobiology Branch (Baltimore, Maryland). PC 12 cells were grown in 
RPMI-1640 medium containing 10% heat inactivated horse serum, 5% fetal bovine 
serum, 2 mM L-glutamine, 50 units penicillin and 50 gg/mL streptomycin. M213-20 
cells were grown in DMEM containing 10% fetal bovine serum, 2 mM L-glutamine, 50 
units penicillin and 50 ja,g/mL streptomycin. Human Bcl-2 transfected PC 12 (PC12HB2-
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3) and vector-transfected (PC12V4) cells were generous gifts from Drs. Yutaka Eguchi 
and Yoshihide Tsujimoto, Osaka University (Osaka, Japan). PC12V4 and PC12HB2-3 
cells were grown in DMEM with 7% horse serum and 4% fetal bovine serum. PC 12 
cells were placed in 75 cm2 cell culture flasks at 37°C under a humidified atmospheric 
condition of 5% CO2 and 95% air, and 3-6 day old cells were used for the experiments. 
M213-20 cells were grown at 33°C in 5% CO2 incubator. Cells were suspended in either 
Krebs-Ringer solution (125 mM NaCl, 5 mM KC1, 25 mM HEPES, 6 mM glucose, 5 
mM NaHCOg, 1.2 mM MgSO^, 1.2 mM KH2PO4, and 2.4 mM CaClz, pH 7.4), serum-
free RPMI-1640 or DMEM at a concentration of 2x10* cells/ml depending upon the 
biochemical assay method. 
Cerebellar granule cell cultures were prepared from 7-8 day old rat pup tissues by the 
method of Gunasekar et al. (1995). Cells were cultured in 10% fetal calf serum-amended 
DMEM, 22 mM glucose, 25 mM KC1 and 1 ml penicillin/streptomycin (5000 U/ml)/l at 
pH 7.4 on poly-L-lysine-coated cover glass in 6-well culture plates. Cytosine 
arabinoside (10 (xM) was added 18 hr later to prevent proliferation of non-neuronal cells. 
Mature cells (10 days in vitro) were used for experiments and ca. 95% of surviving cells 
were cerebellar granule cells. 
Treatment paradigm. PC 12 and M213-20 cells were treated with MMT (0-1000 
|j,M) dissolved in DMSO (final concentration in incubates <0.5%). After 1 hr incubation 
with MMT at 37°C, dead and live cells were determined by trypan blue exclusion 
method using an Improved Nebauer Hemocytometer. Pretreatment with a-MPT was 
performed 24 hr prior to MMT treatment, whereas pretreatments with NAC, deprenyl or 
Trolox were performed 30 min prior to MMT exposure. The cell viability was 
normalized as percent of vehicle control. 
Cerebellar granule cells (10 day) were treated with MMT (0-10 mM) for 1 hr. After 1 hr, 
the culture medium was removed and cells were lysed in a 0.1 M potassium phosphate 
buffer containing 0.5% Triton X-100 (pH 7.4). Cell debris was pelleted by centrifugation 
(10,000xg) and LDH activity was measured as described below. 
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Lactate dehydrogenase assay. Lactate deydrogenase (LDH) activity in the cell-free 
extracellular supernatant was quantified as an index of acute cell death in a 96-well 
format (Kitazawa et al., 2001). Extracellular supernatant (10 pi) was added to 200 jxl of 
0.08 M Tris buffer (pH 7.2) containing 0.2 M NaCl, 0.2 mM NADH, and 1.6 mM 
sodium pyruvate. LDH activity was measured continuously by monitoring the decrease 
in the rate of absorbance at 339 nm using a microplate reader (Molecular Devices, 
Sunnyvale, CA) and the temperature was maintained at 37°C during reading. Changes in 
absorbance per minute (AA/AT) were used to calculate LDH activity (U/I), using the 
following equation: U/I = (AA/AT) x 9682 x 0.66, where 9682 was a coefficient factor, 
and 0.66 was a correction factor at 37°C. Activity was corrected per mg protein and 
expressed as percent total LDH signal. 
Neurotransmitter determinations. Extracellular and intracellular dopamine and 
3,4-dihydroxyphenylacetic acid (DOPAC) were measured by high performance liquid 
chromatography with electrochemical detection (HPLC-EC) as previously described, 
with slight modification (Kanthasamy et al., 1991). Briefly, PC12 cells were 
resuspended in Kreb's-Ringer solution at a density of 3-7xl06 cells/ml. MMT was added, 
and cells were incubated in a shaking water bath for 2 hrs at 37°C. Cells were then 
centrifuged at l,500xg for 15 min, and supematants were collected and stored with 
antioxidant solution (Na^EDTA, 15 mM; Na^O^, 50 mM; HCIO4, 4 mM). Cell pellets 
were resuspended in antioxidant solution and allowed to lyse for 15 min on ice. Samples 
were stored at -80°C until further analysis. Prior to analysis by HPLC-EC, samples were 
centrifuged 10,000xg, 15 min, 4°C to pellet cellular debris. 
The HPLC method was isocratic with a run time of 10 min at 0.7 ml/min using a 
Microsorb-MV™ (86-200-E3 C-18 3|im 100Â J2 10086-4) reverse phase column 
(Varian Analytical Instruments, Walnut Creek, CA) with 20 jal injection volume. 
Samples were maintained at 4°C prior to column injection. The HPLC system consisted 
of an electrochemical detector (Coulochem II Model 5200A; ESA, Chelmsford, MA) 
with a guard cell (ESA Model 5020) and a microdialysis cell (ESA Model 5014B) using 
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MD-TM™ mobile phase (ESA), with detector settings as follows: electrode 1, -175 mV, 
100 |xA; electrode 2,175 mV, 50 nA; guard cell, 375 mV. 
Reactive oxygen species (ROS) assay. We used dichlorofluorescein-diacetate 
(DCF-DA) to measure ROS by fluorometric assay. Briefly, the cells were harvested and 
washed in Kreb's-Ringer solution, resuspended at l-3xl06 cells/ml, and were loaded 
with DCF-DA, 15 min, 37°C. Cells were pelleted, supernatant containing the excess 
fluor was removed, and the pellet was then resuspended in 2 ml of Tris buffer (pH 7.4). 
Production of 2,7-dichlorofluorescein (DCF-H), a fluorescent product of hydrolyzed 
DCF-DA, was monitored over 1 hr by spectrofluorometer (488/525 nm). MMT was 
added to the tubes, vortexed and transferred to cuvettes for fluorescent readings (F(0)). 
After the readings were obtained, the samples were transferred back to the tube and 
placed in a water bath for 60 min incubation. After 60 min, the tubes were removed and 
the fluorescence was read again as the F(60) endpoint measurement. Data were 
expressed as percent of vehicle control. 
Additional experiments were performed using a more selective ROS detection agent, 
dihydroethidine (Kitazawa et al., 2001; Anantharam et al., 2002). Dihydroethidine is a 
sodium borohydride-reduced hydroethidium dye that fluoresces upon oxidation by 
superoxide. Briefly, cells were suspended in Hanks balanced salt solution (HBSS) with 2 
mM calcium at a density of 1 x 106 cells/ml. Cells were then incubated with 10 pM 
hydroethidine for 15 min in dark. After the incubation with dye, excess dye was washed 
once with HBSS, and MMT was added. Fluorescence intensity was measured using a 
flow cytometer (488/585 nm with 42 nm bandpass), and data were analyzed by 
CellQuest software (Becton Dickinson, San Francisco, CA). 
Detection of mitochondrial membrane potential. Depolarization of mitochondrial 
membrane potential (A^Pm) were assessed by flow cytometric analysis using DiOCg 
(Kitazawa et al., 2001). 40 nM DiOCg was added to incubation medium 15 min before 
the end of treatment period, and the incubation continued at 37°C. Then, the cells were 
washed once, resuspended in phosphate-buffer saline (pH 7.4), and analyzed by flow 
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cytometry with excitation at 484 nm and emission at 501 nm using a flow cytometer. 
Data were analyzed by CellQuest software (Becton Dickinson, San Francisco, CA). 
Caspase-3-like activity assay. Caspase-3 activity was determined by following 
procedure previously described with slight modification (Yoshimura et al., 1998). 
Briefly, after the exposure to MMT, cells were washed once with phosphate-buffered 
saline (pH 7.4) and resuspended in lysis buffer containing 50 mM Tris/HCl (pH 7.4), 1 
mM EDTA, 10 mM EOT A, and 10 |xM digitonin. Cells were then incubated at 37°C for 
20 min to allow complete lysis. Lysates were quickly centrifuged, and cell-free 
supematants were incubated with 50 jxM Ac-DEVD-AMC (caspase-3 substrate) at 37°C 
for 1 hr. Formation of 7-amino-4-methylcoumarine (AMC), as a result of cleavage of 
substrates by caspase-3, was measured by spectrafluorometer (Molecular Devices) with 
excitation at 380 nm (slit width 10 nm) and emission at 460 nm (slit width 20 nm). 
Caspase activity was expressed as fluorescence unit (FU) per mg protein per hr of 
incubation. Protein content of samples were measured using the Bradford protein assay 
reagent (BioRad Laboratories, Hercules, CA). 
DNA fragmentation assay. DNA fragmentation assay was performed using the Cell 
Death Detection Elisa Plus Assay Kit (Roche Molecular Biochemicals, Indianapolis, IN). 
This kit measures amount of histone-associated low molecular weight DNA in the 
cytoplasm of cells and has recently been used in quantitation of apoptosis because of its 
reliability and high sensitivity (Anantharam et al., 2002). PC12 cells in antioxidant 
studies were pretreated with antioxidant for 30 min. Cells were then exposed to 200 pM 
MMT for 1 hr. Following MMT treatment, cells were pelleted at 200xg for 5 min and 
washed once with phosphate-buffered saline (pH 7.4). Cells were then incubated with a 
lysis buffer (supplied with the kit) at room temperature. After 30 min, samples were 
centrifuged and 20 (il aliquots of the supernatant were then dispensed into streptavidin-
coated 96 well microtiter plates followed by addition of 80 jal of antibody cocktail and 
incubated for 2 hr at room temperature with mild shaking. The antibody cocktail 
consisted of a mixture of anti-histone biotin and anti-DNA-HRP directed against various 
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histones and antibodies to both ssDNA and dsDNA, which are major constituents of the 
nucleosomes. After incubation, unbound components were removed by washing with 
the incubation buffer supplied with the kit. Quantitative determination of the amount of 
nucleosomes retained by anti-DNA-HRP in the immunocomplex was determined 
spectrophotometrically with ABTS as a HRP substrate (supplied with the kit). 
Measurements were made at 405 nm against an ABTS solution as a blank (reference 
wavelength 490 nm) using a Molecular Devices Spectramax Microplate Reader. 
Western blot analysis of Bcl-2 expression. PC 12 cells were centrifuged at 200x g 
for 5 min. Cell pellets were then washed once with ice-cold Ca2+-free phosphate-
buffered saline and resuspended in 2 ml of homogenization buffer (20 mM Tris-HCl, pH 
8.0, 10 mM EGTA, 2 mM EDTA, 2 mM dithiothreitol, 1 mM phenylmethylsulfonyl 
fluoride, 25 |xg/ml aprotinin, 10 jj.g/ml leupeptin). Suspensions were sonicated for 10 sec, 
and centrifuged at 100,000 x g for 1 hr at 4°C. Supernatants were discarded and pellets 
were gently resuspended in ice-cold Ca2+-free phosphate-buffered saline. Protein 
concentration of each sample was determined using the Bradford protein assay reagent. 
Membrane fractions containing equal amounts of protein were loaded in each lane of 
a 10% SDS-polyacrylamide stacking gel and separated by electrophoresis (23 mA, 3 hr). 
Proteins were then transferred to nitrocellulose membrane by electro-blotting overnight 
at 25 V. Non-specific binding sites were blocked by treating the nitrocellulose 
membranes with 5% non-fat dry milk powder for 2 hr prior to treatment with primary 
antibodies. The nitrocellulose membranes containing the proteins were incubated with 
primary antibodies for 1 hr at room temperature with antibody directed against Bcl-2 
(Santa Cruz Biotechnology, Santa Cruz, CA ). The primary antibody treatments were 
followed by treatment with secondary HRP-conjugated antigoat IgG (Santa Cruz 
Biotechnology) for 1 hr at room temperature. Secondary antibody-bound proteins were 
detected using Amersham's ECL chemiluminescence kit. To confirm equal protein 
loading, blots were reprobed with an HSP-60 antibody (Santa Cruz Biotechnology). 
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In situ assessment of apoptosis. Changes in nuclear morphology and DNA 
conformation of MMT-treated cells were assessed qualitatively with fluorescent DNA-
binding dyes acridine orange. Acridine orange exhibits metachromatic fluorescence that 
is sensitive to DNA conformation. Apoptotic cells stained with acridine orange show 
reduced green and enhanced red fluorescence in comparison to normal cells (Kitazawa et 
al., 2001). PC12 cells were grown on laminin (5 pg/ml) coated slides for 2-3 days in a 
37°C, 5% CO2 incubator. Cells were washed twice with phosphate-buffered saline (pH 
7.4) and treated for 1 hr with MMT (200 p,M). Cells were incubated with 10 |_iM acridine 
orange for 15 min at room temperature in the dark. Cells were again washed with 
phosphate-buffered saline, mounted with cover slips, and observed under a Nikon 
DiaPhot microscope with attached SPOT digital camera (Diagnostic Instruments, 
Sterling Heights, MI). 
Data analysis and statistics. Data are expressed as mean ± SEM and statistical 
significance was determined by analysis of variance (ANOVA) with either Dunnett's 
test in the case of multiple comparisons with control or Tukey-Kramer means separation 
test for multiple comparisons between treatment groups. Single comparisons were 
performed by Student's t-test or Welch-corrected unpaired t-test where appropriate. 
Differences were accepted as significant at p<0.05 or less. 
RESULTS 
MMT decreases cell viability. PC 12 cells were exposed to 0-1000 p,M MMT for 1 
hr and cell viability was measured by trypan blue dye exclusion. Figure 1A shows the 
relationship between MMT concentration (log |iM) and percent cell survival relative to 
the control. Exposure of PC 12 cells to various concentrations of MMT resulted in a 
concentration-dependent decrease in cell viability and the EC50 of MMT was calculated 
to be approximately 206 jiM by three-parameter non-linear regression. Based upon these 
results, subsequent measurement of various biochemical indices in key mechanistic 
studies were performed in PC12 cells treated with 200 p.M MMT. Treatment with as 
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high as 1 mM inorganic Mn2+ did not show any significant alteration in cell viability in 
PC 12 cells for 1-hr exposure, and more than 24 hrs were required to induce cytotoxicity 
in PC 12 cells (data not shown). 
To determine whether dopamine producing cells are more susceptible to MMT 
toxicity, we compared the cytotoxic effect of MMT on PC 12 cells with a GABAergic 
cell line (M213-20; Fig. 1A). EC50 for 1 hr exposure of M213-20 cells to MMT was 
approximately 591 |iM. The difference in the EC50 values of PC12 and M213-20 cells 
was statistically significant (Fig 1A; p<0.02). In a separate study with cultured rat 
cerebellar granule cells using the trypan blue dye exclusion method showed these cells 
to be unresponsive to the toxic effects of MMT. Additional experiments were performed 
with cerebellar granule cells using a more sensitive acute toxicity assessment by 
measuring extracellular LDH (Fig. IB). Using this method, cytotoxicity in cerebellar 
granule cells was only observed at very high concentrations of MMT (10 mM, p<0.05 
compared with vehicle control). Thus, it appears that dopamine producing cells are more 
susceptible to MMT toxicity. 
MMT causes dopamine depletion. Treatment of PC12 cells with MMT (0-1000 
|iM) for 1 hr resulted in a significant concentration-dependent depletion of intracellular 
dopamine (Fig. 2A; pO.OOOl). Depletion of dopamine by MMT in PC12 cells appeared 
to be biphasic, with an initial depletion of ca. 44% at concentrations of 30-100 pM 
MMT, depleting dopamine further with increasing MMT concentration to >95% 
depletion at concentrations of MMT above 100 pM (Welch-corrected unpaired t-test, 
p<0.02; 300 JJ.M vs. 100 (xM MMT). Extracellular dopamine concentrations did not 
increase across the concentration range of MMT used here, suggesting that MMT does 
not promote dopamine secretion. Extracellular DOPAC increased 2.3 fold and appeared 
to increase inversely to cellular dopamine depletion, whereas intracellular DOPAC did 
not change significantly across the concentration range of MMT used here (Fig. 2B). It 
is presently unclear whether tyrosine hydroxylase inhibition contributes to observed 
dopamine depletion because of the short time (lhr) exposure of MMT. Further studies 
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are needed to determine the exact neurochemical mechanisms underlying MMT-induced 
dopamine depletion and DOPAC formation. 
MMT facilitates ROS generation. Reduction of AYm is an index of mitochondrial 
dysfunction and mitochondria are considered major sources of oxidative stress. When 
mitochondria are impaired, more reactive oxygen species (ROS) may be generated 
(Voehringer and Meyn, 2000). Enhanced generation of ROS was observed in PC12 cells 
at 1 hr following MMT treatment as measured by the ROS-detecting fluor DCF-DA (Fig. 
3A). MMT treatment concentration-dependently increased DCF-H fluorescence, the 
peroxidized product of DCF-DA. Maximal production of ROS by MMT treatment was 
316.3% of vehicle control with an EC50 for MMT treatment of 51.55 (xM as determined 
by three-parameter logistic regression (^=0.93). Further support of ROS generation was 
confirmed by hydroethidine fluorescence measurements, which are relatively specific for 
superoxide radicals. Hydroethidine measurement of superoxide formation revealed a 
concentration-dependent increase in generation of ROS at 30 min posttreatment (Fig. 
3B). 
MMT activates caspase-3 activity in PC12 cells. Mitochondrial dysfunction and 
increased oxidative stress have been implicated in initiation of apoptosis in 
dopaminergic cells by treatment with various toxicants (Lotharius and O'Malley, 2000; 
Robertson and Orrenius, 2000; Kitazawa et al., 2001). Since MMT significantly 
increased intracellular ROS level within 1 hr, other pro-apoptotic molecules may also be 
activated during the exposure period. We measured the activity of caspase-3, an effector 
cysteine-aspartate protease and one of the key pro-apoptotic molecules activated by 
various apoptotic stimuli, using caspase-3 specific fluorescent substrate Ac-DEVD-
AMC following 0-200 |j.M MMT treatment in PC 12 cells. Caspase-3 was activated 
concentration-dependently and caspase-3 activity showed 6- and 15-fold increases from 
basal level with 150 and 200 |iM MMT exposure for 1 hr, respectively (Fig. 4A). 
To examine the possible role of oxidative stress in activation of caspase-3, we 
pretreated PC 12 cells with two different antioxidants, 1 mM Trolox or 5 mM N-acetyl-L-
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cysteine (NAC), for 30 min, then exposed to MMT for another 1 hr. Cells treated with 
Trolox significantly (p<0.05) reduced both 150 and 200 JJ,M MMT-induced caspase-3 
activity (Fig. 4B), with caspase-3 inhibition ranging from 35-50%. Enigmatically, NAC 
was only effective at 150 |iM MMT exposure but not at 200 p.M MMT exposure (Fig. 
4B). 
Results of various studies with dopaminergic cell lines and cultured neurons have 
indicated that dopamine and/or dopamine oxidation products contribute to the level of 
oxidative stress and the propensity of cells to undergo apoptosis (Offen et al., 1999; 
Kitazawa et al., 2001). Since we observed profound changes in dopamine and DOPAC 
levels following MMT treatment (Fig. 2), we investigated the possibility of dopamine to 
contribute to oxidative stress by examining the effects of inhibition of dopamine 
degradation to DOPAC and inhibition of dopamine synthesis. Tyrosine hydroxylase 
inhibition by 500 |iM a-MPT pretreatment for 24 hrs significantly reduced cellular 
dopamine concentrations (83.6 ± 2.1% reduction; p<0.01) and rendered DOPAC 
concentrations below the detectable limits of HPLC-EC method. MAO-B inhibition by 
pretreatment with 100 |iM deprenyl for 30 min significantly reduced cellular DOPAC 
formation (79.7 ± 8.1% reduction; p<0.01), but did not alter cellular dopamine 
concentrations as verified by HPLC-EC. Pretreatment with a-MPT partially inhibited 
MMT-induced caspase-3 activation (Fig. 4B), thus suggesting a contribution of 
dopamine or dopamine metabolite(s) in apoptotic processes. Deprenyl pretreatment did 
not inhibit MMT-induced caspase-3 activation (data not shown), suggesting that 
excessive DOPAC formation may not play a role in initiation of caspase-dependent 
apoptosis. 
MMT induces apoptosis in dopamine producing PC12 cells. Chromatin 
condensation and DNA fragmentation are unique morphological changes during the 
terminal phases of apoptotic cell death. Treatment of PC 12 cells with MMT (200 p,M) 
caused the formation of uncoiled DNA by qualitative assessment using acridine orange 
staining (Fig. 5A). Using a more sensitive ELISA-based method to measure DNA 
fragmentation, we observed approximately a 170% increase in DNA fragmentation with 
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200 fxM MMT exposure within 1 hr (Fig. 5B). Previously, we also demonstrated that 
caspase inhibitors Z-VAD-FMK and Z-DEVD-FMK effectively attenuated MMT-
induced DNA fragmentation, thus caspase-3 plays an important role in apoptosis 
following MMT exposure (Anantharam et al., 2002). 
Mitochondrial dysfunction and the subsequent increase of intracellular ROS levels 
may be the initial responses for triggering apoptotic cascade. To further determine 
whether MMT-induced ROS generation plays a role in apoptotic cell death, cells were 
treated with 1 mM Trolox, which showed profound inhibition of MMT-induced caspase-
3 activation, for 30 min prior to exposure to 200 |oM MMT. Trolox significantly 
(p<0.05) inhibited the nearly 2-fold MMT-induced increase in DNA fragmentation (Fig. 
5B). 
We further investigated whether dopamine plays any role in downstream apoptotic 
cascade, which could help to explain selectivity of MMT for dopamine producing cells. 
As shown in Fig. 5B, depletion of dopamine by a-MPT treatment prior to MMT 
exposure significantly inhibited MMT-induced genomic DNA fragmentation. 
Interestingly, deprenyl (30 min treatment) also attenuated DNA fragmentation observed 
at 1 hr MMT exposure (Fig. 5B). 
Bcl-2 attenuates MMT-altered loss of mitochondrial membrane potential 
(AYm). In order to better substantiate the evidence from pharmacological studies 
performed here with respect to specific implication of mitochondrial dysfunction as a 
key factor in initiation of apoptotic cell death, we tested the effect of MMT on a 
transacted PC 12 cell line overexpressing the apoptotic control protein Bcl-2. 
Verification of the level of Bcl-2 expression in vector-only control (PC12V4) and Bcl-2 
overexpressed (PC12HB2-3) cell lines was performed by Western blot (Fig. 6A), with 
verification of equal protein loading per gel lane by reprobe with anti-HSP60. To 
measure mitochondrion-specific effects, we utilized DiOCe to measure reduction of 
A^Fm following MMT treatment. Acute (1 hr) MMT exposure concentration-
dependently decreased AYm, and the reduction was significant (p<0.01) at 150 and 200 
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jxM MMT in PC12V4 cells (Fig. 6B). The reduction observed was 58.6% and 48.2% of 
vehicle-treated group following 150 and 200 |iM MMT exposure for 1 hr, respectively, 
whereas Bcl-2 overexpressed cells showed 106.8% at 150 |JM MMT exposure, which 
completely attenuated the depolarization of AYm, and 72.2% at 200 |xM MMT. 
Attenuation of ATm by Bcl-2 was significant (p<0.05) at both concentrations of MMT. 
Bcl-2 reduces MMT-induced ROS generation. To examine whether attenuation of 
MMT-induced depolarization of AYm by Bcl-2 was the result of blocked ROS 
generation, we measured ROS generation in PC12V4 and PC12HB2-3 cells following 
MMT treatment. It has previously been shown that MMT rapidly increases cellular ROS 
level within 1 hr, and the peak ROS level is around 15-30 min following MMT treatment 
(Anantharam et al, 2002). As shown in Figs. 7A and 7B, ROS generation increased 
following MMT exposure for 15 or 30 min in PC12V4 cells. Conversely, Bcl-2 
overexpressed PC12HB2-3 cells showed reduced ROS generation, which is significantly 
(p<0.01) less than the levels in PC12V4 cells. Thus, Bcl-2 protein overexpression 
appears to attenuate MMT-induced ROS generation. 
Bcl-2 overexpression protects against caspase-3 activation and DNA 
fragmentation. MMT-mediated mitochondrial dysfunction, as measured by the 
reduction of AYm, was effectively attenuated by Bcl-2 overexpression, suggesting that 
downstream cell death processes could be blocked only if mitochondria regulate MMT-
induced apoptotic cell death. As shown in Figure 8A, PC12V4 cells showed 18- and 23-
fold increase in caspase-3 activity following 150 and 200 (J.M MMT exposure, 
respectively. As we expected, caspase-3 activity in PC12HB2-3 cells was significantly 
(p<0.01) blocked following 1 hr MMT (150 |xM) exposure, and increased caspase-3 
activity was only observed at 200 |xM MMT exposure. 
In addition, we tested the involvement of mitochondrial Bcl-2 on MMT-induced 
DNA fragmentation. MMT exposure for 1 hr (100-200 pM) causes a concentration-
dependent increase in DNA fragmentation in PC12V4 cells (Fig. 8B). Bcl-2 
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overexpressed PC12HB2-3 cells showed almost complete inhibition of MMT-induced 
DNA fragmentation, which correlates with inhibition of reduction of AYm, ROS 
generation and caspase-3 activity. Taken together with attenuation of caspase-3 activity 
by antioxidants, mitochondrial dysfunction and oxidative stress contributes to the 
activation of downstream apoptotic responses during MMT-induced toxicity in 
dopamine producing cells. 
DISCUSSION 
Health effects regarding the use of MMT as a tetraethyl lead replacement in 
automotive fuels have been studied predominantly from the aspect of manganese 
particulate combustion products. However, data presented here delineates a health risk 
potential associated with effects of the parent chemical. Accidental exposures through 
spills or unintended uses of MMT-amended gasoline provides a routine human exposure 
route which, noting both the demonstrated effects of manganese on dopaminergic 
neurochemical systems (Olanow et al., 1996; Rodruigez et al., 1998) and long blood 
plasma half-life of MMT (Zheng et al., 2000), may potentially play a role in 
environmentally-mediated, geriatric-onset PD. Recent epidemiological and case-control 
studies support the role of environmental exposure to metals and other organic toxicants 
such as pesticides in idiopathic PD (Tanner et al., 1999; Gorrel et al., 1999). 
One of the earliest cellular responses following MMT exposure is ROS generation. 
Oxidative stress has also been shown to mediate manganese-induced apoptosis in several 
in vitro models such as PC12 cells and HeLa cells (Desole et al., 1997b; Oubrahim et al., 
2001) and in vivo in manganese-induced neurotoxicity of the rat (Desole et al., 1997a), 
which is relevant within the context of combustion products of MMT-amended fuels. 
Since MMT appears to exert cytotoxic effects also as an organic complex of manganese, 
the potential danger of MMT-amended fuels is possibly enhanced by both pre-
combustion (MMT) and post-combustion (manganese) product exposures (Garrison et 
al., 1995). In this study, we have shown MMT-induced activation of apoptotic signals in 
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PC 12 cells and have further elucidated the mechanisms of MMT-mediated cell death, 
which could have implications for effects of MMT on dopaminergic neuronal systems. 
The results of the present study clearly demonstrate that the cytotoxic ability of 
MMT in in vitro systems resides in the capacity of MMT to kill cells by a mitochondria-
mediated apoptotic mechanism and oxidative stress. One potential additional 
mechanism for MMT-induced oxidative stress was suggested by the apparent ability of 
MMT to produce DOPAC formation accompanied with intracellular dopamine depletion. 
It has been demonstrated previously in a number of studies (Spina and Cohen, 1989; 
Fabre et al., 1999) that DOPAC metabolism generates H2O2 as a byproduct of the 
reaction, either alone or enhanced in the presence of metals, which could also add to 
ROS generation observed here. 
Previous studies have demonstrated that certain environmental cyclodiene 
neurtoxicants such as dieldrin (Kitazawa et al., 2001) and heptachlor epoxide (Kirby et 
al., 2001) evoke dopamine release, which could have deleterious effects towards 
generation of ROS and activation of apoptotic pathways as a result of cytosolic pooling 
of recycled dopamine. Apoptosis resulting from cytosolic pooling of recycled dopamine 
can be attenuated by blocking expression of the presynaptic dopamine transporter 
(Simantov et al., 1996). However, the results of the present work suggest that MMT-
induced dopamine degradation may be an important event in dopaminergic toxicity. 
Striatal dopamine depletion has been observed in mice treated with MMT (Gianutsos 
and Murray, 1982) and may occur in vivo by this mechanism involving degradation of 
dopamine. Of additional note, recent work by Lotharius and O'Malley (2000) 
demonstrates that MPP+ exerts neurotoxic effects not only by complex I inhibition but 
also by redistributing dopamine from the vesicular pool to the cytoplasm, which fosters 
conversion of dopamine to various neurotoxic quinones. However, the authors did not 
find an MPP+-mediated reduction in mitochondrial transmembrane potential (AVm), in 
contrast to their results with rotenone, and suggest the existence of a peripheral source of 
ROS generation leading to catecholamine quinone production. In this respect, the effects 
of MMT on A%n appear to better resemble the rotenone parkinsonism model (Betarbet 
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et al., 2000) and may potentially combine the mitochondrial impairment aspect of this 
model with the catecholamine quinone formation aspect of the MPP+ model. 
MMT cytotoxicity appears to be mediated by oxidative stress produced by both 
mitochondrial impairment and alteration of dopamine catabolism. Earlier studies by 
Autissier and colleagues (Autissier et al., 1997a, 1997b) demonstrated direct effects of 
MMT on mitochondrial complex I and determined that the Mn2+ component of MMT is 
specifically responsible for altering the electronic configuration of the carbonyl groups 
to promote association with complex I. Additionally, MMT not only interferes with 
NAD+-linked substrate energy transfer but also interferes with electron donation to 
ubiquinone, which results in a decrease in oxidative phosphorylation (Autissier et al., 
1977a). In our studies, measurement of the increase in activity of pro-apoptotic 
messengers (caspase-3) and expression of cytotoxic indices (increased DNA 
fragmentation) can be collectively inhibited by various protective agents such as Trolox 
(antioxidant) or a-MPT (tyrosine hydroxylase inhibitor). Deprenyl (MAO-B inhibitor) 
protected cells from DNA fragmentation, but did not have a measurable effect on 
reduction of caspase-3 activity which suggests that MMT-induced DNA fragmentation 
can occur by a caspase-3-independent pathway(s) as observed by other researchers 
(Volbracht et al., 2001). Regardless, the majority of our results implicate the 
mitochondria as either the source of or target of ROS and link the process of apoptosis 
with early events directed at mitochondrial damage. The protective effects of tyrosine 
hydroxylase inhibition additionally implicate dopamine or dopamine byproducts as 
contributing components of apoptotic initiation and may partially help to explain the 
effects of MMT in vivo on dopaminergic systems (Gianutsos and Murray, 1982). 
Additionally, previous studies have demonstrated that inorganic manganese exposure 
produces selective neurotoxic effects on dopaminergic systems, including the 
nigrostriatal tract (Olanow et al., 1996; Rodruigez et al., 1998). 
We further confirmed the mitochondrial impairment aspect of MMT cytotoxicity 
by constructing PC12-derived cell lines specifically tailored to overexpress the apoptotic 
control protein, Bcl-2. In the normal state, phosphorylated Bcl-2 in the mitochondrion 
forms stable heterodimers with pro-apoptotic control proteins in the same gene family 
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(Robertson and Orrenius, 2000; Adams and Cory, 2001). Bcl-2 heterodimeric complexes 
bave the ability to inhibit apoptotic processes by direct interference with pro-apoptotic 
messengers (e.g., Bax, Bak), prevent opening of the mitochondrial permeability 
transition pore, and by unknown mechanisms fosters increased concentrations of 
reduced glutathione in the nuclear envelope and augmentation of the NAD(P)H energy 
pool in mitochondria (Voehringer and Meyn, 2000). The latter two effects also possibly 
have roles in both down-regulation of apoptotic pathways and increased transcription of 
anti-apoptotic/homeostatic genes dependent upon the redox status of the cell, a 
perspective based on several lines of evidence and advocated by Voehringer and Meyn 
(2000). Indeed, in the present study, stabilization of intracellular redox status by 
application of antioxidants appears to compliment hypotheses of Bcl-2 function 
regarding increased expression or activity of ROS-protective mechanisms. 
Dephosphorylation of Bcl-2 tends to favor release of Bax and Bak to form 
homodimers and/or Bax/Bak heterodimers. These Bax and Bak formations promote 
cytochrome C release and mitochondrial transition pore opening, the latter of which 
results in loss of AYm (Adams and Cory, 2001). Stabilization of mitochondrial transition 
pore closed-state in Bcl-2 overexpressed cells was verified by lack of reduction in AYm 
following MMT exposure, whereas a loss of AYm was observed in vector control cells 
treated with MMT. We also previously reported that MMT-induced caspase-3 activation 
is mediated by cytochrome C release from mitochondria (Anantharam et al., 2001, 
submitted), which follows currently understood toxicant-induced apoptosis models 
(Tsujimoto, 1998; Robertson and Orrenius, 2000). Following cytochrome C release, 
Apaf-1 release from dephosphorylated Bcl-2 and subsequent Apaf-1 dimerization to 
cytosolic cytochrome C promotes cleavage and activation of pro-caspase-9, an important 
initiator caspase signalling downstream apoptotic events. These capsase-9-dependent 
events include, but perhaps may not be limited to, cleavage and activation of pro-
caspase-3 and pro-caspase-7. Caspase-3 in particular is known to be a critical effector 
caspase (Abu-Qare and Abou-Donia, 2001; Adams and Cory, 2001), which activates a 
host of downstream pro-apoptotic effectors (e.g., PKC-ô, DNApk), inactivates a variety 
of downstream anti-apoptotic effectors (e.g., PARP, ICAD), and cleaves cytoskeletal 
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structural proteins (e.g., spectrin, actin, lamin). Overexpression of Bcl-2 in its normal 
phosphorylated state provides an abundant pool for sequestration of mitochondrial pro-
apoptotic messengers and further underscores the results of the pharmacological studies 
reported here which suggest that initiation of apoptosis by MMT occurs through 
mitochondrial dysfunction. 
In conclusion, the results presented here delineate that oxidative stress plays an 
important role in mitochondrial mediated apoptotic cell death in cultured dopamine 
producing cells following exposure to MMT. Forthcoming studies conducted in this 
laboratory will attempt to demonstrate whether nigrostiatal neurons are selectively 
susceptible to MMT-mediated neurotoxicity. 
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Figure 1: Effect of MMT on cell viability in dopamine-producing and non-
dopaminergic cells. 
(A) MMT-induced loss of cell viability after 1 hr treatment in dopamine producing PC 12 
cells and M213-20 cells was determined by trypan blue exclusion method and was 
analyzed by three-parameter logistic regression (EC50 and 95% confidence interval of 
EC 5 0 :  PC12 cells, 205.8 |xM, 99.9-424.2 ; M213-20 cells, 590.5 \iM, 453.4-769.0). EC 5 0  
values of PC12 and M213-20 cells were significantly different (p<0.02, Welch-corrected 
unpaired t-test). (B) Cytotoxicity of MMT in cerebellar granule cells was determined by 
measurement of extracellular lactate dehydrogenase (LDH) activity after 1 hr of 
treatment. 'U' denotes untreated cerebellar granule cells. Data represent results of at 
least three separate experiments in triplicate and are expressed as percent of vehicle-
treated group (mean ± SEM). *p<0.05 compared with vehicle-treated group. 
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Figure 2: Dopamine depletion in MMT-treated PC12 cells. 
Intracellular and extracellular dopamine (A) and 3,4-dihydroxyphenylacetic acid 
(DOPAC; B) levels were determined by HPLC-EC following 1 hr treatment of PC 12 
cells with MMT. Significant increases in extracellular DOPAC and decreases in 
intracellular dopamine were analyzed by ANOVA followed by a Dunnett's test (DA, 
pO.OOOl; DOPAC, p<0.02). Data represent the mean ± SEM of four separate 
experiments and are expressed as pmols / 106 cells group. *p<0.05 and **p<0.01 
compared with vehicle-treated group, respectively. 
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Figure 3: Concentration-dependent ROS generation in MMT-treated PC12 cells. 
(A) DCF-H, the fluorescent dye product of peroxidized DCF-DA, was measured 
fluorometrically in MMT-treated PC 12 cells at 1 hr post-treatment and analyzed by 
three-parameter logistic regression (EC50: 51.52 ± 1.93 (iM; r2=0.94). (B) Hydroethidine, 
the fluorescent dye product of dihydroethidine, was measured by flow cytometer in 
MMT-treated PC 12 cells at various concentrations up to 30 min. Data represent the 
mean ± SEM of 3-9 experiments and are expressed as percent vehicle control. *p<0.01 
compared with vehicle-treated group. 
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Figure 4: MMT-induced caspase-3 activation. 
(A) PC 12 cells were exposed to MMT (0-200 pM) for 1 hr, and caspase-3 activity was 
measured using a caspase-3 specific substrate, Ac-DEVD-AMC. (B) PC 12 cells were 
pretreated with 1 mM Trolox or 5 mM NAC for 30 min or with 500 pM a-MPT for 24 
hrs prior to exposure to MMT. Following 1 hr MMT exposure, then cytosolic fraction 
was collected, and caspase-3 activity was measured. All data represent the mean ± SEM 
for three separate experiments in triplicate. *p<0.05 or **p<0.01 compared with vehicle-
treated group. 
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Figure 5: MMT-induced DNA fragmentation in PC12 cells. 
(A) Qualitative assessment of nuclear degradation in 200 |iM MMT-treated PC 12 cells 
stained with acridine orange at 1 hr. Arrows denote apoptotic morphological changes (B) 
PC 12 cells were treated (30 min) with 1 mM Trolox prior to treatment with 200 pM 
MMT. DNA fragmentation was measured by DNA ELISA assay following 1 hr of MMT 
treatment. Asterisks represent results of a Welch-corrected unpaired t-test comparing 
either Trolox alone or Trolox + MMT with MMT alone. Data are expressed as percent 
vehicle-treated group (mean ± SEM) of 3-6 experiments. *p<0.05 or **p<0.01 compared 
with vehicle-treated group. 
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Figure 6: Overexpression of Bcl-2 protects PC12 cells against MMT-induced loss of 
mitochondrial transmembrane potential (ATm). 
(A) Overexpression of Bcl-2 in expression vector control (PC12V4) and Bcl-2 enhanced 
expression positive (PC12HB2-3) cells as verified by Western blot (top panel). 
Verification of equal protein loading per gel lane was verified by membrane reprobe for 
HSP60, a basic mitochondrial protein (bottom panel). (B) PC12V4 and PC12HB2-3 
cells were exposed to 0-200 fxM MMT for 1 hr, and reduction of Afm was determined 
by flow cytometer using 40 nM DiOCe- Relative fluorescence intensity was measured 
and expressed as percent of vehicle-treated group. Data represent the mean ± SEM for 
two separate experiments in triplicate. *p<0.05 or **p<0.01 compared with vehicle-
treated group or between indicated treatment groups. 
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Figure 7: Overexpression of Bcl-2 significantly reduces MMT-mediated reactive 
oxygen species (ROS) generation. 
PC12V4 and PC12HB2-3 cells were exposed to 0-200 |xM MMT, and fluorescence 
intensity of dihydroethidine was measured by flow cytometer at 15 min (A) and 30 min 
(B) following MMT treatment. Data represent the mean ± SEM of 3 experiments in 
triplicate and are expressed as percent vehicle control. *p<0.01 compared with vehicle-
treated group. **p<0.01 compared between vector-transfected and Bcl-2 overexpressed 
PC 12 cells. 
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Figure 8: Overexpression of Bcl-2 protects PC12 cells against MMT-induced 
caspase-3 activation and nuclear DNA fragmentation. 
(A) PC12V4 and PC12HB2-3 cells were exposed to MMT (0-200 |iM) for 1 hr, and 
caspase-3 activity was measured. Caspase-3 activity was expressed as relative 
fluorescence units (FU) per mg protein per hr of incubation with caspase-3 substrate at 
37°C. All data represent the mean ± SEM for 3 separate experiments in triplicate. 
*p<0.05 or **p<0.01 compared with vehicle-treated group or between indicated 
treatment groups. (B) PC12V4 and PC12HB2-3 cells were exposed to MMT (0-200 pM) 
for 1 hr and DNA fragmentation was measured by ELISA method. Data represent the 
mean ± SEM for 2 separate experiments in duplicate. *p<0.05 or **p<0.01 compared 
with vehicle-treated group or between indicated treatment groups. 
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CHAPTER IV: DIELDRIN INDUCES APOPTOSIS BY PROMOTING 
CASPASE-3-DEPENDENT PROTEOLYTIC CLEAVAGE OF PROTEIN KINASE 
C8 IN DOPAMINERGIC CELLS: RELEVANCE TO OXIDATIVE STRESS AND 
DOPAMINERGIC DEGENERATION 
A paper submitted for publication in Neuroscience 
Masashi Kitazawa, Vellareddy Anantharam, and Anumantha G. Kanthasamy 
ABSTRACT 
We previously reported that dieldrin, one of the potential environmental risk 
factors for development of Parkinson's disease, induces apoptosis in dopaminergic cells 
by generating oxidative stress. Here, we demonstrate that the caspase-3-dependent 
proteolytic activation of protein kinase C8 (PKCô) mediates as well as regulates the 
dieldrin-induced apoptotic cascade in dopaminergic cells. Exposure of PC 12 cells to 
dieldrin (100-300 jjM) results in the rapid release of cytochrome C, followed by the 
activation of caspase-9 and caspase-3 in a time- and dose-dependent manner. The SOD 
mimetic MnTBAP significantly attenuates dieldrin-induced cytochrome C release, 
indicating that ROS may contribute to the activation of pro-apoptotic factors. 
Interestingly, dieldrin proteolytically cleaves native PKCô into a 41 kDa catalytic subunit 
and a 38 kDa regulatory subunit to activate the kinase. The dieldrin-induced proteolytic 
cleavage of PKCô and induction of kinase activity are completely inhibited by 
pretreatment with 50-100 |iM concentrations of the caspase inhibitors Z-VAD-FMK and 
Z-DEVD-FMK, indicating that the proteolytic activation of PKCô is caspase-3 -dependent. 
Additionally, Z-VAD-FMK, Z-DEVD-FMK or the PKCÔ specific inhibitor rottlerin 
almost completely block dieldrin-induced DNA fragmentation. Because dieldrin 
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dramatically increases (40-80 fold) caspase-3 activity, we examined whether 
proteolytically activated PKC8 amplifies caspase-3 via positive feedback activation. The 
PKCô inhibitor rottlerin (3-20 |xM) dose-dependently attenuates dieldrin-induced 
caspase-3 activity, suggesting positive feedback activation of caspase-3 by PKCô. Indeed, 
delivery of catalytically active recombinant PKCô via a protein delivery system 
significantly activates caspase-3 in PC 12 cells. Finally, overexpression of the 
kinase-inactive PKCÔk376R mutant in rat mesencephalic dopaminergic neuronal cells 
attenuates dieldrin-induced caspase-3 activity and DNA fragmentation, further 
confirming the pro-apoptotic function of PKCô in dopaminergic cells. Together, we 
conclude that caspase-3-dependent proteolytic activation of PKCô is a critical event in 
dieldrin-induced apoptotic cell death in dopaminergic cells. 
Key Words: neurodegeneration; oxidative stress; mitochondria; caspases; Parkinson's 
disease; environmental factors 
INTRODUCTION 
Parkinson's disease (PD) is a common neurodegenerative disorder among the 
elderly. Despite the intensive efforts in PD research, the exact cause of selective loss of 
dopaminergic neurons is poorly understood. The exogenous mitochondrial neurotoxicant, 
1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), was discovered to cause a 
Parkinson's-like syndrome (Davis et al., 1979) and brought more attention to the possible 
role of environmental factors in the pathogenesis of PD. In support of an environmental 
hypothesis, case-control studies and epidemiological findings have revealed a higher 
association of PD in individuals exposed to chemicals such as pesticides, herbicides, and 
heavy metals (Wong et al., 1991, Semchuk et al., 1992, Seidler et al., 1996, Liou et al., 
1997, Gorell et al., 1998). Recently, a study conducted on thousands of genetically 
identical twins concluded that genetic factors may play an important role in the 
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pathogenesis of young onset of PD, but not in the major form of sporadic PD (Tanner et al., 
1999). The results of this study further suggested that environmental factors are dominant 
risk factors in sporadic PD, which develops in later stage of life. 
Dieldrin is an organochlorine pesticide that was widely used agriculturally to 
control soil pests such as termites, grasshoppers, locusts, beetles, and textile pests. 
Dieldrin was also used to control tsetse flies and other vectors of tropical diseases 
including malaria, yellow fever, Chagas disease, Oraya fever, African sleeping sickness, 
river blindness, and filariasis (de Jong, 1991). After many years of widespread use, the 
U.S. Environmental Protection Agency (USEPA) restricted the use of dieldrin in 1974 due 
to its possible carcinogenicity and bioaccumulation. Based on its chemical stability, the 
USEPA has currently listed dieldrin as one of the top 12 priority persistent 
bioaccumulative and toxic (PBT) chemicals (www.epa. gov/opptintr/pbt/cheminfo.html). 
The Centers for Disease Control (CDC) includes dieldrin in the list of the top 20 human 
hazardous substances (http://www.atsdr.cdc.gov/cxcx3.html). Though dieldrin has been 
banned, humans continue to be exposed to the pesticide mainly through contaminated 
foods due to its persistent accumulation in the environment as well as its continued use in 
some developing countries (Suwalsky et al., 1997, Meijer et al., 2001). High serum 
dieldrin levels in farmers have recently been reported in some agricultural states in the U.S. 
(Brock et al., 1998). Potential adverse neurological effects from dieldrin exposure remain 
a concern. Several lines of evidence indicate that dieldrin exposure is positively 
associated with an increased incidence of PD (Fleming et al., 1994, Corrigan et al., 1998, 
Corrigan et al., 2000). Significant levels of dieldrin were detected in brains from PD 
patients, whereas no dieldrin was detected in age-matched control brains in several 
postmortem studies (Fleming et al., 1994, Corrigan et al., 1998, Corrigan et al., 2000). 
Moreover, dieldrin induces Parkinson's-like symptoms, including tremors, transient 
kinesia, and body rigidity in animals (Sharma et al., 1976, Wagner and Greene, 1978, 
Heinz et al., 1980). An in vitro study also demonstrated that dieldrin targets dopaminergic 
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neurons selectively (Sanchez-Ramos et al., 1998). 
The mechanisms by which various environmental factors including dieldrin 
promote cell death in dopaminergic neurons are still elusive. In our previous study, we 
demonstrated that dieldrin induces dopamine release and generates significant levels of 
reactive oxygen species (ROS) in rat pheochromocytoma (PC 12) cells, and our data 
support that dieldrin-induced ROS plays a causal role in apoptosis because pretreatment 
with antioxidants effectively attenuated dieldrin-induced apoptotic cell death (Kitazawa et 
al., 2001). The present study was undertaken to characterize the downstream signaling 
events of oxidative stress-induced apoptosis following dieldrin exposure. Herein, we 
report that caspase-3-mediated proteolytic cleavage of PKCô contributes to apoptosis of 
dopaminergic PC 12 cells following exposure to dieldrin. Furthermore, we demonstrate 
that activation of PKCô not only plays a pivotal role in downstream execution process of 
dieldrin-induced apoptosis but also regulates upstream caspase signaling cascade through 
positive feedback mechanism. 
EXPERIMENTAL PROCEDURES 
Materials 
Dieldrin, (3-nicotinamide adenine dinucleotide, reduced form (NADH), sodium 
pyruvate, mouse monoclonal (3-actin antibody, histone HI, ^-glycerophosphate, ATP, 
Protein-A-sepharose, phosphatidylserine, dioleoylglycerol, human recombinant active 
PKCô, Hoechst 33342 propidium iodide, and Fas ligand were purchased from Sigma 
Chemicals (St. Louis, MO). Mn(III)tetrakis(4-benzoic acid)porphyrin chloride 
(MnTBAP) was obtained from OXIS international Inc. (Portland, OR). Caspase-3 
specific inhibitor, Ac-DEVD-CHO, and caspase-3 substrate, Ac-DEVD-AMC and 
Ac-DEVD-pNA, were purchased from Bachem Biosciences Inc. (King of Prussia, PA). 
Caspase-3 specific inhibitor, Z-DEVD-FMK, caspase-8 substrate, Ac-IETD-AMC, and 
caspase-9 substrate, Ac-LEHD-AMC, were purchased from Alexis Biochemicals (San 
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Diego, CA). Broad specific caspase inhibitor, Z-VAD-FMK, was purchased from 
Enzyme Systems Products (Livermore, CA). FITC-VAD-FMK was purchased from 
Promega (Madison, WI). Acridine orange was purchased from Molecular Probes (Eugene, 
OR). PKCô specific inhibitor, rottlerin, was purchased from Calbiochem (La Jolla, CA). 
Antibodies to PKCô, PKCa, and PKCpiI were purchased from Santa Cruz Biotechnology 
Inc. (Santa Cruz, CA). Mouse anti-cytochrome C antibody was purchased from BD 
Pharmingen (San Diego, CA). Cleaved caspase-3 antibody was purchased from Cell 
Signaling (Beverly, MA). ECL Western blotting analysis kit was purchased from 
Amersham Pharmacia Biotech, Inc. (Piscataway, NJ). Cell Death Detection Elisa Plus 
Assay Kit was purchased from Roche Molecular Biochemicals (Indianapolis, IN). 
Cytochrome C ELISA kit was obtained from MBL International Corp. (Watertown, MA). 
BioPORTER protein delivery kit was purchased from Gene Therapy Systems (San Diego, 
CA). [y-32P]ATP was purchased from NEN (Boston, MA). RPMI 1640 medium, heat 
inactivated horse serum, fetal bovine serum, L-glutamine, penicillin/streptomycin, and 
PCEP4 plasmid were purchased from InVitrogen (San Diego, CA). Other routine 
laboratory chemicals were obtained from Fisher Scientific (Pittsburgh, PA). Plasmids 
PKCÔk376r-GFP fusion protein and pEGFP-Nl were kind gifts of Dr. Stuart H. Yuspa, 
National Cancer Institute (Bethesda, MD). Immortalized rat mesencephalic (IRB3AN27) 
cell line was a kind gift of Dr. Kedar N. Prasad, Univ. of Colorado Health Sciences Center 
(Denver, CO). 
Cell culture and treatment 
PC12 cells (pheochromocytoma, ATCC CRL1721) were cultured in RPMI-1640 
medium containing 10% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM 
L-glutamine, 50 units penicillin, and 50 |ag/ml streptomycin. Immortalized rat 
mesencephalic cell line (IRB3AN27 cells) was grown in RPMI-1640 medium containing 
10% fetal bovine serum, 2 mM L-glutamine, 50 units penicillin, and 50 gg/ml 
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streptomycin (Prasad et al., 1998). Both PC12 and IRB3AN27 cells were maintained at 
37°C in a humidified atmosphere of 5% CO2. Briefly, cells were resuspended in 
serum-free RPMI-1640 medium at a density of 2 x 106 cells/ml. Dieldrin was dissolved in 
DMSO and added to the cells. The DMSO concentration was maintained at less than 1% 
during incubation and used as the vehicle treatment. Caspase inhibitors, the PKCÔ 
inhibitor, and a free radical scavenger (MnTBAP) were added to cell suspensions 30 min 
prior to the exposure to dieldrin and incubated at 37°C. After the treatment with dieldrin, 
cell suspensions were quickly centrifuged and cell-free supernatant was collected for 
extracellular lactate dehydrogenase (LDH) assay. Cell pellets were further processed to 
determine caspase activity, DNA fragmentation, or cytosolic protein analyses by Western 
blot. Cells treated with DMSO were used as a vehicle-control treatment for all 
experiments, and results from vehicle-treated cells were compared with dieldrin-treated 
cells to determine significance of dieldrin treatments. 
Stable transfection 
Plasmid pPKCôK376R-GFP encodes protein kinase Cô-GFP fusion protein, in 
which lysine at position 376 is mutated to arginine rendering the kinase catalytically 
inactive (Li et al., 1995, Li et al., 1996). Plasmid pEGFP-NI encodes the Green 
Fluorescent Protein alone and used as vector control. pEGFP-NI and pPKCô07611 were 
transfected into IRB3AN27 cells using Lipofectamine Plus reagent according to the 
procedure recommended by the manufacturer and described previously (Anantharam et 
al., 2002). To obtain stable cell lines, IRB3AN27 cells were selected in 400 pg/ml 
hygromycin 48 hr after cotransfection with the PCEP4 plasmid, which conferred 
hygromycin resistance. Colonies were isolated with trypsin and glass cloning cylinders 
and then replated and grown to confluence in culture flasks. The stable cell lines were 
subsequently maintained in 200 p,g/ml hygromycin. The stable expression of PKCô-GFP 
and GFP fusion protein alone was characterized by Western blot analysis. Antibody 
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directed against GFP detected -100 kDa, and 27 kDa bands in cell lines expressing kinase 
inactive mutant PKCÔk376R-GFP and GFP alone, respectively. Similarly, PKCô antibody 
detected ~100 kDa and 72 kDa bands in cell line expressing PKCÔK376R-GFP fusion, 
where as only a 72 kDa band was detected in cells expressing GFP alone. The 100 kDa, 
72 kDa and 27 kDa bands obtained in Western blots correspond to the expression of intact 
mutant PKCÔK376R-GFP fusion protein, native PKCô and GFP protein, respectively. 
Lactate dehydrogenase (LDH) assay 
Cell viability was monitored by LDH activity in the cell-free extracellular 
supernatant as described previously (Kitazawa et al., 2001). This method of LDH release 
is a rapid and accurate quantitative procedure that has been widely employed to appraise 
cytotoxicity (Koh and Choi, 1987, Hartley et al., 1993, Anantharam et al., 2002). 
Extracellular supernatant was added to 0.08 M Tris buffer (pH 7.2) containing 0.2 M NaCl, 
0.2 mM NADH, and 1.6 mM sodium pyruvate. The LDH activity was measured by 
continuously monitoring the rate of absorbance at 339 nm using a SpectraMAX 250 
spectrophotometer (Molecular Devices Corp., Sunnyvale, CA). Temperature was 
maintained at 37°C during quantification. Changes in absorbance per minute (AA/AT) 
were used to calculate U/I, which was a common unit to express the LDH activity. U/I 
was calculated by (AA/AT) x 9682 x 0.66, where 9682 was a coefficient factor, and 0.66 
was a correction factor of U/I at 37°C. 
Detection of cytochrome C release 
Dieldrin-induced cytochrome C release was measured using a cytochrome C ELISA 
commercial kit (MBL International Corp., Watertown, MA). This is a fast, highly 
sensitive, and reliable assay for the detection of early changes in cytochrome C levels. 
Briefly, PC 12 cells were resuspended in serum-free RPMI-1640 at a cell density of 5 x 
106/ml. Cell suspensions were exposed to 100 |xM or 300 p.M dieldrin for 15-30 min at 
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37°C. After exposure, cells were collected and homogenized, and cytochrome C release 
in the cytoplasmic fraction was measured by an ELISA assay kit strictly following the 
protocol provided by the manufacturer. The absorbance in each well was then measured at 
450 nm using a microplate reader (Molecular Devices Corp., Sunnyvale, CA). The 
concentration of cytochrome C was calibrated from a standard curve based on reference 
standards. Also, the control cytosolic preparation was analyzed for cytochrome C and 
mitochondrial protein marker cytochrome C oxidase by Western blot analysis to verify 
that the cytosolic isolation procedure does not cause mitochondrial damage in a 
non-specific manner. 
Caspase activity assay 
Caspase activities were determined as previously described (Yoshimura et al., 1998, 
Anantharam et al., 2002). After dieldrin treatment, cells were lysed and the resulting 
supernatants were incubated with 50 pM Ac-DEVD-AMC (caspase-3 substrate), 50 pM 
Ac-IETD-AMC (caspase-8 substrate), or 50 jjM Ac-LEHD-AMC (caspase-9 substrate) at 
37°C for 1 hr, and caspase activity was measured by spectrafluorometry (Molecular 
Devices Corp., Sunnyvale, CA) with excitation at 380 nm and emission at 460 nm. The 
Fas ligand was used as a positive control for caspase-8 activity (Facchinetti et al., 2002). 
Caspase activity was expressed as fluorescence unit (FU) per mg protein per hr. For 
measurement of caspase-3 activity in GFP-transfected cells, colorimetric substrate 
Ac-DEVD-pNA was used. 50 pM Ac-DEVD-pNA was added to the cytosolic extract and 
incubated for 4 hr at 37°C. The absorbance was measured by using Spectromax 
spectrophotometer (Molecular Devices Corp., Sunnyvale, CA) at 405 nm. 
Activated caspase-3 was also determined by Western blot analysis. Following 
dieldrin exposure, cells (-10 x 106 cells) were resuspended in cell lysis buffer (25 mM 
HEPES pH 7.5, 20 mM ^-glycerophosphate, 0.1 mM NazVC^, 0.3 M NaCl, 1.5 mM 
MgClz, 2 mM EDTA, 2 mM EGTA, 0.5 mM DTT, 10 mM NaF, 1 mM PMSF, 25 gg/ml 
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aprotinin, 10 pg/ml leupeptin, and 0.1% Triton X-100), and kept in ice for 30 min. 
Samples were then centrifuged at 10,000 xg for 10 min, and supernatants were collected. 
90 |_ig proteins were resolved by 12% SDS-PAGE, and cleaved caspase-3 was detected 
using cleavage-specific caspase-3 antibody (Cell Signaling, Beverly, MA). 
In-situ labeling of caspase activity 
For this study, we used Promega's CaspACE kit to label PC 12 cells. The kit 
utilizes FITC-VAD-FMK which is a fluoroisothiocyanate (FITC) conjugate of the cell 
permeable peptide sequences, VAD-FMK, which is cleaved by activated caspase and 
serves as an in situ marker for apoptosis. PC 12 cells were grown on the cover slip coated 
by type I rat tail collagen (6 |ag/cm2) for 1 day in a 37°C, 5% CO% incubator. Cells were 
then exposed to 50, 100 or 300 pM dieldrin for 3 hr. After the exposure, the cells were 
washed once with PBS and treated with 10 joM FITC-VAD-FMK for 40 min at 37°C in 
dark. Cells were rinsed with PBS and fixed in 10% buffered formalin for 30 min at room 
temperature in dark. After fixing, the cells were washed three times with PBS for 5 min 
each to remove formalin and then mounted on slides and observed under Leica TCS-NT 
confocal microscope (Leica Microsystems Inc., Exton, PA). The caspase-activated cells 
displayed green fluorescence under the excitation at 488 nm. 
Isolation of cytosolic fraction 
After the exposure to dieldrin, cell pellet was washed once with ice-cold PBS and 
resuspended in 2 ml homogenization buffer containing 20 mM Tris/HCl (pH 8.0), 2 mM 
EDTA, 10 mM EGTA, 2 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride, 
25 |ig/ml aprotinin, 10 p.g/ml leupeptin. The suspension was then sonicated for 10 sec and 
centrifuged at 100,000 x g for 1 hr at 4°C. The resulting supernatant was used as a 
cytosolic fraction. Protein concentration of each cytosolic fraction was determined using 
a Bradford protein assay dye reagent (Bio-Rad Laboratories; Hercules, CA). Samples 
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were diluted with homogenization buffer according to the protein concentration estimated 
by the assay to equalize protein concentration for gel loading. Each sample was then 
mixed with 2x gel loading buffer containing 10% SDS and 200 mM DTT and placed in 
boiling water for 5 min. 
Immunoblotting 
Proteins were separated on 8-12.5% SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) and blotted onto nitrocellulose membrane. Non-specific binding sites were 
blocked by 5% non-fat milk blocking solution, then the membrane was treated with 
primary antibody for PKCô (1:2000 dilution), cytochrome C (1:1000 dilution), PARP 
(1:750 dilution), or P-actin (1:5000 dilution). Secondary horseradish 
peroxidase-conjugated anti-mouse (1:2000 dilution) or anti-rabbit (1:2000 dilution) 
antibody treatment was followed, and antibody-bound proteins were detected by 
enhanced chemiluminescence (ECL) detection kit. Band intensity was analyzed using 
Quantity One 4.2.0 software (Bio-Rad Laboratories). 
Protein kinase Cô activity assay 
PKCô enzymatic activity was measured using an immunoprecipitation kinase 
assay as described in Reyland et al. (Reyland et al., 1999). Following dieldrin exposure, 
PC 12 cells were washed once with PBS and resuspended in PKC lysis buffer (25 mM 
HEPES, pH7.5, 20 mM ^-glycerophosphate, 0.1 mM sodium orthovanadate, 0.1% Triton 
X 100, 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 10 mM NaF, 4 |ig/ml 
aprotinin, and 4 jig/ml leupeptin). The cell lysate was allowed to sit on ice for 30 min, 
centrifuged at 10,000 x g for 5 min and the supematants were collected as cytosolic 
fraction. Protein concentration was determined using a Bradford protein assay. Cytosolic 
protein (0.25-0.5 mg) was immunoprecipitated overnight at 4°C using 2 jag of anti-PKCô 
antibody, hnmunoprecipitates were then incubated with Protein-A-sepharose for 1 hr at 
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4°C. The Protein-A-bound antigen-antibody complexes were then washed 3 times with 
PKC lysis buffer, 3 times with 2x kinase buffer (40 mM Tris, pH7.4, 20 mM MgClz, 20 
jaM ATP, and 2.5 mM CaCli), and resuspended in 20 fil of 2x kinase buffer. Reaction was 
started by adding 20 gl of reaction buffer containing 0.4 mg histone HI and 5 joCi of 
[y-32P]ATP (4,500 Ci/mM) to the immunoprecipitated samples and incubated for 10 min at 
30°C. SDS gel loading buffer (2x) was added to terminate the reaction, the samples were 
boiled for 5 min and the products were separated on a 12.5% SDS-PAGE gel. The HI 
phosphorylated bands were detected using a Personal Molecular Imager (FX model, 
Bio-Rad Laboratories) and quantification was done using Quantity One 4.2.0 software 
(Bio-Rad Laboratories). 
In-situ labeling of apoptosis 
Hoechst 33342 has been widely used to obtain nuclear condensation, which is 
one of distinct morphological changes observed in apoptotic cells (Siman et al., 1999, 
Saito et al., 2001). In combination with propidium iodide staining, we are able to 
distinguish necrotic cell death and apoptotic cell death under UV illumination using a 
fluorescent microscope. PC 12 cells were grown on cover slips coated by type I rat tail 
collagen (6 (ig/cm2) for 1 day in a 37°C, 5% CO2 incubator. Attached PC12 cells were 
treated with 100 or 300 |_iM dieldrin for indicated periods at 37°C. After the exposure, 
cells were washed once with PBS and treated with 10 |ig/ml Hoechst 33342 for 5 min at 
room temperature in dark. Cells were then washed once with PBS and mounted on 
perfusion chamber with HBSS buffer and observed under Nikon DiaPhot microscope with 
the excitation wavelength at 380 nm. Fluorescent images were captured with a SPOT 
digital camera and analyzed by MetaMorph software (Universal Imaging Corp., 
Downingtown, PA). Quantitative analyses of stained cells were determined by counting 
cells in three to five randomly selected microscopic fields. 
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DNA fragmentation assay 
DNA fragmentation was measured using a Cell Death Detection Elisa Plus Assay 
Kit as described previously (Reyland et al., 1999, Anantharam et al., 2002). Cells were 
pre-treated with various doses of caspase inhibitors or rottlerin for 20 min and then 
exposed to 100 or 300 pM dieldrin for 1 hr at 37°C. After the exposure, cells were 
centrifuged and washed once with PBS. DNA fragmentation was measured in cell lysates 
according to the manufacturer's protocol. The absorbance of the ELISA reaction was 
measured at 490 nm and 405 nm using a SpectraMAX Pro 250 spectrophotometer 
(Molecular Devices Corp., Sunnyvale, CA). 
Intracellular delivery of active PKCô 
PC12 cells (-1-2 x 105 cells/well) were subcultured in 24-well tissue culture plate 
for 24 hr. Human recombinant active PKCô was delivered into cells using BioPORTER 
reagent as strictly following manufacture's protocol. This reagent has recently been used 
for delivery of various bioactive molecules, including antibodies, enzymes (caspase-3, 
caspase-8, (3-galactosidase, kinases and granzyme B), cytochrome C, dextran sulfates, 
phycobiliproteins and albumins into the cytoplasm of numerous adherent and suspension 
cells (Reyland et al., 1999). Briefly, 5 ng of catalytically active human recombinant PKCô 
(Sigma Chemicals, St. Louis) or heat-inactivated PKCô (15 min in boiling water) was 
mixed with BioPORTER reagent and delivered into cells for 4 hr in serum-free DMEM. 
Following the completion of delivery, cells were collected, and caspase-3 activity was 
measured as described above. The efficiency of the protein delivery system was 
determined by FITC-labeled control protein (supplied by the kit) uptake. PC 12 cells were 
treated 5 ng of FITC-labeled goat IgG in serum-free medium for 4 hrs at 37°C. Cells were 
washed 3 times with PBS and observed under fluorescent microscope at emission 488 nm. 
To determine the delivery efficiency, fluorescent cells and non-fluorescent cells were 
counted in 5 randomly selected regions. The delivery efficiency of BioPORTER reagent 
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was approximately 70%. 
Data analysis and statistics 
Data were first analyzed using one-way ANOVA. Dunnett's post-test or 
Bonferroni's multiple comparison test was then performed to compare treated samples, 
and p<0.05 was considered to be significant. 
RESULTS 
Dieldrin-induced cytotoxicity and apoptosis 
First, we characterized dieldrin-induced cytotoxicity over a 5 hr period to 
determine the sequence of cell death signaling mechanisms activated during dieldrin 
exposure in PC 12 cells. To assess dieldrin-induced necrosis and apoptosis, we measured 
LDH and DNA fragmentation, respectively. Cytotoxicity proportionally increased over 
time during dieldrin exposure, indicating that cells were undergoing necrosis or late 
apoptosis (Fig. 1A). To further distinguish necrosis and apoptosis, we examined DNA 
fragmentation, which is one of the unique characteristics of apoptosis. As shown in 
Figure IB, treatment with 100 pM and 300 fiM dieldrin for 1 hr increased DNA 
fragmentation 129% and 180% over control levels, respectively, indicating that dieldrin 
acted as a potent apoptotic cell death inducer. 
To further determine the phase of cell death during the 5-hr period of dieldrin 
exposure, qualitative analysis of apoptotic cell death was performed using Hoechst 33342. 
Hoechst 33342 staining revealed that dieldrin-treated cells were undergoing apoptosis in a 
time-dependent manner, evident from the condensation of chromatin (Fig. 2). The 
number of apoptotic cells increased over time, and the percent of apoptotic cells reached 
55% and 68% following exposure to 100 pM and 300 |iM dieldrin, respectively. The 
vehicle-treated PC 12 cells had normal membrane integrity and no indication of apoptosis 
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during the incubation period. 
Dieldrin-induced cytochrome C release from mitochondria 
Increased ROS production has been shown to trigger mitochondrial cytochrome 
C release into cytosol (Simon et al., 2000, Junn and Mouradian, 2001), which 
subsequently initiates apoptotic signaling processes (Kuida, 2000). Dieldrin-treated PC 12 
cells showed both dose- and time-dependent increases in cytochrome C release as 
determined by Western blot analysis (Fig. 3 A). A profound level of cytosolic cytochrome 
C release was observed at 3 hr of dieldrin exposure. In contrast, non-treated and 
vehicle-treated PC 12 cells did not show detectable levels of cytosolic cytochrome C 
during the entire treatment period. To determine if dieldrin-induced cytochrome C release 
occurs at an earlier time point, we used a more sensitive method to measure cytochrome C 
release. As shown in Figure 3B, ELISA-based cytochrome C detection revealed that 
dieldrin significantly (p<0.05) increased cytosolic cytochrome C as early as 15 min 
post-exposure. Cytochrome C levels were increased 80-100% and 210-230% after 15 min 
of treatment with 100 pM and 300 pM dieldrin, respectively, compared to the 
vehicle-treated levels. 
To further determine if dieldrin-induced cytochrome C release is dependent on 
ROS generation, we examined the effect of a ROS scavenger on cytochrome C release. A 
new cell permeable superoxide dismutase (SOD) mimetic, namely MnTBAP, has been 
shown to attenuate ROS generation and apoptosis in dopaminergic cells (Lotharius and 
O'Malley, 2000, Anantharam et al., 2002). In our recent study, we showed that dieldrin 
generates predominantly superoxides, and MnTBAP protects against dieldrin-induced 
apoptosis (Kitazawa et al., 2001). As shown in Figure 3C, pretreatment with 2-5 pM 
MnTBAP dose-dependently attenuated dieldrin-induced cytochrome C release. Although 
MnTBAP did not completely suppress the dieldrin-induced cytochrome C release, the 
effect was statistically significant (p<0.05, 2 pM MnTBAP; p<0.01, 5 pM MnTBAP). 
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Together, these results suggest that dieldrin-induced ROS is responsible at least in part for 
the release of the initial proapoptotic signal, cytochrome C, from mitochondria. 
Activation of initiator caspases following dieldrin exposure 
When cytochrome C is released into cytosol, it forms a complex with apoptotic 
activating factor-1 (Apaf-1) and activates caspase-9 (Kuida, 2000). Caspase-9 is one of 
the initiator caspases and cleaves downstream effector caspases to further drive apoptotic 
cascade. To determine whether caspase-9 was activated following the release of 
cytochrome C, we have measured the enzyme activity using fluorescent-tagged caspase-9 
specific substrate, Ac-LEHD-AMC. Caspase-9 activity increased 2- to 5-fold in 1-2 hr 
and returned to the basal level at 5 hr in 100 pM dieldrin-treated cells, whereas its activity 
was still significantly (p<0.05) elevated at 5 hr in 300 pM dieldrin-treated cells (Fig. 4A). 
To further confirm whether dieldrin-induced apoptosis is distinctly mediated through a 
mitochondrial cytochrome C-caspase-9 activation pathway, we measured caspase-8 
activity, another major initiator caspase activated primarily by death receptors. As shown 
in Figure 4B, caspase-8 was not significantly increased over the entire exposure period 
following dieldrin treatment. In order to further verify that dieldrin does not activate the 
caspase-8 cascade, we used the known caspase-8 activator Fas ligand (FasL) as a positive 
control in PC 12 cells (Felderhoff-Mueser et al., 2000). Treatment with 50-500 ng/ml of 
FasL dose-dependently increased caspase-8 activity; cells treated with 500 ng/ml showed 
a 2.2-fold increase over control cells (data not shown). Together, these results indicate 
that dieldrin primarily activates the initiator caspase-9 but not caspase-8 in dopaminergic 
cells. 
Activation of caspase-3 by dieldrin in PC12 cells 
Initiator caspase-9 cleaves downstream effector caspases including caspase-3, -6, 
and -7. Among these, caspase-3 is one of the most studied effector caspases and plays a 
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critical role in execution of apoptosis (Dodel et al., 1998, Kitamura et al., 1998, Ochu et al., 
1998, Hartmann et al., 2000, Turmel et al., 2001). Caspase-3 proteolytically cleaves the 
carboxyl site of an aspartate residue in a specific amino acid sequence, Asp-Glu-Val-Asp 
(DEVD). Activation of caspase-3-like activity can be used as an index of 
caspase-mediated apoptosis. Figure 5 A demonstrates that dieldrin induces the activation 
of caspase-3 in a dose- and time-dependent manner. Caspase-3 was significantly (p<0.05) 
activated as early as 30 min following dieldrin exposure, and its activity increased 
substantially over 10- to 46-fold and 15- to 82-fold in 100 and 300 pM dieldrin exposure, 
respectively. The magnitude of caspase-3 activity was far more substantial than that of 
caspase-9, which showed 2- to 5-fold increase over basal level (Fig. 5A). The peak 
activation of caspase-3 was observed between 2 and 3 hr post exposure. At 5 hr, the 
activity of caspase-3 was diminished but still significantly (p<0.05) greater than 
vehicle-treated cells. The time sequence of caspase-3 and caspase-9 activation indicates 
that initiator caspase-9 activation precedes downstream effector caspase-3 activation. An 
in situ caspase fluorescence imaging using FITC-VAD-FMK also demonstrated that 
dieldrin-treated PC 12 cells expressed active caspases within 3 hr of exposure period, and 
caspases were activated in 58-82% cells following dieldrin treatment (Fig. 5B). 
Dieldrin-induced proteolytic cleavage of PKCô 
Active caspase-3 proteolytically cleaves various endogenous molecules that are 
vital for cell survival or apoptosis. Recently, we and others have identified the caspase-3 
activation proteolytically cleaves PKCô (Reyland et al., 1999, Anantharam et al., 2002). 
Exposure to dieldrin over a 5 hr time period resulted in the proteolytic cleavage of native 
PKCô (72 and 74 kDa) into two fragments, 38 kDa regulatory and 41 kDa catalytic 
subunits (Fig. 6). The band intensity of native PKCô decreased, whereas that of the 
proteolytic cleavage PKCô fragmentation increased in dose- and time-dependent manner. 
Cleaved PKCÔ was detected as early as 1 hr after treatment with 300 pM dieldrin and 
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reached maximum at 3 hr of the exposure in both 100 and 300 pM dieldrin-treated PC 12 
cells. Control or vehicle-treated PC 12 cells did not show any proteolytic cleavage of 
PKCô during the entire exposure period. In addition, dieldrin exposure did not induce 
translocation of PKCô from the cytosol to plasma membrane (data not shown), which is 
another process of kinase activation (Powell et al., 1996, Majumder et al., 2000). 
Dieldrin-induced proteolytic cleavage of PKCô is mediated by caspase-3 
To determine whether dieldrin-induced proteolytic cleavage of PKCô was 
mediated by caspase-3, the specific inhibitors for caspase-3, Ac-DEVD-CHO and 
Z-DEVD-FMK, and a broad spectrum caspase inhibitor, Z-VAD-FMK, were used. 
Pre-treatment with Ac-DEVD-CHO (100 to 300 pM) or Z-VAD-FMK (30 to 300 pM) for 
30 min blocked proteolytic cleavage of PKCô in a dose-dependent manner (Fig. 7A-B). 
In addition, pre-treatment with various concentrations of Z-DEVD-FMK (10 to 100 pM), 
an irreversible caspase-3 inhibitor, also dose-dependently inhibited dieldrin-induced 
proteolytic cleavage of PKCô (Fig. 7C). 
In order to determine the specificity of proteolytic cleavage of PKCô during 
dieldrin-induced cell death, the proteolytic cleavage of other PKC isoforms were 
examined. No proteolytic cleavage of PKCa or PKCJ3II was detected in dieldrin-treated 
PC 12 cells as well as vehicle-treated cells over 5 hr of exposure (data not shown). Only 
the native forms of these enzymes were present in both dieldrin-treated and non-treated 
cells. Thus, it appears that dieldrin-induced caspase-3-mediated proteolytic cleavage of 
PKCô is isoform-specific. In addition, both PKCa and PKCfBII did not show increase in 
translocation to plasma membrane (data not shown). Collectively, these data indicate that 
PKCô may be the major isoform of protein kinase that is activated during dieldrin 
exposure of PC 12 cells. 
157 
Proteolytic cleavage of PKCô results in increased PKCô kinase activity 
To further examine whether dieldrin-induced proteolytic cleavage of PKCô 
reflects an increase in kinase activity, we determined PKCô activity by 32P 
phosphorylation assay following immunoprecipitation of PKCô. 32P phosphorylation 
was increased in cells treated with dieldrin for 3 hr (Figure 8 A), reconciling with increased 
proteolytic cleavage of PKCô observed above. Densitometric analysis of phosphorylated 
histone HI bands revealed that 100 pM and 300 pM dieldrin exposure resulted in 145% 
and 149% increase in kinase activity over vehicle-treated cells, respectively. To further 
confirm that the increased PKCô activity was due to proteolytic cleavage of PKCô, we 
examined PKCô activity with or without caspase-3 inhibitor (Z-DEVD-FMK) or PKCô 
specific inhibitor (rottlerin). Rottlerin is widely used as a PKCô inhibitor (Datta et al., 
1999, Junn and Mouradian, 2001). We have previously confirmed that rottlerin at 
concentrations 3-20 pM specifically inhibits PKCô activity as determined by kinase assay 
(Anantharam et al., 2002). As depicted in Figure 8B, PKCô activity in 100 pM 
dieldrin-treated PC 12 cells was completely blocked by 50 pM Z-DEVD-FMK as well as 
20 pM rottlerin. Since the caspase inhibitor almost completely blocked dieldrin-induced 
PKCô activity to basal level, it indicates that PKCÔ activation during dieldrin exposure 
was mediated by caspase-3-dependent proteolytic cleavage. 
Role of PKCÔ in dieldrin-induced DNA fragmentation 
PKCô is one of the key signaling molecules activated by caspase-3 dependent 
apoptotic processes under conditions of dieldrin exposure. To determine the physiological 
and functional role of proteolytic activation of PKCô in dieldrin-induced apoptosis, we 
pretreated PC 12 cells with rottlerin to test whether dieldrin-induced DNA fragmentation 
was attenuated. DNA fragmentation assay showed that pretreatment with 10 pM rottlerin 
in PC 12 cells significantly suppressed dieldrin-induced apoptosis (Fig. 9A). DNA 
fragmentation was reduced from 216% to 124% of control, which was nearly the basal 
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DNA fragmentation level. In addition, we also examined whether caspase inhibitors 
attenuated the dieldrin-induced DNA fragmentation since these inhibitors completely 
blocked the proteolytic cleavage of PKCô (Fig. 7A-C) and its kinase activity (Fig. 8B). 
Caspase inhibitors, Z-DEVD-FMK (50 pM) and Z-VAD-FMK (100 |J.M) significantly 
(p<0.01) attenuated dieldrin-induced DNA fragmentation to the basal level (Fig. 9A) 
consistent with other caspase-3 dependent processes denoted above. Inhibitors alone did 
not alter DNA fragmentation in PC 12 cells (data not shown), indicating the concentrations 
of inhibitors used in the experiment did not cause any toxicity to the cells. We further 
confirmed DNA fragmentation by qualitative analysis of apoptosis. Hoechst 33342 
staining showed nuclear condensation, one of the distinct morphological changes during 
apoptosis, following 3 hr dieldrin exposure (Fig. 9B). Pretreatment with rottlerin 
remarkably reduced dieldrin-induced chromatin condensation from 47% to 18%. 
Together, these results suggest that proteolytic activation of PKCÔ plays an important role 
in execution of apoptosis. 
PKCô is involved in feedback regulation of caspase-3 
Since we observed a dramatic increase in caspase-3 (40-80 fold, Fig. 5A) as 
compared with a moderate increase in caspase-9 (2-5 fold; 4A) activity in PC 12 cells 
following dieldrin exposure, we further examined whether additional regulatory 
mechanisms are involved in activation of caspase-3. It has recently been reported that 
certain protein kinases, such as protein kinase B (PKB), interact with caspases and other 
pro-apoptotic molecules to modulate apoptotic signaling pathways (Cardone et al., 1998, 
Datta et al., 1999). Therefore, we investigated whether PKCô is capable of activating 
caspase-3 by a positive feedback modification of certain molecules involved in 
dieldrin-induced apoptosis. To address this hypothesis, we used a PKCô specific inhibitor, 
rottlerin, to examine changes in caspase-3 activity and proteolytic cleavages of PKCô. 
Treatment with 3 to 20 jj,M rottlerin significantly (p<0.01) and dose-dependently inhibited 
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dieldrin-induced caspase-3 activity by 30% to 89% and 44% to 90% of control in 3-hr 
exposure to 100 and 300 pM dieldrin, respectively (Fig. 10A-B). Treatment of control 
PC 12 cells with rottlerin alone did not alter basal caspase-3 activity, indicating that the 
influence of rottlerin on dieldrin-induced caspase-3 activity was due to feedback 
regulatory mechanism. To further rule out any direct effect of rottlerin on caspase-3 
activity, we demonstrated the changes of active caspase-3 by Western blot. PC 12 cells 
were treated with rottlerin (3-20 pM) for 30 min and then exposed to dieldrin (100 and 300 
pM) for additional 3 hr. As shown in Fig. 10C, 17 kDa active caspase-3 fragment 
decreased as rottlerin concentration increased, and 20 pM rottlerin almost completely 
abolished cleaved caspase-3. This result further confirms that dieldrin-induced caspase-3 
activation may be regulated by activity of PKCô. 
To further confirm whether the feedback activation is due to catalytic activity of 
PKCô as the result of proteolytic cleavage, we delivered a catalytically active PKCô into 
cells and measured caspase-3 activity. Protein delivery was confirmed using 
FITC-labeled antibody supplied by the kit, and approximately 60-70% cells were labeled 
under the fluorescent microscope. Following 4-hr incubation, cells with catalytically 
active PKCô showed 2-fold increase in caspase-3 activity compared with control (reagent 
alone), whereas cells with heat-inactivated PKCô protein were not significantly different 
from control (Fig. 10D). This result clearly provides supporting evidence that PKCô is 
capable of mediating caspase-3 activation. 
Dieldrin-induced proteolytic cleavage of PKCô was also found out to be blocked 
dose-dependently by pre-treatment with rottlerin (Fig. 11 A). Appearance of the catalytic 
subunit (41 kDa) was significantly diminished by 20 pM rottlerin pre-treatment, the 
concentration of which causes approximately 90% reduction in dieldrin-induced 
caspase-3 activity. Dieldrin-induced PKCÔ kinase activity was also significantly (p<0.01) 
reduced by pretreatment with rottlerin (Fig. 8B), which corresponds to the reduced 
catalytic subunit. Through inhibition of PKCô kinase activity, rottlerin indirectly 
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suppressed caspase-3 activity and inhibited proteolytic cleavage of PKCô. These findings 
indicate that PKCô has a positive feedback regulatory mechanism to enhance the 
apoptotic signals. 
Attenuation of dieldrin-induced caspase-3 and DNA fragmentation in mesencephalic 
cells over-expressing PKCô10761* (kinase-inactive) mutant 
To further substantiate the proapoptotic function of PKCô in dopaminergic cell 
death, we examined whether the over-expression of a kinase inactive PKCô mutant 
(dominant negative) suppresses dieldrin-induced apoptosis. We stably transfected 
dopaminergic rat mesencephalic (IRB3AN27) cells with plasmids pPKCôK376R-GFP and 
pEGFP-NI to express a dominant negative PKCô mutant protein (Fig. 12A). Single 
amino acid mutation from lysine to arginine of PKCô at position 376, which is located in 
the active site, completely eliminates kinase activity (Li et al., 1995, Li et al., 1996) (Li et 
al, 1996). The plasmid pPKCôK376R-GFP codes for a kinase inactive PKCô mutant fused 
to the green fluorescent protein (GFP), and the plasmid pEGFP-NI encodes GFP alone 
and was used as a vector control. Figure 12B shows stable GFP expression in IRB3AN27 
cells transfected with GFP alone or kinase inactive mutant PKCÔk376r-GFP. 
Determination of PKCô kinase activity in dominant negative cells showed almost a 
complete suppression of the kinase activity in dieldrin-treated cells as compared to 
vector-transfected cells (Fig. 12C), indicating that the mutant PKCô provides a dominant 
pool of inactive PKCô. 
We then compared the extent of caspase-3 activation and DNA fragmentation in 
PKCô mutant-expressed cells and vector cells following dieldrin exposure. As shown in 
Fig 13A, 100 pM and 300 pM dieldrin exposure for 3 hr in vector-transfected IRB3AN27 
cells increased caspase-3 activity to 235% and 347% of vehicle control, respectively. 
Dieldrin-induced caspase-3 activity was significantly (p<0.01) reduced in PKCô mutant 
cells. Thus, the attenuation of dieldrin-induced caspase-3 activation in PKCÔ mutant cells 
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further supports our hypothesis that PKCô influences caspase-3 activity via positive 
feedback activation during dieldrin-induced apoptosis in dopaminergic cells. 
Measurement of DNA fragmentation in vector-transfected cells showed 165% and 162% 
of vehicle control following 100 and 300 |oM dieldrin exposure, respectively (Fig. 13B). 
Conversely, PKCô mutant-expressed cells almost completely blocked dieldrin-induced 
DNA fragmentation at both 100 and 300 (iM concentrations. These data strongly support 
the pro-apoptotic role of PKCô in dieldrin-induced dopaminergic degeneration. 
DISCUSSION 
Previously, we demonstrated that dieldrin increases ROS as early as 5 min 
post-exposure, and that ROS generation participates in dieldrin-induced apoptotic cell 
death in PC12 cells (Kitazawa et al., 2001). In the present study, we demonstrate that 
dieldrin activates series of signaling molecules, and these molecules are highly organized 
to execute apoptotic cell death. Major findings from our present study are: (i) dieldrin 
activates a cytochrome C, caspase-dependent cell death signaling cascade; (ii) caspase-3 
produces a persistent activation of PKCô by proteolytic cleavage; (iii) proteolytic 
activation of PKCô participates in execution of apoptosis; and (iv) PKCÔ plays an 
important role in the positive feedback regulation of caspase cascade. Collectively, these 
findings demonstrate that caspase-3 mediated proteolytic activation of PKCô is a key 
downstream signaling event in the execution as well as amplification of apoptosis in the 
dopaminergic cells following exposure to environmental neurotoxic agent. 
In the present study, we observed release of cytochrome C into cytosol as early as 
15 min following dieldrin exposure in a dose- and time-dependent manner over 5-hr 
period. Cytochrome C acts as a pro-apoptotic molecule and is released from mitochondria 
into cytoplasm under conditions of increased oxidative stress or mitochondrial damage in 
both neuronal and non-neuronal cells (Petit et al., 1998, Blackstone and Green, 1999, 
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Cassarino et al., 1999, Hollensworth et al., 2000, Lee and Wei, 2000). We previously 
demonstrated that dieldrin increases ROS production within 30 min and significantly 
reduces mitochondrial membrane potential in PC12 cells (Kitazawa et al., 2001). The 
present study further demonstrates that dieldrin-induced ROS triggers cytochrome C 
release from mitochondria to initiate the apoptotic cascade. The influence of dieldrin on 
mitochondrial function may be related to its inhibitory effect on the mitochondrial 
respiratory chain, possibly at or near cytochrome b on complex III (Bergen, 1971). Taken 
together, our study indicates that dieldrin potentially affects mitochondria and is capable 
of inducing cytochrome C release by a mechanism similar to that of other dopaminergic 
toxicants such as MPP+, 6-hydroxydopamine (6-OHDA), paraquat, or MMT (Dodel et al., 
1999, Gomez et al., 2001, Anantharam et al., 2002). 
An initial cell death signaling molecule, cytosolic cytochrome C forms a 
complex with Apaf-1 (apoptotic protease activating factor-1) in the presence of dATP 
(Kuida, 2000) and subsequently activates an initiator caspase, caspase-9 (Liu et al., 1996, 
Li et al., 1997, Cassarino et al., 1999). Caspase-9 then proteolytically cleaves 
procaspase-3 into catalytically active caspase-3 (Budihardjo et al., 1999). We observed a 
dramatic increase in caspase-9 and caspase-3 activity in dieldrin-treated PC 12 cells. The 
sequence of caspase signaling cascade identified in dieldrin-induced apoptosis reconciles 
with the known caspase cascade induced by several apoptosis inducers in various cells 
(Dodel et al., 1999, Gamen et al., 2000, Liu et al., 2000, Yamazaki et al., 2000). Recently, 
it has been demonstrated that caspase-3 is a vulnerability factor and a critical effector in 
apoptotic cell death induced in both MPTP mouse model and in human patients with 
Parkinson's disease (Hartmann et al., 2000). Apoptotic neuronal cell death has recently 
been recognized as a prominent mode of dopaminergic neurodegeneration in substantia 
nigra in idiopathic PD (Mattson et al., 1999, Albers and Beal, 2000, Chun et al., 2001). 
Despite evidence from other studies which suggest that all key pro-apoptotic molecules 
are located within close proximity to each other, this study indicates that dieldrin is 
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capable of activating a specific cell death pathway involving mitochondrial cytochrome C, 
caspase-9 and caspase-3. 
One significant outcome of the current study is selective activation of PKCô by 
caspase-3 through proteolytic cleavage. PKC family members are involved in activation 
of downstream regulatory mechanisms of apoptosis in non-neuronal systems (Shao et al., 
1997, Chen et al., 1999). Recent reports indicate that certain PKC isoforms play specific 
and often divergent roles in apoptotic cell death (Ruvolo et al., 1998, Gschwendt, 1999, Li 
et al., 1999, Reyland et al., 1999, Cross et al., 2000, Musashi et al., 2000, Reyland et al., 
2000). PKCa has been shown to phosphorylate anti-apoptotic proteins, such as PKB and 
Bcl-2, and serves as a survival signal (Ruvolo et al., 1998, Li et al., 1999, Deng et al., 
2000). In contrast, PKCô is known to translocate to plasma membrane during phorbol 
ester treatment or UV-B irradiation and induces apoptosis (Emoto et al., 1995, Chen et al., 
1999, Cross et al., 2000). Our present results demonstrate that PKCô, but not 
conventional PKC family members including PKCa or PKCpiI, was proteolytically 
cleaved and activated during dieldrin exposure. Blockade of proteolytic cleavage of 
PKCô by pre-treatment with caspase-3 specific inhibitors demonstrated that caspase-3 
cleaves PKCô into its active form following exposure to dieldrin in dopaminergic cells. 
Recently, caspase-3-mediated PKCô activation was also observed during apoptosis in 
other cell types including U-937 cells, neutrophils, and etoposide-treated salivary gland 
acinar cells (Emoto et al., 1995, Ghayur et al., 1996, Pongracz et al., 1999, Reyland et al., 
1999). Our results further demonstrate that proteolytic cleavage of PKCô results in 
persistent activation of the kinase activity in dopaminergic cells. Although the 
downstream events involving PKCô and those that specifically lead to apoptotic cell death 
remain to be defined, DNA protein kinase (DNA-PK), an enzyme essential for the repair 
of DNA strand breaks, has been shown to be regulated by PKCô through phosphorylation 
(Bharti et al., 1998, Pongracz et al., 1999). 
To further clarify the proteolytic activation of PKCÔ and its role in apoptotic cell 
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death following dieldrin exposure, a series of experiments was conducted to elucidate 
whether PKCô performs a critical function in dieldrin-induced apoptosis. Pretreatment 
with caspase-3 inhibitors and a PKCô-specific inhibitor almost completely suppressed 
dieldrin-induced apoptosis, indicating that PKCô participates in apoptotic cell death. 
Additionally, we performed dominant negative mutant experiments by stably transacting 
an inactive PKCô*0761* gene in a dopaminergic cell model and examining dieldrin-induced 
cell death pathways. Dieldrin exposure produced a significant increase in DNA 
fragmentation in vector-transfected cells, whereas no significant DNA fragmentation was 
observed in PKCôK376R mutant cells. Taken together with inhibitor studies, our data 
provide convincing evidence that PKCô plays a key role in execution of apoptosis in 
dopaminergic cells. 
In addition to a role of PKCô in apoptosis, the results from experiments 
demonstrating suppression of caspase-3 activity by PKCô inhibitor rottlerin or activation 
of caspase-3 activity by catalytically active PKCô indicate the existence of a positive 
feedback interaction between caspase-3 and PKCô. Our finding corroborates a recent 
report showing a similar regulatory mechanism in salivary gland acinar cells following 
etoposide exposure (Reyland et al., 1999). Recently, PKCô has been shown to be 
translocated to the mitochondrial membrane and promotes cytochrome C release 
(Majumder et al., 2000). In this regard, PKCô may act on upstream apoptotic molecules 
and facilitate apoptotic cascade. 
In conclusion, dieldrin, a putative environmental risk factor for development of 
PD, induces caspase-3-dependent apoptosis through a mitochondrial-mediated activation 
pathway. The results obtained in this series of studies help to build a proposed mechanism 
for dieldrin-induced apoptosis in dopaminergic cells (Fig. 14). Dieldrin-induced ROS 
promotes cytochrome C release into the cytosol to initiate the caspase cascade. Activation 
of caspase-9 is followed by activation of caspase-3, which in turn cleaves PKCô to an 
active catalytic product. PKCô participates in the feedback activation of the 
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dieldrin-induced caspase cascade, thereby amplifying downstream apoptotic signaling 
molecules. Thus, PKCô serves as an obligatory regulator for caspase-3 in directing cells 
to apoptosis. For the first time, this study establishes an important role for PKCô in 
apoptotic cell death in in vitro models of Parkinson's disease. However, further studies are 
needed to understand the exact mechanisms by which PKCô regulates the apoptotic 
pathway in dopaminergic cells following exposure to environmental toxins. 
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FIG 1. Dieldrin-induced cytotoxicity and apoptosis in PC12 cells. 
(A) PC 12 cells (2 x 106 cells/ml) were exposed to 100 or 300 j-iM dieldrin for 1, 2, 3, or 5 
hr at 37°C. After the exposure, the cell-free supernatants were collected, and LDH 
activity was measured by UV-spectrophotometer. Each data point represents mean ± SEM 
from at least three separate experiments in triplicate. (B) PC 12 cells were exposed to 100 
or 300 |uM dieldrin for 1 hr, and DNA fragmentation was assayed using the Cell Death 
Detection ELISA-Plus assay. The data are expressed as the percentage of DNA 
fragmentation observed in vehicle-treated PC 12 cells. Each point represents mean ± SEM 
from three separate experiments in duplicate. The average baseline control value for DNA 
fragmentation is 23 optical density (O.D.)/mg protein. **p<0.01 compared with 
vehicle-treated group. 
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FIG 2. Apoptotic morphology of PC12 cells following dieldrin exposure. 
PC 12 cells were grown on type I rat-tail collagen-coated (6 jj,g/cm2) cover slips for 24 hr at 
37°C. The cells were exposed to 100 or 300 JJM dieldrin for 1, 3, or 5 hr, treated with 10 
|j,g/ml Hoechst 33342, and observed under a fluorescent microscope with excitation at 380 
rim as described under "Experimental procedures." Arrows indicate chromatin 
condensation typically observed in apoptotic cells. Percentage of apoptotic cells is shown 
in the bottom right of each panel. This experiment was repeated twice with similar results. 
FIG 3. Cytochrome C release following exposure of PC12 cells to dieldrin. 
(A) PC12 cells (~1 x 107 cells) were exposed to 100 pM or 300 pM dieldrin for 1 to 3 hr 
at 37°C. Cytochrome C release into cytosol was determined by Western blot analysis 
as described under "Experimental Procedures." 2 pg of cytosolic samples were 
resolved by 12.5% SDS-polyacrylamide gel. Arrowhead indicates cytosolic 
cytochrome C (~15 kDa). Levels of p-actin (43 kDa) confirm equal protein loading in 
each lane. (B) PC 12 cells (~1 x 107 cells) were exposed to 100 pM or 300 pM dieldrin 
for 15 to 30 min at 37°C, and cytosolic fraction was analyzed using cytochrome C 
ELISA kit. Each data point is expressed as percent of vehicle-treated group and 
represents mean ± SEM from two separate experiments in duplicate. *p<0.05 or 
**p<0.01 compared with vehicle-treated group. (C) PC12 cells were pretreated with 
2-5 pM MnTBAP for 30 min and then exposed to 100 pM dieldrin for another 30 min. 
Cytosolic cytochrome C was measured using an ELISA kit. Each data point is 
expressed as percent of control group of two separate experiments in triplicate. 
*p<0.05 or **p<0.01 compared with 100 pM dieldrin-treated group. Baseline value 
(control) is 0.414 ± 0.03 O.D./IO6 cells, and vehicle-treated group shows similar value 
(0.441 ± 0.005). 
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FIG 4. Activation of initiator caspases following exposure of PC12 cells to dieldrin. 
PC12 cells (2 x 106 cells/ml) were exposed to 100 or 300 jaM dieldrin for 30 min, 1, 2, 3, 
or 5 hr at 37°C, and (A) caspase-9 or (B) caspase-8 activity was measured using caspase-9 
or caspase-8 specific substrates, Ac-LEHD-AMC or Ac-IETD-AMC, respectively as 
described under "Experimental Procedures." The data are expressed as fluorescence unit 
(FU) per mg protein per hr of incubation. Each point represents mean ± SEM from at least 
three separate experiments in triplicate. The baseline activities of caspase-9 and caspase-8 
were not significantly changed between untreated (control) and vehicle treated cells 
(caspase-9: control = 857.9 ± 74.7 vs vehicle = 685.7 ± 67.8 FU/mg protein/hr, and 
caspase-8: control = 2285 ± 92 vs vehicle = 1589 ± 51 FU/mg protein/hr). **p<0.01 
compared with vehicle-treated groups. 
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FIG 5. Activation of caspase-3 following exposure of PC12 cells to dieldrin. 
PC 12 cells (2 x 106 cells/ml) were exposed to 100 or 300 pM dieldrin for up to 5 hr at 
37°C, and caspase-3 activity was measured using caspase-3 specific substrate, 
Ac-DEVD-AMC as described under "Experimental Procedures." The data are expressed 
as FU per mg protein per hr of incubation. Each point represents mean ± SEM from at 
least three separate experiments in triplicate. The caspase-3 activity in control cells was 
similar to that of vehicle-treated cells (control = 481.1 ± 121.6 vs vehicle = 480.8 ± 97.1 
FU/mg protein/hr). Dieldrin-treated cells showed statistically significant (p<0.01) 
compared with vehicle-treated cells in all time point. (B) PC 12 cells were grown on type 
I rat-tail collagen coated (6 p,g/cm2) cover slip for 24 hr at 37°C. The cells were exposed 
to 100 or 300 pM dieldrin for 3 hr, treated with FIT C-VAD-FMK, and observed under a 
fluorescent microscope with excitation at 488 nm as described under "Experimental 
procedures." The percent of cells that show activated caspases is indicated in the bottom 
right of each image. 
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FIG 6. Proteolytic cleavages of PKCÔ following exposure of PCI 2 cells to dieldrin. 
PC12 cells (~1 x 107 cells) were exposed to 100 |jM or 300 |iM dieldrin for 1, 3 or 5 hr at 
37°C, and cytosolic proteins were collected as described under "Experimental 
Procedures." Approximately 5 |ig of cytosolic proteins were resolved by 10% 
SDS-polyacrylamide gel and determined proteolytic cleavage of PKCô. Proteolytic 
cleavage of PKCô was observed as early as 3 hr following dieldrin treatment. Arrowheads 
indicate native PKCô (72-74 kDa), catalytic subunit (41 kDa) and regulatory subunit (38 
kDa) resulting in proteolytic cleavage of PKCô. (3-actin (43 kDa) confirms equal protein 
loading in each lane. 
FIG 7. Dieldrin-induced proteolytic cleavage of PKCô is inhibited by caspase 
inhibitors in PCI2 cells. 
PC 12 cells were pre-treated with Ac-DEVD-CHO, Z-VAD-FMK (A and B), or 
Z-DEVD-FMK (C) for 30 min, then exposed to 100 p,M or 300 pM dieldrin for 3 hr, and 
cytosolic proteins were collected as described under "Experimental Procedures." 
Approximately 2 jag of cytosolic proteins were resolved by 10% SDS-PAGE and 
detected dieldrin-induced proteolytic cleavage of PKCô. Arrowheads indicate native 
PKCô and cleaved subunits, as indicated in the figure. |3-actin confirms equal protein 
loading in each lane. 
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FIG 8. PKCô kinase activity during caspase-3-dependent proteolytic cleavage in 
dieldrin-treated PCI2 cells. 
(A) PC 12 cells (~1 x 107 cells) were exposed to dieldrin for 3 hr, and PKCô activity was 
assayed using an immunoprecipitation kinase assay as described under "Experimental 
Procedures." Densitometric analysis of phosphorylated histone in each treatment group is 
expressed as percent of control. The data represent three separate experiments. *p<0.05 
compared with vehicle-treated groups. (B) PKCô activity was assayed as in panel A. 
PC 12 cells were pretreated for 30 min with 20 |o,M rottlerin or 50 pM Z-DEVD-FMK and 
exposed to 100 pM dieldrin for 3 hr. This experiment was repeated twice with similar 
results. Densitometric analysis of phosphorylated histone in each treatment group is 
expressed as percent of control. #p<0.05 compared with vehicle-treated groups, and 
**p<0.01 compared with dieldrin-treated groups. 
FIG 9. DNA fragmentation and apoptosis in PCI2 cells exposed to dieldrin. 
(A) PC 12 cells (2 x 106 cells/ml) were exposed to 100 pM dieldrin for 1 hr with or 
without the 30 min pretreatment with rottlerin (10 pM), Z-DEVD-FMK (50 pM), or 
Z-VAD-FMK (100 pM). DNA fragmentation was assayed using the Cell Death 
Detection ELISA-Plus assay which measures DNA fragmentation as described under 
"Experimental Procedures." The data are expressed as the percentage of DNA 
fragmentation observed in vehicle-treated PC 12 cells. Each point represents mean ± 
SEM from three separate experiments in duplicate. Baseline DNA fragmentation is 35 
± 9 (control), and vehicle-treated group shows similar value (29 ± 8). *p<0.01 
compared with vehicle-treated group, or **p<0.01 compared with 100 pM 
dieldrin-treated group. (B) PC 12 cells were grown on type I rat-tail collagen coated (6 
pg/cm2) cover slip for 24 hr at 37°C. Apoptotic morphology of PC12 cells following 3 
hr of (a) vehicle-treated, (b) 10 pM rottlerin alone, (c) 100 pM dieldrin-treated, and (d) 
100 pM dieldrin with 10 pM rottlerin pretreatment, was examined using Hoechst 33342 
(10 pg/ml), and observed under a fluorescent microscope with excitation at 380 nm as 
described under "Experimental procedures." Arrowheads indicate nuclear 
condensation typically observed in apoptotic cells. 
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FIG 11. Inhibition of dieldrin-induced proteolytic cleavages of PKCÔ by rottlerin in 
PC12 cells. 
PC 12 cells (~1 x 107 cells) were pre treated with 0-20 jaM rottlerin for 90 min, then 
exposed to 100 or 300 dieldrin for 2 hr. Cytosolic proteins were collected as described 
under "Experimental Procedures." Approximately 2-5 jag of cytosolic proteins were 
resolved by 8-10% SDS-polyacrylamide gel and detected PKCô. Solid and open 
arrowheads indicate native and cleaved proteins, respectively. P-actin confirms equal 
protein loading in each lane. 
FIG. 12. Overexpression of catalytically inactive PKCô protein in immortalized 
dopaminergic neuronal cell line (IRB3AN27). 
(A) Description of plasmid: pEGFP-NI construct codes for the Green Fluorescent 
Protein (GFP) mRNA transcribed under the 5' Human cytomegalovirus (CMV) 
immediate early promoter and the mRNA is stabilized with the 3' SV40 mRNA 
polyadenylation signal (pA) and was used as vector control. PKCÔK376R-GFP construct 
codes for the kinase inactive PKCô-GFP fusion transcript. (B) Stable expression of 
GFP (a) and PKCÔK376R-GFP fusion protein (b) in IRB3AN27 cells was confirmed under 
a fluorescence microscope, and images were obtained with a SPOT digital camera. (C) 
(a) Vector- and (b) PKCôK376R-transfected IRB3AN27 cells were treated with 100 |aM 
dieldrin for 3 hr, and cytosolic fraction was collected. PKCô kinase activity assay was 
performed following immunoprecipitation of PKCô. The data represent a mean ± SEM 
of two separate experiments. **p<0.01 compared with control. 
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FIG 13. Overexpression of catalytically inactive PKCÔ protein blocks dieldrin 
induced caspase-3 and DNA fragmentation 
Subconfluent cultures of undifferentiated IRB3AN27 cells stably expressing vector or 
PKC5k376r-GFP fusion protein were treated with 100 and 300 pM dieldrin for 3 hr. (A) 
Caspase-3 activity was determined using colorimetric substrate, Ac-DEVD-pNA, and (B) 
DNA fragmentation was assayed using DNA ELISA assay as described under "Materials 
and Methods". The data are expressed as percentage of caspase-3 activity (average 
baseline value is 1.4 O.D./mg protein/hr) or DNA fragmentation (average baseline value is 
28 O.D./mg protein) observed in vehicle-treated cells. The data represent a mean ± S EM 
of six individual measurements from two separate experiments. Single asterisk denotes 
p<0.05, and double asterisks indicates pO.Ol. 
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FIG 14. A proposed mechanism for dieldrin-induced apoptotic signaling molecules 
in dopaminergic cells. 
Based on our studies, the following signaling pathways occur in dopaminergic cells 
exposed to dieldrin: 1) dieldrin increases ROS levels in the cell; 2) cytochrome C is 
released from the mitochondria into the cytosol, and cytochrome C release can be blocked 
by a ROS scavenger, such as MnTBAP; 3) cytosolic cytochrome C activates caspase-3 via 
caspase-9; 4) caspase-3 activates PKCô by proteolytic cleavage; 5) dieldrin-induced 
proteolytic cleavage of PKCô is blocked by pretreatment with the caspase-3 inhibitors, 
Ac-DEVD-CHO, Z-VAD-FMK & Z-DEVD-FMK; 6) the catalytically active PKCô 
fragment positively regulates caspase-3 activity; 7) pretreatment with PKCô inhibitor or 
overexpression of PKCÔK376R (dominant negative mutant) reduces caspase-3 activity in 
dieldrin-treated PC 12 cells; and 8) PKCô further executes apoptotic cell death by 
activating downstream signaling molecules. 
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CHAPTER V: DIELDRIN INDUCES APOPTOSIS IN A MESENCEPHALIC 
DOPAMINERGIC NEURONAL N27 CELL LINE VIA CASPASE-3-
DEPENDENT PROTEOLYTIC ACTIVATION OF PROTEIN KINASE C8 
A paper to be submitted for publication in Neurotoxicology 
Masashi Kitazawa, Yongjie Yang, Siddharth Kaul, Michael L. Kirby, Vellareddy 
Anantharam, and Anumantha G. Kanthasamy 
ABSTRACT 
Previously, we have investigated dieldrin cytotoxicity and its signaling cell death 
mechanisms in dopaminergic PC 12 cells. Dieldrin has been reported to be one of the 
environmental factors of Parkinson's disease and may selectively destroy dopaminergic 
neurons. Here, we further investigated dieldrin toxicity in dopaminergic neuronal cells, 
namely N27 cells. We have observed that dieldrin-treated N27 cells underwent a rapid 
and significant increase in reactive oxygen species followed by cytochrome c release 
into cytosol. The cytosolic cytochrome c activated caspase-dependent apoptotic 
pathway, and the increased caspase-3 activity was observed following 3-hr dieldrin 
exposure in dose-dependent manner. Furthermore, as previously reported, dieldrin 
caused the caspase-dependent proteolytic cleavage of protein kinase Cô (PKCô) into 41 
kDa catalytic and 38 kDa regulatory subunits. PKCô plays a critical role in the 
execution of apoptotic process in dieldrin-treated dopaminergic neuronal cells. 
Pretreatment with rottlerin, or transaction and over-expression of catalytically inactive 
PKCôK376R significantly attenuate dieldrin-induced DNA fragmentation and chromatin 
condensation, unique morphological features for apoptosis. Together, we conclude that 
caspase-3-dependent proteolytic activation of PKCô is a critical event in dieldrin-
induced apoptotic cell death in dopaminergic neuronal cells. 
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INTRODUCTION 
Epidemiological studies of Parkinson's disease (PD) over the past decade have 
promoted the conclusion that idiopathic, geriatric-onset PD is an environmentally-
mediated neurodegenerative disorder (Veldman et al., 1998; Stoessl, 1999; Engel et al., 
2001; Herishanu et al., 2001; Anca et al., 2002). PD-associated factors most often cited 
include residence in a rural area, use of well water as a drinking water source and 
occupational use of pesticides, all of which can be linked to pesticide exposures, and 
have been reported in numerous epidemiological studies (Langston, 1996; Schulte et al., 
1996; Liou et al., 1997; Chan et al., 1998; Marder et al., 1998; Smargiassi et al., 1998; 
Le Couteur et al., 1999; Taylor et al., 1999; Priyadarshi et al., 2000; Ritz and Yu, 2000; 
Tuchsen and Jensen, 2000; Priyadarshi et al., 2001). A recent landmark epidemiology 
study by Tanner and colleagues (Tanner et al., 1999) of nearly 20,000 twin pairs from a 
WWII veterans health care database determined that no clear genetic correlate exists to 
explain the incidence of PD and concluded that PD is an environmentally-mediated 
disorder. Postmortem studies of PD have reported significantly higher brain 
concentrations of chlorinated hydrocarbons and among these cyclodiene insecticides 
(Fleming et al., 1994; Corrigan et al., 1998; Corrigan et al., 2000), thus further 
suggesting a direct link between environmental exposure to neurotoxicants and PD. 
Cyclodiene insecticides are heavily chlorinated toxicants that are known to primarily 
act as antagonists of the GABAA receptor ionophore (Gant et al., 1987; Bloomquist, 
1993). Since the majority of G ABA projections in brain are inhibitory in function, 
cyclodienes are pharmacologically defined as pro-convulsant chemicals (Bloomquist, 
1992; Hawkinson and Casida, 1992; Bloomquist, 1993). Pharmacokinetically, 
cyclodienes and similar lipophilic chlorinated cage toxicants, collectively termed 
polychlorocycloalkanes, have been shown to accumulate in fatty tissues and brain 
(Matsumura, 1985; Murphy and Harvey, 1985). Dieldrin, specifically, is one of the most 
environmentally persistent insecticides known (Joy, 1994). Polychlorocycloalkanes 
were used extensively due to their excellent latent kill activity against crop and structural 
pests and the low cost of their manufacture, however bioaccumulation and 
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biomagnifïcation issues in non-target species led to the banning of these chemistries in 
the 1970's, with a few exceptions (e.g., g-HCH, endosulfan, methoxychlor). 
Approximately 3 billion tons of these chemistries were manufactured and used 
commercially for insect control to date (Casida et al., 1988). Regardless of the current 
restricted use polychlorocycloalkanes in Western countries, ongoing human exposure 
through either direct contact with environmental residues, ground water exposure, or 
consumption of imported products from countries where these chemistries are still legal 
for agricultural and industrial use continues to pose a significant human health risk. 
Daily dietary exposure to dieldrin, according to a study of 120,000 U.S. adults, is 
estimated to be in excess of EPA minimum safety standards (Macintosh et al., 1996). 
Attempts to link dieldrin to emerging models of disease progression in idiopathic PD 
have been reported from our laboratory (Kitazawa et al., 2001; Kitazawa et al., 2002) 
and laboratories of other researchers (Chun et al., 2001). Previously, we demonstrated 
the existence and regulation of a selective toxicant-evoked apoptotic pathway in PC 12 
cells which incorporates a signal amplification loop between caspase-3 and protein 
kinase Cô (Kitazawa et al., 2002). Herein we report additional work towards 
characterization of dieldrin-specific pro-apoptotic effects in a rat mesencephalic cell line 
(N27) with dopaminergic characteristics. The present work strongly reflects results 
reported in PC 12 cell studies which indicated that dieldrin initiates apoptosis in cells by 
a mitochondrial mechanism that facilitates early onset reactive oxygen species 
generation, cytochrome c release to the cytoplasm, caspase cascade activation and PKCô 
cleavage and activation. The central role of PKCô as a link between initiation and end-
point effects in dieldrin-induced apoptosis, as shown previously in our PC 12 studies, is 
supported by evidence presented here and is discussed in the present work. 
MATERIALS AND METHODS 
Materials. Dieldrin, Hoechst 33342, and mouse monoclonal anti-(3-actin antibody 
were purchased from Sigma (St. Louis, MO, USA). Caspase-3 substrate, Ac-DEVD-
AMC was purchased from Bachem Biosciences Inc. (King of Prussia, PA). Caspase-3 
197 
specific inhibitor, Z-DEVD-FMK was purchased from Alexis Biochemicals (San Diego, 
CA). Hydroethidine was purchased from Molecular Probes (Eugene, OR, USA). Rabbit 
polyclonal anti-nPKCô antibody was purchased from Santa Cruz Biotechnology Inc. 
(Santa Cruz, CA). ECL Western blotting analysis kit was purchased from Amersham 
Pharmacia Biotech, Inc. (Piscataway, NJ). Cell Death Detection Elisa Plus Assay Kit 
was purchased from Roche Molecular Biochemicals (Indianapolis, IN). Cytochrome c 
ELISA kit was obtained from MBL International Corp. (Watertown, MA). All tissue 
culture supplies were purchased from Gibco-BRL (Gaithersburg, MD, USA). Other 
routine laboratory reagents were purchased from Fisher Scientific (Pittsburg, PA, USA). 
Plasmids PKC8K376R-GFP fusion protein and pEGFP-Nl were kind gifts of Dr. Stuart H. 
Yuspa, National Cancer Institute (Bethesda, MD). Immortalized rat mesencephalic 
(N27) cell line was a kind gift of Dr. Kedar N. Prasad, Univ. of Colorado Health 
Sciences Center (Denver, CO). 
Animals. Adult male Sprague Dawley rats (125-150 g; Zivic Miller Laboratory, 
Alison Park, PA) were used in all experiments with animal tissues. Rats were housed 
one per cage in a temperature-controlled room (23°C) with a 12:12 L:D cycle. Animals 
were fed standard laboratory diet and water ad libitum. Experimental procedures used 
here were approved by the Institutional Animal Care and Use Committee at Iowa State 
University. The Iowa State University vivarium is an AAALAC approved facility. 
Cell lines. Immortalized rat mesencephalic cells (IRB3AN27, abbreviated here as 
N27 cells) were grown in RPMI medium supplemented with 10% fetal bovine serum, 
1% L-glutamine, penicillin (100 U/ml), and streptomycin (100 U/ml), maintained at 
37°C in a humidified atmosphere of 5% CO2 (Clarkson et al., 1999; Anantharam et al., 
2002). Vector-transfected (N27-pEGFP-NI) and PKCô dominant negative mutant (N27-
pPKCôK376R) were maintained in the supplemented medium above amended with 200 
Hg/ml hygromycin. 
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Stable transfection. Plasmid pPKCôK376R-GFP encodes protein kinase C8-GFP 
fusion protein, the number K376R refers to the mutation of lysine residue at position 376 
to arginine in the catalytic site of PKCô rendering it inactive (Li et al., 1999). Plasmid 
pEGFP-NI encodes the Green Fluorescent Protein alone and used as vector control. 
pEGFP-NI and pPKCôK376R were transfected into N27 cells using Lipofectamine Plus 
reagent according to the procedure recommended by the manufacturer. In brief, 8 gg of 
DNA, 24 fj.1 of lipid and 24 jo.1 of Plus reagent were used to transfect N27 cells in 100-
mm tissue culture dishes at 50% confluence in 4 ml of culture medium without serum. 
Fresh medium containing serum was added 3 hr later. For stable cell lines, the N27 cells 
were selected in 400 p.g/ml hygromycin, 48 hr after cotransfection with PCEP4 plasmid, 
which confers hygromycin resistance. Colonies were isolated with trypsin and glass 
cloning cylinders, and they were then re-plated and grown to confluence in T75 flasks 
and subsequently, the stable cell lines were maintained in 200 pg/ml hygromycin. 
Isolation of cytosolic fraction in N27 cell homogenates. Cells were pelleted by 
centrifugation at 200 x g, 10 min, 4°C. The cell pellet was washed once with ice-cold 
PBS and resuspended in 2 ml homogenization buffer (20 mM Tris HC1, 2 mM EDTA, 
10 mM EGTA, 2 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 25 |ig/ml 
aprotonin, 10 pg/ml leupeptin). The suspension was then sonicated for 10 sec and 
centrifuged at 100,000 x g for 1 hr at 4°C. Resulting supernatant was used as a cytosolic 
fraction. Protein concentration of each cytosolic fraction was determined using a 
Bradford protein assay dye reagent (BioRad Laboratories; Hercules, CA, USA). 
Samples were diluted with homogenization buffer according to the protein concentration 
estimated by the assay to equalize protein concentration for gel loading. Each sample 
was then mixed with 2x gel loading buffer containing 10% SDS and 200 mM DTT and 
placed in boiling water for 5 min. 
Cell treatment methods. After 2-4 days in culture, N27 cells were harvested and 
resuspended in serum-free growth medium at a cell density of 1-3 x 106/ml. Cell 
suspensions were treated with DMSO (0.1% final concentration) or DMSO containing 
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varying concentrations of dieldrin (30-300 |xM) over a period of 5 min to 3 hr at 37°C. 
In inhibitor studies, Z-DEVD-FMK (caspase-3-specific inhibitor, 50 |iM) was added 30 
min prior to the addition of dieldrin. The reaction samples were removed at various time 
points, centrifuged at 200 x g (5 min, 4°C), and cell pellets were used for assessing 
cytochrome c release, caspase-3 enzymatic activities, PKCô cleavage and DNA 
fragmentation. Cell samples used for flow cytometry were further treated with 
visualization fluors and are described in methods below. 
Brain slice preparation and treatment. Sprague Dawley male rats (125-150g) 
were euthanized by ether and decapitated. Brains were removed by brain case dissection 
to a cold table, dura and pia mater were removed by forceps, and brains were rinsed with 
0.9% sterile saline. Brain sections (300 |im) were cut in 4°C carboxygenated (5% 
COz/95% O2) artificial cerebrospinal fluid slicing medium (1.4 mM KC1, 685 |iM 
NaHzPC^, 14 mM NaHCOg, 2 mM CaCli, 1.2 mM MgSCU, 50 mM sucrose, 2.5 mM 
dextrose) using a Lancer Vibratome (model 1000; The Vibratome Co., St. Louis, MO, 
USA). Sections were transferred to carboxygenated artificial cerebrospinal fluid (ACSF; 
126 mM NaCl, 2.5 mM KC1, 1.25 mM NaH^PO^ 26 mM NaHCOg, 2 mM CaClz, 1.2 
mM MgSÛ4, 2.5 mM dextrose) and allowed to recover from trauma for 2 hr at 37°C 
prior to treatment with toxicants. At 2 hr, the incubation medium was refreshed with 
37°C carboxygenated ACSF and DMSO (0.033% final concentration) or DMSO 
containing dieldrin (30-100 jiM final concentration) was added to the medium and 
allowed to incubate with slices for 3 hr at 37°C. Following incubations, slices were 
removed to 1.5 ml tubes, centrifuged briefly at 1000 x g, the supernatant was discarded, 
and tissues were prepared for western blot by Dounce homogenization (15 strokes) in a 
modified lysis buffer (25 mM HEPES, 100 gM Na^VO^, 300 gM NaCl, 1.5 mM MgCl^, 
200 |xM EDTA, 50 mM dithiothreitol, 10 p.1 Triton X-100, 20 mM NaF, 20 mM (3-
glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, 25 (J.g/ml aprotinin, 50 |ig/ml 
leupeptin) at 400 gl/slice. Homogenates were centrifuged (12,000 x g, 20 min, 4°C) and 
protein concentrations of supematants were determined using a Bradford protein assay 
dye reagent (BioRad Laboratories, Hercules, CA, USA). Samples were diluted to 
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protein concentrations appropriate for gel loading and boiled 5 min in 2x gel loading 
buffer containing 10% SDS and 20 mM dithiothreitol. Samples were stored at -80°C 
until used for western blot analysis. 
Reactive oxygen species (ROS) flow cytometry. Flow cytometry analysis was 
performed on a Becton Dickenson FACScan™ flow cytometer (Beeton Dickinson, San 
Francisco, CA). Hydroethidine, a sodium borohydride-reduced derivative of ethidium 
bromide, is used to detect ROS produced specifically O2" inside the cell (Narayanan et al., 
1997). Hydroethidine loaded to cells binds to cellular macromolecules and reacts with 
O2" as it is generated, converting hydroethidine to ethidium bromide, increasing red 
fluorescence (620 nm). A 15-mW air-cooled argon-ion laser was used as an excitation 
source for hydroethidine at 488 nm and the optical filter was 585/42 nm bandpass. Cells 
were detected and distinguished from the background by forward-angle light scattering 
(FSC) and orthogonal light scattering (SSC) characteristics. All the flow cytometric data 
were analyzed by Cellquest™ data analysis software to determine the significant increase 
or decrease of fluorescence intensity. 
Cytochrome c release assay. Dieldrin-induced cytochrome c release was measured 
using a cytochrome c ELISA kit as described previously (Anantharam et al., 2002). 
Briefly, N27 cells (5 x 106 cells) were resuspended in serum-free RPMI-1640. Cell 
suspensions were exposed to 100 |o.M or 300 p.M dieldrin for 15-30 min at 37°C. After 
exposure, cells were collected, washed once with ice-cold phosphate-buffered saline 
(PBS; pH 7.4) and resuspended in 1 ml of ice-cold homogenization buffer (10 mM Tris 
HC1 pH 7.5, 0.3 M sucrose, 1 mM phenylmethylsulfonyl fluoride, 25 pg/ml aprotinin, 10 
(j.g/ml leupeptin). Following homogenization, cells were centrifuged at 10,000xg for 60 
min at 4°C. Resulting supernatants were collected as cytoplasmic fraction and used to 
measure cytochrome c release by cytochrome c ELISA assay kit strictly following the 
protocol provided by the manufacturer (MBL, Watertown, MA, USA). Optical density 
of each well was then measured at 450 nm using a microplate reader (Molecular Devices 
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CORP., SUNNYVALE, CA, USA). CONCENTRATION OF CYTOCHROME C WAS CALIBRATED FROM A 
STANDARD CURVE BASED ON REFERENCE STANDARDS. 
Caspase-3 activity. CASPASE ACTIVITIES WERE DETERMINED AS PREVIOUSLY DESCRIBED 
(ANANTHARAM ET AL., 2002). BRIEFLY, AFTER THE EXPOSURE TO DIELDRIN, CELLS WERE WASHED 
ONCE WITH PBS AND RESUSPENDED IN LYSIS BUFFER CONTAINING 50 MM TRIS/HCL (PH 7.4), 1 
MM EDTA, 10 MM EOT A, AND 10 |IM DIGITONIN. CELLS WERE THEN INCUBATED AT 37°C FOR 
20-30 MIN TO ALLOW COMPLETE LYSIS. LYSATES WERE QUICKLY CENTRIFUGED AND CELL-FREE 
SUPEMATANTS WERE INCUBATED WITH 50 |IM AC-DEVD-AMC (CASPASE-3 SUBSTRATE) AT 37°C 
FOR 1 HR. CASPASE ACTIVITY WAS THEN MEASURED USING A MICROPLATE READER (MOLECULAR 
DEVICES CORP., SUNNYVALE, CA) WITH EXCITATION AT 380 NM AND EMISSION AT 460 NM. 
CASPASE ACTIVITY WAS EXPRESSED AS FLUORESCENCE UNIT (FU) PER MG PROTEIN PER HR. 
Western blot. CYTOPLASMIC FRACTIONS OR BRAIN TISSUE SAMPLES CONTAINING EQUAL 
AMOUNTS OF PROTEIN (5-10 JIG) WERE LOADED IN EACH LANE AND SEPARATED ON A 10% SDS-
POLYACRYLAMIDE GEL. PROTEINS WERE THEN TRANSFERRED TO NITROCELLULOSE MEMBRANE BY 
ELECTRO-BLOTTING OVERNIGHT (4°C, 25 V). NON-SPECIFIC BINDING SITES WERE BLOCKED BY 
TREATING THE NITROCELLULOSE MEMBRANES WITH 5% NON-FAT DRY MILK POWDER FOR 2 HR PRIOR TO 
TREATMENT WITH PRIMARY ANTIBODIES. NITROCELLULOSE MEMBRANES CONTAINING THE PROTEINS 
WERE INCUBATED WITH RABBIT ANTI-PKCÔ FOR 1 HR AT RT (1:2000 DILUTION). PRIMARY 
ANTIBODY TREATMENTS WERE FOLLOWED BY TREATMENT WITH SECONDARY HRP-CONJUGATED ANTIR-
ABBIT IGG (1:2000 DILUTION) FOR 1 HR AT RT. SECONDARY ANTIBODY-BOUND PROTEINS WERE 
DETECTED USING AMER SHAM'S ECL CHEMILUMINESCENCE KIT. TO CONFIRM EQUAL PROTEIN 
LOADING, BLOTS WERE RE-PROBED WITH A (3-ACTIN ANTIBODY (1:5000 DILUTION). GEL 
PHOTOGRAPHS WERE TAKEN WITH A GEL IMAGING SYSTEM AND QUANTIFICATION OF BANDS WAS 
PERFORMED USING SCION IMAGE. 
Annexin V and propidium iodide flow cytometry. FLOW CYTOMETRY ANALYSIS OF 
APOPTOTIC AND NECROTIC N27 CELLS FOLLOWING 3 HR EXPOSURE TO DIELDRIN (100 |IM) WAS 
PERFORMED BY ANNEXIN V-FTIC AND PROPIDIUM IODIDE (PI) STAINING KIT (BO PHARMINGEN) 
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AS PER THE MANUFACTURER'S SPECIFICATIONS. ANNEXIN V BINDS TO PHOSPHATIDYLSERINE (PS) 
AND OTHER NEGATIVELY CHARGED PHOSPHOLIPIDS PRODUCING FLUORESCENCE PRIMARILY INDICATIVE 
OF PS TRANSLOCATION FROM THE INNER TO THE OUTER CELL MEMBRANE LEAFLET REFLECTIVE OF 
AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN APOPTOTIC CELLS (BRATTON ET AL., 1997). PI IS A 
NUCLEIC ACID DYE THAT PENETRATES THE NUCLEAR ENVELOPE OF NECROTIC CELLS AND WAS USED HERE 
AS A COUNTER STAIN TO DIFFERENTIATE BETWEEN LIVE, APOPTOTIC, LATE STAGE APOPTOTIC/EARLY STAGE 
NECROTIC, AND NECROTIC CELLS. FLOW CYTOMETRY ANALYSIS WAS PERFORMED ON A BECTON 
DICKENSON FACSCAN™ FLOW CYTOMETER (BECTON DICKINSON, SAN FRANCISCO, CA). N27 
CELLS WERE WASHED 2X WITH COLD PHOSPHATE-BUFFERED SALINE (PH 7.4) AND RESUSPENDED IN A 
BINDING BUFFER (10 MM HEPES, 140 MM NACL, 2.5 MM CACL2; PH 7.4) AT A 
CONCENTRATION OF 0.5 X 106 CELLS/ML. CELL ALIQUOTS OF 100 |IL WERE INCUBATED WITH ANNEXIN 
V-FITC (5 P.1) AND PI (2 |IL) FOR 15 MIN AT RT IN THE DARK. AFTER 15 MIN, INCUBATES WERE 
DILUTED WITH 400 JLII OF BINDING BUFFER AND ANALYZED BY FLOW CYTOMETRY. A 15-MW AIR-
COOLED ARGON-ION LASER WAS USED AS AN EXCITATION SOURCE FOR ANNEXIN V-FITC AT 488 NM 
WITH OPTICAL FILTER AT 530/15 NM BANDPASS. PI FLUORESCENCE WAS MEASURED WITH OPTICAL 
FILTER AT 650/42 NM BANDPASS. CELLS WERE DETECTED AND DISTINGUISHED FROM THE 
BACKGROUND BY FORWARD-ANGLE LIGHT SCATTERING (FSC) AND ORTHOGONAL LIGHT SCATTERING 
(SSC) CHARACTERISTICS. ALL THE FLOW CYTOMETRIC DATA WERE ANALYZED BY CELLQUEST™ DATA 
ANALYSIS SOFTWARE TO DETERMINE THE SIGNIFICANT INCREASE OR DECREASE OF FLUORESCENCE 
INTENSITY. 
DNA fragmentation analysis. DNA FRAGMENTATION ASSAY WAS PERFORMED USING A 
RECENTLY DEVELOPED CELL DEATH DETECTION ELISA PLUS ASSAY KIT (ROCHE APPLIED SCIENCE, 
BASEL, SWITZERLAND). N27 CELLS WERE EXPOSED TO DMSO (0.1% FINAL CONCENTRATION) OR 
DMSO CONTAINING DIELDRIN (30-100 GM) FOR 3 HR AT 37°C. FOLLOWING TREATMENT, CELLS 
WERE CENTRIFUGED 200 X G, 5 MIN, 4°C AND WASHED ONCE WITH IX PHOSPHATE-BUFFERED 
SALINE (PH 7.4). CELLS WERE THEN INCUBATED WITH A LYSIS BUFFER (SUPPLIED WITH THE KIT) AT 
RT FOR 30 MIN. INCUBATES WERE CENTRIFUGED 10,000 X G, 20 MIN, 4°C AND 20 |XL ALIQUOTS 
OF SUPERNATANT WERE DISPENSED TO STREPTAVIDIN-COATED 96 WELL MICROTITER PLATES FOLLOWED 
BY ADDITION OF 80 GL OF ANTIBODY COCKTAIL. PLATES WERE INCUBATED FOR 2 HR AT RT WITH MILD 
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SHAKING. THE ANTIBODY COCKTAIL CONSISTED OF A MIXTURE OF ANTI-HISTONE BIOTIN AND ANTI-
DNA-HRP DIRECTED AGAINST VARIOUS HISTONES AND ANTIBODIES TO BOTH SINGLE STRAND DNA 
AND DOUBLE STRAND DNA, WHICH ARE MAJOR CONSTITUENTS OF THE NUCLEOSOMES. AFTER 
INCUBATION, UNBOUND COMPONENTS WERE REMOVED BY WASHING WITH THE INCUBATION BUFFER 
SUPPLIED WITH THE KIT. QUANTITATIVE DETERMINATION OF THE AMOUNT OF NUCLEOSOMES RETAINED 
BY ANTI-DNA-HRP IN THE IMMUNOCOMPLEX WAS DETERMINED SPECTROPHOTOMETRICALLY WITH 
ABTS AS A HRP SUBSTRATE (SUPPLIED WITH THE KIT). MEASUREMENTS WERE MADE AT 405 NM 
AGAINST AN ABTS SOLUTION AS A BLANK (REFERENCE WAVELENGTH -490 NM) USING A MICROPLATE 
READER (MOLECULAR DEVICES CORP., SUNNYVALE, CA, USA). 
Immunocytochemistry. N27 CELLS WERE GROWN ON COLLAGEN (6 JIG/CM2) COATED SLIDES 
FOR 2-3 DAYS IN A 37°C, 5% C02 INCUBATOR. CELLS WERE WASHED TWICE WITH PHOSPHATE-
BUFFERED SALINE (PH 7.4) AND TREATED FOR 3 HR WITH DMSO (0.1% FINAL CONCENTRATION) OR 
DMSO CONTAINING DIELDRIN (100 PM). CELLS WERE AGAIN WASHED WITH PHOSPHATE-BUFFERED 
SALINE AND WERE FIXED WITH 10% BUFFERED FORMALDEHYDE FOR 30 MIN AT ROOM TEMPERATURE, 
FOLLOWED BY STAINING WITH HOECHST 33342 (10 FIG/ML) FOR 3 MIN IN THE DARK. CELLS STAINED 
WITH HOECHST 33342 DYE FLUORESCE BRIGHT BLUE UPON BINDING TO DNA IN THE NUCLEUS. THE 
NUCLEUS OF APOPTOTIC CELLS EXHIBITS STRONG BLUE STAINING AND STAINING PATTERN IS 
HETEROGENEOUS AND OCCURS IN PATCHES, INDICATIVE OF CHROMATIN CONDENSATION, WHEREAS THE 
NUCLEUS OF NON-APOPTOTIC CELLS EXHIBIT MORE DIFFUSED, WEAK AND HOMOGENOUS STAINING 
(SHIMIZU ET AL., 1996; DU ET AL., 1997). SLIDE-MOUNTED CELLS WERE OBSERVED UNDER A 
NIKON DIAPHOT MICROSCOPE UNDER UV ILLUMINATION, AND PICTURES WERE CAPTURED WITH A 
SPOT DIGITAL CAMERA (DIAGNOSTIC INSTRUMENTS, STERLING HEIGHTS, MI). 
Data analysis. DATA WERE FIRST ANALYZED USING ONE-WAY ANOVA. DUNNETT'S 
POST-TEST OR BONFERRONI'S MULTIPLE COMPARISON TEST WAS THEN PERFORMED TO COMPARE 
TREATED SAMPLES, AND P<0.05 WAS CONSIDERED TO BE SIGNIFICANT. 
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RESULTS 
Dieldrin-induced reactive oxygen species (ROS). EXPOSURE OF N27 CELLS TO DIELDRIN 
RESULTED IN A RAPID, TRANSIENT INCREASE IN GENERATION OF ROS AS MEASURED BY FLOW 
CYTOMETRIC ANALYSIS OF HYDROETHIDIUM DYE OXIDATION (FIG. 1 A). A SIGNIFICANT SHIFT OF 
FLUORESCENT INTENSITY INDICATES THE MASSIVE GENERATION OF INTRACELLULAR ROS IN TIME-
DEPENDENT MANNER. MODERATE CONCENTRATIONS OF DIELDRIN (30 PM) PRODUCED A SIGNIFICANT 
TIME-DEPENDENT INCREASE OF CA. 65% IN ROS LEVELS 5 MIN AFTER TREATMENT (P<0.01), WHICH 
APPEARED TO REACH SIGNAL SATURATION BY 15 MIN AT CA. 200% OF VEHICLE CONTROL (FIG. IB). 
COMPARISON OF EXPOSURE OF N27 CELLS TO VARIOUS CONCENTRATIONS OF DIELDRIN (30-200 P.M) 
INDICATED THAT APPROXIMATELY SIMILAR LEVELS OF ROS GENERATION WERE REACHED AT 5 MIN 
POST-TREATMENT (CA. 145-165% VEHICLE CONTROL) AND SUBSEQUENTLY REVERSED AT 
CONCENTRATIONS OF DIELDRIN GREATER THAN 100 |IM BEYOND 5 MIN EXPOSURE (DATA NOT SHOWN). 
Dieldrin promotes mitochondrial cytochrome c release. DIELDRIN-MEDIATED CYTOCHROME C 
RELEASE, AN EARLY EVENT IN APOPTOSIS, MEASURED COLORIMETRICALLY BY ELISA INDICATED TIME-
AND DOSE-DEPENDENT INCREASES IN THE APPEARANCE OF CYTOCHROME C IN CYTOSOL OVER A 30 
MIN DIELDRIN EXPOSURE PERIOD (FIG. 2). DIELDRIN SIGNIFICANTLY INCREASED CYTOCHROME C 
RELEASE 50% AND 140% AT 15 AND 30 MIN POST-TREATMENT, RESPECTIVELY (P<0.01). 
EXPOSURE OF N27 CELLS TO 300 P.M DIELDRIN EVOKED A SIGNIFICANT INCREASE IN ACCUMULATION 
OF CYTOSOLIC CYTOCHROME C 110% AND 260% FOLLOWING 15 MIN AND 30 MIN OF DIELDRIN 
EXPOSURE, RESPECTIVELY (PO.OOOL). 
Dieldrin-mediated activation of caspase-3. DIELDRIN INCREASED N27 CELL ACTIVITY OF 
CASPASE-3, AN IMPORTANT EFFECTOR CASPASE IN APOPTOSIS, IN A DOSE-DEPENDENT MANNER AFTER 
3 HR OF EXPOSURE AS MEASURED BY AC-DEVD-AMC FLUOROMETRY (P<0.001; FIG. 3). 
INCREASES IN CASPASE-3 ACTIVITIES MEASURED WERE 210%, 260% AND 340% OF VEHICLE 
CONTROL FOR 30, 100 AND 300 |IM DIELDRIN, RESPECTIVELY. NO SIGNIFICANT VEHICLE EFFECT 
(DMSO, 0.2% FINAL CONCENTRATION) WAS OBSERVED, SUGGESTING THAT MEASURED EFFECTS WERE 
DIRECTLY ATTRIBUTABLE TO DIELDRIN EXPOSURE. CONCENTRATIONS OF DIELDRIN ABOVE 100 |A.M 
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APPEARED TO PRODUCE SIMILAR LEVELS OF CASPASE-3 ACTIVITIES, WHEREAS 30 P.M DIELDRIN-
INDUCED INCREASES IN CASPASE-3 ACTIVITIES WERE INTERMEDIATE WITH RESPECT TO 
CONCENTRATIONS ABOVE 100 |IM AND THE VEHICLE CONTROL. 
Caspase-3-dependent dieldrin-induced cleavage and activation of PKCô. CONCENTRATIONS 
OF DIELDRIN (100 AND 300 GM) EFFECTING MAXIMUM INCREASES IN CASPASE-3 ACTIVITIES 
INCREASED THE CLEAVAGE AND ACTIVATION OF PKCÔ IN A CONCENTRATION-DEPENDENT MANNER 3 HR 
FOLLOWING TREATMENT AS MEASURED BY WESTERN BLOT ANALYSIS (FIG. 4A). PREVIOUSLY, IT HAS 
BEEN DOCUMENTED THAT PKCÔ IS SELECTIVELY ACTIVATED BY CASPASE-3 UNDER CONDITIONS OF 
TOXICANT EXPOSURE (EMOTO ET AL., 1995; REYLAND ET AL., 1999; ANANTHARAM ET AL., 2002). 
INCUBATION WITH A SELECTIVE CASPASE-3 INHIBITOR, Z-DEVD-FMK (50 PM), FOR 30 MIN 
PRIOR TO 3 HR TREATMENT OF N27 CELLS WITH 100 P.M DIELDRIN MARKEDLY REDUCED PKCÔ 
CLEAVAGE AND ACTIVATION (CA. 70% REDUCTION; FIG. 4B) APPROXMATING BASAL LEVELS OF 
CLEAVED PRODUCTS OBSERVED IN CONTROLS, CONFIRMING PROTEOLYTIC CLEAVAGE OF PKCÔ IS 
CASPASE-3 DEPENDENT. 
PRELIMINARY RESULTS FROM INCUBATIONS OF 300 |IM CORONAL SECTIONS OF RAT MIDBRAIN 
TISSUE WITH CONCENTRATIONS OF DIELDRIN (30 P.M) INDICATED RESULTS SIMILAR TO THAT SEEN 
ABOVE IN N27 CELLS (FIG. 4C). DIELDRIN AT 30 JAM PRODUCED A 75.3% INCREASE IN CLEAVED 
PRODUCTS OF PKCÔ, REMINISCENT OF CHANGES OBSERVED WITH 100 JXM DIELDRIN IN N27 CELLS 
(SEE FIG. 4B) AND SUGGESTED THAT SIMILAR PROTEOMIC PROCESSES MAY BE ACTIVATED in situ 
FOLLOWING DIELDRIN EXPOSURE. ALSO, BRAIN TISSUES APPEARED TO BE MORE SENSITIVE TO 
DIELDRIN NEUROTOXICITY, INDICATING THAT DIELDRIN COULD CAUSE GREATER ADVERSE EFFECT IN 
DOPAMINERGIC NEURONS IN ACTUAL SITUATION. 
Annexin V and propidium iodide indicate dieldrin-mediated apoptosis. FLOW CYTOMETRIC 
ANALYSIS OF N27 CELLS INCUBATED 3 HR WITH DMSO (0.1% FINAL CONCENTRATION) OR DMSO 
CONTAINING DIELDRIN (100 PM) PRODUCED MARKED INCREASES IN BOTH APOPTOTIC (ANNEXIN V, 
51%) AND APOPTOTIC/NECROTIC OR LATE APOPTOTIC (ANNEXIN V AND PROPIDIUM IODIDE, 31%) 
INDICES, WHEREAS VEHICLE-TREATED CELLS DID NOT INCREASE APOPTOSIS AS INDICATED TO BE 9% 
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AND 13% ON APOPTOTIC AND LATE APOPTOTIC, RESPECTIVELY (FIG. 5). CHI SQUARE ANALYSIS OF 
THE DISTRIBUTION OF ANNEXIN V FITC AND PROPIDIUM IODIDE POSITIVE CELLS INDICATED A 
POSITIVE TREND TOWARD APOPTOSIS IN DIELDRIN-TREATED N27 CELLS (%2=69.12, PCO.OOOL). 
Dieldrin-mediated DNA fragmentation and apoptosis. WE MEASURED DIELDRIN-INDUCED 
DNA FRAGMENTATION BY ELISA METHOD IN N27 CELLS TREATED WITH 100 PM DIELDRIN FOR 
ANOTHER 3 HR WITH OR WITHOUT PRETREATMENT OF 1-3 PM ROTTLERIN, A SELECTIVE PKCS SPECIFIC 
INHIBITOR, FOR 30 MIN, TO FURTHER CONFIRM THE ROLE OF PKC6 ACTIVITY DURING DIELDRIN-
INDUCED APOPTOSIS. AS SHOWN IN FIG. 6A, ROTTLERIN DOSE-DEPENDENTLY PROTECTED DIELDRIN-
INDUCED DNA FRAGMENTATION. ESPECIALLY, 3 MM ROTTLERIN SIGNIFICANTLY (P<0.01) 
ATTENUATED DIELDRIN TOXICITY, AND NEARLY 30% REDUCTION OF DNA FRAGMENTATION WAS 
OBSERVED. THE LEVELS OF CHROMATIN CONDENSATION OBSERVED BY HOECHST 33342 WERE 64%, 
40%, AND 28% IN 100 PM DIELDRIN ONLY, DIELDRIN + 1 PM ROTTLERIN, AND DIELDRIN + 3 PM 
ROTTLERIN, RESPECTIVELY. 
WE HAVE ALSO UTILIZED GENETIC APPROACH TO CHARACTERIZE THE PRO-APOPTOTIC FUNCTION 
OF PKCÔ. CATALYTICALLY INACTIVE PKCÔ MUTANT (PKCÔK376R) WAS STABLY TRANSFECTED TO 
N27 CELLS, DIELDRIN-INDUCED DNA FRAGMENTATION WAS MEASURED. VECTOR-TRANSFECTED N27 
AND PKCÔ MUTANT-TRANSFECTED N27 CELLS WERE TREATED WITH 100 PM DIELDRIN FOR 3 HR. 
DNA FRAGMENTATION WAS INDICATED A SIGNIFICANT DIELDRIN CONCENTRATION-DEPENDENT 
INCREASE (FIG. 7A; N27-VECTOR, PO.OOOL; N27-PKCÔK376R, PO.OOL). MAXIMAL 
INCREASES IN DNA FRAGMENTATION WERE OBSERVED WITH 100 PM DIELDRIN TREATMENT (N27-
VECTOR, 346.7%; N27- PKCÔ107611, 212.4%). COMPARISON OF THE N27-VECTOR AND N27-
PKCÔK376R CELL LINES TREATED WITH 100 PM DIELDRIN REVEALED A SIGNIFICANT DECREASE IN 
DNA FRAGMENTATION (134.3% DECREASE, P<0.01) IN THE DOMINANT NEGATIVE MUTANT PKCÔ 
CELL LINE. OUR PREVIOUS REPORT THAT CELLS EXPRESSING A DOMINANT NEGATIVE FORM OF PKCÔ 
WERE NEARLY COMPLETELY RESISTANT TO DNA FRAGMENTATION FOLLOWING 
METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL EXPOSURE WAS PERFORMED IN CELLS 
TRANSIENTLY EXPRESSING A CATALYTICALLY INACTIVE MUTANT OF PKCÔ (ANANTHARAM ET AL., 2002). 
IN THE PRESENT STUDY, THE N27-DN CELL LINE STABLY EXPRESSES CATALYTICALLY INACTIVE PKCÔ 
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AT LOWER LEVELS THAN THAT ACHIEVED WITH TRANSIENT EXPRESSION AND IS LIKELY THE REASON FOR 
THE PARTIAL EFFECT OBSERVED HERE. CHROMATIN CONDENSATION INDICATIVE OF APOPTOSIS WERE 
ALSO EXAMINED BY HOECHST 33342 STAINING OF 3 HR DIELDRIN-TREATED N27-DN CELLS (FIG. 
7B). 
DISCUSSION 
RESULTS PRESENTED HERE FURTHER SUPPORT OUR HYPOTHESIS THAT DIELDRIN CONTRIBUTES TO 
APOPTOTIC CELL DEATH IN DOPAMINERGIC NEURONAL CELLS. PREVIOUSLY, WE AND OTHER 
RESEARCHERS HAVE SHOWN THE SELECTIVE TOXICITY OF DIELDRIN ON DOPAMINERGIC CELLS 
(SANCHEZ-RAMOS ET AL., 1998; KITAZAWA ET AL., 2001) AS WELL AS CHARACTERIZED THE 
SUBSEQUENT SIGNALING CELL DEATH MECHANISM IN DOPAMINERGIC PC12 CELLS (KITAZAWA ET AL., 
2002). HERE, WE HAVE USED CLONAL DOPAMINERGIC NEURONAL CELLS, WHICH WERE MORE 
RELEVANT TO LINK BETWEEN THE EFFECT OF DIELDRIN AND DOPAMINERGIC NEURODEGENERATION. THE 
CELL DEATH PATHWAY OBSERVED IN DOPAMINERGIC NEURONAL CELLS FOLLOWING ACUTE EXPOSURE TO 
DIELDRIN WAS IDENTICAL TO THAT OBSERVED IN PC 12 CELLS; THAT IS, I) INITIAL AND RAPID INCREASE 
OF REACTIVE OXYGEN SPECIES (ROS), II) POSSIBLE MITOCHONDRIAL DAMAGE AND SUBSEQUENT 
RELEASE OF CYTOCHROME C, III) CASPASE-3 ACTIVATION AND PROTEOLYTIC CLEAVAGE OF PKCÔ, AND 
IV) APOPTOTIC CELL DEATH AS A RESULT OF ACTIVATION OF THESE PRO-APOPTOTIC MOLECULES. 
GENERATION OF ROS WAS A RAPID RESPONSE TO DIELDRIN TOXICITY. WITHIN 5 MIN AFTER 
THE EXPOSURE, CELLS INCREASED INTRACELLULAR ROS BY 50% FROM THE BASAL LEVEL, SUGGESTING 
DIELDRIN SOMEHOW INTERACTS WITH CERTAIN CELLULAR MOLECULES TO POTENTIATE THE PRODUCTION 
OF ROS AS SOON AS IT GETS INTO THE CELLS. POSSIBLE CANDIDATES COULD BE MITOCHONDRIAL 
MEMBRANE PROTEINS RESPONSIBLE FOR CELLULAR RESPIRATION. IT HAS BEEN REPORTED THAT DIELDRIN 
INHIBITS MITOCHONDRIAL ELECTRON TRANSPORT SYSTEM (ETS) NEAR THE COMPLEX III (BERGEN, 
1971). TERMINATION OF ETS CAUSES ACCUMULATION OF REDUCED FORM OF ELECTRON CARRIER 
PROTEINS AND UNUSED OXYGEN, RESULTING IN UNCOUPLING IN MITOCHONDRIA AND CONVERSION OF 
OXYGEN INTO ROS. SINCE THE GENERATION OF ROS WAS OBSERVED SO RAPIDLY, THE PRIMARY 
TARGET OF DIELDRIN COULD BE MITOCHONDRIA AS ALSO SHOWN PREVIOUSLY (KITAZAWA ET AL., 2001). 
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SUBSEQUENTLY, SIGNIFICANT RELEASE OF CYTOCHROME C WAS OBSERVED. THE RELEASE OF 
CYTOCHROME C WAS DOSE- AND TIME-DEPENDENT, AND IT WAS AS EARLY AS 15 MIN FOLLOWING 
DIELDRIN EXPOSURE. THE RELEASE OF CYTOCHROME C AND OTHER PRO-APOPTOTIC FACTORS, SUCH AS 
APAF-1 FROM MITOCHONDRIA HAVE BEEN KNOWN TO ACTIVATE CASPASE-9 (LI ET AL., 1997; KUIDA, 
2000). CASPASE-9 SERVES AS AN INITIATOR CASPASE, AND IT FURTHER PROTEOLYTICALLY CLEAVES AND 
ACTIVATES EFFECTOR CASPASES INCLUDING CASPASE-3, -6, AND -7 (BUDIHARDJO ET AL., 1999). WE 
HAVE OBSERVED SIGNIFICANT INCREASE IN CASPASE-3 ACTIVITY FOLLOWING 3-HR DIELDRIN EXPOSURE 
IN DOSE-DEPENDENT MANNER. BOTH 100 AND 300 PIM DIELDRIN SHOWED SIGNIFICANCE OVER 
CONTROL AND VEHICLE TREATED CELLS, INDICATING THE LEVEL OF DIELDRIN-INDUCED CYTOCHROME C 
RELEASE IS SUFFICIENT TO PROMOTE MITOCHONDRIAL-MEDIATED APOPTOTIC CELL PROCESS IN 
DOPAMINERGIC CELLS. 
ACCUMULATING EVIDENCE STRONGLY SUGGESTED THE PRO-APOPTOTIC ROLE OF PKCÔ 
DURING APOPTOSIS (EMOTO ET AL., 1995; REYLAND ET AL., 1999; MATASSA ET AL., 2001). WE 
HAVE VERIFIED THAT THE PROTEOLYTIC ACTIVATION OF PKCÔ WAS DUE TO CASPASE-3 ACTIVATION. 
CASPASE-3 SPECIFIC INHIBITOR, Z-DEVD-FMK, BLOCKED THE PROTEOLYTIC CLEAVAGE OF PKCÔ 
BY 70%, INDICATING MAJORITY OF PKCÔ CLEAVAGE WAS DUE TO CASPASE-3. PREVIOUSLY, WE 
HAVE ALSO SHOWN THAT PKCÔ PLAYS AN ESSENTIAL ROLE IN ENVIRONMENTAL CHEMICAL-INDUCED 
APOPTOTIC CELL DEATH IN PC12 CELLS (ANANTHARAM ET AL., 2002; KITAZAWA ET AL., 2002). IN 
THESE REPORTS, PKCÔ NOT ONLY FACILITATES DOWNSTREAM APOPTOTIC PROCESS INCLUDING DNA 
FRAGMENTATION, BUT ALSO MODULATE UPSTREAM PROCESS INCLUDING CASPASE-3 ACTIVITY, WITH 
UNKNOWN MECHANISM. THE REGULATORY ROLE OF PKCÔ HAS ALSO BEEN DOCUMENTED IN 
ELSEWHERE (REYLAND ET AL., 1999), BUT THE EXACT MECHANISM AND FUNCTION OF PKCÔ IN 
REGULATORY ROLE REMAIN TO BE ELUCIDATED. 
IN THE PRESENT PAPER, WE FOCUS ON THE EXECUTION ROLE OF PKCÔ. WE HAVE SHOWN 
DIELDRIN-INDUCED APOPTOSIS USING ANNEXIN-V-FITC. FURTHER EXPERIMENTS WERE CONDUCTED 
TO CHARACTERIZE WHETHER PKCÔ PLAYED AN IMPORTANT ROLE IN DIELDRIN-INDUCED DNA 
FRAGMENTATION. TO ANSWER THIS QUESTION, WE HAVE UTILIZED CATALYTICALLY INACTIVE PKCÔ 
MUTANT (PKCÔK376R)-EXPRESSED DOPAMINERGIC CELLS AND MEASURED DNA FRAGMENTATION 
USING ELISA TECHNIQUE. THE KINASE ACTIVITY OF MUTANT CELLS HAS BEEN DOCUMENTED 
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PREVIOUSLY BY OUR LABORATORY (KITAZAWA ET AL., 2002). MUTANT CELLS SHOWED PARTIALLY 
PROTECTIVE FOLLOWING DIELDRIN EXPOSURE, INDICATING THAT PKCÔ IS MODULATING DNA 
FRAGMENTATION SOMEHOW. FURTHERMORE, PRETREATMENT WITH PKCÔ SPECIFIC INHIBITOR, 
ROTTLERIN, ALSO DOSE-DEPENDENTLY REDUCED NUCLEAR CONDENSATION. THESE RESULTS MATCH WITH 
PREVIOUSLY PUBLISHED DATA. 
IN CONCLUSION, WE HAVE VERIFIED THAT DIELDRIN IS A POTENT APOPTOSIS INDUCED IN 
DOPAMINERGIC NEURONAL CELLS. COMPARING WITH OUR PREVIOUS DATA FROM DOPAMINERGIC 
PC 12 CELLS, NEURON-DERIVED CELLS SEEM TO BE MORE SENSITIVE TO DIELDRIN TOXICITY. FURTHER 
RESEARCH WILL BE NECESSARY TO UNDERSTAND DIELDRIN NEUROTOXICITY AND THE IMPACT TO 
PATHOGENESIS OF NEURODEGENERATIVE DISORDERS INCLUDING PARKINSON'S DISEASE. 
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Figure 1 : Dieldrin-induced ROS generation in N27 cells. 
N27 CELLS (~1 X 106 CELL/ML) WERE TREATED WITH 30 PM DIELDRIN FOR 0-30 MIN. 
HYDROETHIDINE FLUORESCENCE INTENSITY WAS MEASURED AT VARIOUS TIME POINTS (0, 5, 15, 30 
MIN) BY A FLOW CYTOMETRY. (A) REPRESENTATIVE SHIFT OF FLUORESCENT INTENSITY DURING 
DIELDRIN TREATMENT. (B) QUANTITATIVE ANALYSIS OF ROS GENERATION. DATA REPRESENT THE 
MEAN ± SEM FOR THREE SEPARATE EXPERIMENTS PERFORMED IN TRIPLICATE. SIGNIFICANCE WAS 
DETERMINED BY ANOVA FOLLOWED BY DUNNETT'S POST-TEST BETWEEN THE VEHICLE-TREATED 
GROUP AND DIELDRIN-TREATED GROUP (*P<0.05 AND **P<0.01). 
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Figure 2: Dieldrin-induced cytochrome c release in N27 cells. 
N27 CELLS (5 X 106 CELLS) WERE EXPOSED TO 100 OR 300 PM DIELDRIN FOR 15-30 MIN. 
MITOCHONDRIA-FREE CYTOSOLIC FRACTION WAS COLLECTED AS DESCRIBED IN "MATERIALS AND 
METHODS", AND CYTOSOLIC CYTOCHROME C WAS MEASURED USING ELISA CYTOCHROME C ASSAY. 
DATA REPRESENT THE MEAN ± SEM FOR THREE SEPARATE EXPERIMENTS PERFORMED IN TRIPLICATE. 
*P<0.05 OR **P<0.01 COMPARED WITH VEHICLE-TREATED GROUP IN EACH TIME POINT. 
217 
40000 
•J c 30000 
O ® CO +z 
TO 2 
Ô 20000-
! E 
<8 3 
^ £ 10000 
Control Vehicle 30 100 300 
dieldrin (^M) 
Figure 3: Dieldrin-induced caspase-3 activity in N27 cells. 
N27 CELLS (2 X 106 CELLS/ML) WERE EXPOSED TO 30-300 DIELDRIN FOR 3 HR AT 37°C, 
AND CASPASE-3 ACTIVITY WAS MEASURED USING CASPASE-3 SPECIFIC SUBSTRATE, AC-DEVD-
AMC AS DESCRIBED UNDER "MATERIALS AND METHODS." THE DATA ARE EXPRESSED AS 
FLUORESCENT UNIT (FU) PER MG PROTEIN PER HR OF INCUBATION. EACH POINT REPRESENTS MEAN ± 
SEM FROM TWO SEPARATE EXPERIMENTS IN TRIPLICATE. *P<0.05 OR **P<0.01 COMPARED WITH 
VEHICLE-TREATED CELLS. 
Figure 4: Proteolytic cleavage of PKCô following dieldrin treatment in N27 cells. 
(A) N27 CELLS (~1 X 107 CELLS) WERE EXPOSED TO 100 PM OR 300 PM DIELDRIN FOR 3 HR AT 
37°C, AND CYTOSOLIC PROTEINS WERE COLLECTED AS DESCRIBED UNDER "MATERIALS AND 
METHODS." APPROXIMATELY 5 JAG OF CYTOSOLIC PROTEINS WERE RESOLVED BY 10% 
SDS-PAGE AND DETERMINED NATIVE PKCÔ (72 KDA), CATALYTIC SUBUNIT (41 KDA) AND 
REGULATORY SUBUNIT (38 KDA) OF PROTEOLYTICALLY CLEAVED PKCÔ. (B) N27 CELLS WERE 
PRETREATED WITH CASPASE-3 SPECIFIC INHIBITOR, Z-DEVD-FMK (50 PM), FOR 30 MIN, THEN 
EXPOSED TO 100 |IM DIELDRIN FOR ANOTHER 3 HR. THE EQUAL PROTEIN LOADING WAS CONFIRMED 
BY REPROBING WITH (3-ACTIN (43 KDA). (C) BRAIN SLICES (300 PM) FROM SPRAGUE DAWLEY 
MALE RATS WERE TREATED WITH 30-100 PM DIELDRIN FOR 3 HR. CYTOSOLIC FRACTION WAS 
COLLECTED, AND PROTEINS WERE RESOLVED BY 10% SDS-PAGE. NATIVE PKCÔ (72 KDA) AND 
PROTEOLYTICALLY CLEAVED PKCÔ (38-41 KDA) WERE DETECTED USING PKCÔ ANTIBODY (SANTA 
CRUZ BIOTECHNOLOGY). 
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Figure 5: Dieldrin-induced apoptosis in N27 cells. 
N27 CELLS (~1 X 106 CELLS/ML) WERE TREATED WITH 100 PM DIELDRIN FOR 3 HR, AND 
APOPTOTIC CELLS WERE DETECTED BY FLOW CYTOMETRY AS DESCRIBED IN "MATERIALS AND 
METHODS." BY THE DUAL STAINING OF CELLS WITH ANNEXIN-V-FITC AND PROPIDIUM IODIDE, 
DETECTED CELLS WERE DIVIDED INTO FOUR REGIONS (A, B, C, AND D). REGION A IS APOPTOTIC 
CELLS, B IS APOPTOTIC AND NECROTIC CELLS, C IS LIVE OR HEALTHY CELLS, AND D IS NECROTIC CELLS. 
EXPERIMENT WAS REPEATED THREE TIMES AND DATA REPRESENT THE AVERAGE OF EACH REGION. 
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Figure 6: The role of PKCô in dieldrin-induced DNA fragmentation and nuclear 
condensation in N27 cells. 
N27 CELLS WERE PRETREATED WITH 1-3 PM ROTTLERIN FOR 30 MIN THEN TREATED WITH 100 
PM DIELDRIN FOR ANOTHER 3 HR. (A) DNA FRAGMENTATION WAS QUANTITATIVELY MEASURED BY 
ELISA DNA FRAGMENTATION ASSAY KIT. EACH BAR REPRESENTS MEAN ± SEM FOR TWO SEPARATE 
EXPERIMENTS IN TRIPLICATE. **P<0.01 COMPARED WITH DIELDRIN-TREATED GROUP. (B) 
CHROMATIN CONDENSATION WAS OBSERVED USING HOECHST 33342 STAINING. THE PERCENTAGE OF 
NUCLEAR CONDENSATION WAS CALCULATED BY COUNTING POSITIVE CELLS IN THREE TO FIVE RANDOMLY 
SELECTED REGIONS. THE EXPERIMENT WAS REPEATED THREE TIMES, AND SIMILAR RESULTS WERE 
OBTAINED. 
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Figure 7: The role of PKCô in dieldrin-induced DNA fragmentation and nuclear 
condensation in N27 cells. 
VECTOR-TRANSFECTED N27 CELLS AND PKCÔK376R-TRANSFECTED N27 CELLS WERE EXPOSED 
TO DIELDRIN FOR 3 HR. DNA WAS EXTRACTED AND DNA FRAGMENTATION WAS MEASURED USING 
ELISA DNA FRAGMENTATION ASSAY KIT AS DESCRIBED IN "MATERIALS AND METHODS." EACH BAR 
REPRESENTS MEAN ± SEM. *P<0.05 OR **P<0.01 COMPARED WITH VEHICLE-TREATED CELLS OR 
BETWEEN INDICATED GROUPS. (B) PKCÔK376R-TRANSFECTED N27 CELLS WERE TREATED WITH 100 
|IM DIELDRIN FOR 3 HR, AND NUCLEI WERE STAINED USING 10 PG/ML HOECHST 33342. THE 
PERCENTAGE OF CHROMATIN CONDENSATION WAS CALCULATED BY COUNTING POSITIVE CELLS IN THREE 
TO FIVE RANDOMLY SELECTED REGIONS. THE EXPERIMENT WAS REPEATED THREE TIMES, AND SIMILAR 
RESULTS WERE OBTAINED. 
223 
CHAPTER VI: ROLE OF PROTEIN KINASE C8 AND BCL-2 IN 
CASPASE-3-DEPENDENT APOPTOSIS DURING MANGANESE EXPOSURE 
IN DOPAMINERGIC CELLS 
A PAPER TO BE SUBMITTED FOR PUBLICATION IN PROCEEDINGS OF NATIONAL ACADEMY OF SCIENCES 
MASASHI KITAZAWA, VELLAREDDY ANANTHARAM, YOKO HIRATA, AND ANUMANTHA G. 
KANTHASAMY 
ABSTRACT 
CHRONIC INORGANIC MANGANESE EXPOSURE CAUSES SELECTIVE TOXICITY TO THE 
NIGROSTRIATAL DOPAMINERGIC SYSTEM RESULTING IN A PARKINSONIAN-LIKE NEUROLOGICAL CONDITION 
KNOWN AS MANGANISM. HOWEVER, THE MECHANISMS UNDERLYING MANGANESE-INDUCED 
DOPAMINERGIC CELL DEATH ARE NOT WELL CHARACTERIZED. HEREIN, WE EXAMINED THE 
MANGANESE-INDUCED APOPTOTIC CELL DEATH PROCESS IN TWO CELL CULTURE MODELS OF 
PARKINSON'S DISEASE, PC 12 CELLS AND MESENCEPHALIC DOPAMINERGIC NEURONAL CELLS. 
CHRONIC EXPOSURE OF PC 12 CELLS TO MANGANESE INDUCED A SEQUENTIAL ACTIVATION OF 
MITOCHONDRIAL DEPENDENT PRO-APOPTOTIC EVENTS INCLUDING MITOCHONDRIAL MEMBRANE 
DEPOLARIZATION, CYTOCHROME C RELEASE, CASPASE-3 ACTIVATION, AND DNA FRAGMENTATION. 
OVEREXPRESSION OF BCL-2 IN PC 12 CELLS REMARKABLY ATTENUATED MANGANESE-INDUCED 
MITOCHONDRIAL MEMBRANE DEPOLARIZATION, CYTOCHROME C RELEASE, CASPASE-3 ACTIVITY, AND 
DNA FRAGMENTATION, INDICATING THAT THE MITOCHONDRIAL DEPENDENT APOPTOTIC CASCADE 
CONTRIBUTES TO MANGANESE-INDUCED APOPTOSIS. FURTHERMORE, WE IDENTIFIED THAT PROTEIN 
KINASE CÔ (PKCÔ) IS AN IMPORTANT DOWNSTREAM CELLULAR TARGET OF CASPASE-3, WHICH 
PROTEOLYTICALLY CLEAVES THE KINASE TO CAUSE PERSISTENT ACTIVATION. THE 
MANGANESE-INDUCED PROTEOLYTIC CLEAVAGE OF PKCÔ WAS ALSO SIGNIFICANTLY BLOCKED BY 
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BCL-2 OVEREXPRESSION. ADMINISTRATION OF ACTIVE RECOMBINANT PKCÔ INDUCED DNA 
FRAGMENTATION IN PC 12 CELLS, SUGGESTING AN IMPORTANT ROLE OF PKCÔ IN APOPTOTIC CELL 
DEATH. WE ALSO EVALUATED THE ROLE OF PKCÔ IN DOPAMINERGIC NEURONAL CELLS (N27 CELLS) 
EXPRESSING A CATALYTICALLY INACTIVE PKCÔK376R PROTEIN (PKCÔ DOMINANT NEGATIVE MUTANT) 
AFTER MANGANESE EXPOSURE. DNA FRAGMENTATION WAS SIGNIFICANTLY REDUCED IN 
N27PKCÔK376R CELLS AS COMPARED TO FRAGMENTATION IN VECTOR-TRANSFECTED CELLS FOLLOWING 
MANGANESE TREATMENT. TOGETHER, THESE RESULTS SUGGEST THAT THE MITOCHONDRIAL DEPENDENT 
APOPTOTIC CASCADE MEDIATES APOPTOSIS VIA PROTEOLYTIC ACTIVATION OF PKCÔ IN 
MANGANESE-INDUCED DOPAMINERGIC TOXICITY. 
Key Words: MANGANESE, BCL-2, CASPASE-3, MITOCHONDRIA, ENVIRONMENTAL FACTORS, 
PARKINSON'S DISEASE. 
INTRODUCTION 
CHRONIC EXPOSURE TO HIGH LEVELS OF MANGANESE IS KNOWN TO CAUSE NEUROLOGICAL 
SYMPTOMS SIMILAR TO IDIOPATHIC PARKINSON'S DISEASE (PD) IN BOTH HUMANS AND LABORATORY 
ANIMALS (1). THE HALLMARK OF IDIOPATHIC PD IS THE SELECTIVE DEGENERATION OF 
DOPAMINERGIC NEURONS IN THE SUBSTANTIA NIGRA PARS COMPACTA, RESULTING IN DEBILITATING 
MOTOR IMPAIRMENT. MANGANESE EXPOSURE IS ASSOCIATED WITH MANY OCCUPATIONS SUCH AS 
MINING, AUTOMOBILE GARAGE MAINTENANCE, DRY CELL BATTERY MANUFACTURING, AND AGRICULTURAL 
APPLICATION OF MANGANESE CONTAINING PESTICIDES (MANEB) (2). HOWEVER, THE MANGANESE 
CONTAINING ORGANIC COMPOUND METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL (MMT), 
USED AS AN ANTI-KNOCKING AGENT IN GASOLINE AND EMITTED AS INORGANIC MANGANESE UPON 
COMBUSTION (3, 4), WAS RECENTLY LEGALIZED IN THE U.S.. CONSEQUENTLY, EXPOSURE TO 
MANGANESE IS LIKELY TO INCREASE. MANGANESE INDUCES A VARIETY OF CELLULAR CHANGES 
INCLUDING DOPAMINE DEPLETION, IMPAIRMENT OF THE ANTIOXIDANT SYSTEM, AND INCREASED 
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OXIDATIVE STRESS (1, 5). 
APOPTOSIS IS RECOGNIZED AS A MAJOR CELL DEATH PROCESS IN NEURODEGENERATIVE 
DISORDERS INCLUDING PARKINSON'S DISEASE (6, 7). MANGANESE INDUCED APOPTOSIS IN HUMAN 
B CELLS (8) AND IN RAT PHEOCHROMOCYTOMA (PC 12) CELLS (9, 10). IN ADDITION, MANGANESE 
ENHANCES OXIDATIVE STRESS-MEDIATED L-DOPA TOXICITY, INDICATING THAT MANGANESE IS A 
POTENT DOPAMINERGIC NEUROTOXICANT (11). THE MITOCHONDRION IS ONE OF THE IMPORTANT 
CELLULAR TARGETS IN MANGANESE-INDUCED APOPTOTIC CELL DEATH IN DOPAMINERGIC CELLS (12-14). 
THE BCL-2 FAMILY PROTEINS HAVE CENTRAL REGULATORY ROLES IN MITOCHONDRIAL DEPENDENT 
APOPTOTIC CELL DEATH (15). OVEREXPRESSION OF BCL-2 PROTEINS ATTENUATES APOPTOSIS 
INDUCED BY VARIOUS CHEMICALS (8, 16, 17), DEMONSTRATING THE IMPORTANT ANTI-APOPTOTIC 
FUNCTION OF BCL-2 PROTEINS. 
THE DOWNSTREAM TARGETS OF ACTIVATED CASPASE-3 IN MANGANESE-INDUCED APOPTOSIS 
THAT RESULT IN DNA FRAGMENTATION ARE NOT WELL CHARACTERIZED. IN THE PRESENT STUDY, WE 
EXAMINED THE SEQUENTIAL ACTIVATION OF APOPTOTIC SIGNALING MOLECULES IN TWO DOPAMINERGIC 
CELL MODELS, PHEOCHROMOCYTOMA (PC 12) CELLS (18, 19) AND IMMORTALIZED RAT 
MESENCEPHALIC DOPAMINERGIC NEURONAL (N27) CELLS (20, 21). HEREIN, WE DEMONSTRATE 
THAT MANGANESE ACTIVATES PRIMARILY THE MITOCHONDRIAL-DEPENDENT APOPTOTIC CASCADE IN 
DOPAMINERGIC CELLS, AND THAT PROTEOLYTIC CLEAVAGE OF PROTEIN KINASE CÔ (PKCÔ) BY 
CASPASE-3 IS KEY IN THE MEDIATION OF APOPTOTIC CELL DEATH. 
MATERIALS AND METHODS 
Chemicals 
MANGANESE CHLORIDE, MOUSE MONOCLONAL (3-ACTIN ANTIBODY, PROPIDIUM IODIDE, 
AND HUMAN RECOMBINANT ACTIVE PKCÔ PROTEIN WERE PURCHASED FROM SIGMA CHEMICAL CO. 
(ST. LOUIS, MO). PHORBOL-12-MYRISTATE-13-ACETATE (TPA) WAS PURCHASED FROM 
CALBIOCHEM (LA JOLLA, CA). THE CASPASE-3 SUBSTRATE AC-DEVD-AMC WAS PURCHASED 
FROM BACHEM BIOSCIENCES INC. (KING OF PRUSSIA, PA). THE CASPASE-9 SUBSTRATE 
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AC-LEHD-AMC AND THE CASPASE-3 INHIBITOR Z-DEVD-FMK WERE PURCHASED FROM 
ALEXIS BIOCHEMICALS (SAN DIEGO, CA). THE CASPASE INHIBITOR Z-VAD-FMK WAS 
PURCHASED FROM ENZYME SYSTEMS PRODUCTS (LIVERMORE, CA). ACRIDINE ORANGE WAS 
PURCHASED FROM MOLECULAR PROBES (EUGENE, OR). RABBIT POLYCLONAL ANTI-NPKCÔ 
ANTIBODY AND MOUSE MONOCLONAL BCL-2 ANTIBODY WERE PURCHASED FROM SANTA CRUZ 
BIOTECHNOLOGY, INC. (SANTA CRUZ, CA). THE ECL WESTERN BLOTTING ANALYSIS KIT WAS 
PURCHASED FROM AMERSHAM PHARMACIA BIOTECH, INC. (PISCATAWAY, NJ). THE CYTOCHROME 
C ELISA KIT WAS OBTAINED FROM MBL INTERNATIONAL CORP. (WATERTOWN, MA). THE CELL 
DEATH DETECTION ELISA PLUS ASSAY KIT WAS PURCHASED FROM ROCHE MOLECULAR 
BIOCHEMICALS (INDIANAPOLIS, IN). THE CYTOTOXICITY DETECTION KIT WAS PURCHASED FROM 
ROCHE (MANNHEIM, GERMANY). BIOPORTER WAS PURCHASED FROM GENE THERAPY 
SYSTEMS (SAN DIEGO, CA). DULBECCO'S MODIFIED EAGLE MEDIUM (DMEM) WAS 
PURCHASED FROM MEDIATECH, INC. (HERNDON, VA). HEAT INACTIVATED HORSE SERUM AND FETAL 
BOVINE SERUM WERE PURCHASED FROM GIBCO BRL PRODUCTS (GAITHERSBURG, MD). OTHER 
ROUTINE LABORATORY CHEMICALS WERE OBTAINED FROM FISHER SCIENTIFIC (PITTSBURGH, PA). 
THE BCL-2-TRANSFECTED PC 12 CELLS (PC12HB2-3) AND VECTOR-TRANSFECTED PC 12 CELLS 
(PC12V4) WERE GENEROUS GIFTS FROM DRS. YUTAKA EGUCHI AND YOSHIHIDE TSUJIMOTO, OSAKA 
UNIVERSITY (OSAKA, JAPAN). THE IMMORTALIZED RAT MESENCEPHALIC (IRB3AN27 OR N27) 
CELL LINE WAS A KIND GIFT FROM DR. KEDAR N. PRASAD, UNIVERSITY OF COLORADO HEALTH 
SCIENCES CENTER (DENVER, CO). PLASMIDS PKCÔK376R-GFP FUSION PROTEIN AND 
PEGFP-NL WERE KIND GIFTS FROM DR. STUART H. YUSPA, NATIONAL CANCER INSTITUTE 
(BETHESDA, MD). 
Cell culture 
PC12V4 AND PC12HB2-3 CELLS WERE GROWN IN DULBECCO'S MODIFIED EAGLE'S 
MEDIUM (DMEM) WITH 7% HEAT-INACTIVATED HORSE SERUM AND 4% FETAL BOVINE SERUM. 
THE IMMORTALIZED RAT MESENCEPHALIC CELL LINE (N27 CELLS) WAS GROWN IN RPMI-1640 
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MEDIUM CONTAINING 10% FETAL BOVINE SERUM, 2 MM L-GLUTAMINE, 50 UNITS PENICILLIN, AND 
50 P,G/ML STREPTOMYCIN. BOTH CELL LINES WERE INCUBATED AT 37°C IN A HUMIDIFIED 
ATMOSPHERE CONTAINING 5% CO2. 
3-(4,5-dimethylthiazol-3-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay 
THE MTT ASSAY IS ANOTHER METHOD USED TO ASSESS CYTOTOXICITY (9, 22). N27 
CELLS (-10,000 CELLS/WELL) WERE PLATED ONTO A 96-WELL PLATE FOR 24 HR AND TREATED WITH 
VARIOUS CONCENTRATIONS OF MNCL2 FOR 24 HR. AFTER THE TREATMENTS, CELLS WERE WASHED 
ONCE AND THEN INCUBATED IN SERUM-FREE MEDIUM CONTAINING 0.25 MG/ML MTT FOR 3 HR AT 
37°C. SUPEMATANTS WERE REMOVED AND MTT CRYSTALS WERE SOLUBILIZED WITH ACIDIC 
ISOPROPANOL. THE CYTOTOXICITY INDEX WAS MEASURED BY SPECTROPHOTOMETRY AT 570 NM 
WITH THE REFERENCE WAVELENGTH AT 630 NM, AS DESCRIBED PREVIOUSLY (18). 
Cytochrome c detection assay 
MANGANESE-INDUCED CYTOCHROME C RELEASE WAS MEASURED USING A CYTOCHROME C 
ELISA KIT FOLLOWING THE STEP-BY-STEP PROCEDURE AS DESCRIBED IN THE MANUFACTURER'S 
PROTOCOL. BRIEFLY, PC 12 CELLS (~5 X 106 CELLS) WERE EXPOSED TO 1 MM MNCLZ, 
CYTOPLASMIC FRACTIONS WERE COLLECTED AS DESCRIBED PREVIOUSLY, AND LEVELS OF CYTOSOLIC 
CYTOCHROME C WERE ANALYZED BY AN ELISA METHOD (23). THE OPTICAL DENSITY OF EACH 
WELL WAS THEN MEASURED AT 450 NM USING A MICROPLATE READER (MOLECULAR DEVICES CORP., 
SUNNYVALE, CA). THE CONCENTRATION OF CYTOCHROME C WAS CALIBRATED FROM A STANDARD 
CURVE BASED ON REFERENCE STANDARDS. 
Mitochondrial membrane potential detection assay 
MITOCHONDRIAL MEMBRANE POTENTIAL(AYM) DEPOLARIZATION WAS ASSESSED USING A 
BECTON DICKINSON FACSCAN FLOW CYTOMETER (BECTON DICKINSON, SAN FRANCISCO, CA) (24). 
PC 12 CELLS (~1 X 106 CELLS) WERE EXPOSED TO 1 MM MNCL; FOR UP TO 40 HR, AND 40 NM 
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3,3' -DEHEXYLOXACARBOCYANINE (DIOCE) WAS ADDED FOR 15 MIN. THE CELLS WERE THEN 
WASHED ONCE AND RESUSPENDED WITH PHOSPHATE BUFFERED SALINE (PBS), AND AYM WAS 
MEASURED BY FLOW CYTOMETRY WITH EXCITATION AT 484 NM AND EMISSION AT 501 NM. 
MEASUREMENT WAS COMPLETED WHEN 10,000 CELLS WERE ANALYZED. 
Caspase-3 activity assay 
CELLS (-1-2 X 105 CELLS/WELL) WERE SUBCULTURED IN A 24-WELL TISSUE CULTURE PLATE 
FOR 24 HR AND TREATED WITH MNCL% FOR 0 TO 48 HR. CELLS WERE WASHED ONCE WITH PBS (PH 
7.4) AND RESUSPENDED IN LYSIS BUFFER CONTAINING 50 MM TRIS/HCL (PH 7.4), 1 MM EDTA, 
10 MM EGTA, AND 10 JAM DIGITONIN. CELLS WERE THEN INCUBATED AT 37°C FOR 20 MIN TO 
ALLOW COMPLETE LYSIS. LYSATES WERE QUICKLY CENTRIFUGED AT 10,000 X G, AND CELL-FREE 
SUPERNATANTS WERE COLLECTED. CASPASE-3 ACTIVITY WAS MEASURED USING THE CASPASE-3 
SPECIFIC FLUORESCENT SUBSTRATE AC-DEVD-AMC, AS DESCRIBED PREVIOUSLY (23, 25). 
FORMATION OF 7-AMINO-4-METHYLCOUMARINE (AMC), RESULTING FROM CASPASE SUBSTRATE 
CLEAVAGE, WAS MEASURED BY SPECTROFLUOROMETRY (MOLECULAR DEVICES, SUNNYVALE, CA) 
WITH EXCITATION AT 380 NM (SLIT WIDTH 10 NM) AND EMISSION AT 460 NM (SLIT WIDTH 20 NM). 
CASPASE ACTIVITY WAS EXPRESSED AS FLUORESCENCE UNIT (FU) PER MG PROTEIN PER HR. 
Isolation of cytosolic fractions 
CELLS (~1 X 107 CELLS) WERE EXPOSED TO MNCL] AT 37°C FOR THE INDICATED PERIODS. 
CELLS WERE WASHED ONCE WITH ICE-COLD PBS AND RESUSPENDED IN HOMOGENIZATION BUFFER 
CONTAINING 20 MM TRIS/HCL (PH 8.0), 2 MM EDTA, 10 MM EGTA, 2 MM DITHIOTHREITOL 
(DTT), 1 MM PHENYLMETHYLSULFONYL FLUORIDE, 25 PG/ML APROTININ, 10 PG/ML LEUPEPTIN, 5 
MM SODIUM FLUORIDE, AND 50 PM SODIUM ORTHOVANADATE. CELLS WERE THEN SONICATED FOR 
10 SEC AND CENTRIFUGED AT 100,000 X G FOR 60 MIN AT 4°C TO PRODUCE THE SUPERNATANT 
CYTOSOLIC FRACTIONS. TO COLLECT MEMBRANE FRACTIONS, PELLETS WERE DISSOLVED IN 
HOMOGENIZATION BUFFER CONTAINING 1% TRITON X-100 TO FORM SUSPENSIONS AND THEN 
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SONICATED AND CENTRIFUGED AT 10,000 X G FOR 30 MIN. THE PROTEIN CONCENTRATION OF EACH 
CYTOSOLIC FRACTION WAS DETERMINED USING A BRADFORD PROTEIN ASSAY DYE REAGENT (BIO-RAD 
LABORATORIES, HERCULES, CA). CYTOSOLIC FRACTION SAMPLES WERE MIXED WITH 2X GEL 
LOADING BUFFER CONTAINING 10% SDS AND 200 MM DTT AND PLACED IN BOILING WATER FOR 5 
MIN. 
Western blotting 
PROTEINS IN CYTOSOLIC FRACTIONS WERE RESOLVED BY 10% SDS-POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE) AND BLOTTED ONTO NITROCELLULOSE MEMBRANE (BIO-RAD 
LABORATORIES). NON-SPECIFIC BINDING SITES WERE BLOCKED BY 5% NON-FAT MILK BLOCKING 
SOLUTION (AMERSHAM PHARMACIA BIOTECH). THE MEMBRANE WAS THEN TREATED WITH 
ANTI-PKCÔ (1:2000 DILUTION) ANTIBODY, FOLLOWED BY SECONDARY HORSERADISH 
PEROXIDASE-CONJUGATED ANTI-RABBIT (1:2000 DILUTION) ANTIBODY. ANTIBODY-BOUND PROTEINS 
WERE DETECTED BY AN ENHANCED CHEMILUMINESCENCE (ECL) SYSTEM. TO CONFIRM EQUAL 
PROTEIN IN EACH LANE, ANTIBODIES WERE STRIPPED FROM MEMBRANES WITH STRIPPING BUFFER 
(GENO TECHNOLOGY, ST. LOUIS, MO) AND REPROBED WITH P-ACTIN (1:5000 DILUTION). 
In situ apoptotic labeling 
ACRIDINE ORANGE AND PROPIDIUM IODIDE DOUBLE STAINING WAS PERFORMED TO ASSESS 
DNA DAMAGE IN APOPTOTIC CELLS (26). PC 12 CELLS WERE GROWN ON COVER SLIPS COATED 
WITH TYPE I RAT TAIL COLLAGEN (6 |J,G/CM2) FOR 24 HR AT 37°C, AND MNCL^ WAS ADDED FOR THE 
INDICATED PERIODS. AFTER THE EXPOSURES, CELLS WERE WASHED ONCE WITH PBS AND STAINED 
WITH 5 JAM ACRIDINE ORANGE AND 5 |_IM PROPIDIUM IODIDE FOR 10 MIN OR 10 PM HOECHST 
33342 FOR 5 MIN AT ROOM TEMPERATURE IN THE DARK. THE CELLS WERE WASHED ONCE WITH 
PBS AND MOUNTED ON A PERFUSION CHAMBER WITH HBSS BUFFER AND OBSERVED UNDER A 
NIKON DIAPHOT MICROSCOPE (NIKON INC., MELVILLE, NY) WITH THE EXCITATION WAVELENGTH AT 
360 NM, 488 NM, OR 540 NM FOR HOECHST 33342, ACRIDINE ORANGE, OR PROPIDIUM IODIDE, 
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RESPECTIVELY. FLUORESCENT IMAGES WERE CAPTURED WITH A SPOT DIGITAL CAMERA. 
DNA fragmentation assay 
DNA FRAGMENTATION WAS MEASURED USING A CELL DEATH DETECTION ELISA PLUS 
ASSAY KIT, AS DESCRIBED PREVIOUSLY (23, 27). CELLS (~1 X 106 CELLS) WERE SUBCULTURED IN 
6-WEIL CULTURE PLATES FOR 24 HR AND EXPOSED TO MNCL% WITH OR WITHOUT VARIOUS INHIBITORS 
FOR THE INDICATED PERIODS AT 37°C. THE NUMBER OF APOPTOTIC PC 12 CELLS WAS DETERMINED 
EXACTLY AS DESCRIBED BY THE MANUFACTURER, AND DNA FRAGMENTATION WAS EXPRESSED AS A 
PERCENTAGE OF CONTROL. 
In vitro delivery of catalytically active PKCô 
PC12V4 CELLS (-1-2 X 105 CELLS/WELL) WERE SUBCULTURED IN 24-WELL TISSUE CULTURE 
PLATES FOR 24 HR. HUMAN RECOMBINANT CATALYTICALLY ACTIVE PKCÔ PROTEIN WAS DELIVERED 
INTO CELLS USING BIOPORTER REAGENT, STRICTLY FOLLOWING THE MANUFACTURER'S PROTOCOL. 
BRIEFLY, CELLS WERE INCUBATED FOR 4 HR WITH 5 NG OF RECOMBINANT PKCÔ OR HEAT-INACTIVATED 
RECOMBINANT PKCÔ (15 MIN IN BOILING WATER) WITH 3 PI BIOPORTER REAGENT IN 
SERUM-FREE DMEM. CELLS WERE COUNTED AND EQUAL NUMBERS OF CELLS WERE ANALYZED BY 
DNA FRAGMENTATION ASSAY AS DESCRIBED ABOVE. 
Data analysis and statistics 
DATA FROM MTT, CASPASE ACTIVITY, CYTOCHROME C RELEASE AND DNA FRAGMENTATION 
ASSAYS WERE FIRST ANALYZED USING ONE-WAY ANOVA. DUNNETT'S POST-TEST OR BONFFERONI'S 
MULTIPLE COMPARISON TEST WAS THEN PERFORMED TO COMPARE TREATED SAMPLES, AND P<0.05 
WAS CONSIDERED SIGNIFICANT. 
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RESULTS 
Dose- and time-dependent manganese-induced cytotoxicity in vector PC 12 cells 
(PC12V4) and Bcl-2 overexpressing PC12 cells (PC12HB2-3) 
First, we performed a dose-response cytotoxicity study to determine the optimal 
manganese concentrations for additional mechanistic studies in PC12V4 (vector control) 
and PC12HB2-3 (Bcl-2-overexpressing) cells. As shown in Figure 1, exposure to 
various doses of manganese (0-1 mM) over 72 hr produced dose-dependent cytotoxicity 
in both PC12V4 and PC12HB2-3 cells. However, manganese (over 400 pM) induced 
significantly less toxicity in Bcl-2 overexpressing cells (p<0.01) as compared to the 
vector control cells. We found that 1 mM manganese produced approximately 50% 
cell death in PC12HB2-3 cells and 75% cell death in PC12V4 cells at 72 hr. We also 
found that 1 mM manganese showed time-dependent increase in cell death, and did not 
significantly cause necrotic cell death at earlier time point (measured by LDH assay; 
data not shown). Therefore, we used 1 mM manganese in subsequent experiments 
evaluating the cellular mechanism of dopaminergic cell death during manganese 
exposure at up to 48 hr. 
Manganese affects mitochondrial function and releases pro-apoptotic cytochrome c 
Manganese reportedly accumulates in mitochondria and inhibits mitochondrial 
Complex I and/or II activity (14, 28, 29). We examined the effect of manganese on 
mitochondrial functions and found that the mitochondrial membrane potential (AYm) 
was significantly (p<0.05) depolarized in a time-dependent manner following 1 mM 
manganese treatment in PC12V4 cells (Fig. 2A). The significant depolarization of 
AYm was detected after 24 hr and continued up to 40 hr. Bcl-2 overexpression 
effectively suppressed and delayed the manganese-induced depolarization of AYm. 
Mitochondrial insults often result in release of cytochrome c into cytoplasm to 
initiate the apoptotic caspase cascade. As shown in Figure 2B, manganese caused 
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significant (p<0.05) release of cytochrome c in the cytosol at 28 hr post-exposure, the 
time point just proceeding the significant AYm depolarization. However, cytosolic 
cytochrome c levels were not significantly increased in PC12HB2-3 cells, indicating that 
Bcl-2 overexpression protects against manganese toxicity at the mitochondrial level. 
Manganese induces the caspase-3 cascade in PC 12 cells 
Since cytochrome c release is known to initiate the caspase cascade following 
binding to apoptosis activating factor-1 (Apaf-1), the next series of experiments was 
designed to examine whether or not manganese exposure induces the effector caspase-3 
in dopaminergic cells. Exposure of PC12V4 cells to manganese (ImM) 
time-dependently increased caspase-3 activity 1.3- to 4.3-fold above basal levels at 24 to 
48 hr post-exposure, but not earlier than 24 hr (Fig. 3A). Thus, the caspase-dependent 
cell death process was initiated between 24 and 28 hr after manganese exposure, when 
depolarization of AYm and cytochrome c release occurred. We also found that the 
manganese-induced caspase-3 activation between 28-48 hr was significantly suppressed 
(p<0.05) in cells overexpressing Bcl-2; To determine if caspase-3 activation was 
mediated by initiator caspase-9, we evaluated the effect of the caspase-9 specific 
inhibitor Z-LEHD-FMK. As shown in Figure 3B, pretreatment with Z-LEHD-FMK 
(50 jaM or 100 pM) dose-dependently inhibited manganese-induced caspase activity, 
indicating that manganese-induced caspase-3 activation is mainly dependent on 
caspase-9. Capase-8, another initiator caspase linked to receptor-mediated apoptosis, 
could not be measured during the entire manganese exposure (data not shown). 
Manganese-induced proteolytic cleavage of PKCÔ 
We recently showed that PKCô is an important substrate for caspase-3, which 
proteolytically cleaves and activates the kinase to promote apoptosis in dopaminergic 
cells (23, 30). We monitored PKCô proteolytic cleavage every 4 hr for 48 hr following 
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manganese (ImM) treatment in both PC12V4 and PC12HB2-3 cells. As shown in 
Figure 4A, the native PKCô (74 kDa) was proteolytically cleaved into a catalytically 
active fragment (41 kDa) starting 24 hr post-exposure to manganese in PC12V4 cells. 
The PKCô cleavage increased in a time-dependent manner over a 48 hr period, and 
slight cleavage was noted at the 48 hr time point. The temporal pattern (time course) of 
PKCô cleavage paralleled caspase-3 activation. In PC12HB2-3 cells, the proteolytic 
cleavage of PKCô was not detected at all during the entire 48 hr manganese exposure 
period (Fig. 4B), indicating that Bcl-2 can suppress the caspase-mediated apoptotic cell 
death process. 
To confirm that manganese-induced proteolytic cleavage of PKCô was 
caspase-mediated, we treated PC12V4 cells with the pan caspase inhibitor Z-VAD-FMK 
and the caspase-3 specific inhibitor Z-DEVD-FMK along with manganese. 
Pretreatment with Z-VAD-FMK (50-100 pM) or Z-DEVD-FMK (50-100 pM) 
significantly inhibited manganese-induced proteolytic cleavage of PKCô in a 
dose-dependent manner, suggesting that the manganese-induced proteolytic activation of 
PKCô was caspase-3-dependent (Fig. 4C and 4D). Manganese treatment did not induce 
translocation of PKCô to the membrane, which is a common mechanism of PKCô 
activation, in either PC12V4 or PC12HB2-3 cells (data not shown). Therefore, the 
increased PKCô activity during manganese exposure was mainly through a 
caspase-mediated proteolytic activation mechanism. 
To further characterize capase-3 activation and proteolytic cleavage of PKCô 
following manganese treatment, we performed dose-response studies in PC12V4 cells 
following exposure to various doses (0-600 pM) of manganese over a 72 hr period. As 
shown in Figure 5A, caspase-3 activity dose-dependently increased up to 4-fold 
following a 72-hr manganese treatment in PC12V4 cells, but not in PC12HB2-3 cells; 
these findings agree with the cytotoxicity data shown in Figure 1. In addition, 
manganese (400-600 pM) induced the proteolytic cleavage of PKCô in a dose- and 
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time-dependent manner, indicating that the proteolytic cleavage of PKCô may be an 
obligatory event in the apoptotic cell death process during chronic manganese exposure. 
Manganese-induced DNA fragmentation in PC 12 cells 
We examined the effect of Bcl-2 on manganese-induced DNA fragmentation, 
the final stage of the apoptotic cell death process. DNA fragmentation was detected in 
PC12V4 cells as early as 24 hr after exposure to 1 mM manganese, and it increased 
time-dependently by 8-, 15-, and 21-fold at 24, 36, and 48 hr, respectively (Fig. 6A). 
DNA fragmentation was dramatically attenuated at all time points in manganese-treated 
PC12HB2-3 cells, indicating that Bcl-2 can rescue dopaminergic cells from apoptotic 
cell death during manganese exposure. 
We further confirmed manganese-induced apoptotic cell death using acridine 
orange/propidium iodide double staining or Hoechst 33342 nuclear staining. Both 
acridine orange and Hoechst 33342 are used to detect chromatin integrity, which is an 
index of apoptosis (26), and propidium iodide detects cells undergoing necrosis or the 
late stage of apoptosis or necrosis. As shown in Figure 6B, apoptotic cell death 
increased from 24 hr of manganese (1 mM) exposure in PC12V4 cells, and necrosis 
followed at the later time point. However, membrane integrity was normal in 
PC12HB2-3 cells and very few of the cells were apoptotic during the entire 48 hr of 
manganese exposure. Taken together, Bcl-2 overexpression protected against both 
necrosis and apoptosis following manganese exposure. 
We next examined the effect of caspase inhibitors on DNA fragmentation 
during manganese treatment. In Figure 6C, manganese-induced DNA fragmentation 
was significantly (p<0.01) suppressed by pretreatment with 100 pM Z-VAD-FMK, a 
potent caspase inhibitor, at 24- and 36-hr post-exposure in PC12V4 cells. This 
concentration of Z-VAD-FMK completely blocked manganese-induced caspase-3 
activity at 36 hr (data not shown). In addition, 100 pM Z-DEVD-FMK also 
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significantly (p<0.01) attenuated manganese-induced DNA fragmentation at 36 hr, 
although not as effectively as Z-VAD-FMK. The caspase inhibitors alone did not 
significantly alter basal DNA fragmentation levels during the entire experimental period 
(data not shown). 
Pro-apoptotic role of PKCÔ in dopaminergic cells 
The next series of experiments was designed to examine whether PKCô 
activation plays any role in manganese-induced apoptosis. Chronic treatment with low 
dose TPA down-regulates PKCs (31, 32). PC12V4 cells were treated with 0.2 pM TPA 
for 24 hr to down-regulate PKC proteins, and cells were then exposed to manganese (1 
mM) for 24 to 36 hr. As shown in Figure 7A, 24 hr of TPA treatment resulted in a 
prolonged down-regulation of PKCô for more than 72 hr. Other PKC isoforms except 
PKCÇ, an atypical PKC class, were also down-regulated in the same manner (data not 
shown). We found that these PKC-deficient dopaminergic cells are significantly 
(p<0.01) more resistant to manganese-induced DNA fragmentation as compared to 
control cells (Fig. 7B). Although we recognized that TPA down-regulates most of the 
PKC isoforms, this initial experiment in PKC-deficient cells provided support that PKCs 
are important in manganese-induced apoptosis. 
To further determine the specific role of PKCô in apoptosis in dopaminergic 
cells, we delivered the active recombinant PKCô protein into cells and then monitored 
DNA fragmentation. We recently demonstrated, along with others, that various 
biologically active proteins including enzymes can be delivered into cells using a new 
lipid mediated protein delivery system known as BioPORTER (23, 33). Human 
recombinant PKCô was administered (5 ng) to cells by the BioPORTER system. The 
delivery effectiveness of BioPORTER was determined using FITC-labeled antibody 
(supplied by kit), and treated cells were observed under a fluorescence microscope (30). 
In our previous study, we confirmed the biological activity of the recombinant PKCô 
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administered to cells (34). As shown in Figure 7C, DNA fragmentation was increased 
2.5-fold in active recombinant PKCô-delivered cells over the BioPORTER reagent 
treated (control) cells, whereas DNA fragmentation was increased only slightly in 
heat-inactivated PKCô protein-administered cells. Thus, catalytically active PKCô 
plays an important role in the execution of apoptotic cell death. 
Protein kinase Cô is a critical effector of manganese-induced apoptosis 
Since PKCô displayed pro-apoptotic functions in PC 12 cells, we further 
characterized the role of PKCô in neuronal apoptosis during manganese exposure in 
mesencephalic dopaminergic neuronal (N27) cells. We found that this clonal 
dopaminergic neuronal cell line was more susceptible to manganese toxicity than PC 12 
cells. Exposure of N27 cells to various concentrations (0-1000 pM) of manganese 
produced dose-dependent cytotoxicity (Fig. 8A). The LC50, or death in 50% of the 
cells, following 24 hr of manganese treatment was calculated to be 345 pM based on the 
cell viability data. We thus selected two concentrations (100 and 300 pM) for the 
following experiments to clarify the role of PKCô in manganese-induced apoptosis. 
Treatment of N27 cells with 300 pM manganese for 24 hr induced profound proteolytic 
cleavage of PKCô (Fig. SB), indicating that manganese activated similar or identical 
apoptotic mechanisms in N27 cells as in PC 12 cells. 
To determine if PKCô activation is important in manganese toxicity in 
dopaminergic neuronal cells, we examined the effect of the specific PKCô inhibitor 
rottlerin on manganese-induced DNA fragmentation. Rottlerin concentrations between 
1-5 pM effectively inhibit PKCô activity, as determined by in vitro measurement of 
phosphorylation (23, 35). N27 cells were pretreated with rottlerin (1-5 pM) for 30 min 
prior to manganese (300 pM) treatment for an additional 24 hr. Manganese-induced 
DNA fragmentation was significantly (pO.Ol) reduced to 65% and 46% in N27 cells 
pretreated with 3 and 5 |iM rottlerin, respectively (Fig. 8C). 
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To further substantiate the pro-apoptotic function of PKCô in 
manganese-induced apoptotic cell death in dopaminergic neuronal cells, we adopted a 
genetic approach to determine if overexpression of a kinase inactive PKCô mutant 
(dominant negative) suppresses manganese-induced DNA fragmentation. Catalytically 
inactive PKCô (PKCÔK376R) fused with GFP was stably transfected in N27 cells. 
Previously, we showed loss of the kinase activity in PKCÔk376R overexpressing N27 cells 
(N27-PKCÔK376r) as compared to the vector (pEGFP-Nl) transfected control 
(N27-vector) (30), thereby confirming the dominant negative property of these 
dopaminergic neuronal cells. As shown in Figure 9A, N27-PKCÔK376r cells underwent 
significantly (p<0.01) less DNA fragmentation for 24 hr as compared to N27-vector cells 
following manganese exposure (100-300 pM). To determine if upstream apoptotic 
events were altered by the overexpression of mutant PKCô, we also measured caspase-3 
activity in N27-PKCÔK376R following manganese treatment. As shown in Figure 9B, 
caspase-3, however, did not significantly differ between N27-vector and N27PKCÔK376R 
cells, indicating that reduction of DNA fragmentation was due to inactivation of PKCô 
kinase activity. In conclusion, PKCô is a critical effector molecule in 
manganese-induced apoptosis in dopaminergic neuronal cells. 
DISCUSSION 
Manganese primarily targets the nigrostriatal dopaminergic system in the CNS; 
however, the cellular mechanisms underlying manganese-induced cell death are not well 
characterized. The present study demonstrates that (i) manganese induces apoptotic 
cell death in dopaminergic cells, and mesencephalic dopaminergic neuronal cells are 
highly sensitive to the neurotoxic effect; (ii) manganese depolarizes the mitochondrial 
membrane potential to promote the release of the initial pro-apoptotic factor cytochrome 
c; iii) manganese activates the caspase-3 dependent apoptotic cascade; iv) mitochondrial 
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anti-apoptotic protein Bcl-2 negatively modulates the manganese-induced apoptotic 
cascade; and v) caspase-3 dependent proteolytic activation of PKC6 is a critical 
downstream contributor to apoptotic cell death in dopaminergic neuronal cells. 
Furthermore, these findings indicate that mitochondria promote the manganese-induced 
apoptotic cell death process via sequential activation of the apoptotic signaling pathway 
depicted in Figure 10. 
Manganese has been reported to accumulate in mitochondria and inhibit 
mitochondrial complex I activity (28, 36, 37). Reactive oxygen species (ROS) are 
generated upon mitochondrial inhibition. In a recent study, manganese increased ROS 
generation in isolated mitochondrial fractions from mouse brain (38). Recently, we 
demonstrated that ROS plays a causal role in apoptotic cell death following exposure to 
the organic manganese compound methylcyclopentadienyl manganese tricarbonyl 
(MMT) (39). ROS in a dopamine rich environment contribute to oxidative stress by 
forming dopamine derived quinone radicals (40, 41). Therefore, the increased 
susceptibility of dopaminergic neurons to manganese-induced neurotoxic insult can be 
attributed to the enhanced sensitivity of dopaminergic neurons to oxidative stress. 
Although we did not measure ROS generation in the present study, the observed 
mitochondrial membrane depolarization indicates the possible involvement of oxidative 
insult in manganese-induced neurotoxicity. 
Mitochondrial membrane depolarization results in the rapid release of the 
pro-apoptotic factor cytochrome c into cytoplasm to initiate the caspase cascade. Our 
result is consistent with other recent reports of caspase-3 activation observed during 
manganese toxicity in various in vitro models (10, 42, 43). However, Oubrahim et al. 
(2001) reported that manganese-induced caspase-3 activation and apoptosis in HeLa 
cells (derived from human epithelial adenocarcinoma) were not mediated by 
mitochondria because manganese did not alter the mitochondrial membrane potential 
(AlFm). Mitochondria from cancer cells appear to be resistant to manganese toxicity. 
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Another study by Roth et al. (2000) concluded that manganese-induced apoptosis is a 
caspase-independent process because the caspase inhibitor Z-VAD-FMK failed to 
attenuate manganese-induced cell death in PC12 cells at 24 hr (10). Since the 
investigators did not measure DNA fragmentation directly, the functional role of 
caspase-3 in the apoptotic process is difficult to ascertain. Also, they examined the 
effect of Z-VAD-FMK on manganese toxicity only up to 24 hr, and apoptosis could have 
occurred at a later time point. Our data show that caspase-3 activation starts to rise at 
24 hr and peaks around 36 hr, whereas maximal DNA fragmentation occurs around 
36-48 hr manganese post-treatment. Thus, the mode of the manganese-induced cell 
death process appears to be specific to cell type and time-dependent. Nevertheless, our 
data clearly demonstrate that chronic manganese exposure targets mitochondria and 
activates caspase-dependent apoptosis in dopaminergic neuronal cells, which are known 
to be selectively affected in manganese-induced neurotoxicity. Furthermore, 
attenuation of manganese-induced depolarization of AYm, cytochrome c release, 
caspase-3 activation, and apoptosis by the mitochondrial anti-apoptotic protein Bcl-2 
indicates that mitochondria may serve as an initial regulator of manganese-induced 
apoptosis in dopaminergic cells. Furthermore, recent evidences strongly suggest that 
manganese may affect endoplasmic reticulum (ER) and induce caspase-12-dependent 
apoptotic cascade (42, 44). Manganese may target multiple organelles and promotes 
cell death. 
Caspase-dependent apoptosis has been reported in dopaminergic degeneration 
resulting from exposure to various dopaminergic neurotoxins (including MPP+) 
treatment (23, 30, 34, 45, 46) as well as in brains of PD patients (47). However, the 
key downstream events that contribute to DNA fragmentation are not well characterized. 
One significant finding of the current study is identification of PKCô proteolytic 
activation upon manganese exposure. PKCô belongs to the novel isoform family of 
PKCs and is activated in a Ca2+ independent manner. Traditionally, PKCs have been 
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considered to have anti-apoptotic functions, but PKCô is emerging as a key 
pro-apoptotic factor. Lipid-dependent translocation and proteolytic activation are two 
major activation mechanisms of PKCô (27, 48-50). Recently, we demonstrated that 
PKCô proteolytic activation mediates apoptotic cell death in dopaminergic cells 
following exposure to environmental neurotoxic chemicals (23, 30). In these studies as 
well as in the present study, PKCô was not activated by translocation, indicating that 
proteolytic activation is the primary mode of activation in dopaminergic cells. 
Induction of DNA fragmentation by delivery of the catalytically active PKCô protein 
and attenuation of manganese-induced DNA fragmentation by pharmacological and 
genetic modulation of PKCô clearly show that PKCô is a key downstream substrate of 
caspase-3. The cellular substrates of PKCô that specifically mediate apoptotic cell 
death have not yet been defined. However, several signaling molecules such as DNA 
protein kinase (DNA-PK), MAP-kinase, scrambalase, and NF-kappa transcription factor 
have been proposed to function in apoptosis (51-54). Previously, Hirata et al. (1998) 
reported activation of the JNK pathway by phosphorylation of a serine-threonine kinase 
in PC 12 cells (9). 
In conclusion, chronic manganese exposure in dopaminergic cells induces 
caspase-3-dependent PKCô activity, and the active PKCô may contribute to downstream 
apoptotic events, including DNA fragmentation. Further identification of critical 
cellular targets of PKCô important in apoptotic cell death in dopaminergic cells 
following manganese exposure may provide insight into manganese-induced 
dopaminergic degeneration. 
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Fig. 1. Manganese-induced cytotoxicity in PC 12 cells 
PC12V4 and PC12HB2-3 cells were treated with 200-1000 |_iM manganese for 72 hr, 
and cytotoxicity was determined using trypan blue exclusion by counting live vs. dead 
(stained) cells in three to five randomly selected fields. Each point represents mean ± 
SEM for two separate experiments in triplicate. **p<0.01 compared between cells in 
the same manganese treatment groups. 
246 
PC12V4 PC12HB2-3 
Oh ImM Mn 
24h ImM Mn 
40h ImM Mn 
II 
m ==i 
E S o 90 
•=1^  
I f  -g 80 Q 
75 
-PC12V4 
PC12HB2-3 
B 
0) 250-
S 
2 =5 200H 
S e  E S O 150 
sr 
5 
100 
50 
12 18 24 30 36 42 
Time (hr) 
]PC12V4 
IPC12HB2-3 
i n1 m III 
12 18 24 28 
Time (hr) 
32 
Fig. 2. Effect of manganese on mitochondrial function and cytochrome c release 
(A) Both PC12V4 and PC12HB2-3 cells (~1 x 106 cells/ml) were exposed to 1 mM 
manganese for 0-40 hr, then mitochondrial membrane potential (A^Pm) was measured by 
using DiOCe (40 nM). Histogram is the representative data for depolarization of A4Jm 
at 0, 24, and 40 hr. The graph represents the reduction of Af m as percent of control. 
Each point represents mean ± SEM for two separate experiments in triplicate. *p<0.05 
or **p<0.01 compared with 0 hr treatment (control) group in each cell line. (B) 
Release of cytochrome c into cytosol was detected using a cytochrome c ELISA kit. 
Each bar represents mean ± SEM for two separate experiments in triplicate. *p<0.05 or 
**p<0.01 compared with 0 hr treatment group in each cell line. 
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Fig. 3. Manganese-induced caspase-3 activity in PC12V4 and PC12HB2-3 cells 
(A) Both PC12V4 and PC12HB2-3 cells were treated with 1 mM manganese for 0-48 hr. 
Cytosolic supematants were collected and caspase-3 activity was measured by 
incubating the supernatant with 50 ^M Ac-DEVD-AMC, a fluorogenic caspase-3 
substrate, for 1 hr at 37°C, and expressed as fluorescent unit (FU) per mg protein per hr 
incubation. Each point represents mean ± SEM for at least three separate experiments 
in triplicate. **p<0.01 compared with control. (B) PC12V4 cells were pretreated 
with 50-100 jj,M of the caspase-9 specific inhibitor Z-LEHD-FMK for 30 min and 
exposed to 1 mM manganese for 28 hr. Caspase-3 activity was measured as described 
above. Each bar represents mean ± SEM for at least two separate experiments in 
triplicate. #p<0.01 compared with control and *p<0.05 or **p<0.01 compared with 1 
mM manganese treated group. 
Fig. 4. Manganese induced proteolytic cleavage of PKC6 in PC 12 cells 
PC12V4 or PC12HB2-3 cells (1 x 107 cells) were treated with 1 mM manganese for 
0-48 hr. Cytosolic fractions were collected, and equal amounts of proteins were 
resolved in 10% SDS-PAGE followed by polyclonal PKCô antibody. Time-course 
study of PKCÔ in PC12V4 cells (A) or PC12HB2-3 cells (B). Native PKCô appears at 
72-74 kDa and the cleaved, catalytically active PKCô appears at around 41 kDa. (E 
and F) PC12V4 cells were treated with 1 mM manganese with or without 50-100 pM 
Z-VAD-FMK, a pan-caspase inhibitor (C) or 50-100 |J,M Z-DEVD-FMK, a caspase-3 
specific inhibitor (D). The cells were pretreated with the caspase inhibitors for 30 min 
prior to the treatment with 1 mM manganese for 36 hr. Cytosolic fractions were 
isolated and proteins were resolved in 10% SDS-PAGE. Native PKCô (72-74 kDa) and 
cleaved PKCô (38-41 kDa) were detected. Equal protein loading (5 |ag) was confirmed 
by re-probing with (3-actin. 
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Fig. 5. Caspase-3 activation and proteolytic cleavage of PKCS induced by chronic 
low-dose manganese exposure in PC 12 cells 
(A) Chronic exposure (72 hr) to lower doses of manganese dose-dependently increased 
caspase-3 activity in PC12V4 cells. Cells were treated with 200, 400, or 600 pM 
manganese for 72 hr and caspase-3 activity was measured. Each bar represents mean ± 
SEM for two separate experiments performed in triplicate; *p<0.05 or **p<0.01 
compared with each control group. (D) Chronic exposure (48-96 hr) to lower doses of 
manganese also induced the proteolytic cleavage of PKCô in PC12V4 cells. After the 
treatment, cytosolic fractions were isolated and proteins were resolved in 10% 
SDS-PAGE. Native PKCô (72-74 kDa) and cleaved PKCô (38-41 kDa) were detected. 
Equal protein loading (5 pg) was confirmed by re-probing with |3-actin. 
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Fig. 6. Manganese-induced apoptosis in PC 12 cells 
(A) Apoptotic cell death was determined by measuring DNA fragmentation. Cells were 
treated with 1 mM manganese for 0-48 hr, and the level of DNA fragmentation was analyzed 
using a DNA ELISA assay kit. Each bar represents mean ± SEM for three separate 
experiments in duplicate. **p<0.01 compared with control (0 hr) or between PC12V4 and 
PC12HB2-3 cells. (B) Qualitative detection of manganese-induced apoptosis. Cells were 
plated on collagen-coated cover slips and exposed to 1 mM manganese for 0-48 hr. Cells 
were then stained with 5 pg/ml acridine orange and 5 pg/ml propidium iodide or 10 pg/ml 
Hoechst 33342, and observed under a fluorescence microscope. Arrows indicate cells 
undergoing apoptosis. (C) PC12V4 cells were exposed to 1 mM manganese with or without 
100 pM Z-VAD-FMK, a pan-caspase inhibitor, or 100 pM Z-DEVD-FMK, a caspase-3 
specific inhibitor, for 24 or 36 hr. DNA fragmentation was determined using a DNA ELISA 
assay kit. Each bar represents mean ± SEM for two separate experiments in duplicate. 
**p<0.01 compared with 1 mM manganese-treated cells. 
Fig. 7. The catalytically active PKCô protein plays a critical role in the execution of 
DNA fragmentation 
(A) PC12V4 cells were treated with 0.2 pM TPA for 24 to 72 hr, and down-regulation of 
PKCô was determined by Western blot. (B) PC12V4 cells were treated with 0.2 pM 
TPA for 24 hr, exposed to 1 mM manganese for 24 or 36 hr, and DNA fragmentation was 
measured by ELISA assay. Each bar represents mean ± SEM for two separate 
experiments in triplicate. *p<0.01 compared with control group and **p<0.01 
compared with 1 mM manganese-treated PC12V4 cells without TPA pretreatment. (C) 
PC12V4 cells were treated with 10 pi BioPORTER reagent and 5 ng of human PKCô 
catalytically active protein in serum-free DMEM for 4 hr to successfully deliver active 
PKCô protein into the cells. For comparison, 5 ng of heat-inactivated PKCô protein 
(15 min in boiling water) or solvent (PBS) was delivered with the BioPORTER reagent. 
After the 4 hr treatment, equal numbers of cells were collected and processed to 
determine DNA fragmentation levels using a DNA ELISA assay kit. DNA 
fragmentation was expressed as percent control (10 pi BioPORTER reagent + PBS). 
Each bar represents mean ± SEM for two separate experiments in triplicate. *p<0.05 or 
**p<0.01 compared between indicated treatment groups. 
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Fig. 8. Effect of manganese on mesencephalic dopaminergic (N27) neuronal cells 
(A) Cell viability following manganese treatment for 24 hr in N27 cells was assessed 
using an MTT assay. The data were plotted against logarithmic doses of manganese, 
and the EC50 was calculated by three-parameter nonlinear regression analysis. Each 
point represents mean ± SEM for two separate experiments in triplicate. (B) N27 cells 
were treated with 100 or 300 |_iM manganese for 24 hr, and proteolytic cleavage of 
PKCô was determined by Western blot. Equal protein loading (5 jag) was confirmed by 
reprobing with P-actin. (C) N27 cells were pretreated with the PKCô specific inhibitor 
rottlerin (1-5 (iM) for 30 min prior to 300 (iM manganese treatment for 24 hr. DNA 
fragmentation was assayed using a DNA ELISA assay kit. Each bar represents mean ± 
SEM for two separate experiments in triplicate. **p<0.01 compared with 
manganese-treated cells. 
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Fig. 9. Proapoptotic role of PKCô in manganese-induced apoptosis in N27 cells 
Catalytically inactive PKCÔK376r and its vector were stably transfected in N27 cells. 
Cells were exposed to 100-300 ]uM manganese for 24 hr and DNA fragmentation was 
assayed using a DNA ELISA kit (A), or caspase-3 activity was measured using the 
colorimetric substrate Ac-DEVD-pNA (B). Each bar represents mean ± SEM for two 
separate experiments performed in triplicate. *p<0.05 or **p<0.01 compared with 
control or between vector- and PKC8K376R-transfected cells. 
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Fig. 10. Schematic diagram of manganese-induced apoptotic pathway in dopaminergic 
cells 
Based on our present findings, we propose the following apoptotic cell signaling 
pathway during manganese exposure in dopaminergic neuronal cells. Manganese 
treatment depolarizes the mitochondrial membrane potential to induce cytochrome c 
release, which subsequently promotes activation of caspase-3. Activated caspase-3 
proteolytically cleaves PKCô to promote the downstream execution process of apoptosis. 
Mitochondrial Bcl-2 overexpression, pharmacological caspase inhibition 
(Z-LEHD-FMK, Z-DEVD-FMK, and Z-VAD-FMK), or genetic modulation of PKCô 
activity significantly attenuates the manganese-induced apoptotic process. 
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CHAPTER VII: MITOCHONDRIAL TRANSLOCATION OF PROTEIN 
KINASE CÔ INACTIVATES BCL-2 BY PROTEOLYTIC DEGRADATION 
DURING ENVIRONMENTAL NEUROTOXIC INSULT IN DOPAMINERGIC 
CELLS 
A paper to be submitted for publication in Journal of Neurochemistry 
Masashi Kitazawa and Anumantha G. Kanthasamy 
ABSTRACT 
Previously, we demonstrated that exposures to environmental neurotoxic agents 
such as MPP+, dieldrin, and methylcyclopentadienyl manganese tricarbonyl (MMT) 
induce proteolytic activation of protein kinase Cô (PKCô) via a caspase-3-dependent 
pathway in dopaminergic cells. We further characterized that PKCÔ activation not only 
mediates apoptosis but also regulates the upstream caspase cascade through positive 
feedback activation. Herein, we have investigated the pro-apoptotic role of PKCô in 
the upstream caspase cascade following dieldrin or MMT treatment in dopaminergic 
PC12 cells. Following acute exposure to dieldrin (100 pM) or MMT (200 |_iM), native 
PKCô rapidly translocated into mitochondria within 1 hr, resulting in release of key 
mitochondrial pro-apoptotic molecules including cytochrome c and second 
mitochondrial activation of caspases (Smac). The PKCÔ specific inhibitor rottlerin 
blocked cytochrome c release without affecting PKCô translocation, indicating that 
PKCô kinase effects on mitochondria are important in initiating the apoptotic cascade. 
Additionally, we examined the regulatory effect of catalytically active recombinant 
PKCô on mitochondria. Delivery of active recombinant PKCô into dopaminergic cells 
induced depolarization of mitochondrial membrane potential, cytochrome c release, and 
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caspase-9 activation in dopaminergic cells, further confirming that PKCô is an important 
regulator of mitochondrial pro-apoptotic function. Immunoprecipitation analyses 
revealed that PKCô associated with Bcl-2 and caspase-3 during dieldrin or MMT 
exposure, and an in vitro phosphorylation assay indicated that PKCô phosphorylated 
Bcl-2, possibly resulting in the loss of Bcl-2 anti-apoptotic function. Interestingly, 
Bcl-2 was proteolytically cleaved in PC 12 cells 3 hr after dieldrin or MMT treatment, 
and the cleavage was blocked by PKCô and a caspase-3 inhibitor. Together, our results 
suggest that mitochondrial translocation of PKCô is an important pro-apoptotic event 
that promotes proteolytic inactivation of Bcl-2 by caspase-3 during the environmental 
chemical-induced dopaminergic degenerative process. 
Keywords: mitochondria, Smac, caspase-3, phosphorylation, dieldrin, MMT 
INTRODUCTION 
Recent reports indicate that both environmental and genetic components are 
important in the pathogenesis of Parkinson's disease (Polymeropoulos et al. 1997; 
Kruger et al. 1998; Tanner et al. 1999; Lim et al. 2002). A recent landmark 
epidemiology study by Tanner et al (1999) suggests that genetic factors may be 
important in the young-onset PD (YOPD) but not in the major form of late-onset 
sporadic PD. In support of environmental hypothesis in the sporadic PD, several 
epidemiological and case control studies show that pesticides and heavy metals are 
dominant chemical risk factors of PD (Ho et al. 1989; Gorell et al. 1997; Liou et al. 
1997; Gorell et al. 1998). Exposure to certain pesticides and metal containing 
compounds has been shown to replicate some extent the behavioral, neurochemical and 
pathological futures of PD (Couper 1837; Sharma et al. 1976; Wagner and Greene 1978; 
Sechi et al. 1992). However, the cellular mechanism involved in dopaminergic 
degeneration process following environmental chemical exposure remains elusive. We 
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and others have shown that the mitochondria are important cell target of neurotoxic 
agents in inducing cell death process in dopaminergic cells (Choi et al. 1999; Stoessl 
1999; Kitazawa et al. 2002a; Kitazawa et al. 2002b). Despite apoptosis is recognized 
as a major mode of the cell death process in neurotoxin exposure, the event downstream 
of caspase-3 is not well characterized. 
Protein kinase C (PKC) family proteins are serine/threonine protein kinases and 
classified into three subgroups based on the activation mechanisms (Mellor and Parker 
1998; Musashi et al. 2000; Way et al. 2000:Nishizuka, 1988 #39). Conventional PKCs 
(PKCa, (31, [311, and y) are Ca2+ and phospholipids dependent isoforms whereas the 
activation of novel PKCs (PKCô, s, r\, and 0) is independent of intracellular Ca2+. The 
atypical isoforms (PKCÇ and À,/i) require neither Ca2+ nor lipid for their activation. 
Most of PKC isoforms are expressed in the central nervous system, and they have been 
known to play an important role in various physiological and pathological conditions 
including cell differentiation, proliferation, development, synaptic plasticity, epilepsy, 
ischemia and neurodegeneration (Dekker et al. 1989; Mailhos et al. 1994; Miettinen et al. 
1996; Newton 1997; Mellor and Parker 1998; Gschwendt 1999; Franklin and McCubrey 
2000; Naik et al. 2000). PKCô has recently been recognized as a pro-apoptotic kinase 
in non-neuronal cells during chemical induced apoptotic cell death (Reyland et al. 1999; 
Fujii et al. 2000; Majumder et al. 2000; Reyland et al. 2000). In this context, we have 
recently demonstrated that PKCô, in dopaminergic cells, is proteolytically cleaved and 
activated by caspase-3, which subsequently mediates apoptotic cell death in a known 
Parkinsonian toxin MPP+ induced apoptosis as well as other environmental chemicals 
that have been thought to be risk factors of PD namely dieldrin (a organochlorine 
pesticide) and MMT (methylcyclopentadienyl manganese tricarbonyl; an organic 
manganese compound) (Sanchez-Ramos et al. 1998; Anantharam et al. 2002; Kitazawa 
et al. 2002a; Kitazawa et al. 2002b). We also found that the toxin-induced PKCô 
activation amplifies upstream caspase cascade via positive feedback activation. 
The purpose of present study was to examine the cellular and molecular basis of 
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regulatory mechanism of PKCô at the level of mitochondria during environmental 
chemical-induced apoptosis in dopaminergic cells. Herein, we report that PKCô 
translocates to mitochondria and activates pro-apoptotic events including mitochondrial 
depolarization, cytochrome c release, caspase-9 and caspase-3 activation and 
inactivation of bcl2 by caspase-3 dependent proteolytic cleavage in dopaminergic cells 
following exposure dieldrin or MMT. 
MATERIALS AND METHODS 
Chemicals 
Mouse monoclonal p-actin antibody, human recombinant Bcl-2, active human 
recombinant caspase-3, and active human recombinant PKCô were purchased from 
Sigma Chemicals (St. Louis, MO). Phorbol-12-myristate-13-acetate (PMA) is 
purchased from Calbiochem (La Jolla, CA). The caspase-3 substrate Ac-DEVD-AMC 
was purchased from Bachem Biosciences, Inc. (King of Prussia, PA). The caspase-9 
substrate Ac-LEHD-AMC was purchased from Alexis Biochemicals (San Diego, CA). 
The caspase-3 inhibitor Z-DEVD-FMK was purchased from Enzyme Systems Products 
(Livermore, CA). Rabbit polyclonal nPKCô antibody, caspase-3 antibody, caspase-9 
antibody, and mouse monoclonal Bcl-2 antibody were purchased from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA). The ECL Western blotting analysis kit was 
purchased from Amersham Pharmacia Biotech, Inc. (Piscataway, NJ). The cytochrome 
c ELISA kit was obtained from MBL International Corp. (Watertown, MA). The Cell 
Death Detection Elisa Plus Assay Kit was purchased from Roche Molecular 
Biochemicals (Indianapolis, IN). BioPORTER was purchased from Gene Therapy 
Systems (San Diego, CA). 32P-ATP was purchased from NEN. Dulbecco's modified 
Eagle medium (DMEM) was purchased from Mediatech, Inc. (Hemdon, VA). 
Heat-inactivated horse serum and fetal bovine serum were purchased from Gibco BRL 
Products (Gaithersburg, MD). Other routine laboratory chemicals were obtained from 
Fisher Scientific (Pittsburgh, PA). BcI-2-transfected PC 12 cells (PC12HB2-3) and 
262 
vector-transfected PC12 cells (PC12V4) were generous gifts from Drs. Yutaka Eguchi 
and Yoshihide Tsujimoto, Osaka University (Osaka, Japan). 
Cell culture and treatment regiment 
PC12V4 (vector-transfected PC 12 cells) and PC12HB2-3 (Bcl-2-transfected 
PC 12 cells) cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 
7% heat-inactivated horse serum and 4% fetal bovine serum at 37°C in a humidified 
atmosphere containing 5% CO?. Subconfluent cells were used in experiments. Cells 
were resuspended in serum-free DMEM and dieldrin or MMT was added. The final 
concentration of DMSO (used as vehicle) was less than 0.5%. 
For PKCô delivery studies, cells were subcultured on 24-well culture plate at a 
density of 0.2 x 106 cells/well. After the cells were subconfluent, a mixture of 
BioPORTER reagent and human recombinant PKCô (5 ng) in serum-free DMEM was 
added, and the cells were incubated for 4 hr, as described previously (Anantharam et al. 
2002; Kitazawa et al. 2002a). After incubation, cells were used for following 
experiments. 
Determination of mitochondrial membrane potential 
Depolarization of mitochondrial membrane potential (AYm) was measured 
using flow cytometry and DiOC& (Kitazawa et al. 2002b). Briefly, 40 nM DiOCg was 
added to the cells 15 min before the end of treatment period, and the incubation 
continued at 37°C. Cells were then washed once, resuspended in PBS (pH 7.4), and 
analyzed by flow cytometry with excitation at 484 nm and emission at 501 nm. Data 
were analyzed by CellQuest software (Becton Dickinson, San Francisco, CA). 
Cytochrome c assay 
Cytosolic cytochrome c release was measured using a cytochrome c ELISA kit 
(MBL International Corp). We followed the procedure as described previously 
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(Anantharam et al. 2002; Kitazawa et al. 2002a). Briefly, cells were washed once with 
PBS (pH 7.4) and resuspended in homogenization buffer containing 10 mM Tris HC1 
(pH 7.5), 0.3 M sucrose, 1 mM phenylmethylsulfonyl fluoride, 25 pg/ml aprotinin, and 
10 pg/ml leupeptin. Cells were dounce homogenized and centrifuged. The resulting 
supernatants were collected as mitochondria-free cytoplasmic fractions. The 
cytoplasmic extracts were processed for cytochrome c detection as per the 
manufacturer's ELISA protocol. The absorbance was measured at 450 nm using a 
microplate reader (Molecular Devices Corp., Sunnyvale, CA). 
Caspase-9 activity assay 
Caspase-9 activity was determined by following the procedure previously 
described by our laboratory (Anantharam et al. 2002; Kitazawa et al. 2002a). After the 
delivery of PKCô, cells were washed once with PBS (pH 7.4) and resuspended in lysis 
buffer containing 50 mM Tris/HCl (pH 7.4), 1 mM EDTA, 10 mM EGTA, and 10 pM 
digitonin. Cells were then incubated at 37°C for 20 min to allow complete lysis. 
Lysates were quickly centrifuged, and cell-free supernatants were incubated with 50 pM 
of the caspase-9 substrate Ac-LEHD-AMC at 37°C for 1 hr. Caspase-9 activity was 
measured by spectrofluorometry (Molecular Devices) with excitation at 380 nm (slit 
width 10 nm) and emission at 460 nm (slit width 20 nm). The activity was expressed 
as fluorescence unit (FU) per mg protein per hr of incubation with substrate. Protein 
estimation was measured using the Bradford protein assay reagent (BioRad Laboratories, 
Hercules, CA). 
Subcellular fractionation 
Cells (~1 x 107 cells) were exposed to dieldrin at 37°C for the indicated periods. 
Cells were washed once with ice-cold PBS and resuspended in homogenization buffer 
containing 20 mM Tris/HCl (pH 8.0), 2 mM EDTA, 10 mM EGTA, 2 mM dithiothreitol 
(DTT), 1 mM phenylmethylsulfonyl fluoride, 25 pg/ml aprotinin, 10 pg/ml leupeptin, 5 
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mM sodium fluoride, and 50 pM sodium orthovanadate. Cells were kept on ice for 30 
min then homogenized using a Dounce homogenizer. Homogenates were centrifuged 
at 1,000 x g for 10 min at 4°C to isolate nuclei and unlysed cells. Supernatants were 
centrifuged at 10,000 xg for 15 min at 4°C to isolate the mitochondrial membrane rich 
fractions. The supernatants were further centrifuged at 100,000 x g for 60 min at 4°C 
to collect cytosolic fractions. The protein concentration of each cytosolic fraction was 
determined using a Bradford protein assay dye reagent (Bio-Rad Laboratories, Hercules, 
CA). Cytosolic fraction samples were mixed with 2x gel loading buffer containing 
10% SDS and 200 mM DTT and placed into boiling water for 5 min. 
Immunoprecipitation 
Each cell extract (500 pg/ml) was incubated with PKCS antibody or Bcl-2 
antibody (10 pi per 200 pi of sample) at 4°C overnight. After the incubation, 100 pi 
protein A-sepharose (for PKCô IP) or protein G-sepharose (for Bcl-2 IP) (Sigma 
Chemicals) was added to each sample and further incubated for 1-2 hr at 4 °C. Protein 
A- or protein G-bound antigen-antibody complex was collected and resuspended with 
homogenization buffer or kinase reaction buffer for immunoblotting or kinase activity 
assay, respectively. 
Immunoblotting 
Proteins in cytosolic fractions were resolved by 10% SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and blotted onto nitrocellulose membrane (Bio-Rad 
Laboratories). Non-specific binding sites were blocked by 5% non-fat milk blocking 
solution (Amersham Pharmacia Biotech); the membrane was then treated with 
anti-PKCô (1:2000 dilution) antibody, followed by secondary horseradish 
peroxidase-conjugated anti-rabbit (1:2000 dilution) antibody. Antibody-bound proteins 
were detected by the enhanced chemiluminescence (ECL) system. To confirm equal 
amount of protein in each lane, antibodies were stripped from membranes with stripping 
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buffer (Geno Technology, St. Louis, MO) and reprobed with (3-actin (1:5000 dilution) to 
confirm equal protein loading in each lane. 
In vitro PKCô kinase activity assay 
PKCô enzymatic activity was measured using an immunoprecipitation kinase 
assay as described by Reyland et al. (Reyland et al. 1999). The protein-A-bound 
antigen-antibody complexes collected by immunoprecipitation were washed three times 
with homogenization buffer, three times with 2x kinase buffer (40 mM Tris, pH 7.4, 20 
mM MgClz, 20 pM ATP, and 2.5 mM CaClz), and resuspended in 20 pi of 2x kinase 
buffer. Reaction was started by adding 20 pi of reaction buffer containing 10 pg 
histone Hi and 5 pCi of [y-32P]ATP (4,500 Ci/mM) to the immunoprecipitated samples 
and incubated for 10 min at 30°C. For detamination of Bcl-2 phosphorylation by 
PKCô, human recombinant Bcl-2 protein (3 pg) was used as a substrate instead of 
histone and reacted with purified PKCô from cell extracts. SDS gel loading buffer (2x) 
was added to terminate the reaction, the samples were boiled for 5 min, and the products 
were separated on a 12.5% SDS-PAGE gel. The HI phosphorylated bands were 
detected using a Personal Molecular Imager (FX model, Bio-Rad Laboratories) and 
quantified using Quantity One 4.2.0 software (Bio-Rad Laboratories). 
Data analysis and statistics 
Caspase activity and DNA fragmentation data were first analyzed using 
one-way ANOVA and then Dunnett's post-test or Bonfferoni's multiple comparison test 
was performed to compare differences between the treatment groups; p<0.05 or less was 
considered significant. 
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RESULTS 
PKCÔ translocation into mitochondria is an initial apoptotic signal in dieldrin- or 
MMT-induced apoptosis 
Previously, we demonstrated that dieldrin or MMT activates mitochondrial 
dependent apoptotic cascade involving cytochrome c release and caspase-9 and 
caspase-3 activation in dopaminergic cells (Anantharam et al. 2002; Kitazawa et al. 
2002a). We also found that PKCô is proteolytically activated by caspase-3 and then 
acts downstream in the apoptotic process and upstream to amplify caspase signaling 
through a possible feedback mechanism. In the present study, we found a significant 
level of native PKCô (72-74 kDa) translocated into mitochondria following dieldrin or 
MMT treatment in PC 12 cells (Figure 1A-B). The translocation of PKCô was rapid, 
starting as early as 0.5 hr after dieldrin (100 |oM) or MMT (200 pM) exposure, and 
maximal migration occurred 1-2 hr post exposure. Especially, the PKCô band intensity 
in mitochondrial membrane increased up to 217%, 213%, 707% and 749% at 0.5, 1, 2, 
and 3 hr following MMT treatment, respectively. The caspase-3-dependent 
proteolytically cleaved PKCô products (38-41 kDa) were observed in cytosol starting 1 
hr after the treatments, whereas noticeable translocation to mitochondria occurred 3 hr 
after dieldrin or MMT treatment, indicating that the translocation of native PKCÔ into 
mitochondria is the initial signaling event during dieldrin- or MMT-induced apoptosis, 
and may alter mitochondrial function. 
Mitochondrial translocation of PKCô promotes release of the mitochondrial 
proapoptotic factor cytochrome c 
In the next set of experiments, we examined the impact of PKCô translocation 
on mitochondrial function. Cytochrome c release from mitochondria is one of the early 
proapoptotic events known to trigger the caspase cascade, and we previously 
demonstrated increased cytosolic cytochrome c levels in PC 12 cells following both 
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dieldrin and MMT treatment (Anantharam et al. 2002; Kitazawa et al. 2002a). Since 
acute stimulation of cells with the synthetic lipid analog TPA is known to cause 
translocation of PKCô to mitochondria (Majumder et al. 2000), we compared the effect 
of TPA, dieldrin, or MMT on cytochrome c release. Stimulation of PC 12 cells with 1 
fj,M TPA for 30 min caused pronounced translocation of PKCÔ to mitochondria and 
increased the accumulation of cytochrome c in the cytosolic fraction (Figure 2A). 
Dieldrin treatment (100 pM) also increased the cytosolic cytochrome c levels as 
compared to untreated control cells. 
To further verify that translocation of PKCô into mitochondria mediates 
cytochrome c release, we generated PKCô-defïcient PC 12 cells by down-regulating the 
kinase. In contrast to acute TPA stimulation, chronic treatment with low-dose TPA (0.2 
pM for 24 hr) down-regulates endogenous PKC proteins (Morino et al. 2001). 
Previously, we showed that treatment with TPA (0.2 p,M) for 24 hr almost completely 
eliminated PKCô levels for over 72 hr (Chapter VI). As shown in Figure 2A, dieldrin 
treatment did not induce mitochondrial translocation of PKCô or cytochrome c 
accumulation in TPA-down-regulated PC 12 cells. 
To determine if PKCô kinase activity is required for the mitochondrial release 
of cytochrome c, we pretreated PC 12 cells with the PKCô specific inhibitor rottlerin (5 
|_iM) for 30 min, and then treated the cells with dieldrin or MMT for another 3 hr. We 
have shown that 5 pM rottlerin inhibits PKCô kinase activity by more than 60%, as 
determined in an in vitro 32P phosphorylation assay (Anantharam et al. 2002; Kitazawa 
et al. 2002a). As depicted in Figure 2B, pretreatment with rottlerin significantly 
inhibited dieldrin- or MMT-induced cytochrome c release without affecting PKCô 
translocation into mitochondria. These data strongly suggest the translocation and 
activation of PKCô are important in mediating cytochrome c release during dieldrin or 
MMT treatment. 
In addition to cytochrome c release, second mitochondrial activation of 
caspases (Smac), often referred to as DIABLO, is another proapoptotic molecule that 
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was released in a time-dependent manner from mitochondria following dieldrin or MMT 
treatment (Figure 2C). As shown in Figure 1C, release of Smac occurred immediately 
after PKCô translocation into mitochondria. 
Delivery of active recombinant PKCô alters mitochondrial function in 
dopaminergic cells 
PKCô regulation of mitochondrial function was also confirmed by delivering 
human recombinant PKCô using a lipid mediated protein delivery system. In our 
recent studies, we observed 60-70% delivery efficiency (Anantharam et al. 2002) and a 
dose-dependent increase in PKCô intracellular kinase activity (unpublished observation). 
In the present study, mitochondrial membrane potential (A%n), cytochrome c release 
(50%), and caspase-9 activity were measured in active PKCô-delivered PC 12 cells. As 
shown in Figures 3 A, 3B, and 3C, delivery of active human PKCô produced significant 
increases (p<0.01) in mitochondrial membrane depolarization, cytochrome c release, and 
caspase-9 activity. In comparison, these parameters were not significantly changed in 
cells delivered heat-inactivated recombinant PKCÔ, further supporting our finding that 
PKCô has an important proapoptotic role in mitochondrial function. 
Bcl-2 associates with PKCÔ during dieldrin- or MMT-induced apoptosis 
We sought to determine whether PKCÔ phosphorylates certain mitochondrial 
proteins and thereby alters mitochondrial function. Since phosphorylation of the major 
anti-apoptotic protein Bcl-2 inhibits activation of the proapoptotic process involving 
cytochrome c release (Haldar et al. 1995; Attalla et al. 1998; Tashiro et al. 1998; Fan et 
al. 2000; Torcia et al. 2001), we examined whether PKCô phosphorylates Bcl-2 to 
inactivate its anti-apoptotic effect. We treated Bcl-2 over-expressing PC 12 
(PC12HB2-3) cells with dieldrin (100 and 300 (J.M) pr MMT (100 and 200 JJ.M) for 3 hr 
and then performed immunoprecipitation studies in the cell lysates. PKCô was 
immunoprecipitated, and resulting samples were immunoblotted with Bcl-2. As shown 
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in Figure 4A, Bcl-2 levels were increased in PKCô-immunoprecipitated samples 
following both dieldrin and MMT treatments. To confirm the positive association 
between Bcl-2 and PKCô, we performed reverse immunoprecipitation studies in which 
samples were immunoprecipitated with Bcl-2 and then immunoblotted with PKCÔ. As 
shown in Figure 4B, Bcl-2 and PKCô were not associated in control or vehicle treated 
PC12HB2-3 cells, whereas PKCÔ was detected in dieldrin or MMT treated cells in a 
dose-dependent manner, further confirming the association between PKCô and Bcl-2. 
Bcl-2 (IP PKCô) or PKCô (IP Bcl-2) bands were not detected in vector-transfected PC 12 
(PC12V4) cells, confirming that the protein bands were specific for Bcl-2 and PKCô 
(Figure 4C). 
Since we observed PKCô translocation to mitochondria and its association with 
Bcl-2, the next logical step was to determine if PKCô phosphorylates Bcl-2. We 
evaluated Bcl-2 phosphorylation by PKCô using an in vitro kinase assay. Recombinant 
Bcl-2 was used as the substrate for PKCô in the kinase assay and the 32P-ATP reaction 
was carried out in the presence or absence of the PKCô inhibitor rottlerin (10 p,M). 
The phosphoimage showed phosphorylated Bcl-2 bands, indicating that PKCô 
phosphorylated the Bcl-2 protein (Figure 4D). Rottlerin significantly inhibited Bcl-2 
phosphorylation, suggesting that the phosphorylation of Bcl-2 was mediated by PKCô. 
Bcl-2 is proteolytically cleaved by caspase-3 during dieldrin- or MMT-induced 
apoptosis 
In our previous study, we found that PKCô contributes to the dramatic increase 
(40-60 fold) in caspase-3 levels via positive feedback activation during dieldrin or MMT 
treatment (Anantharam et al. 2002; Kitazawa et al. 2002a). Since the present study 
demonstrated an interaction between PKCÔ and Bcl-2, we further evaluated whether 
caspase-3 plays a role in the interaction. Immunoprecipitation of dieldrin or MMT 
treated cell lysates with PKCô antibody followed by caspase-3 immunoblotting showed 
that caspase-3 is associated with PKCô (Figure 5A). However, when 
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PKCô-immunoprecipitated samples were immunoblotted for caspase-9, PKCô and 
caspase-9 were not associated (data not shown). 
We further examined the functional consequence of PKCô, Bcl-2, and caspase-3 
interactions during dieldrin- or MMT-induced neurotoxicity. Amino acid sequence 
analysis using NIH database revealed a possible caspase-3 cleavage site (DAGD) in the 
Bcl-2 protein (Figure 5A). Also, recent studies have demonstrated that caspase-3 
cleaves Bcl-2 in non-neuronal cells (Liang et al. 2002). Therefore, we examined the 
proteolytic cleavage of Bcl-2 following dieldrin or MMT treatment in Bcl-2 
over-expressed PC 12 (PC12HB2-3) cells. After a 3 hr exposure period, Bcl-2 cleavage 
product (23 kDa) was observed in a dose-dependent manner (Figure 5B), whereas 
vehicle treated cells showed only native Bcl-2 protein (26 kDa). Pretreatment with the 
caspase-3 inhibitor Z-DEVD-FMK (50-100 |iM) almost completely inhibited Bcl-2 
cleavage, indicating that caspase-3 cleaves Bcl-2 (Figure 5C-D). Furthermore, 
pretreatment with the PKCô inhibitor rottlerin (5-10 jj.M) dose-dependently inhibited the 
Bcl-2 cleavage (Figure 5C-D), suggesting that PKCô may play an important role in the 
proteolytic cleavage of Bcl-2. Taken together with the Bcl-2 phosphorylation studies, 
the results suggest that phosphorylation of Bcl-2 by PKCô may be required for its 
proteolytic cleavage by caspase-3. 
DISCUSSION 
In our previous studies, we have demonstrated the caspase-3-dependent 
proteolytic activation of PKCô and the important pro-apoptotic function of PKCÔ in 
dieldrin- or MMT-induced dopaminergic cell death. We have discovered that inhibition 
of PKCô attenuated caspase-3 activity, indicating that PKCô might have positive 
association with caspase-3 activity. Our present study further investigated the 
regulatory role of PKCô in upstream apoptotic processes at the level of mitochondria, 
and the results demonstrate that dieldrin or MMT treatment in dopaminergic cells 
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activates PKCô that (i) rapidly translocates to mitochondria, (ii) subsequently promotes 
release of mitochondrial proapoptotic factors cytochrome c and smac, (iii) 
phosphorylates Bcl-2 and promotes cleavage by caspase-3. To our knowledge this is 
the first report that demonstrates an important regulatory proapoptotic function for 
PKCô in the mitochondria following exposure to environmental chemical exposure in 
dopaminergic cells. 
PKC activation normally has been shown to be anti-apoptotic role in various 
cell model, however, we and other recently demonstrated that activation of PKCô, a key 
member of novel PKC isoform family, promotes apoptosis in neuronal cells as well as 
non-neuronal cells (Chen et al., 1999; Li et al., 1999; Reyland et al., 1999; Cross et al., 
2000; Fukunaga et al., 2001; Majumder et al., 2001; Anantharam et al., 2002; 
Garcia-Fernandez et al., 2002; Kitazawa et al., 2002a). One of the proapoptotic action 
of PKCô is augmentation of mitochondrial mediated caspase cascade (Li et al., 1999; 
Majumder et al., 2001; Garcia-F ernandez et al., 2002), but cellular mechanisms 
underlying the positive regulation of the apoptotic signaling is not well characterized. 
Our results indicate that translocation of PKCô and subsequent release of proapoptotic 
factors by inactivating the major mitochondrial anti-apoptotic protein Bcl-2 via 
proteolytic cleavage by caspase-3. 
Mitochondrial membrane-associating Bcl-2 family proteins play an important 
role in apoptotic process. Pro-apoptotic Bcl-2 proteins include Bax, Bad, Hrk, Bim and 
Bid, and all possess Bel-3 homology (BH3) domain, which regulates the translocation to 
mitochondrial membranes (Strasser et al., 2000). Among them, Bad and Bax have been 
reported to be regulated by phosphorylation and dephosphorylation. For example, Akt 
and PKA are known to phosphorylate Bad at Ser 136 and Ser 112, respectively, and 
inactivate pro-apoptotic function of Bad by dissociating from mitochondrial membranes 
and interacting with 14-3-3 protein (Zha et al., 1996; Datta et al., 1997). On the other 
hand, anti-apoptotic Bcl-2 proteins including Bcl-2, Bcl-XL, and Bcl-w, are only found 
in mitochondrial membranes and prevent depolarization of A^Fm during apoptosis. 
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Potentiation of pro-apoptotic signaling mechanism through inactivation of 
anti-apoptotic function of Bcl-2 has been documented previously (Haldar et al., 1995; 
Attalla et al., 1998; Tashiro et al., 1998; Fan et al., 2000; Torcia et al., 2001). In cell 
extract, Bcl-2 are phosphorylated at serine residues, and Bcl-2 overexpressed cells did 
not prevent okadaic acid- or taxol-induced apoptosis, strongly suggesting 
phosphorylation of serine residues in Bcl-2 abolishes its anti-apoptotic property (Haldar 
et al., 1995). Further studies indicate that MAPK, especially c-Jun N-terminal kinase 
(JNK) phosphorylates and inactivates Bcl-2 during vinblastine-induced cell cycle arrest 
(Tashiro et al., 1998; Fan et al., 2000). On the other hand, the translocation of p38 
MAPK, not JNK, into mitochondria is responsible for phosphorylation of Bcl-2 during 
nerve growth factor deprivation-induced apoptosis in memory B cells (Torcia et al., 
2001). These reports convince the fact that apoptosis-related protein kinases play an 
important regulatory role in Bcl-2 function. Specifically, three amino acid residues 
(Ser70, Ser 87, and Thr69) in Bcl-2 were determined to be phosphorylated during 
paclitaxel-induced G2/M cell cycle arrest in Jurkat T cells, and resulted in inactivation of 
Bcl-2 (Yamamoto et al., 1999). They have identified that JNK was responsible for the 
phosphorylation of these three amino acid residues in Bcl-2. Srivastava et al. (1998) 
reported PKA primarily phosphorylates Ser70 of Bcl-2 during apoptotic process, further 
indicating the direct modulation of Bcl-2 anti-apoptotic function by phosphorylation 
during apoptosis (Srivastava et al., 1998). In addition, recently caspase-3-mediated 
Bcl-2 proteolytic cleavage and inactivation was observed in neocarzinostatin 
(NCS)-induced apoptosis in Bcl-2 overexpressed PC 12 cells (Liang et al., 2002), further 
indicating the enhancing effect of apoptosis by directly interfering Bcl-2 function. 
However, these reports did not describe detail mechanisms underlying the inactivation of 
Bcl-2 during apoptosis. 
Thus, we have hypothesized a novel mechanism of Bcl-2 inactivation and 
intiation/potentiation of apoptosis in dieldrin or MMT treatment as shown in Figure 6. 
Mitochondrial translocation of PKCô is one of the earliest signaling mechanisms, and 
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PKCô appears to phosphorylate Bcl-2 protein and inactivate its anti-apoptotic function 
following translocation. In addition, caspase-3 also cleaves Bcl-2 to further facilitate 
pro-apoptotic signaling processes. Our present data strongly suggest that Bcl-2 and 
PKCô associate together following dieldrin or MMT treatment, and PKCô plays an 
important role in modulating the anti-apoptotic function of Bcl-2 at earlier phase of 
dieldrin- or MMT-induced apoptosis in dopaminergic cells. 
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Figure 1 : Dieldrin- or MMT-induced translocation of PKCô into mitochondria and 
release of cytochrome c or Smac in PC12 cells. 
PC12V4 cells (~1 x 107 cells) were treated with 100 jaM dieldrin (A) or 200 pM MMT 
(B) for 0.5, 1, 2, and 3 hr. Mitochondrial fraction and cytosolic fraction were isolated 
and approximately 10 jag proteins per sample were resolved by 10% SDS-PAGE. 
Native PKCô and proteolytically activated PKCô are found in 72 kDa and 41 kDa, 
respectively. Reprobing the membranes with a-tubulin (50 kDa) and HSP60 (60 kDa) 
confirms purity of each subcellular fraction. (C) Cytosolic fractions were further used 
to determine the release of cytochrome c and/or Smac, major pro-apoptotic signaling 
molecules found in mitochondria. 17 kDa cytochrome c and/or 26 kDa Smac were 
detected time-dependently in dieldrin- or MMT-treated PC 12 cells, a-tubulin and 
HSP60 confirmed no contamination of mitochondrial fraction. 
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Figure 2: Down-regulation of PKCô attenuated dieldrin-induced cytochrome c 
release. 
(A) PC12V4 cells (~1 x 107 cells) were pretreated with 0.2 JJM TPA for 24 hr or with 50 
|o,M Z-DEVD-FMK for 30 min. The cells were then treated with 100 p,M dieldrin for 3 
hr, and mitochondrial fractions and cytosolic fractions were collected. Approximately 
10 pg proteins were resolved in 10% SDS-PAGE, and cytosolic cytochrome c (17 kDa) 
and mitochondrial PKCô (72 kDa) were detected. 1 |aM TPA treatment for 30 min was 
used as a positive control for mitochondrial translocation of PKCô and cytochrome c 
release, a-tubulin and HSP60 confirmed the purity of cytosolic fraction. (B) PC12V4 
cells (~1 x 107 cells) were pretreated with 5 JJ,M rottlerin for 30 min, then exposed to 100 
pM dieldrin or 200 pM MMT for 3 hr. After the completion of exposure, 
mitochondrial and cytosolic fractions were collected, and mitochondrial translocation of 
PKCô and cytosolic release of cytochrome c were measured by Western blot. 
282 
A 
B 
Jî 
111 80'  
• i l , , .  
<0 u CD -p d) s 100 
11» 
o _ 
60 
i i Bioporter reagent 
Heat-inactivated PKCô 
• Active PKC8 
o 8 150 
P 100 
i i Bioporter reagent 
was Heat-inactivated PKCô 
• Active PKCô 
i i Bioporter reagent 
Raw Heat-inactivated PKCô 
• Active PKCô 
Figure 3: Alteration of mitochondrial membrane potential (À^m), cytochrome c 
release and caspase-9 activation following delivery of active PKCÔ protein in PC12 
cells. 
PC12V4 cells were subcultured on 24-well culture plate at a density of 1-2 x 106 
cells/well. BioPORTER reagent was used to deliver active human recombinant PKCô 
protein (5 ng/well). After 4 hr incubation with BioPORTER reagent with PKCô protein, 
cells were collected, and (A) depolarization of ATm was measured by flow cytometry, 
(B) cytochrome c release was measured by ELISA cytochrome c assay, or (C) caspase-9 
activity was measured using fluorogenic substrate, Ac-LEHD-AMC. Each bar 
represents mean ± SEM for two separate experiments in triplicate. *p<0.05 or 
**p<0.01 compared with reagent-control group or between indicated groups. 
Figure 4: Association of PKCÔ with Bcl-2 during dieldrin or MMT treatment in 
Bcl-2 overexpressed PC 12 cells. 
(A) Bcl-2 overexpressed PC12 (PC12HB2-3) cells (1 x 107 cells) were treated with 
dieldrin (100 or 300 (iM) or MMT (100 or 200 jaM) for 3 hr, and cytoplasmic (cytosolic 
+ mitochondrial) fractions were collected. Samples (500 pg/ml) were 
immunoprecipitated with PKCô, and immunoblotted with Bcl-2 (26 kDa), caspase-3 (32 
kDa) and caspase-9 (30 kDa). (B) Vector-transfected PC12 (PC12V4) cells (1 x 107 
cells) were treated with 300 pM dieldrin or 200 jj.M MMT for 3 hr, and cytoplasmic 
fractions were collected. Samples (500 pg/ml) were immunoprecipited with PKCô and 
immunoblotted with Bcl-2 (26 kDa). 1 p,g human recombinant Bcl-2 protein was also 
loaded as a positive control. (C) Cytoplasmic samples (500 pg/ml) were now 
immunoprecipitated with Bcl-2 and immunoblotted with PKCô to confirm the specificity 
of association between Bcl-2 and PKCô. (D) PKCô was immunoprecipitated from cell 
extract and incubated in the presence of human recombinant Bcl-2 protein (3 jj.g) and 
32P-ATP for 10 min at 30 °C without (lane 1) or with (lane 2) 10 pM rottlerin. 
Negative control (lane 3) contains only human recombinant Bcl-2 protein and 32P-ATP. 
Bar graph represents the relative intensity of phosphorylated Bcl-2 expressed as percent 
of negative control. 
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Figure 5: Dieldrin- or MMT-induced proteolytic cleavage of Bcl-2 in Bcl-2 
overexpressed PC 12 cells. 
(A) Human Bcl-2 amino acid sequence is shown. Amino acid sequence at 31-34 
(DAGD) could be a possible tetrapeptide for caspase-3 cleavage. Also, gray letters (S 
and T) indicate possible amino acid for phosphorylation by PKCÔ. (B) Bcl-2 
overexpressed PC12 (PC12HB2-3) cells (1 x 107 cells) were treated with dieldrin (100 
or 300 pM) or MMT (100 or 200 pM) for 3 hr, and whole cell lysates were collected. 
Approximately 3 mg proteins were loaded to each lane and resolved in 15% SDS-PAGE. 
26 kDa native Bcl-2 and its cleaved fragment (approximately 23 kDa) were detected in 
dose-dependent manner. (C and D) Bcl-2 overexpressed PC12 (PC12HB2-3) cells (1 x 
107 cells) were pretreated with 5-10 pM rottlerin or 50-100 pM Z-DEVD-FMK for 30 
min, then treated with 200 pM MMT (C) or 300 pM dieldrin (D) for 3 hr. After the 
treatment period, whole cell lysates were collected. Approximately 3 mg proteins were 
loaded to each lane and resolved in 15% SDS-PAGE. Cleaved Bcl-2 decreased in 
rottlerin- or Z-DEVD-FMK-pretreated PC 12 cells. 
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Figure 6: Proposed mechanism of inactivation of Bcl-2 by PKCÔ and caspase-3 
following dieldrin or MMT treatment in PC 12 cells. 
Based on the present results, we have proposed a possible inactivation processes of 
Bcl-2 anti-apoptotic function by PKCô and caspase-3. (1) PKCô translocates into 
mitochondrial membrane following dieldrin or MMT insults, (2) PKCô is activated and 
phosphorylates Bcl-2, (3) phosphorylated Bcl-2 loses anti-apoptotic function, resulting 
in depolarization of mitochondriam membrane potential, cytochrome c release and 
activation of caspase cascade, and (4) upon activation of caspase-3, phosphorylated 
and/or non-phosphorylated Bcl-2 proteins are further proteolytically cleaved and lose 
anti-apoptotic function. 
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CHAPTER VIII: GENERAL CONCLUSIONS 
The major findings of my research described in this dissertation have already 
been discussed in the Discussion sections of each chapter. The overall conclusions 
derived from these studies and a proposed environmental chemical-induced apoptotic 
cell death mechanism in dopaminergic neurons and its relevance to the pathogenesis of 
Parkinson's disease (PD) will be discussed here. 
Susceptibility of dopaminergic cells to environmental chemical toxicity 
Dopaminergic neurons are among the most vulnerable cells in the brain due to 
their unique biochemical and physiological properties. Although cellular mechanisms 
underlying the 'selective vulnerability' of the substantia nigra have not yet been 
characterized, nigrostriatal dopaminergic neurons appear to be intrinsically vulnerable 
due to their relatively low levels of catalase and cellular GSH (Chance et al., 1979; Perry 
et al., 1982; Percy, 1984; Jenner, 1998). Furthermore, this brain region possesses high 
concentrations of pro-oxidant metal iron and serves as a 'sink' for accumulation of many 
transition metals due to high levels of iron binding protein (Riederer et al., 1989). 
Furthermore, the presence of dopamine and its metabolic system (MAO-B) contribute to 
the generation of oxidative stress in dopaminergic neurons. Thus, oxidative stress may 
play an initial role in triggering dopaminergic neurodegeneration and pathogenesis of PD. 
We first determined whether dopamine and oxidative stress play major roles in 
environmental chemical-induced apoptosis. We demonstrated that dopaminergic PC 12 
cells were more susceptible to acute dieldrin or MMT as compared to non-dopaminergic 
cells, such as cerebellar granule cells, striatal GABAergic (M213-20) cells, human 
cortical neuronal (HCN-2) cells, and mouse pancreatic a-endocrine (a-TC) cells. In 
addition, rat mesencephalic dopaminergic neuronal (IRB3AN27 or N27) cells were more 
susceptible to dieldrin and MMT than dopaminergic PC 12 cells (unpublished 
observation). These results support our hypothesis that dopaminergic cells are more 
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vulnerable to environmental insults than non-dopaminergic cells. Next, we examined 
the cellular mechanisms underlying the environmental chemical-induced dopaminergic 
degenerative process in detail. 
To understand the mechanisms behind the enhanced susceptibility, we focused 
on the neurochemicals present in dopaminergic cells, dopamine and its metabolites. 
Dopamine is one of the most unstable chemicals in nature, and it is readily oxidized in 
oxygen-rich environments to form highly reactive dopamine quinones (Graham, 1984; 
Stokes et al., 1999). Also, during normal catabolic processes, dopamine generates 
hydrogen peroxide (H2O2) as a byproduct through MAO-B reaction when it is 
catabolized to DOPAC, the major breakdown metabolite of dopamine. Both dieldrin 
and MMT significantly increased dopamine release and catabolism resulting in DOPAC 
formation, strongly suggesting that more ROS was generated. The resulting ROS 
oxidizes vesicle-free dopamine to exacerbate oxidative stress. To confirm whether the 
presence of dopamine and/or the alteration of dopamine catabolism contributed to 
generation of ROS following dieldrin- or MMT-treatment in PC 12 cells, we depleted the 
dopamine content with the tyrosine hydroxylase inhibitor cc-methyl-p-tyrosine (a-MPT) 
or inhibited MAO-B activity with selegiline (Deprenyl®) and measured ROS generation 
during dieldrin or MMT toxicity. ROS generation was significantly blocked by these 
pretreatments, and surprisingly, downstream caspase-3 activity and DNA fragmentation 
were also significantly attenuated. The same effect was observed following 
pretreatment with antioxidants (MnTBAP, SOD, or trolox). Our results strongly 
suggest that environmental chemicals (dieldrin and MMT) induce oxidative stress by 
altering the dopamine system, and the subsequent elevation of cellular oxidative stress 
triggers the caspase cascade in dopaminergic cells. These findings explain why 
dopaminergic cells are more susceptible to toxicants and generate more ROS than 
non-dopaminergic cells. 
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Dieldrin, MMT, and manganese as mitochondrial toxicants 
Dieldrin, MMT, and manganese have been reported to block mitochondrial 
oxidative phosphorylation by inhibiting electron transport complexes (Bergen, 1971; 
Autissier et al., 1977; Gavin et al., 1992; Galvani et al., 1995). MPTP is a well-known 
chemical that induces PD-like syndromes in humans and other mammals and inhibits 
mitochondrial Complex I activity. MPP+, an active metabolite of MPTP, selectively 
enters dopaminergic cells/neurons via the dopamine transporter (DAT) because of its 
similar structure to dopamine. Thus, MPTP is selectively and potently toxic to 
dopaminergic cells but not other cells or neurons. It is not known if dieldrin and MMT 
are selectively toxic to dopaminergic cells. Dieldrin blocks at or near the Complex III 
or cytochrome b, and MMT and manganese interact with and inhibit the Complex I 
activity as well as aconitase and succinate dehydrogenase activities (Zheng et al., 1998; 
Malecki, 2001). The exact mechanisms by which these chemicals act on specific sites 
of mitochondrial complexes remain unclear. However, in the case of MMT, the 
manganese ion component of MMT may be specifically responsible for altering the 
electronic configuration of the carbonyl groups to promote association with complex I. 
Additionally, MMT not only interferes with NAD+-linked substrate energy transfer but 
also interferes with electron donation to ubiquinone, resulting in decreased oxidative 
phosphorylation (Autissier et al., 1977). Although dieldrin, MMT, and manganese are 
potent mitochondrial toxicants and may act via similar mechanisms as MPTP in side the 
dopaminergic cells, the role of these chemicals in the activation of apoptosis and the 
development of PD is not yet understood . 
In the present study, we observed the depolarization of mitochondrial 
membrane potential (AYm) following treatments with these toxicants. When 
mitochondrial electron transport is blocked, electron carriers such as NADH and FADH2 
cannot pass electrons and the ratio of oxidized and reduced forms of these electron 
carriers are altered. As a result, cells shift their energy production from an aerobic to 
an anaerobic pathway to consume oxidized NADH or FADH2 and to produce energy for 
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survival. Simultaneously, oxygen consumption is reduced in cells due to impaired 
mitochondrial function, and mitochondria initiate mitochondrial transition pore (MTP) 
opening to uncouple the proton gradient and compensate for the use of oxygen 
molecules (Skulachev, 1996; Cassarino et al., 1999). These changes eventually cause 
mitochondria to swell and depolarize the transmembrane potential. The depolarization 
of A^Fm observed in our studies further suggests that dieldrin, MMT, and manganese are 
mitochondrial toxicants and inhibit mitochondrial complexes. 
MTP opening not only causes a loss of AxFm but also induces the release of 
mitochondrial proteins into cytosol. Mitochondria contain several critical pro-apoptotic 
as well as anti-apoptotic proteins (Kroemer, 1999; Desagher and Martinou, 2000) and 
therefore, are considered one of the most important organelles regulating cell survival 
and death. The major pro-apoptotic proteins found in mitochondria are cytochrome c, 
apoptosis activating factor-1 (Apaf-1), Smac/DIABLO, AIF, and caspase-9 (Shi, 2001). 
We showed a significantly increased release of cytochrome c into cytosol following 
depolarization of A^m. Furthermore, cytochrome c release was blocked by 
overexpression of the anti-apoptotic mitochondrial protein Bcl-2, indicating that dieldrin, 
MMT, and manganese do not release cytochrome c by simply disrupting the 
mitochondrial membrane. Rather, mitochondria are functionally changed and MTP 
opens to release pro-apoptotic proteins. Released cytochrome c along with Apaf-1 and 
ATP activate caspase-9 (Cain et al., 2002). As a result, downstream effector caspases 
including caspase-3, -6, and -7 are proteolytically cleaved and activated. Also, Smac 
interacts with inhibitor of apoptosis protein (IAP) to further enhance caspase activity. 
A dramatic activation of caspase-3 was observed in cells treated with these three 
chemicals, indicating these dopaminergic neurotoxins are potent inducers of apoptosis. 
In addition, the acute studies with dieldrin and MMT revealed the rapid increase 
in reactive oxygen species (ROS) within a few minutes of exposures. Mitochondria 
may be an additional source of ROS generation, especially when their normal 
physiological function is disrupted (Beal et al., 1993; Kowaltowski et al., 2001). The 
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mitochondrion is the major organelle utilizing oxygen molecules, accounting for more 
than 90% of the total cellular oxygen consumption, and impairment of mitochondrial 
function results in increased levels of unconsumed oxygen molecules. The 
significantly increased levels of superoxide anion (O2™) observed, possibly derived 
directly from oxygen molecules following dieldrin or MMT exposure, may have resulted 
from impaired mitochondrial function. Bcl-2 overexpressed PC 12 cells generated 
significantly reduced levels of ROS and had preserved AYm, indicating mitochondrial 
protection. 
Taken together, the primary target of dieldrin, MMT, and manganese is possibly 
the mitochondrion and the dysfunction of mitochondrial activity results in the generation 
of ROS and initiation of the mitochondrial-mediated caspase-dependent apoptotic 
pathway. Further studies are needed to verify the effect of these neurotoxic agents in 
isolated mitochondria. 
Caspase-dependent apoptosis and significance of PKCô proteolytic cleavage on 
apoptotic execution 
In neuronal apoptosis, downstream effectors of caspase-3 that contribute to 
apoptotic cell death are not well characterized. The present study identified PKCô as a 
key effector molecule during neurotoxic insult in dopaminergic cells. The exact 
physiological roles of PKCô in neurons are not well understood yet. PKCô has been 
reported to play an important role in cell proliferation and differentiation in early 
developmental stages in non-neuronal cells (Gschwendt, 1999). PKCô was recently 
found to be involved in apoptotic cell death in various non-neuronal models. 
PKC family proteins are classified into three subfamilies: conventional PKC 
(cPKC), novel PKC (nPKC), and atypical PKC (aPKC). The activation process and 
physiological function of each subfamily is different. Intracellular calcium elevation is 
important for the activation of cPKCs, and their physiological functions are stimulation, 
synthesis, and secretion of certain hormones for digestion (Kawakita et al., 1995). Also, 
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some cPKCs (PKCa) play critical roles in apoptosis, mainly to prevent apoptosis and 
rescue cells (Deng et al., 2000; Ruvolo, 2001). On the other hand, nPKC does not 
require intracellular calcium elevation for activation but is activated through activation 
of PLC and formation of DAG in the plasma membrane. Recently, nPKCs were 
identified as substrates for caspase-3 during apoptosis (Shao et al., 1997; Reyland et al., 
1999; Cross et al., 2000). As shown in the present study, proteolytic cleavage and 
activation of PKCô occurs following caspase-3 activation after dieldrin, MMT, and 
manganese treatments in dopaminergic cells. Caspase-3-like-protease-mediated PKCÔ 
cleavage has also been reported in non-neuronal cells (Emoto et al., 1995; Reyland et al., 
1999). Once PKCô is proteolytically cleaved into the regulatory and catalytic subunits, 
the kinase of the catalytic subunit remains persistently active, as demonstrated in the 
present study. 
PKCÔ may phosphorylate other apoptosis-related molecules and facilitate the 
execution process of apoptosis. Phosphorylation and dephosphorylation act as a 
biological switch controlling physiological functions of enzymes and other molecules. 
Thus, PKCô is speculated to modulate pro- and/or anti-apoptotic molecules upon 
activation by caspase-3. The target substrate of PKCô responsible for promoting DNA 
fragmentation has not yet been identified. The results in this dissertation demonstrate 
that DNA fragmentation is significantly attenuated by the PKCô specific inhibitor 
rottlerin and in PKCô mutant overexpressed cells following dieldrin, MMT, or 
manganese exposures. Thus, PKCô may directly or indirectly regulate the activity of 
other key molecules involved in DNA fragmentation. Considering the abundance of 
PKCô in neuronal cells and the heightened susceptibility of dopaminergic cells to 
environmental toxins, xenobiotics may play an important role in the pathogenesis of PD. 
During apoptosis, caspase-dependent DNase (CAD) causes DNA fragmentation by 
translocating into the nucleus to cleave DNA into small base pairs (Kom et al., 2002). 
PKCô was recently reported to translocate into the nucleus during apoptosis and 
subsequently phosphorylate transcription factors to promote apoptosis (Cross et al., 
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2000). Though not proven, PKCô may phosphorylate activated CAD and potentiate its 
activity as a possible mechanism of regulating DNA fragmentation. However, the 
present study also demonstrates an alternative regulatory role of PKCô during apoptosis 
and DNA fragmentation: PKCô's feedback mechanism in the caspase cascade. 
Role of PKCô in feedback activation of the caspase cascade 
Several lines of evidence suggest that PKCô regulates upstream apoptotic 
events upon activation. Pharmacological or genetic inhibition of PKCô results in 
decreased caspase-3 activity and the subsequent attenuation of DNA fragmentation 
(Reyland et al., 1999; Reyland et al., 2000; Anantharam et al., 2002). Two possible 
mechanisms of PKCô pro-apoptotic effects on upstream events are proposed. First, 
PKCô may phosphorylate upstream pro-apoptotic molecules and modulate caspase-3 
activity directly or indirectly. Our data showed that PKCô associated with caspase-3 
following dieldrin or MMT treatment, and caspase-3 may be one of the substrates for 
PKCô, and upon phosphorylation by PKCô, caspase-3 protease may be enhanced.. 
Caspase-9 is regulated through phosphorylation by Akt (Cardone et al., 1998); likewise, 
caspase-3 activity may be modulated by phosphorylation. PKCô translocates into the 
mitochondrial membrane following TPA and H2O2 treatments, and this translocation 
process is essential for cytochrome c release and activation of the apoptotic mechanism 
(Li et al., 1999; Majumder et al., 2000). Inactive PKCô overexpressed cells failed to 
release cytochrome c into cytosol following chemical stimulation, strongly suggesting 
that PKCô strictly regulates the initiation process of apoptosis. Furthermore, PKCô 
functions not downstream, but upstream to initiate apoptosis. Yet, the exact mechanism 
by which PKCô regulates the release of cytochrome c from mitochondria is not well 
known. 
In the present study, we also observed early translocation of PKCô into 
mitochondrial membranes to promote cytochrome c and Smac release into cytosol. An 
immunoprecipitation study revealed that PKCô associates with Bcl-2, an anti-apoptotic 
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Bcl-2 family protein. Bcl-2 is a highly important molecule associated with PKCô 
because Bcl-2 as well as Bad are regulated by phosphorylation and dephosphorylation. 
Mitogen activated protein (MAP) kinase phosphorylates Bad. Phosphorylated Bad 
then associates with the chaperone protein 14-3-3, resulting in the inactivation of its 
pro-apoptotic function by its movement into cytosol (Masters et al., 2001; Masters et al., 
2002). On the other hand, Bcl-2 is inactivated upon phosphorylation, yet the kinases 
responsible for Bcl-2 inactivation have not been identified (Haldar et al., 1995; Tashiro 
et al., 1998; Fan et al., 2000; Torcia et al., 2001). 
In the present study, in vitro delivery of recombinant active PKCô into PC 12 
cells results in the release of cytochrome c, activation of caspase-9 and caspase-3, and 
subsequent increase in DNA fragmentation. Furthermore, dieldrin promotes 
translocation of native PKCô into the mitochondrial membrane, independent of 
caspase-3 activity. Cytochrome c release was attenuated in cells treated with low-dose 
(200 nM) TPA treatment to down-regulate PKC (Bjaaland et al., 1988; Morino et al., 
2001) and in inactive PKCô overexpressed dopaminergic cells following dieldrin 
treatment. Thus, translocation of native PKCô into the mitochondrial membrane is 
important to induce the subsequent cytochrome c release as an initiation step of 
apoptotic cell death. However, current evidence suggests phosphorylation of Bcl-2 by 
PKCô and proteolytic cleavage of Bcl-2 by caspase-3, leading to inactivation of Bcl-2 
and promotion of apoptosis. Further studies are required to better understand the 
regulatory mechanism of PKCô in mitochondria during apoptosis. 
In summary, we identified the major apoptotic cell death mechanism following 
exposure to environmental chemicals (Figure 14). During the initial phase, 
dopaminergic cell responses to dieldrin or MMT may differ in terms of its sensitivity, 
but not in terms of neurotoxic mechanisms. Dopamine release is promoted, and 
DOPAC formation is increased, resulting in increased generation of oxidative radicals 
intracellular!^ which triggers mitochondrial dysfunction. Dieldrin and MMT may act 
directly on mitochondria and inhibit oxidative phosphorylation, leading to depolarization 
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of mitochondrial membrane potential and dysfunction. Additionally, dieldrin and 
MMT promote translocation of PKCô into mitochondria by an unknown mechanism, 
and translocated PKCô phosphorylates Bcl-2 to inactivate its anti-apoptotic function. 
These initial processes facilitate the release of pro-apoptotic molecules including 
cytochrome c and Smac into cytosol. Once cytochrome c and/or Smac are released, the 
caspase cascade is activated via Apaf-1. Caspase-9 activation by Apaf-1/cytochrome c 
complex (apoptosome) is followed by caspase-3 activation. Activated caspase-3 
proteolytically cleaves its substrates including PKCô, which plays a critical role in both 
upstream and downstream steps in the apoptotic pathway. PKCÔ induces DNA 
fragmentation and cells undergo apoptotic cell death. Activated PKCô also associates 
with caspase-3 and possibly enhances enzymatic caspase-3 activity by phosphorylation. 
In addition, caspase-3 proteolytically cleaved Bcl-2 further potentiates the apoptotic 
cascade. Although some evidence indicates that PKCô translocates into mitochondria 
after proteolytic cleavage, the involvement of the cleaved fragment in mitochondria in 
modulating mitochondrial function is not clear. Inhibitor studies further confirmed the 
proposed apoptotic pathway. Tyrosine hydroxylase (TH) and MAO-B inhibitors 
significantly reduce dieldrin- or MMT-induced ROS generation, caspase-3 activity, and 
DNA fragmentation, indicating dopamine plays an important role in this pathway. 
Antioxidants and Bcl-2 over-expression inhibit cytochrome c release, and caspase 
inhibitors almost completely suppress downstream apoptotic events. PKCô inhibition 
blocks not only DNA fragmentation, but also cytochrome c release, supporting the dual 
role of PKCô in both downstream and upstream processes. Finally, both PKCô and 
caspase-3 inhibitors inhibit inactivation of Bcl-2. 
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Figure 14: Integrated Cell Death Pathway Induced by Environmental 
Chemicals 
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Relevance of environmental chemical exposure to Parkinson's disease 
From the present study, these environmental chemicals induce a common cell 
death mechanism in dopaminergic cells. The enhanced susceptibility of dopaminergic 
cells to these environmental chemicals due to the presence of dopamine may support but 
not prove the causality of environmental factors in PD. Furthermore, dopaminergic 
neurons in the SNc seem to be more susceptible to oxidative insults due to their 
insufficient antioxidant defense mechanisms. Cellular GSH levels in the SNc are lower 
than in other brain regions. Also, dopamine degradation and oxidation result in extra 
sources of oxidative stress, such as H2O2 and dopamine quinones. In general, catalase 
activity is significantly low in the brain, whereas SOD activity is high. This 
imbalanced ROS scavenging activity further results in the accumulation of H2O2 in 
neurons. Thus, exposure to certain environmental chemicals that alter dopamine 
catabolism and/or cause oxidative insults may facilitate dopaminergic neurodegeneration. 
Recent histological studies in human PD cases demonstrating oxidative markers, 
caspase-3, PKCs, and apoptosis in Lewy bodies, a hallmark of PD pathology, support 
our finding that oxidative stress and apoptosis are critical in dopaminergic degeneration. 
Also, results from post-mortem and case-control studies indicate that environmental 
chemicals are positively associated with the pathogenesis of PD. Dieldrin, especially, 
was significantly high in PD brains. Manganese induces the Parkinson-like syndrome 
known as Manganism following chronic exposure. Though the current evidence is 
incomplete, MMT may be a potential risk factor because it is structurally similar to 
dieldrin's cyclodiene moiety, as it contains manganese in its structure. Current 
evidence partially supports the positive association with PD by means of the cell death 
signaling mechanisms induced by these chemicals in dopaminergic cells. However, 
chronic toxicological studies and cell/molecular biological evidence supporting the 
association are needed to establish a more solid conclusion about the potential risk of 
chemicals in PD pathogenesis. Future intensive investigations will provide insight into 
the molecular mechanism of dopaminergic degeneration and etiopathogenesis of PD. 
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